INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Floxepci 400mg 10 f.c. tab', 19161, 'فلوكسيبسي 400مجم 10 اقراص', '176', '120', 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Moxifloxacin', 'Egpi > globe international pharmaceuticals', 'Tab', 'أقراص', '400mg', '2', 'مضاد حيوي', NULL, NULL, '6224008365464', 4616, '2024-07-02', NULL, 0, 'For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).', 'The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.', 'Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: _Corynebacterium_ species, _Micrococcus luteus_, _Staphylococcus aureus_, _Staphylococcus epidermidis_, _Staphylococcus haemolyticus_, _Staphylococcus hominis_, _Staphylococcus warneri_, _Streptococcus pneumoniae_, and _Streptococcus viridans_ group. Aerobic Gram-negative microorganisms: _Acinetobacter lwoffii_, _Haemophilus influenzae_, and _Haemophilus parainfluenzae_. Other microorganisms: _Chlamydia trachomatis_. Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Soft lax massage cream 60 gm', 8822, 'سوفت لاكس مساج كريم 60 جم', '70', '55', 'Massage cream', 'Massage cream', NULL, 'Camphor oil+menthol crystals', 'Aglan pharma', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, NULL, NULL, 805, '2024-12-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fortiferrum 14 sachets', 30562, 'فورتيفيروم 14 كيس', '255', '195', 'Iron supplement', 'Iron supplement', NULL, 'Iron+vitamin c', 'A.e.i. 24 > splendid pharma', 'Sachet', 'أكياس', NULL, '1', 'مكمل غذائى لعلاج حالات الانيميا ودعم الجهاز المناعى وامداد الجسم بالطاقة', NULL, 'it is a liposomal iron supplement with high absorption and bioavailability. fortiferrumï¿½+ has a pleasant strawberry flavor and it is taken orally cutting the sachet at the opening end and consuming product directly. for people with difficulty swallowing', '8437016502228', 13662, '2024-10-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Max filler cream', 5612, 'ماكس فيلر كريم لنفخ الخدود والشفاه', '401', NULL, NULL, NULL, NULL, NULL, 'Company', 'Cream', 'كريم', NULL, '1', NULL, NULL, NULL, '9016000411303', 819, '2022-12-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Isoprinosine 60ml syrup', 21015, 'ايزوبرينوزين 60 مل شراب', '27', '13.2', 'Antiviral', 'Antiviral', NULL, 'Isoprinosine', 'Mup > new port-ireland', 'Syrup', 'شراب', '60ml', '1', NULL, NULL, 'indications / uses : chickenpox mumps rhinovirus influenza a measles encephalitis herpes zoster herpes simplex labialis hepatitis a acute viral b hepatitis herpes genitalis. immunorestoration in individuals suffering from pre-aids/persistent generalized l', '6221508060714', 2443, '2023-09-07', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Distocide 600mg 4 f.c.tab.', 17726, 'ديستوسيد 600 مجم 4 أقراص', '11', NULL, 'Anthelmintic', 'Anthelmintic', NULL, 'Praziquantel', 'Eipico > shin pong-korea', 'Tab', 'أقراص', '600mg', '1', NULL, NULL, 'about praziquantel anthelmintic a trematodicide. mechanism of action of praziquantel it is a broad spectrum anthelminthic against trematodes & cestodes and their larval forms. the drug exerts its action by producing strong muscular contractions which lead', '6221032111425', 1258, '2022-12-04', NULL, 0, 'Praziquantel is indicated in patients aged 1 year and older for the treatment of the schistosomiasis due to all species of Schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium) and clonorchiasis and opisthorchiasis due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini (approval of this indication was based on studies in which the two species were not differentiated).[L50021]', 'Although the exact mechanism of action is unknown, praziquantel was hypothesized to target the β subunits of voltage-gated Ca<sub>2+</sub> channels, particularly in Schistosoma mansoni and Schistosoma japonicum, due to the lack of two conserved serine residues in these subunits. This is supported by the finding that co-administration of calcium channel blockers like nicarpidine and nifedipine renders 50% of Schistosoma mansoni resistant to praziquantel.[L50021,A1664]



Increased exposure of antigens on the worm surface was also observed, but little research has been done to elucidate on the mechanism of action.[A1664]', 'In vitro studies on trematodes and cestodes have shown that praziquantel induces a rapid contraction of schistosomas by a specific effect on the permeability of the cell membrane. The drug further causes vacuolization and disintegration of the schistosome tegument. The effect is more marked on adult worms compared to young worms. An increased Ca2<sup>+</sup>-influx may play an important role.[L40268]



Secondary effects are inhibition of glucose uptake, lowering of glycogen levels and stimulation of lactate release. The action of praziquantel is specific to trematodes and cestodes; nematodes (including filariae) are not affected.[L40268]



Praziquantel is active against schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium), and infections due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini. Published in vitro data have shown a potential lack of efficacy of praziquantel against migrating schistosomulae.[L50021]



An interesting quirk of praziquantel is that it is relatively ineffective against juvenile schistosomes. While initially effective, effectiveness against schistosomes decreases until it reaches a minimum at 3-4 weeks. Effectiveness then increases again until it is once again fully effective at 6-7 weeks.[A1664]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neuroeba original 30 tablet', 3132, 'نيوريويبا الأصلي 30 قرص', '140', '120', 'Multivitamin+ b complex+folic acid+ vitamin d3', 'Multivitamin+ b complex+folic acid+ vitamin d3', NULL, 'Benfotiamine vit b1+b2+b6+methylcobalamin vit b12 vitamin d3+folic acid', 'Obaid pharma company', 'Tablet', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1076, '2025-04-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neuth dna sun protection lotion spf 50+ - 100 ml', 23494, 'نيوث للحماية من الشمس لوشن بمعامل حماية 50 100مل', '285', NULL, 'Sun block', 'Sun block', NULL, NULL, 'Neuth > eva pharma', 'Lotion', 'لوشن', '100 ml', '1', NULL, NULL, 'neuth dna sun protection system is a complete system of protection that provides broad spectrum protection against uva & uvb rays. in addition tit stimulates the skins natural defense mechanisms to counteract any damage. directions apply a generous amount', NULL, 858, '2022-07-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bilino oral drops 15 ml', 4126, 'بيلينو نقط فم 15 مل', '78', '69', 'Laxative', 'Laxative', NULL, 'Agar', 'Ibm pharma', 'Drops', 'نقط', '15 ml', '1', 'ملين ومنظم لحركة الامعاء', NULL, NULL, '6224011371100', 1814, '2025-07-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nodilase 30 tabs', 7401, 'نوديليز 30 قرص', '185', NULL, 'Anti-inflammatory', 'Anti-inflammatory', NULL, 'Alpha amylase', 'Nutrillion international for pharmaceutical and food supplement', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 800, '2025-09-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sensicare cream 50 gm', 10320, 'سينسيكير كريم 50 جم', '98', '85', 'Topical care', 'Topical care', NULL, 'Propolis+panthenol+soya protein+chamomile', 'Leader cosmetics > original pharma group', 'Cream', 'كريم', '50 gm', '1', 'يستخدم بشكل موضعي لتحسين شكل وملمس الجلد كي يعود لملمسه الطبيعي', NULL, 'for normal skin structure', NULL, 1322, '2025-02-10', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cardiocare 2.5mg 60 s.r. capsules', 15842, 'كارديوكير 2.5مجم 60 كبسولة', '15', NULL, 'Anti-ischemic', 'Anti-ischemic', NULL, 'Nitroglycerin', 'Arab caps > acdima international trading', 'Capsule', 'كبسولة', '2.5mg', '1', 'للذبحة الصدرية', NULL, NULL, NULL, 11330, '2023-02-02', NULL, 0, 'Sublingual nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.[L7102,L38369,L42320] Transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease.[L7141]



Intravenous nitroglycerin is indicated for the treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta (β)-blockers; and for induction of intraoperative hypotension.[L7099] 



Topical nitroglycerin ointment is used to treat moderate to severe pain associated with chronic anal fissure.[L42445]', 'Nitroglycerin is converted by mitochondrial aldehyde dehydrogenase in smooth muscle cells to nitric oxide (NO), a potent vasodilator. NO activates the enzyme guanylate cyclase, which converts guanosine triphosphate (GTP) to cyclic guanosine 3'',5''-monophosphate (cGMP) in vascular smooth muscle and other tissues.[A180166,A180169,A249970] cGMP is an endogenous vasodilator of vascular smooth muscle:[A180172] it causes protein kinase-dependent phosphorylation and activates downstream cascades that promote relaxation and increased blood flow in veins, arteries and cardiac tissue.[A180172,A249970] An _in vitro_ study using mouse aorta suggests that nitric oxide, an active metabolite of nitroglycerin, targets the natriuretic peptide receptors.[A5526] ', 'Nitroglycerin causes the relaxation of vascular smooth muscles, causing arteriolar and venous dilatation.[L38369] It increases blood flow to the myocardium and reduces cardiac preload and afterload, decreasing myocardial wall stress and ameliorating anginal symptoms.[A180172,A249970,L7102] Nitroglycerin also reduces coronary artery spasm, decreasing systemic vascular resistance as well as systolic and diastolic blood pressure.[L38369]



Like other organic nitrates, repeated and prolonged administration of nitroglycerin can lead to the development of tolerance or desensitization of vascular smooth muscle to further nitroglycerin-induced vasorelaxation. This loss of efficacy may be associated with the inhibition of mitochondrial aldehyde dehydrogenase, which is an important enzyme involved in the bioactivation of nitroglycerin.[A180166,A180169,A180172] Nitroglycerin tolerance may be accompanied by pro-oxidant effects, endothelial dysfunction, and increased sensitivity to vasoconstrictors.[A180172]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Superkids 2 in 1 (shampoo & conditioner) 300 ml', 33714, 'سوبركيدز 2 في 1 شامبو وبلسم 300 مل', '190', '135', 'Hair care', 'Hair care', NULL, NULL, 'Parkville', 'Amp', 'أمبول', '300 ml', '1', NULL, NULL, NULL, NULL, 589, '2024-05-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Callife mix 30 tabs.', 32178, 'كالايف ميكس 30 قرص', '81', NULL, 'Calcium supplement', 'Calcium supplement', NULL, 'Calcium+magnesium+vitamin d', 'Organics > torrent pharma', 'Tab', 'أقراص', NULL, '3', 'مكمل غذائى لدعم صحة العظام والوقاية من الكساح وهشاشة العظام', NULL, NULL, NULL, 621, '2023-04-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Insulinagypt n 100 i.u./ml (4ml) vial', 20869, 'انسوليناجيبت ان 100 وحدة/مل 4 مل فيال', '26', NULL, 'Anti-diabetic.insulin analouge', 'Anti-diabetic.insulin analouge', NULL, 'Insulin isophane protamine human', 'Mup', 'Vial', 'فيال', '4ml', '1', 'علاج مرض ارتفاع السكر بالدم', NULL, 'about insulin isophane nph pancreatic hormone intermediate-acting insulin analogue antidiabetic agent. mechanism of action of insulin isophane nph it is an intermediate acting antihyperglycaemic drug. insulin acts through binding to a subunit of insulin r', NULL, 1140, '2022-07-13', NULL, 0, 'Human insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus.', 'The primary activity of insulin is the regulation of glucose metabolism. Insulin promotes glucose and amino acid uptake into muscle and adipose tissues, and other tissues except brain and liver. It also has an anabolic role in stimulating glycogen, fatty acid, and protein synthesis. Insulin inhibits gluconeogenesis in the liver.

Insulin binds to the insulin receptor (IR), a heterotetrameric protein consisting of two extracellular alpha units and two transmembrane beta units. The binding of insulin to the alpha subunit of IR stimulates the tyrosine kinase activity intrinsic to the beta subunit of the receptor. The bound receptor is able to autophosphorylate and phosphorylate numerous intracellular substrates such as insulin receptor substrates (IRS) proteins, Cbl, APS, Shc and Gab 1. These activated proteins, in turn, lead to the activation of downstream signaling molecules including PI3 kinase and Akt. Akt regulates the activity of glucose transporter 4 (GLUT4) and protein kinase C (PKC) which play a critical role in metabolism and catabolism.', 'Insulin is a natural hormone produced by beta cells of the pancreas. In non-diabetic individuals, a basal level of insulin is supplemented with insulin spikes following meals. Postprandial insulin spikes are responsible for the metabolic changes that occur as the body transitions from a postabsorptive to absorptive state. Insulin promotes cellular uptake of glucose, particularly in muscle and adipose tissues, promotes energy storage via glycogenesis, opposes catabolism of energy stores, increases DNA replication and protein synthesis by stimulating amino acid uptake by liver, muscle and adipose tissue, and modifies the activity of numerous enzymes involved in glycogen synthesis and glycolysis. Insulin also promotes growth and is required for the actions of growth hormone (e.g. protein synthesis, cell division, DNA synthesis). ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Plenamase 30 capsule', 3213, 'بلينميز 30 كبسولة', '150', NULL, 'Diet', 'Diet', NULL, 'Fibers(fructooligosacchrides+inulin+konjack glucomannan+psyllium husk)+chitosan', 'Spirit pharm', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 1030, '2025-03-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Youth-elixir vitamin c facial serum 30 ml', 773, 'يوث اليكسير فيتامين سي سيروم للوجه 30 مل', '300', '200', 'Skin care', 'Skin care', NULL, 'Liposomal vitaminc+niacinamide+retinyl palmitate+collagen+acerola extract+propolis extract+vitamin e', 'Orchidia pharmaceutical industries', 'Serum', 'سيروم', '30 ml', '1', NULL, NULL, NULL, NULL, 842, '2025-03-09', NULL, 0, 'Investigated for use/treatment in neuropathy (diabetic) and peripheral vascular disease.', 'The encapsulated formulation (Liprostin) has been shown to improve the therapeutic index of PGE-1, positively impacting many areas of treatment, such as heart attacks, occlusive disease, ischemic ulcers, critical limb salvage, claudicants, and arthritis.', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Rego hair lotion 250 ml', 25807, 'ريجو لوشن 250مل', '180', NULL, 'Hair care', 'Hair care', NULL, 'Dimethicone+emu oil+tea tree oil+sage leaves extract+aloe vera extract+eruca leaves extract+jojoba o', 'Macro group pharmaceuticals', 'Lotion', 'لوشن', '250 ml', '1', NULL, NULL, '- hair follicle & scalp toner for intensive care for all hair types - provides hair with essential nutrients elements and vitamins needed for activation of hair follicle. - has anti- oxidant effect of rose mary extract that prevents oxidative stress & pre', NULL, 627, '2022-08-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('U-richi carbamide cream 50 gm', 5800, 'يو ريتشي كارباميد كريم 50 جم', '50', '50', 'Skin care.moisturizing', 'Skin care.moisturizing', NULL, NULL, 'U-richi', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 792, '2025-07-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Depovit b12-1000mcg/ml 3 i.m. amps.', 16193, 'ديبوفيت ب12 1000مكجم مل 3 امبول عضل', '51', '34.5', 'Vitamin b12', 'Vitamin b12', NULL, 'Hydroxocobalamin', 'Amriya', 'Amp', 'أمبول', '1000mcg', '3', NULL, NULL, NULL, '6221075030905', 2038, '2024-07-23', NULL, 0, 'For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning.', 'Vitamin B12 exists in four major forms referred to collectively as cobalamins; deoxyadenosylcobalamin, methylcobalamin, hydroxocobalamin, and cyanocobalamin. Two of these, methylcobalamin and 5-deoxyadenosyl cobalamin, are primarily used by the body. Methionine synthase needs methylcobalamin as a cofactor. This enzyme is involved in the conversion of the amino acid homocysteine into methionine. Methionine in turn is required for DNA methylation. 5-Deoxyadenosyl cobalamin is a cofactor needed by the enzyme that converts L-methylmalonyl-CoA to succinyl-CoA. This conversion is an important step in the extraction of energy from proteins and fats. Furthermore, succinyl CoA is necessary for the production of hemoglobin, the substances that carries oxygen in red blood cells.', 'Hydroxocobalamin is a synthetic, injectable form of Vitamin B12. Hydroxocobalamin is actually a precursor of two cofactors or vitamins (Vitamin B12 and Methylcobalamin) which are involved in various biological systems in man. Vitamin B12 is required for the conversion of methylmalonate to succinate. Deficiency of this enzyme could therefore interfere with the production of lipoprotein in myelin sheath tissue and so give rise to neurological lesions. The second cofactor, Methylcobalamin, is necessary for the conversion of homocysteine to methionine which is essential for the metabolism of folic acid. Deficiency of tetrahydrafolate leads to reduced synthesis of thymidylate resulting in reduced synthesis of DNA which is essential for cell maturation. Vitamin B12 is also concerned in the maintenance of sulphydryl groups in reduced form, deficiency leading to decreased amounts of reduced SH content of erythrocytes and liver cells. Overall, vitamin B12 acts as a coenzyme for various metabolic functions, including fat and carbohydrate metabolism and protein synthesis. It is necessary for growth, cell replication, hematopoiesis, and nucleoprotein as well as myelin synthesis. This is largely due to its effects on metabolism of methionine folic acid, and malonic acid.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Beevitox 30 caps.', 15041, 'بيفيتوكس 30 كبسولة', '50', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Bee propolis+folic acid+nicotinamide+ascorbic acid+zinc+manganese', 'Mash premiere', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, 'improve general body functions & health. *one capsule daily.', NULL, 909, '2022-08-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Betadine dry powder spray 2.5% 55 gm', 10040, 'بيتادين بودرة جافة سبراي بخاخ 2.5% 55 جم', '220', '123.03', 'Antiseptic', 'Antiseptic', NULL, 'Povidone- iodine', 'El nile. > mundipharma', 'Spray', 'بخاخ', '2.5%', '1', 'مطهر للجروح والحروق والقرح', NULL, 'povidone iodine is effective against bacteria fungi spores viruses and certain protozoa. reliable superficial wound antiseptic as it helps prevent infections. use: spray one to several times daily on the required area until visibly covered with the golden', '5291043000026', 2131, '2024-03-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Genmycin 0.3% cream 15 gm', 19687, 'جينمايسين 0.3% كريم 15 جم', '7', NULL, 'Antibiotic topical', 'Antibiotic topical', NULL, 'Gentamicin', 'Hikma pharma > chemipharm', 'Cream', 'كريم', '0.3%', '1', NULL, NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6222006500542', 814, '2022-12-05', NULL, 0, NULL, 'There are 3 key phases of aminoglycoside entry into cells.[A232294] The first “ionic binding phase” occurs when polycationic aminoglycosides bind electrostatically to negatively charged components of bacterial cell membranes including with lipopolysaccharides and phospholipids within the outer membrane of Gram-negative bacteria and to teichoic acids and phospholipids within the cell membrane of Gram-positive bacteria. This binding results in displacement of divalent cations and increased membrane permeability, allowing for aminoglycoside entry.[A232294, A232304, A232309, A232314]

The second “energy-dependent phase I” of aminoglycoside entry into the cytoplasm relies on the proton-motive force and allows a limited amount of aminoglycoside access to its primary intracellular target - the bacterial 30S ribosome.[A232294, A232314] This ultimately results in the mistranslation of proteins and disruption of the cytoplasmic membrane.[A233320] Finally, in the “energy-dependent phase II” stage, concentration-dependent bacterial killing is observed. Aminoglycoside rapidly accumulates in the cell due to the damaged cytoplasmic membrane, and protein mistranslation and synthesis inhibition is amplified.[A232294, A232314, A232319] The necessity of oxygen-dependent active transport explains why aminoglycosides are ineffective against anaerobic bacteria.[A234130]

Hence, aminoglycosides have both immediate bactericidal effects through membrane disruption and delayed bactericidal effects through impaired protein synthesis; observed experimental data and mathematical modeling support this two-mechanism model.[A232294, A232299]

Inhibition of protein synthesis is a key component of aminoglycoside efficacy. Structural and cell biological studies suggest that aminoglycosides bind to the 16S rRNA in helix 44 (h44), near the A site of the 30S ribosomal subunit, altering interactions between h44 and h45. This binding also displaces two important residues, A1492 and A1493, from h44, mimicking normal conformational changes that occur with successful codon-anticodon pairing in the A site.[A232324, A232329] Overall, aminoglycoside binding has several negative effects including inhibition of translation, initiation, elongation, and ribosome recycling.[A232294, A232334, A232339] Recent evidence suggests that the latter effect is due to a cryptic second binding site situated in h69 of the 23S rRNA of the 50S ribosomal subunit.[A232329, A232339] Also, by stabilizing a conformation that mimics correct codon-anticodon pairing, aminoglycosides promote error-prone translation.[A232344] Mistranslated proteins can incorporate into the cell membrane, inducing the damage discussed above.[A232294, A232319]', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Protek hand sanitizer gel 100 ml', 25416, 'بروتيك محلول لتطهير اليد 100مل', '15', NULL, 'Antiseptic', 'Antiseptic', NULL, 'Ethyl alcohol 96%', 'Mup', 'Gel', 'جل', '100 ml', '1', NULL, NULL, NULL, NULL, 698, '2022-07-23', NULL, 0, 'Investigated for use/treatment in burns and burn infections, cardiac surgery, inflammatory disorders (unspecified), ischemic reperfusion injury, and sepsis and septicemia.', 'CTI-01 inhibits the systemic release of cytokines, such as TNF-alpha and HMGB1, which promote the body''s inflammatory response. The over-expression of these cytokines has been linked to diseases that occur in critical care settings, such as severe organ damage following cardiopulmonary bypass (CPB) and post-operative ileus following abdominal surgery.', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neurotop 400mg 100 tab.', 23477, 'نيوروتوب ريتارد 400 مجم 100 قرص', '450', '162.5', 'Anti-epileptic.carboxamides', 'Anti-epileptic.carboxamides', NULL, 'Carbamazepine', 'Gerot pharma > b.p pharma', 'Tab', 'أقراص', '400mg', '10', NULL, NULL, 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', NULL, 1051, '2024-11-12', NULL, 0, 'Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.[L1335] In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures.[A180301,L1335] Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.[L1335] Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome.[A180415,A180421]', 'Carbamazepine''s mechanism of action is not fully elucidated and is widely debated.[A180310,L9713] One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves.[A180403,T634] In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms.[L7216]



A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes.[A180436] A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation.[A180439]', '**General effects**



Carbamazepine treats seizures and the symptoms of trigeminal neuralgia by inhibiting sodium channels.  In bipolar 1 disorder, carbamazepine has been found to decrease mania symptoms in a clinically significant manner according to the Young Mania Rating Scale (YMRS).[L1335] Carbamazepine has a narrow therapeutic index.[A180301]



**A note on genetic variation and carbamazepine use**



In studies of Han Chinese ancestry patients, a pronounced association between the HLA-B*1502 genotype and Steven Johnson syndrome and/or toxic epidermal necrolysis (SJS/TEN) resulting from carbamazepine use was observed.[A180397]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('X-tension 150mg 28 scored tab.', 29780, 'اكستنشن 150مجم 28 قرص', '100', '72', 'Antihypertensive.angiotensin blocker', 'Antihypertensive.angiotensin blocker', NULL, 'Irbesartan', 'Marcyrl co. > rameda', 'Tab', 'أقراص', '150mg', '4', NULL, NULL, 'about irbesartan angiotensin ii receptor blocker a non-peptide compound antihypertensive. mechanism of action of irbesartan it is a competitive antagonist of angiotensin-2 at at-1 receptor. it decreases peripheral resistance and lowers bp in hypertensive', '6223003973810', 1240, '2024-10-13', NULL, 0, 'Irbesartan is indicated to treat hypertension and diabetic nephropathy in hypertensive patients with type 2 diabetes, elevated serum creatinine, and proteinuria.[L7456] A combination product with hydrochlorothiazide is indicated for hypertension in patients with uncontrolled hypertension with monotherapy or first line in patients not expected to be well controlled with monotherapy.[L7459]', 'Irbesartan prevents angiotensin II binding to the AT<sub>1</sub> receptor in tissues like vascular smooth muscle and the adrenal gland.[L7456,L7459] Irbesartan and its active metabolite bind the AT<sub>1</sub> receptor with 8500 times more affinity than they bind to the AT<sub>2</sub> receptor.[L7456,L7459] Irbesartan''s prevention of angiotensin II binding causes vascular smooth muscle relaxation and prevents the secretion of aldosterone, lowering blood pressure.[L7456,L7459]



Angiotensin II would otherwise bind to the AT<sub>1</sub> receptor, inducing vasoconstriction and aldosterone secretion, raising blood pressure.[L7456,L7459]', 'Irbesartan is an angiotensin receptor blocker used to treat hypertension and diabetic nephropathy.[L7456,L7459] It has a long duration of action as it is usually taken once daily and a wide therapeutic index as doses may be as low as 150mg daily but doses of 900mg/day were well tolerated in healthy human subjects.[L7456,L7459,A181165]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Exforge 10mg/160mg 14 f.c. tab.', 4537, 'اكسفورج 10مجم/160مجم 14 قرص', '218', '146', 'Antihypertensive. combined angiotensin blocker with calcium channel blocker', 'Antihypertensive. combined angiotensin blocker with calcium channel blocker', NULL, 'Amlodipine+valsartan', 'Novartis', 'Tab', 'أقراص', '10mg', '2', 'لمرضى الضغط المرتفع', NULL, 'exforge tablets are formulated in four strengths for oral administration with a combination of amlodipine besylate equivalent to 5 mg or 10 mg of amlodipine free-base with 160 mg or 320 mg of valsartan providing for the following available combinations: 5', '6223002642175', 3404, '2024-10-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Amlostat 10/10 mg 10 f.c. tab.', 13966, 'املوستات 10/10 مجم 10 اقراص', '19', NULL, 'Antihyperlipidemic.statin combined with ca channel blocker', 'Antihyperlipidemic.statin combined with ca channel blocker', NULL, 'Amlodipine+atorvastatin', 'Unipharma co.', 'Tab', 'أقراص', '10 mg', '1', NULL, NULL, 'indications for atorvastatin + amlodipine this is a combination of calcium channel blocker amlodipine and hmg-coa reductase inhibitor atorvastatin. the combination generic is used to treat 1.hypertension 2.angina (that occurs with high cholesterol or trig', NULL, 834, '2022-07-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pedielectro oral rehydration solution 360 ml', 7967, 'بيدي اليكترو محلول معالجة الجفاف 360 مل', '55', NULL, 'Electrolyte solution', 'Electrolyte solution', NULL, 'Potassium+sodium chloride+zinc', 'Elite', 'Solution', 'محلول', '360 ml', '1', NULL, NULL, NULL, NULL, 720, '2025-11-10', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Genteal eye drops 10 ml', 5444, 'جينتيال قطرة عين 10 مل', '18', NULL, 'Eye lubricant', 'Eye lubricant', NULL, 'Hypromellose', 'Novartis > novartis scientific office', 'Drops', 'نقط', '10 ml', '1', NULL, NULL, 'mechanism of action hydroxypropyl cellulose is a derivative of cellulose that is soluble in both water and organic solvents. it is particularly good at trapping water and producing a film that serves as a barrier to water loss. hydroxypropyl cellulose pos', NULL, 1306, '2022-08-15', NULL, 0, 'Used as an ophthalmic protectant and lubricant, in artificial tears, and as a diagnostic aid (contact lens procedures; gonioscopy).[L1805]', 'Promotes corneal wetting by the stabilization and thickening the precorneal tear film and prolonging the tear film breakdown time, which is usually shortened in dry eye conditions. Hypromellose also acts to lubricate and protect the eye [L1809].



The surface active properties of the vehicles found in artificial tears solutions act to stabilize the tear film and increase tear viscosity to prevent delay tear evaporation and delay tear drainage [L1805].



In the intact eye, the corneal surface is moistened primarily by the mucin that is produced in the conjunctiva. Mucin is adsorbed on the corneal surface and forms a hydrophilic surface. This creates a moisture barrier. In the typical dry eye, and particularly in case of mucin deficiency, the application of artificial tear fluid is highly recommended. Both its surface activity and its adsorptive capacity make hypromellose optimal for this use. Hypromellose has a physical-chemical action and leads to, in an aqueous solution, a reduced surface tension as well as an increased level of viscosity. Hypromellose adheres well to the cornea and conjunctiva and provides ample moisture. Irritation symptoms caused by blinking, which occur in the case of tear fluid deficiency, are therefore decreased and symptoms of epithelial desiccation are also alleviated [L1809].



', 'Hypromellose is the most commonly used in hydrophilic matrix fabrication. It allows for controlled release of drug substances, increasing duration of therapeutic effects [L1803].  The physical characteristics of this drug resemble natural tears, providing lubrication to the ocular surface and maintaining corneal hydration in dry eye syndromes [L1811].



Hypromellose is considered an inert substance as it has no direct pharmacological activity. The viscosity promoting properties of hypromellose prolong the retention time and improve adhesion of synthetic tears to the cornea and conjunctiva. As a result, the tear film breakdown time is prolonged and/or the tear film stability is enhanced. A stable tear film protects the cornea from dryness and epithelial cells [L1809].





Hypromellose is a methyl and hydroxypropyl mixed ether of cellulose. It is utilized as artificial tears to prevent conjunctival and corneal damage due to impaired lacrimal secretions. It is also used as a visco-elastic promoting agent by maintaining a deep, viscous chamber and allowing for easier manipulation, helping the vitreous surface to be pushed back, thus preventing the formation of a postoperative flat chamber [L1808].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Copadtada 2.5 mg 20 tabs', 662, 'كوبادتادا 2.5مجم 20 قرص', '80', NULL, 'Tonic for men', 'Tonic for men', NULL, 'Tadalafil', 'Copad egypt', 'Tab', 'أقراص', '2.5 mg', '2', NULL, NULL, NULL, NULL, 1298, '2022-10-29', NULL, 0, 'Tadalafil is indicated for the treatment of erectile dysfunction (ED) and either alone or in combination with [finasteride] for the treatment of benign prostatic hypertrophy (BPH).[L39095,L39439] It is also indicated for the treatment of pulmonary arterial hypertension (PAH) both alone and in combination with [macitentan] or other endothelin-1 antagonists.[L39100,L39105,L50622]', 'Tadalafil is a selective phosphodiesterase-5 (PDE5) inhibitor that produces several downstream effects with the most common therapeutic effect being smooth muscle relaxation. [L39095] Patients may experience ED due to a variety of causes including psychogenic, neurogenic, vasculogenic, iatrogenic, or endocrine. [A242392] These causes result in dysfunction of penile smooth muscle relaxation through either disrupted neuronal signaling or direct influence on smooth muscle cells. During sexual arousal, non-adrenergic non-cholinergic (NANC) neurons release nitric oxide (NO). Nitric oxide stimulates guanylate cyclase which converts guanosine triphosphate to cyclic guanosine monophosphate (cGMP).[A242287, A242377] cGMP activates the cGMP-dependent kinase (PKG) in a signal cascade which activates K+ channels leading to inhibition of Ca2+ channels, inhibits platelet activation, and inhibits smooth muscle cell proliferation while inducing apoptosis. This signal cascade is attenuated by PDE5 which breaks the phosphodiester bond of cGMP, converting it to GMP. Inhibition of PDE5 by tadalafil increases signaling via the PKG cascade which supports penile smooth muscle relaxation during sexual arousal by decreasing Ca2+ entry into smooth muscle cells. This smooth muscle relaxation allows blood to fill the corpus cavernosum thereby producing an erection.



In PAH, blood pressure in the pulmonary arteries is raised due to a variety of mechanisms stemming from endothelial dysfunction.[A242377] Decreased production of NO and prostacyclin reduce vasodilatory signaling while overproduction of endothelin-1 and thromboxane increase vasoconstriction. Inflammation, thromboses, and hypoxia later contribute to vascular remodeling which further reduces luminal size. The resultant increase in blood pressure reduces the capacity for gas exchange and increases afterload at the right ventricle, producing symptoms of dyspnea, fatigue, and dizziness as well as leading to right-sided heart failure. Tadalafil exerts its therapeutic effect in PAH through boosting NO-cGMP signaling to contribute to smooth muscle relaxation as with ED.



Lastly, tadalafil is used to treat BPH.[L39095] BPH produces urinary dysfunction through hyperproliferation of the epithelial and smooth muscle layers of the prostate.[A242382] The increased size of the prostate blocks urine flow through the urethra resulting in higher residual volumes due to incomplete emptying. Tadalafil does not appear to exert its benefit via smooth muscle relaxation of the prostate. It may instead exert its effect through a mix of increased oxygenation and decreased inflammation, which decreases tissue remodeling, and inhibition of cell proliferation through the cGMP cascade.



The decreased affinity for PDE6 compared to other PDE5 inhibitors may explain the decreased incidence of visual side effects as PDE6 is present in the eye and contributes to color vision.[L39100, L39105, A242287]', 'Tadalafil exerts a therapeutic effect in ED by increasing sexual stimulation-dependant smooth muscle relaxation in the penis, allowing the corpus cavernosum to fill with blood to produce an erection.[A242287, A242377] Smooth muscle relaxation in the pulmonary vasculature helps to produce vasodilation in PAH which reduces blood pressure in the pulmonary arteries.[A242377] In BPH, tadalafil may contribute to decreased smooth muscle cell proliferation which may reduce the size of the prostate and relieve the anatomical obstruction which produces urinary symptoms of BPH.[A242382] The decreased affinity of tadalafil for PDE6 compared to other PDE5 inhibitors may explain the reduced incidence of visual side effects.[L39100, L39105, A242287]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Topicrem sos repair body cream 200 ml', 28317, 'توبيكريم سوس كريم 200مل', '299', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Laboratoire dermatologique > spring', 'Cream', 'كريم', '200 ml', '1', NULL, NULL, '*use twice daily . *cintains 10 % urea.', NULL, 653, '2022-08-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Crosta hair serum 120 ml', 16916, 'كروستا سيرم للشعر 120 مل', '130', NULL, 'Hair care', 'Hair care', NULL, 'Dimethicone+simethicone+paraffin oil', 'Hi-care > pro pharm', 'Serum', 'سيروم', '120 ml', '1', 'سيروم بتركيبة فريدة لتنعيم الشعر. يجعل الشعر ذو لمعان فائق كالكريستال. يعمل وبشكل فوري على ازالة التقصف لنهايات الشعر. يسرح الشعر ويظهره اكثر كثافة و سوف يبدو اكثر جمالا وسحرا.', NULL, 'use: -apply a suitable amount on hair then rub gently for 2-3 minutes.', NULL, 1890, '2022-07-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Postpeal cream 50 gm', 32208, 'بوستبيال كريم 50 جرام', '89', '45', 'Rejuvenating cream and skin emollient', 'Rejuvenating cream and skin emollient', NULL, 'Bee propolis+honey+tea tree oil+panthenol', 'Dreams > egy heart', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 1520, '2025-07-26', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Malcon cream', 3798, 'مالكون كريم', '60', NULL, NULL, NULL, NULL, NULL, 'Company', 'Cream', 'كريم', NULL, '1', NULL, NULL, NULL, NULL, 900, '2023-04-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Jessi curl hair tonic 120 ml', 21167, 'جيسي كيرل مقوي للشعر 120 مل', '85', NULL, 'Hair care', 'Hair care', NULL, NULL, 'Egyptian company for cosmetics > derma sun', 'Unknown', 'غير محدد', '120 ml', '1', NULL, NULL, 'hair tonic with caffeine keratin & protein - hair fall control - reduces hair loss', NULL, 1064, '2022-08-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefrom 1 gm vials', 2276, 'سفروم 1 جم 1فيال', '68', NULL, 'Antibiotic cephalosporine fourth generation', 'Antibiotic cephalosporine fourth generation', NULL, 'Cefpirome 1 g', 'Kahira >eva pharma', 'Vial', 'فيال', '1 gm', '1', NULL, NULL, NULL, NULL, 852, '2022-09-22', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Izoptomil 120mg 10 scored coated tabs.', 21106, 'ايزوبتوميل 120 مجم 10 اقراص', '5', NULL, 'Antihypertensive.cardioselective calcium chennel blocker', 'Antihypertensive.cardioselective calcium chennel blocker', NULL, 'Verapamil', 'Arab drug company.', 'Tab', 'أقراص', '120mg', '1', NULL, NULL, NULL, NULL, 698, '2022-07-27', NULL, 0, 'Verapamil is indicated in the treatment of vasopastic (i.e. Prinzmetal''s) angina, unstable angina, and chronic stable angina. It is also indicated to treat hypertension, for the prophylaxis of repetitive paroxysmal supraventricular tachycardia, and in combination with digoxin to control ventricular rate in patients with atrial fibrillation or atrial flutter.[L8791] Given intravenously, it is indicated for the treatment of various supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm in patients with supraventricular tachycardia and for temporary control of ventricular rate in patients with atrial fibrillation or atrial flutter.[L10481]



Verapamil is commonly used off-label for prophylaxis of cluster headaches.[A13983]', 'Verapamil inhibits L-type calcium channels by binding to a specific area of their alpha-1 subunit,[L10478]Cav1.2, which is highly expressed on L-type calcium channels in vascular smooth muscle and myocardial tissue where these channels are responsible for the control of peripheral vascular resistance and heart contractility.[A175396] Calcium influx through these channels allows for the propagation of action potentials necessary for the contraction of muscle tissue and the heart''s electrical pacemaker activity. Verapamil binds to these channels in a voltage- and frequency-dependent manner, meaning affinity is increased 1) as vascular smooth muscle membrane potential is reduced, and 2) with excessive depolarizing stimulus.[L10478] 



Verapamil''s mechanism of action in the treatment of angina and hypertension is likely due to the mechanism described above. Inhibition of calcium influx prevents the contraction of vascular smooth muscle, causing relaxation/dilation of blood vessels throughout the peripheral circulation - this lowers systemic vascular resistance (i.e. afterload) and thus blood pressure. This reduction in vascular resistance also reduces the force against which the heart must push, decreasing myocardial energy consumption and oxygen requirements and thus alleviating angina.[L8791]



Electrical activity through the AV node is responsible for determining heart rate, and this activity is dependent upon calcium influx through L-type calcium channels. By inhibiting these channels and decreasing the influx of calcium, verapamil prolongs the refractory period of the AV node and slows conduction, thereby slowing and controlling the heart rate in patients with arrhythmia.[L8791]



Verapamil''s mechanism of action in the treatment of cluster headaches is unclear, but is thought to result from an effect on other calcium channels (e.g. N-, P-, Q-, or T-type).[A13983]



Verapamil is known to interact with other targets, including other calcium channels,[A188490,A13984,A188502,A15331] potassium channels,[A188496,A13985,A13983] and adrenergic receptors.[A20291,A31755]', 'Verapamil is an L-type calcium channel blocker with antiarrhythmic, antianginal, and antihypertensive activity.[L8791] Immediate-release verapamil has a relatively short duration of action, requiring dosing 3 to 4 times daily,[L8791] but extended-release formulations are available that allow for once-daily dosing.[L10478,L10637] As verapamil is a negative inotropic medication (i.e. it decreases the strength of myocardial contraction), it should not be used in patients with severe left ventricular dysfunction or hypertrophic cardiomyopathy as the decrease in contractility caused by verapamil may increase the risk of exacerbating these pre-existing conditions.[L10478]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Unipridol forte 15mg/5ml syp. 100 ml', 28749, 'يونيبريدول فورت 15مجم/5مل شراب 100مل', '69', '46.5', 'Glucocorticoid', 'Glucocorticoid', NULL, 'Prednisolone', 'Unipharma co.', 'Unknown', 'غير محدد', '15mg', '1', NULL, NULL, 'about prednisolone systemic synthetic glucocorticoid immunosuppressant. mechanism of action of prednisolone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid re', '6224001183850', 1729, '2024-07-26', NULL, 0, 'Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.[L9542]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.[A187463] Prednisolone has a short duration of action as the half life is 2.1-3.5 hours.[A187394] Corticosteroids have a wide therapeutic window as patients make require doses that are multiples of what the body naturally produces.[A187463] Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Atrakta dandr-off hair shampoo 250 ml', 14582, 'اتراكتا داندر اوف شامبو للشعر 250 مل', '320', '300', 'Hair care', 'Hair care', NULL, NULL, 'Ce.is.co srl > macro group pharmaceuticals', 'Amp', 'أمبول', '250 ml', '1', NULL, NULL, 'need(s): treatment for seasonal dandruff and seborrheic dermatitis. an anti-dandruff specialist who manages different dandruff causes and relieves its symptoms and it acts deeply to treat dandruff as well as dry scalp flakes causes helping to prevent its', NULL, 688, '2025-03-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cold stop syrup 120 ml', 2891, 'كولد ستوب شراب 120 مل', '7', NULL, 'Cold drugs', 'Cold drugs', NULL, 'Chlorpheniramine+dextromethorphan+paracetamol(acetaminophen)+pseudoephedrine', 'Arab caps', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 1423, '2022-12-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Anti dep 150 mg 20 cap', 769, 'انتي ديب 150مجم 20 كبسولة', '8', NULL, 'Psychiatric.mood stabilizers', 'Psychiatric.mood stabilizers', NULL, 'Hypericum', 'Mepaco', 'Cap', 'كبسولة', '150 mg', '2', 'مضاد اكتئاب ويعمل على تحسين المزاج والحالة النفسية', NULL, NULL, '6223002211036', 1433, '2022-12-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Folicurex 400 mcg 30 tabs', 13329, 'فوليكيوريكس 400مكجم 30 قرص', '23', NULL, 'Folic acid', 'Folic acid', NULL, 'Folic acid', 'Multicare', 'Tab', 'أقراص', '400 mcg', '3', 'مكمل غذائي بحمض الفوليك -- لعلاج نقص حمض الفوليك -- علاج حالات الانيميا', NULL, NULL, NULL, 3124, '2023-02-03', NULL, 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cholerose 10mg 21 f.c.tab', 2513, 'كوليروز 10مجم 21 قرص', '102', '76.5', 'Antihyperlipidemic.statins', 'Antihyperlipidemic.statins', NULL, 'Rosuvastatin', 'Marcyrl co.', 'Tab', 'أقراص', '10mg', '3', 'علاج ارتفاع الدهون الثلاثية في الدم -- علاج ارتفاع الكوليسترول في الدم -- الوقاية من امراض القلب', NULL, NULL, '6223003579845', 22458, '2024-07-20', NULL, 0, 'The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia.[F4649]



The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.[F4652]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4649] The overall effect is a decrease in plasma LDL and VLDL. 



In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration.[A1807] The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts.[A1787] Rosuvastatin increases the bioavailability of nitric oxide[A1807,A1799,A1787] by upregulating NOS[A1791] and by increasing the stability of NOS through post-transcriptional polyadenylation.[A1796] It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.', 'Rosuvastatin is a synthetic, enantiomerically pure antilipemic agent. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. These risks can occur at any dose level, but are increased at the highest dose (40 mg). Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age ≥ 65 years, inadequately treated hypothyroidism, renal impairment).



The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (such as [fenofibrate] or [niacin]), [gemfibrozil], [cyclosporine], [atazanavir]/[ritonavir], [lopinavir]/ritonavir, or [simeprevir].  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors, including rosuvastatin, coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4649] 



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Enzyme Abnormalities**



Increases in serum transaminases have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. In most cases, the elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy. There were two cases of jaundice, for which a relationship to rosuvastatin therapy could not be determined, which resolved after discontinuation of therapy. There were no cases of liver failure or irreversible liver disease in these trials.[F4649]



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including rosuvastatin calcium tablets. Based on clinical trial data with rosuvastatin, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus.[F4649]



An in vitro study found that [atorvastatin], [pravastatin], [rosuvastatin], and [pitavastatin] exhibited a dose-dependent cytotoxic effect on human pancreas islet β cells, with reductions in cell viability of 32, 41, 34 and 29%, respectively, versus control]. Moreover, insulin secretion rates were decreased by 34, 30, 27 and 19%, respectively, relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and lower cholesterol levels and, as such, might theoretically blunt adrenal or gonadal steroid hormone production. Rosuvastatin demonstrated no effect upon nonstimulated cortisol levels and no effect on thyroid metabolism as assessed by TSH plasma concentration. In rosuvastatin treated patients, there was no impairment of adrenocortical reserve and no reduction in plasma cortisol concentrations. Clinical studies with other HMG-CoA reductase inhibitors have suggested that these agents do not reduce plasma testosterone concentration. The effects of HMG-CoA reductase inhibitors on male fertility have not been studied. The effects, if any, on the pituitarygonadal axis in premenopausal women are unknown.[F4652]



**Cardiovascular**



Ubiquinone levels were not measured in rosuvastatin clinical trials, however significant decreases in circulating ubiquinone levels in patients treated with other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4652]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by a concomitant increase in the Lipoprotein(a) [Lp(a)] concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease. It is thus desirable to maintain and reinforce lifestyle changes in high-risk patients placed on rosuvastatin therapy.[F4652] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Viru-merz serol 1gm/100gm gel', 29410, 'فيرو-ميرز سيرول 1جم/100جم جل', '12', NULL, 'Antiviral', 'Antiviral', NULL, 'Tromantadine', 'Pharco > merz', 'Gel', 'جل', '1gm', '1', NULL, NULL, NULL, NULL, 875, '2022-06-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cervitam 20 caps.', 2425, 'سيرفيتام 20 كبسولة', '118', '86', 'Cerebral circulatory inhancer', 'Cerebral circulatory inhancer', NULL, 'Piracetam+vincamine', 'Egyphar', 'Cap', 'كبسولة', NULL, '2', 'علاج الدوخة والدوار - دوار الحركة - وقصور الدورة الدموية المخية', NULL, 'piracetam: it is neotropic known as intelligence booster. it facilitates the oxygen supply to the brain and enhances communication between the left and right parts of the brain. it also enhances the memory. vincamine: it has been proven that it is very ef', '6224001026324', 23992, '2025-04-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Escitapram 20 mg 20 f.c.tabs.', 18546, 'اسيتابرام 20 مجم 20 قرص', '116', '96', 'Psychiatric.antidepressants', 'Psychiatric.antidepressants', NULL, 'Escitalopram', 'Sigma > pharma mix-egypt', 'Tab', 'أقراص', '20 mg', '2', NULL, NULL, 'about escitalopram selective serotonin reuptake inhibitor (ssri) antidepressant. mechanism of action of escitalopram escitalopram is the s enantiomer of racemic citalopram. it is 100 times more potent than r-enantiomer. escitalopram blocks the re-uptake o', '6225000352094', 1363, '2024-08-24', NULL, 0, 'Escitalopram is indicated for the acute and maintenance treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years old and older and for the acute treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years old and older.[L8513,L8513] It is additionally indicated for symptomatic relief of obsessive-compulsive disorder (OCD) in Canada.[L8516]', 'Escitalopram, like other selective serotonin re-uptake inhibitors, enhances serotonergic activity by binding to the orthosteric (i.e. primary) binding site on the serotonin transporter (SERT), the same site to which endogenous 5-HT binds, and thus prevents the re-uptake of serotonin into the presynaptic neuron.[A185420,A39738,A185726] Escitalopram, along with [paroxetine], is also considered an allosteric serotonin re-uptake inhibitor - it binds to a secondary allosteric site on the SERT molecule to more strongly inhibit 5-HT re-uptake. Its combination of orthosteric and allosteric activity on SERT allows for greater extracellular 5-HT levels, a faster onset of action, and greater efficacy as compared to other SSRIs. [A185825,A185726] The sustained elevation of synaptic 5-HT eventually causes desensitization of 5-HT<sub>1A</sub> auto-receptors, which normally shut down endogenous 5-HT release in the presence of excess 5-HT - this desensitization may be necessary for the full clinical effect of SSRIs and may be responsible for their typically prolonged onset of action.[A185828,A185726]



Escitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects.[L8513,L8516,L8522,A185726]', 'Escitalopram belongs to a class of medications called selective serotonin re-uptake inhibitors (SSRIs). These agents cause an increase in serotonin levels in neuronal synapses by preventing the re-uptake of serotonin (5-HT) into the presynaptic terminals of serotonergic neurons.[A185420,A39738,L8513,L8516] As compared to other SSRIs, it appears to have a relatively quick onset of effect due to its potency.[A185819,A185822]



SSRIs as a class have been associated with abnormal bleeding, particularly in patients receiving concomitant therapy with other medications affecting hemostasis, and with the development of serotonin syndrome. Use escitalopram with caution in patients with a higher-than-baseline risk of bleeding and in patients receiving concomitant therapy with other serotonergic drugs. Escitalopram may also cause a discontinuation syndrome with abrupt removal of the drug, and should be slowly tapered if discontinuation of therapy is warranted.[L8513,L8516,L8522]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Westgrelor 90mg 10 f. c. tabs.', 29648, 'ويستجريلور 90مجم 10 قرص', '137', '100', 'Antiplatelet', 'Antiplatelet', NULL, 'Ticagrelor', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '90mg', '1', NULL, NULL, NULL, NULL, 1064, '2025-08-15', NULL, 0, 'Ticagrelor is indicated to reduce the risk of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome or a history of myocardial infarction.[L14201] Ticagrelor is also indicated to reduce the risk of a first myocardial infarction or stroke in high risk patients with coronary artery disease.[L14201]', 'Ticagrelor is a P2Y<sub>12</sub> receptor antagonist.[A17595]



The P2Y<sub>12</sub> receptor couples with Gα<sub>i2</sub> and other G<sub>i</sub> proteins which inhibit adenylyl cyclase.[A204164] G<sub>i</sub> mediated signalling also activates PI3K, Akt, Rap1b, and potassium channels.[A204164] The downstream effects of these activities mediate hemostasis and lead to platelet aggregation.[A204164]



Antagonism of the P2Y<sub>12</sub> receptor reduces development of occlusive thromboses, which can reduce the risk of myocardial infarction and ischemic stroke.[A204164]', 'Ticagrelor is a P2Y<sub>12</sub> receptor antagonist that inhibits the formation of thromboses to reduce the risk of myocardial infarction and ischemic stroke.[A17595,A204164] It has a moderate duration of action as it is given twice daily, and a wide therapeutic index as high single doses are well tolerated.[L14201,L14207] Patients should be counselled regarding the risk of bleeding, dyspnea, and bradyarrhythmias.[L14201]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ramipril 10 mg 7 caps.', 25661, 'راميبريل 10مجم 7 كبسول', '17', NULL, 'Antihypertensive.ace', 'Antihypertensive.ace', NULL, 'Ramipril', 'Pharopharma', 'Cap', 'كبسولة', '10 mg', '1', NULL, NULL, 'about ramipril angiotensin - converting enzyme inhibitor antihypertensive. mechanism of action of ramipril it is a prodrug and converted in to active ramiprilat; which is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1', NULL, 918, '2022-07-12', NULL, 0, 'For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. [FDA Label] To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy. [T116] ', 'Ramipril inhibits the RAAS system by binding to and inhibiting ACE thereby preventing the conversion of angiotensin I to angiotensin II. [T116] As plasma levels of angiotensin II fall, less activation of the G-protein coupled receptors angiotensin receptor I (AT<sub>1</sub>R) and angiotensin receptor II (AT<sub>2</sub>R) occurs. 



AT<sub>1</sub>R mediates vasoconstriction, inflammation, fibrosis, and oxidative stress through a variety of signaling pathways. [T116] These include G<sub>q</sub> coupling to the inositol triphosphate pathway, activation of phospholipases C, A<sub>2</sub>, and D which contribute to eicosanoid production, activation of Ca<sup>2+</sup>-dependent and MAP kinases, G<sub>i</sub> and G<sub>12/13</sub>, and eventual activation of the Jak/STAT pathway leading to cell growth and production of extracellular matrix components. AT<sub>1</sub>R activation also leads to increased activity of membrane-bound NADH/NADPH oxidase which contributes to production of reactive oxygen species. Decreased activation of this receptor mediates the renoprotective, antihypertensive, and cardioprotective effects of ramipril by reducing inflammation and vasoconstriction.



AT<sub>2</sub>R acts in opposition to the effects of AT<sub>1</sub>R by activating phosphotyrosine phosphatases which inhibit MAP kinases, inhibiting Ca<sup>2+</sup> channel opening, and stimulating cGMP and nitric oxide production leading to vasodilation. [T116] These counteracting effects are shared by the Mas receptor which is activated by Ang(1-7), a subtype of angiotensin produced by plasma esterases from AngI or by ACE2 from AngII produced through a secondary pathway by tonin and cathepsin G. Ang(1-7) also activates AT<sub>2</sub>R although the bulk of its effect is mediated by MasR.



ACE is also responsible for the breakdown of bradykinin. [T116] The resulting buildup of bradykinin due to ACE inhibition is thought to mediate the characteristic dry-cough as a side effect of ACE inhibitor medications.



', 'Ramipril is an ACE inhibitor similar to benazepril, fosinopril and quinapril. [T116] It is an inactive prodrug that is converted to ramiprilat in the liver, the main site of activation, and kidneys. Ramiprilat confers blood pressure lowing effects by antagonizing the effect of the RAAS. The RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from the granular cells of the juxtaglomerular apparatus in the kidneys. In the blood stream, renin cleaves circulating angiotensinogen to ATI, which is subsequently cleaved to ATII by ACE. ATII increases blood pressure using a number of mechanisms. First, it stimulates the secretion of aldosterone from the adrenal cortex. Aldosterone travels to the distal convoluted tubule (DCT) and collecting tubule of nephrons where it increases sodium and water reabsorption by increasing the number of sodium channels and sodium-potassium ATPases on cell membranes. Second, ATII stimulates the secretion of vasopressin (also known as antidiuretic hormone or ADH) from the posterior pituitary gland. ADH stimulates further water reabsorption from the kidneys via insertion of aquaporin-2 channels on the apical surface of cells of the DCT and collecting tubules. Third, ATII increases blood pressure through direct arterial vasoconstriction. Stimulation of the Type 1 ATII receptor on vascular smooth muscle cells leads to a cascade of events resulting in myocyte contraction and vasoconstriction. In addition to these major effects, ATII induces the thirst response via stimulation of hypothalamic neurons. ACE inhibitors inhibit the rapid conversion of ATI to ATII and antagonize RAAS-induced increases in blood pressure. ACE (also known as kininase II) is also involved in the enzymatic deactivation of bradykinin, a vasodilator. Inhibiting the deactivation of bradykinin increases bradykinin levels and may sustain the effects of ramiprilat by causing increased vasodilation and decreased blood pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sanso c plus 14 tabs', 26509, 'سانسو سي بلس 14 قرص', '95', '80', 'Multivitamins', 'Multivitamins', NULL, 'Zinc+vitamin c+vitamin d3+vitamin e+vitamin a', 'Aug pharma', 'Tab', 'أقراص', NULL, '1', NULL, NULL, NULL, '6223005464682', 1034, '2025-01-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Rotahelex cysteine syrup 100 ml', 3660, 'روتا هيليكس سيستايين شراب 100 مل', '75', '60', 'Cough products', 'Cough products', NULL, 'Ivy leaves+acetyl cysteine', 'Egypharma-egypt', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, '6224001820120', 1587, '2025-11-21', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dinitra 10mg 60 tab.', 3707, 'دينيترا 10مجم 60 قرص', '12', NULL, 'Anti-ischemic', 'Anti-ischemic', NULL, 'Isosorbide dinitrate', 'Eipico > sanofi aventis', 'Tab', 'أقراص', '10mg', '3', 'علاج الذبحة الصدرية — الوقاية من الذبحة الصدرية — لعلاج آلام شديدة فى الصدر — فشل القلب الاحتقانى', NULL, 'about isosorbide dinitrate alkyl nitrate derivative a direct vasodilator antianginal. mechanism of action of isosorbide dinitrate it is a direct smooth muscle relaxant which have a prominent action vascular smooth muscles preferentially veins than arterie', '6221032111197', 3128, '2022-12-04', NULL, 0, 'For the prevention of angina pectoris due to coronary artery disease.', 'Isosorbide dinitrate is converted to the active nitric oxide to activate guanylate cyclase. This activation increases levels of cyclic guanosine 3'',5''-monophosphate (cGMP). cGMP activates protein kinases and causes a series of phosphorylation reactions which leads to dephosphorylation of myosin light chains of smooth muscle fibres. Finally there is a release of calcium ions which causes smooth muscle relaxation and vasodilation.', 'Isosorbide Dinitrate is a moderate to long acting oral organic nitrate used for the relief and prophylactic management of angina pectoris. It relaxes the vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter. Dilatation of the veins promotes peripheral pooling of blood and decreases venous return to the heart, thereby reducing left ventricular end- diastolic pressure and pulmonary capillary wedge pressure (preload). Arteriolar relaxation reduces systemic vascular resistance, systolic arterial pressure, and mean arterial pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tag vita syrup 120 ml', 8285, 'تاج فيتا شراب 120 مل', '50', NULL, NULL, NULL, NULL, NULL, NULL, 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 833, '2025-12-07', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Elevit pregnancy 30 caps.', 30465, 'ايليفيت للحوامل 30 كبسولة', '435', NULL, 'Multi-vitamins.combination', 'Multi-vitamins.combination', NULL, 'Multivitamins+minerals+omega 3', 'Bayer consumer care-switzerland > ramco', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, 'multivitamins and minerals with omega-3 to support foetal eye and brain development - 2nd & 3rd trimester - specially formulated - 1x daily', '9310160820488', 2646, NULL, NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cetal cold & flu 20 caplets', 2438, 'سيتال كولد اند فلو 20 قرص', '36', '21', 'Cold drugs', 'Cold drugs', NULL, 'Chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Eipico', 'Cap', 'كبسولة', NULL, '2', 'علاج نزلات البرد -- مسكن وخافض للحرارة -- مضاد للحساسية -- علاج الزكام والرشح', NULL, 'indication: runny noses blocked noses and sinus sneezing watery itchy eyes sinus pain fever headache body aches & pain information: pseudoephedrine hydrochloride belongs to a group of medicines called sympathomimetic decongestants. it works by reducing co', '6221032157188', 12422, '2024-10-28', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Napibradine 7.5mg 30 f.c. tabs.', 8564, 'نابيبرادين 7.5مجم 30 قرص', '243', '186', 'Anti-ischemic', 'Anti-ischemic', NULL, 'Ivabradine', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '7.5mg', '3', NULL, NULL, 'about ivabradine antianginal drug mechanism of action of ivabradine ivabradine is a heart rate lowering agent that works through selective and specific inhibition of the cardiac pacemaker if current. if current controls the spontaneous diastolic depolaris', '6224000821845', 1875, '2024-09-12', NULL, 0, 'Ivabradine is indicated by the FDA to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction ≤35%, who are in sinus rhythm with resting heart rate ≥70 beats per minute and either are on maximally tolerated doses of beta-blockers or have a contraindication to beta-blocker use. It is also indicated for treatment of stable symptomatic heart failure as a result of dilated cardiomyopathy for pediatric patients 6 months of age or more[FDA Label].', 'Ivabradine lowers heart rate by selectively inhibiting If channels ("funny channels") in the heart in a concentration-dependent manner without affecting any other cardiac ionic channels (including calcium or potassium). Ivabradine binds by entering and attaching to a site on the channel pore from the intracellular side and disrupts If ion current flow, which prolongs diastolic depolarization, lowering heart rate. The If currents are located in the sinoatrial node and are the home of all cardiac pacemaker activity. Ivabradine therefore lowers the pacemaker firing rate, consequently lowering heart rate and reducing myocardial oxygen demand. This allows for an improved oxygen supply and therefore mitigation of ischemia, allowing for a higher exercise capacity and reduction in angina episodes. ', 'The funny channels (If) open during repolarization and close during depolarization, making ivabradine''s activity dependent on heart rate or the closing and opening of the channels. Therefore ivabradine exhibits use-dependence and is more pharmacologically active at higher heart rates. Ivabradine exhibits a linear dose-dependent heart-rate lowering activity (bradycardic effect) until a maximum dose of 30-40mg. At higher doses, the concentration of ivabradine tends to plateau, reducing risk of serious sinus bradycardia.  It has been shown that the metabolite of ivabradine lowers heart rate as well, contributing to ivabradine''s overall effect. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Magnabiotic 460mg/5ml susp. 80ml', 7675, 'ماجنابيوتيك 460 مجم/5مل معلق 80 مل', '37', NULL, 'Penicillins.penicillin with b-lactamase inhibitor', 'Penicillins.penicillin with b-lactamase inhibitor', NULL, 'Amoxicillin+clavulanic acid', 'Sedico', 'Susp', 'معلق', '460mg', '1', NULL, NULL, 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '6221042493016', 1345, '2022-10-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Aromalock 2.5 mg 30 f.c. Tabs', 32443, 'ارومالوك 2.5مجم30 قرص', '621', '432', 'Non-steroidal aromatase inhibitor', 'Non-steroidal aromatase inhibitor', NULL, 'Letrozole', 'Marcyrl pharmaceutical industries (mpi)', 'Tab', 'أقراص', '2.5 mg', '3', 'ليتروزول يزيد من فرص الحمل ويساعد على الحمل خاصة لدى النساء اللواتي يعانين من متلازمة المبيض المتعدد الكيسات.', NULL, NULL, '6223003572549', 20709, '2024-09-25', NULL, 0, 'Letrozole is indicated to treat postmenopausal women with hormone receptor (HR) positive early breast cancer, postmenopausal women with early breast cancer who have periviously been treated with tamoxifen, and postmenopausal women with HR+ or unknown advanced breast cancer.[L11623] Letrozole, given with ribociclib, is indicated to treat pre, peri, and postmenopausal women with HR+ and human epidermal growth factor 2 (HER2) negative advanced or metastatic breast cancer.[L11626]', 'Letrozole is a non-steroidal type II aromatase inhibitor.[A1559] It blocks the active site, and therefore the electron transfer chain of CYP19A1.[A1559] This competitive inhibition prevents the conversion of androgens to estrogen.[A1559] This action leads to a reduction in uterine weight and elevated leuteinizing hormone.[L11623] In postmenopausal women, the action of aromatase is responsible for the majority of estrogen production.[L11623] With reduced availability of estrogen, estrogen-dependant tumors regress.[L11623] Third generation aromatase inhibitors do not significantly affect cortisol, aldosterone, and thyroxine levels.[A190546]', 'Letrozole is an aromatase inhibitor used in the treatment of breast cancer. Aromatase inhibitors work by inhibiting the action of the enzyme aromatase, which converts androgens into estrogens by a process called aromatization. As breast tissue is stimulated by estrogens, decreasing their production is a way of suppressing recurrence of the breast tumor tissue.



Letrozole is a third generation type II aromatase inhibitor used to treat estrogen dependant breast cancers.[L11623] It has a long duration of action as it has a half life of over 42 hours in breast cancer patients.[A190546,A190555,L11623] Patients should be counselled regarding the risk of interstitial lung disease, pneumonitis, QT prolongation, elevated transaminase levels, neutropenia, and embryo-fetal toxicity.[L11623]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Janca-z 30 f.c. tab.', 33026, 'جانكا -زد 30 قرص', '75', '60', 'Calcium coated tablets', 'Calcium coated tablets', NULL, 'Calcium+vit. d3+magnesium+zinc+boron+copper+manganese+selenium', 'Janso pharm', 'Tab', 'أقراص', NULL, '3', 'مكمل غذائى يدعم نمو العظام ويقى من الكساح ولين العظام ويقلل من الشد العضلى', NULL, 'calcium 800mg with vitamin d3 500 iu magnesium zinc boron copper manganese and selenium', '6225000501119', 1817, '2025-05-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Navoproxin plus 20 f.c. tab.', 23328, 'نافوبروكسين بلس 20 قرص', '44', '27', 'Antiemetic', 'Antiemetic', NULL, 'Meclizine+vitamin b6', 'Delta pharma', 'Tab', 'أقراص', NULL, '2', NULL, NULL, 'about meclizine first generation h1 antagonist piperazine derivative antihistamine antiemetic antinauseant. mechanism of action of meclizine meclizine produces antiemetic action by its central action on chemoreceptor trigger zone (ctz). it decreases the s', '6221163013643', 4128, '2024-09-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Maxrdax gel 100 gm', 30876, 'ماكس ردكس جل 100 جم', '95', '55', 'Massage', 'Massage', NULL, 'Menthol+camphor+eucalyptus+clove oil+alpha tocopherol+methyl salicylate', 'Egyptian co. for cosmetics > medix pharm', 'Gel', 'جل', '100 gm', '1', NULL, NULL, 'analgesic', NULL, 644, '2025-08-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Turnalev 5 mg 10 f.c. tab.', 28608, 'تورناليف 5مجم 10 اقراص', '3', NULL, 'Antihistamine.non-sedative.third-generation', 'Antihistamine.non-sedative.third-generation', NULL, 'Levocetirizine', 'Debeiky > lamar pharma', 'Tab', 'أقراص', '5 mg', '1', NULL, NULL, NULL, NULL, 784, '2022-07-13', NULL, 0, 'Levocetirizine is indicated to treat symptoms of perennial allergic rhinitis and uncomplicated skin manifestations of chronic idiopathic urticaria.[L7694] It is also used over the counter for a variety of mild allergy symptoms.[A181748]', 'Levocetirizine selectively inhibits histamine H<sub>1</sub> receptors.[L7694] This action prevents histamine from activating this receptor and causing effects like smooth muscle contraction, increased permeability of vascular endothelium, histidine uptake in basophils, stimulation of cough receptors, and stimulation of flare responses in the nervous system.[A181790]', 'Levocetirizine is a second generation histamine H<sub>1</sub> antagonist used to treat various allergic symptoms.[A181748,A181790,L7694] It has a long duration of action as it is generally taken once daily, and a wide therapeutic window as animal studies show the maximal nonlethal dose is over 100x a normal dose.[L7694] Patients are cautioned to avoid tasks that require complete alertness, avoid alertness, and use caution in patients with factors predisposing urinary retention.[L7694]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Thiotex 300mg 30 caps.', 11382, 'ثيوتكس 300مجم 30 كبسولة', '90', NULL, 'Antioxidant', 'Antioxidant', NULL, 'Thioctic acid(alpha lipoic acid)', 'Marcyrl co.', 'Cap', 'كبسولة', '300mg', '3', 'مضاد لللكسدة -- مقوي للاعصاب -- زيادة التركيز والانتباه والذاكرة', NULL, 'uses alpha-lipoic acid (ala) has been used as an antioxidant for the treatment of diabetes and hiv. it also has been used for cancer liver ailments and various other conditions. dosing oral dosage of alpha-lipoic acid given in numerous clinical studies ra', '6223003579951', 5985, '2023-05-14', NULL, 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Keranty shampoo 250 ml', 21346, 'كيرانتي شامبو 250 مل', '240', '210', 'Hair care', 'Hair care', NULL, 'Biotin+keratin+caffeine+argan oil', 'Egyptian company for cosmetics > prime international pharma', 'Amp', 'أمبول', '250 ml', '1', NULL, NULL, '**sulfate-free anti-breakage anti-frizz strengthening & replenishing **instructions for use: - work on a small amount of keranty shampoo on wet hair. - massage into hair & leave on scalp for 3-4 minutes then rinse. - best results use 4 times a week for 30', '6224011686327', 1185, '2025-08-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Anabrammune 75 mg 10 tabs.(n/a yet)', 14087, 'انابراميون 75 مجم 10 اقراص', '9', NULL, 'Immunosuppressants', 'Immunosuppressants', NULL, 'Cyclosporin', 'Sigma', 'Tab', 'أقراص', '75 mg', '1', NULL, NULL, NULL, NULL, 754, '2022-07-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Solarine 18 spf sun block lotion 70ml', 27239, 'سولارين 18+ للحماية من الشمس 70مل', '40', NULL, 'Sun block', 'Sun block', NULL, 'Sun protection formula', 'Weiser', 'Lotion', 'لوشن', '70ml', '1', NULL, NULL, 'water resistance during swimming. for sensitive & delicate skin of children and adults.', NULL, 878, '2022-07-13', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sensorate mouth wash 120ml', 26797, 'سينسورات غسول للفم 120 مل', '20', NULL, 'Oral care', 'Oral care', NULL, NULL, 'Global health', 'Mouth wash', 'غسول للفم', '120ml', '1', 'عناية بالفم.', NULL, NULL, NULL, 2318, '2022-05-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Azolacone 200mg vial(n/a yet)', 14824, 'ازولاكون 200مجم فيال', '400', NULL, 'Antifungals.triazoles', 'Antifungals.triazoles', NULL, 'Voriconazole', 'Sigma tec > sigma', 'Vial', 'فيال', '200mg', '1', NULL, NULL, NULL, NULL, 859, '2022-08-25', NULL, 0, 'For the treatment of esophageal candidiasis, cadidemia, invasive pulmonary aspergillosis, and serious fungal infections caused by <i>Scedosporium apiospermum</i> and <i>Fusarium</i> spp.[L9821, L15571] ', 'Voriconazole is used to treat fungal infections caused by a variety of organisms but including _Aspergillus spp._ and _Candida spp_. Voriconazole is a triazole antifungal exhibiting fungistatic activity against fungal pathogens.[A236050, A236045, L9821] Like other triazoles, voriconazole binds to 14-alpha sterol demethylase, also known as CYP51, and inhibits the demethylation of lanosterol as part of the ergosterol synthesis pathway in yeast and other fungi. The lack of sufficient ergosterol disrupts fungal cell membrane function and limits fungal cell growth. With fungal growth limited, the host''s immune system is able to clear the invading organism.', 'Voriconazole is a fungistatic triazole antifungal used to treat infections by inhibiting fungal growth.[L9821] It is known to cause hepatotoxic and photosensitivity reactions in some patients.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Manuclear acne gel 30 gm', 31785, 'مانوكلير أكن جل 30 جم', '89', NULL, 'Skin care.acne', 'Skin care.acne', NULL, NULL, 'Smartec for cosmetics > htd pharma', 'Gel', 'جل', '30 gm', '1', NULL, NULL, 'skin perfecting formula helps to treat acne vulgaris through keratolytic antimicrobial sebo-suppressive actions of salycilic acid manuka honey and hyaluronic acid.', NULL, 583, '2023-03-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Potassium chloride 0.2% & dextrose 5% (otsuka ateco) i.v. inf. 500 ml (rubber cap)', 25086, 'بوتاسيوم كلوريد 0.2% و دكستروز 5% محلول للحقن الوريدي', '11', NULL, 'Sterile solution', 'Sterile solution', NULL, 'Glucose (dextrose)+potassium chloride', 'Otsuka ateco pharma', 'Cap', 'كبسولة', '0.2%', '1', NULL, NULL, 'treatment of hypokalemia', NULL, 690, '2022-07-26', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Retch gan cream 150 gm', 25941, 'ريتتش جان كريم 120جم', '109', NULL, 'Firming topical', 'Firming topical', NULL, NULL, 'Egyptian company for cosmetics > prime international pharma', 'Cream', 'كريم', '150 gm', '1', NULL, NULL, 'anti-stretch marks & firming cream apply twice a day with massage for 15 minutes. do not wash.', NULL, 761, '2022-08-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Moist code h.a oral spray 60 ml', 4307, 'مويست كود سبراي للفم 60 مل', '75', NULL, NULL, NULL, NULL, NULL, 'Company', 'Spray', 'بخاخ', '60 ml', '1', NULL, NULL, NULL, NULL, 852, '2025-06-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cephalexcid 500 mg 12 caps.', 16113, 'سيفاليكسيد 500 مجم 12 كبسولة', '10', NULL, 'Antibiotic.cephalosporin.first-generation', 'Antibiotic.cephalosporin.first-generation', NULL, 'Cefalexin', 'Cid', 'Cap', 'كبسولة', '500 mg', '1', NULL, NULL, 'about cefalexin a first-generation cephalosporin antibiotic. mechanism of action cephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synth', NULL, 820, '2022-07-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Convulex 150mg 40 caps.', 3029, 'كونفيولكس 150 مجم 40 كبسولة', '45', NULL, 'Anticonvulsant', 'Anticonvulsant', NULL, 'Valproic acid', 'Gerot pharma > b.p pharma', 'Cap', 'كبسولة', '150mg', '4', NULL, NULL, 'about valproic acid histone deacetylase inhibitor a gaba transaminase inhibitor anticonvulsant antimanic migraine prophylactic. mechanism of action of valproic acid valproic acid prolongs the inactivated state of voltage sensitive neuronal sodium ion chan', '9008732008340', 937, '2022-09-09', NULL, 0, '**Indicated** for:[Label] 



1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures. 



2) Adjunctive therapy in the management of multiple seizure types that include absence seizures. 



3) Prophylaxis of migraine headaches.



4) Acute management of mania associated with bipolar disorder.





**Off-label** uses include:

 

1) Maintenance therapy for bipolar disorder.[A177919]



2) Treatment for acute bipolar depression.[A177928,A177931,A177934]



3) Emergency treatment of status epilepticus.[A177955]', 'The exact mechanisms by which valproate exerts it''s effects on epilepsy, migraine headaches, and bipolar disorder are unknown however several pathways exist which may contribute to the drug''s action.



Valproate is known to inhibit succinic semialdehyde dehydrogenase.[A177991] This inhibition results in an increase in succinic semialdehyde which acts as an inhibitor of GABA transaminase ultimately reducing GABA metabolism and increasing GABAergic neurotransmission. As GABA is an inhibitory neurotransmitter, this increase results in increased inhibitory activity.[A457] A possible secondary contributor to cortical inhibition is a direct suppression of voltage gated sodium channel activity and indirect suppression through effects on GABA.



It has also been suggested that valproate impacts the extracellular signal-related kinase pathway (ERK).[A457] These effects appear to be dependent on mitogen-activated protein kinase (MEK) and result in the phosphorylation of ERK1/2. This activation increases expression of several downstream targets including ELK-1 with subsequent increases in c-fos, growth cone-associated protein-43 which contributes to neural plasticity, B-cell lymphoma/leukaemia-2 which is an anti-apoptotic protein, and brain-derived neurotrophic factor (BDNF) which is also involved in neural plasticity and growth. Increased neurogenesis and neurite growth due to valproate are attributed to the effects of this pathway. An additional downstream effect of increased BDNF expression appears to be an increase in GABA<sub>A</sub> receptors which contribute further to increased GABAergic activity.[A177997]



Valproate exerts a non-competitive indirect inhibitory effect on myo-inosital-1-phophate synthetase.[A178000] This results in reduced de novo synthesis of inositol monophosphatase and subsequent inositol depletion. It is unknown how this contributed to valproate''s effects on bipolar disorder but [lithium] is known to exert a similar inositol-depleting effect.[A178003] Valproate exposure also appears to produce down-regulation of protein kinase C proteins (PKC)-α and -ε which are potentially related to bipolar disorder as PKC is unregulated in the frontal cortex of bipolar patients. This is further supported by a similar reduction in PKC with lithium.[A178015] The inhibition of the PKC pathway may also be a contributor to migraine prophylaxis.[A178018] Myristoylated alanine-rich C kinase substrate, a PKC substrate, is also downregulated by valproate and may contribute to changes in synaptic remodeling through effects on the cytoskeleton.[A178021]



Valproate also appears to impact fatty acid metabolism.[A457] Less incorporation of fatty acid substrates in sterols and glycerolipids is thought to impact membrane fluidity and result in increased action potential threshold potentially contributing to valproate''s antiepileptic action.[A178024] Valproate has been found to be a non-competitive direct inhibitor of brain microsomal long-chain fatty acyl-CoA synthetase.[A14708] Inhibition of this enzyme decreases available arichidonyl-CoA, a substrate in the production of inflammatory prostaglandins. It is thought that this may be a mechanism behind valproate''s efficacy in migraine prophylaxis as migraines are routinely treated with non-steroidal anti-inflammatory drugs which also inhibit prostaglandin production.



Finally, valproate acts as a direct histone deactylase (HDAC) inhibitor.[A178030] Hyperacetylation of lysine residues on histones promoted DNA relaxation and allows for increased gene transcription. The scope of valproate''s genomic effects is wide with 461 genes being up or down-regulated.[A178027] The relation of these genomic effects to therapeutic value is not fully characterized however H3 and H4 hyperacetylation correlates with improvement of symptoms in bipolar patients.[A178033] Histone hyperacetylation at the BDNF gene, increasing BDNF expression, post-seizure is known to occur and is thought to be a neuroprotective mechanism which valproate may strengthen or prolong.[A178036] H3 hyperacetylation is associated with a reduction in glyceraldehyde-3-phosphate dehydrogenase, a pro-apoptotic enzyme, contributing further to valproate''s neuroprotective effects.[A11814]', 'Valproate has been shown to reduce the incidence of complex partial seizures and migraine headaches.[FDA Label,A177841] It also improves symptom control in bipolar mania.[A178033] Although the exact mechanisms responsible are unknown, it is thought that valproate produces increased cortical inhibition to contribute to control of neural synchrony. It is also thought that valproate exerts a neuroprotective effect preventing damage and neural degeneration in epilepsy, migraines, and bipolar disorder.



Valproate is hepatotoxic and teratogenic. The reasons for this are unclear but have been attributed to the genomic effects of the drug.[A457]



A small proof-of concept study found that valproate increases clearance of human immunodeficiency virus (HIV) when combined with highly active antiretroviral therapy (HAART) by reactivating the virus to allow clearance, however, a larger multicentre trial failed to show a significant effect on HIV reservoirs when added to HAART.[A458,A177859] The FDA labeling contains a warning regarding HIV reactivation during valproate use.[label].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Paracetamol-pharco b 1% soln. i.v. inf. 100 ml', 24557, 'باراسيتامول-فاركو بي 1% محلول للتنقيط الوريدي 100 مل', '47', '33', 'Antipyretic', 'Antipyretic', NULL, 'Paracetamol(acetaminophen)', 'Pharco b', 'Sol', 'محلول', '1%', '1', 'مسكن -- خافض للحرارة -- امن علي الحوامل والمرضعات -- مسكن للصداع -- مسكن لالام الاسنان -- مسكن لاعراض البرد -- لالام العظام -- امن على المعدة -- امن للاطفال -- امن لمرضى الضغط والسكر', NULL, 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', '6222012235131', 5595, '2025-08-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Megadroxil 250mg/5ml oral susp. 60 ml', 22469, 'ميجادروكسيل مضاد حيوي 250مجم/5مل شراب 60مل', '11', NULL, 'Antibiotic.cephalosporin.first-generation', 'Antibiotic.cephalosporin.first-generation', NULL, 'Cefadroxil', 'Mash premiere', 'Susp', 'معلق', '250mg', '1', NULL, NULL, 'about cefadroxil first generation cephalosporin para-hydroxy derivative of cefalexin oral broad-spectrum antibiotic mechanism of action cefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram neg', NULL, 805, '2022-07-16', NULL, 0, 'For the treatment of the following infections (skin, UTI, ENT) caused by; <i>S. pneumoniae, H. influenzae, staphylococci, S. pyogenes</i> (group A beta-hemolytic streptococci), <i>E. coli, P. mirabilis, Klebsiella</i> sp, coagulase-negative staphylococci and <i>Streptococcus pyogenes</i>', 'Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor.', 'Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Escinogel topical gel 40 gm', 4383, 'اسينوجيل جل موضعي 40 جم', '10', NULL, NULL, NULL, NULL, 'Bamethan+escin', 'Sedico', 'Gel', 'جل', '40 gm', '1', NULL, NULL, NULL, '6221042308020', 909, '2022-12-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Once pro oral powder 400 gm', 4381, 'وانس برو باودر عن طريق الفم 400 جم', '1,157', NULL, 'Dietary supplement', 'Dietary supplement', NULL, NULL, 'Otsuka', 'Powder', 'بودرة', '400 gm', '1', NULL, NULL, NULL, NULL, 990, '2025-06-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Donifoxate 40 mg 30 f.c. tablets', 17824, 'دونيفوكسيت 40مجم 30 قرص', '102', '73.25', 'Antigout', 'Antigout', NULL, 'Febuxostat', 'Eva pharma', 'Tablet', 'أقراص', '40 mg', '3', NULL, NULL, 'indication: treatment of hyperuricaemia in conditions where urate deposition has already occured. dose: 1 tablet once daily', '6224009763085', 1622, '2023-09-10', NULL, 0, 'Febuxostat is indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of [allopurinol], who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.[L46073] It is not recommended for the treatment of asymptomatic hyperuricemia [L32238] or secondary hyperuricemia.[A230583] ', 'Gout is a form of acute arthritis that is characterized by the accumulation of crystals of monosodium urate and urate crystals in or around a joint, leading to inflammation and persistent urate crystal deposition in bones, joints, tissues, and other organs that may exacerbate over time. Hyperuricemia is closely related to gout, whereby it may exist for many years before the first clinical attack of gout; thus, aberrated serum uric acid levels and hyperuricemia are believed to be the biochemical aberration involved in the pathogenesis of gout.[A230548] Xanthine oxidoreductase (XOR) can act as a xanthine oxidase or xanthine dehydrogenase. In humans, it is a critical enzyme for uric acid production as it catalyzes the oxidation reaction steps from hypoxanthine to xanthine and from xanthine to uric acid in the pathway of purine metabolism.[A19658] Febuxostat potently inhibits XOR, blocking both its oxidase and dehydrogenase activities. With high affinity, febuxostat binds to XOR in a molecular channel leading to the molybdenum-pterin active site, where [allopurinol] demonstrates relatively weak competitive inhibition.[A230548] 



XOR is mainly found in the dehydrogenase form under normal physiological conditions; however, in inflammatory conditions, XOR can be converted into the xanthine oxidase form, which catalyzes reactions that produce reactive oxygen species (ROS), such as peroxynitrite. ROS contribute to vascular inflammation and alterations in vascular function. As febuxostat can inhibit both forms of XOR, it can inhibit ROS formation, oxidative stress, and inflammation.[A2743] In a rat model, febuxostat suppressed renal ischemia-reperfusion injury by attenuating oxidative stress.[A2744]', 'Febuxostat is a novel, selective xanthine oxidase/dehydrogenase inhibitor that works by decreasing serum uric acid in a dose-dependent manner. In healthy subjects, febuxostat decreased the mean serum uric acid and serum xanthine concentrations, as well as the total urinary uric acid excretion. Febuxostat at daily doses of 40-80 mg reduced the 24-hour mean serum uric acid concentrations by 40 to 55%.[L32238] Closely related to the drug-induced reduction of serum uric acid levels and mobilization of urate crystals in tissue deposits, febuxostat is associated with gout flares.[A230583] 



Unlike [allopurinol] and [oxypurinol], febuxostat has no inhibitory actions against other enzymes involved in purine and pyrimidine synthesis and metabolism, because it does not structurally resemble purines or pyrimidines.[A230548] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Immu-c effe 10 sachet', 6408, 'اميو-سي 10 اكياس فوارة', '30', '9', NULL, NULL, NULL, 'Echinacea dry extract+vitamin c+zinc', 'Company', 'Sachet', 'أكياس', NULL, '1', 'دعم وتقوية المناعة.', NULL, NULL, '6223002213085', 1735, '2024-07-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Actifast 12.5mg 20 tab.', 98, 'اكتيفاست 12.5مجم 20 قرص', '9', NULL, 'Analgesic .nsaid.acetic acid derivatives', 'Analgesic .nsaid.acetic acid derivatives', NULL, 'Diclofenac potassium', 'Sigma > october pharma', 'Tab', 'أقراص', '12.5mg', '2', 'مسكن آلام . خافض حرارة . مضاد التهاب', NULL, 'about diclofenac potassium nsaid anti-inflammatory antipyretic and analgesic. mechanism of action of diclofenac potassium diclofenac possess analgesic anti-inflammatory and antipyretic action. it inhibits the enzyme cyclo-oxygenase and there by inhibits t', '6221051011454', 1518, '2022-12-01', NULL, 0, 'Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with [misoprostol] as a gastro-protective agent in patients with high risk of developing NSAID-induced ulcers.', 'Diclofenac inhibits cyclooxygenase-1 and -2, the enzymes responsible for production of prostaglandin (PG) G<sub>2</sub> which is the precursor to other PGs.[label,T116] These molecules have broad activity in pain and inflammation and the inhibition of their production is the common mechanism linking each effect of diclofenac.



PGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.



PGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to β adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.



PGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.

', 'Diclofenac reduces inflammation and by extension reduces nociceptive pain and combats fever.[label,T116] It also increases the risk of developing a gastrointestinal ulcer by inhibiting the production of protective mucus in the stomach.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ferriprox 100mg/ml (500ml) oral solution', 4819, 'فريبروكس 100مجم/مل 500 مل محلول بالفم', '1,195', NULL, 'Iron chelating agent', 'Iron chelating agent', NULL, 'Deferiprone', 'Apotex inc. canada > egyptian pharmex', 'Solution', 'محلول', '100mg', '1', NULL, NULL, 'description deferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. as a resul', NULL, 880, '2022-04-10', NULL, 0, 'Deferiprone is indicated in thalassemia syndromes when first line chelation agents are not adequate to treat transfusional iron overload.', 'Deferiprone is an iron chelator that binds to ferric ions (iron III) and forms a 3:1 (deferiprone:iron) stable complex and is then eliminated in the urine. Deferiprone is more selective for iron in which other metals such as zinc, copper, and aluminum have a lower affinity for deferiprone.', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dexamethasone-mup 8mg/2ml 5 amp', 17423, 'ديكساميثازون-المهن 8مجم/2مل 5 امبولات', '65', '45', 'Glucocorticoid', 'Glucocorticoid', NULL, 'Dexamethasone sodium phosphate', 'Mup', 'Amp', 'أمبول', '8mg', '5', 'مضاد للالتهابات يستخدم فى علاج مختلف أنواع الالتهابات مثل التهاب المفاصل، والجهاز المناعي، وخلل الهرمونات، وأمراض الدم،', NULL, NULL, '6221508171922', 40321, '2024-07-11', NULL, 0, 'Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.[L10698] Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Oral tablets are indicated for the treatment of multiple myeloma.[L10710] An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.[L10719] Various ophthalmic formulations are indicated for inflammatory conditions of the eye.[L10704,L10707,L10713,L10716,L10722,L10725]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.[A187463] Dexamethasone''s duration of action varies depending on the route.[L10698,L10701,L10704,L10707,L10710,L10713,L10716,L10719,L10722,L10725] Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces.[A187463] Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Caventol syrup 120 ml', 30281, 'كافينتول شراب 120 مل', '49', '43', 'Anti-cough.antitussive and expectorant', 'Anti-cough.antitussive and expectorant', NULL, 'Honey+thyme oil white+vit c+fennel oil+eucalyptus oil+marshmallow ext+ivy ext+zinc gluconate+propolis ext', 'Copad egypt', 'Syrup', 'شراب', '120 ml', '1', 'شراب عشبي يساعد على تخفيف السعال والتهاب الحلق. ويستخدم لتحسين اداء الجهاز التنفسي وتحسين المناعة', NULL, 'herbal syrup that help to relieve the cough and sore throat. dietary supplement. directions for use: one small spoon 5ml 3-4 times daily.', '6224008933915', 3650, '2023-10-10', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Reflector sunscreen cream spf 50+ (75gm)', 32067, 'ريفليكتور كريم واقى شمس اس بي اف 50+ (75جم)', '100', NULL, 'Sunscreen cream', 'Sunscreen cream', NULL, 'Avobenzone+octocrylene+zinc oxide+titanium dioxide', 'Dreams elhaboba > true care pharma', 'Cream', 'كريم', '75gm', '1', NULL, NULL, 'sunscreen cream spf 50+ broad spectrum u.v.a & u.v.b water resistant.', NULL, 638, '2023-03-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pressothioval 160/25mg 14 f.c.tab.', 25197, 'بريسوثيوفال 160/25مجم 14 اقراص', '32', NULL, 'Antihypertensive. combined angiotensin blocker with diuretic', 'Antihypertensive. combined angiotensin blocker with diuretic', NULL, 'Hydrochlorothiazide+valsartan', 'Debeiky', 'Tab', 'أقراص', '25mg', '2', NULL, NULL, 'about hydrochlorothiazide thiazide derivatibve diuretic. mechanism of action of hydrochlorothiazide it is thiazide diuretic which exerts its action by acting at site-3(central dilating segment of early distal tubule). it binds to na+cl- symporter and inhi', '6224000873295', 1028, '2022-07-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Largactil 100mg 5 supp', 7109, 'لارجاكتيل 100مجم 5 اقماع لبوس', '3', NULL, 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Chlorpromazine', 'Sanofi', 'Supp', 'لبوس', '100mg', '1', 'علاج الامراض النفسية', NULL, NULL, NULL, 1137, '2023-04-30', NULL, 0, 'For the treatment of schizophrenia; to control nausea and vomiting; for relief of restlessness and apprehension before surgery; for acute intermittent porphyria; as an adjunct in the treatment of tetanus; to control the manifestations of the manic type of manic-depressive illness; for relief of intractable hiccups; for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance.', 'Chlorpromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects).

Additionally, Chlorpromazine is a weak presynaptic inhibitor of Dopamine reuptake, which may lead to (mild) antidepressive and antiparkinsonian effects. This action could also account for psychomotor agitation and amplification of psychosis (very rarely noted in clinical use).', 'Chlorpromazine is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Chlorpromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Chlorpromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bone d 30 tabs', 13198, 'بون دي 30 قرص', '113', '85', NULL, NULL, NULL, NULL, 'Bionel pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1192, '2025-08-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Joypox 60 mg 6 f.c. tabs.', 21194, 'جويبوكس 60مجم 6 اقراص', '106', NULL, 'Delay action', 'Delay action', NULL, 'Dapoxetine', 'Sedico > rameda', 'Tab', 'أقراص', '60 mg', '6', 'للتأخير للرجال', NULL, 'about dapoxetine dapoxetine is a short-acting selective serotonin reuptake inhibitor (ssri) marketed for the treatment of premature ejaculation in men. mechanism of action of dapoxetine the mechanism of action of dapoxetine in premature ejaculation is pre', '6223003974695', 15624, '2022-12-09', NULL, 0, 'For the treatment of premature ejaculation.', 'The drug''s mechanism of action is thought to be related to inhibition of neuronal reuptake of serotonin and subsequent potentiation of serotonin activity. The central ejaculatory neural circuit comprises spinal and cerebral areas that form a highly interconnected network. The sympathetic, parasympathetic, and somatic spinal centers, under the influence of sensory genital and cerebral stimuli integrated and processed at the spinal cord level, act in synergy to command physiologic events occurring during ejaculation. Experimental evidence indicates that serotonin (5-HT), throughout brain descending pathways, exerts an inhibitory role on ejaculation. To date, three 5-HT receptor subtypes (5-HT(1A), 5-HT(1B), and 5-HT(2C)) have been postulated to mediate 5-HT''s modulating activity on ejaculation.', 'Dapoxetine is a selective serotonin reuptake inhibitor currently undergoing trials through Alza (under license from GenuPro, a collaboration between Eli Lilly and PPD). Dapoxetine is a short-acting SSRI drug currently being considered for approval by the Food and Drug Administration (FDA) for the treatment of premature ejaculation in men, which would make it the first drug approved for such treatment. Despite two clinical trials finished in 2006, experts doubt it will be approved by the FDA soon because SSRIs come with undesirable side-effects after long-term use, such as psychiatric problems, dermatological reactions, increase in body weight, lower sex-drive, nausea, headache, upset stomach and weakness, thus not significantly outweighing the benefit of premature ejaculation medication versus the risks. By contrast with SSRIs approved for depression, which take 2 weeks or longer to reach steady-state concentration, dapoxetine has a unique pharmacokinetic profile, with a short time to maximum serum concentration (about 1 h) and rapid elimination (initial half-life of 1-2 h).', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Silkren shampoo 250 ml', 26973, 'سيلكرين شامبو 250مل', '150', '90', 'Hair care', 'Hair care', NULL, 'Selenium sulphide+panthenol+vitamin (a+e)+aloe vera+thyme+salicylic acid', 'Hi-care > pixel pharmaceutical company', 'Amp', 'أمبول', '250 ml', '1', NULL, NULL, NULL, '6224000201777', 2271, '2024-05-31', NULL, 0, 'For treatment of tinea versicolor, tinea capitis, dandruff and seborrheic dermatitis of the scalp.', 'Topical selenium sulfide may act by an antimitotic action, resulting in a reduction in the turnover of epidermal cells. It also has local irritant, antibacterial, and mild antifungal activity, which may contribute to its effectiveness. An antimitotic mechanism of action is suggested by data showing that selenium sulfide decreases the rate of incorporation of radioactively labeled thymidine into the DNA of dermal epithelial cells. The following organisms are generally considered susceptible to selenium sulfide in vitro: <i>Malassezia furfur</i>, <i>Microsporum sp.</i> including <i>Microsporum audouinii</i> and <i>Microsporum canis</i>, <i>Pityrosporon sp.</i>, <i>Trichophyton sp.</i> including <i>Trichophyton schoenleinii</i> and <i>Trichophyton tonsurans</i>. Selenium sulfide has been shown to be sporicidal to <i>T. tonsurans</i>, the most common etiologic agent of tinea capitis. One in-vitro study demonstrated that 2.5% selenium sulfide was equivalent in sporicidal activity to both 1% and 2% zinc pyrithione.', 'Selenium sulfide is an antifungal agent often used in shampoos for the treatment of dandruff and seborrheic dermatitis. Selenium sulfide is highly active in inhibiting the growth of <i>P. ovale</i>. It is also a proven cytostatic agent, slowing the growth of both hyperproliferative and normal cells in dandruff and seborrheic dermatitis. A 0.6% micronized form of selenium sulfide is also safe and effective for dandruff.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Gram bone 30 tab', 18756, 'جرام بون 30 قرص', '99', '81', 'Multivitamin', 'Multivitamin', NULL, 'Calcium+vitamin d3', 'Pharma gram', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 794, '2025-08-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pramover top. oint. 40 gm', 25126, 'براموفير مرهم 40جم', '27', NULL, NULL, NULL, NULL, 'Bacitracin+neomycin+polymyxin+pramoxine', 'Marcyrl co. > vertex pharmaceuticals-egypt', 'Oint', 'مرهم', '40 gm', '1', NULL, NULL, NULL, '0215970204', 705, '2022-07-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bio balance sun protection cream spf 50+ 75 ml', 15222, 'بيو بالانس كريم للحماية من الشمس بعامل حماية 50+ 75 مل', '230', NULL, 'Sun block', 'Sun block', NULL, NULL, 'Alpaya dermaceuticals > vamer pharma', 'Cream', 'كريم', '75 ml', '1', NULL, NULL, 'product details cream biobalance sunscreen for the face wide and suitable for all skin types - sensitive skin mixed and dry a skin moisturizer with shea butter and glycerol it contains anti-inflammatory substances + grape seed extract + extract of rosemar', NULL, 771, '2022-07-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefazone plus 1.5 gm (i.v/i.m) inj. vial', 2225, 'سيفازون بلس 1.5جم فيال', '77', '52.5', 'Antibiotic.cephalosporin.third-generation', 'Antibiotic.cephalosporin.third-generation', NULL, 'Cefoperazone+sulbactam', 'Pharco b', 'Inj', 'حقن', '1.5 gm', '1', 'مضاد حيوى واسع المدى وهو فعال ضد كثير من الجراثيم ويعالج الكثير من الالتهابات', NULL, 'indications for cefoperazone sodium + sulbactam sodium it is a combination of third generation cephalosporins cefperazone sodium and beta-lactamase inhibitor sulbactam. 1.pharyngitis 2.tonsillitis 3.pneumonia 4.bronchitis 5.other respiratory tract infecti', '6222012238538', 11482, '2025-02-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Similac gold 2 milk 400 gm', 27004, 'سيميلاك جولد 2 لبن اطفال 400 جم', '360', '224.3', 'Milk products.second stage (age 6-12 months)', 'Milk products.second stage (age 6-12 months)', NULL, 'Milk formula stage 2', 'Abbott laboratories > ibn sina', 'Unknown', 'غير محدد', '400 gm', '1', NULL, NULL, 'not to replace mother s milk. for infants from 6-12 months age. to be used within one month from opening.', '5099864011364', 809, '2025-09-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Glycerin luna soap', 3348, 'جلسرين لونا صابون', '20', NULL, NULL, NULL, NULL, 'Glycerin', 'Luna', 'Soap', 'صابون', NULL, '1', NULL, NULL, NULL, '6221039304332', 1226, '2023-01-12', NULL, 0, 'It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.', 'When administered rectally, glycerin exerts a hygroscopic and/or local irritant action, drawing water from the tissues into the feces and reflexively stimulating evacuation. 

Glycerin decreases intraocular pressure by creating an osmotic gradient between the blood and intraocular fluid, causing fluid to move out of the aqueous and vitreous humors into the bloodstream.', 'Glycerin is commonly classified as an osmotic laxative but may act additionally or alternatively through its local irritant effects; it may also have lubricating and fecal softening actions. Glycerin suppositories usually work within 15 to 30 minutes.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Alpecin active shampoo a1 for normal or dry scalp 250 ml (n/a)', 13821, 'البسين اكتيف شامبو ايه 1 250 مل', '100', NULL, 'Hair care', 'Hair care', NULL, NULL, 'Dr. kurt wolff > nerhadou international co.', 'Amp', 'أمبول', '250 ml', '1', NULL, NULL, 'menthol refreshes and pleasantly activates the scalp and promotes circulation panthenol is a provitamin from the b-group that provides scalp and hair with moisture storage and reduces taut sensations caffeine activates skin regeneration and fortifies the', NULL, 637, '2022-08-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sensoderm cream 50 gm', 26792, 'سنسوديرم كريم 50 جرام', '65', '60', 'Soothing topical', 'Soothing topical', NULL, 'Panthenol+liquorice+vitamin e+urea+bees wax+calendula+triclosan+dimethicone', 'Hi-care > novex', 'Cream', 'كريم', '50 gm', '1', 'كريم ترطيب وتغذية البشرة غنى بالفيتامينات ومضادات الاكسدة', NULL, 'indications : sensitive skin . neonates and babies skin hygiene . contact dermatitis and sweat rash .', '6224000201173', 2104, '2025-01-31', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zswev joint 30 tabs', 3566, 'زسف جوينت 30 قرص', '390', NULL, 'Multivitamin', 'Multivitamin', NULL, 'Glucosamine sulfate+chondroitin sulfate+msm+ginkgo biloba+protein nlt+copper+manganese+vitamin d3+vitamin c', 'Advent pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1354, '2025-04-17', NULL, 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ciprofar 500mg 10 f.c.tab', 2638, 'سيبروفار 500 مجم 10 اقراص', '69', '47', 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Ciprofloxacin', 'Pharco', 'Tab', 'أقراص', '500mg', '1', 'مضاد حيوي', NULL, NULL, '6221151002697', 7724, '2024-08-24', NULL, 0, 'Ciprofloxacin is only indicated in infections caused by susceptible bacteria.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]



Ciprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.[L6481,L6478]



A ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa.[L6469,L6484] Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa.[L6490] A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.[L6493]



A ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis.[L6472] A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.[L6475]



A ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.[L6487]', 'Ciprofloxacin acts on bacterial topoisomerase II (DNA gyrase) and topoisomerase IV.[A178885] Ciprofloxacin''s targeting of the alpha subunits of DNA gyrase prevents it from supercoiling the bacterial DNA which prevents DNA replication.[A178876,A178882]', 'Ciprofloxacin is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria.[A178870,L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV.[A178885] Ciprofloxacin binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.[A178894] There is no cross resistance between fluoroquinolones and other classes of antibiotics, so it may be of clinical value when other antibiotics are no longer effective.[A178894] Ciprofloxain and its derivatives are also being investigated for its action against malaria, cancers, and AIDS.[A178885]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Duranftat 200 mg 30 f.c. tabs.', 17969, 'ديورانفتات 200 مجم 30 قرص', '38', NULL, 'Anti-ischemic', 'Anti-ischemic', NULL, 'Naftidrofuryl', 'Rameda', 'Tab', 'أقراص', '200 mg', '3', 'علاج قصور الدموية -- تنشيط الدولرة الدموية للمخ -- منشط للدورة الدموية بعد الجلطات', NULL, 'naftidrofuryl oxalate works in two main ways. firstly it causes the blood vessels to widen. secondly it increases the ability of cells to remove waste products. in peripheral vascular diseases the blood vessels in the extremities are narrowed and the bloo', NULL, 1591, '2022-05-30', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tulangocal syrup 100 ml', 31744, 'تولانجوكال شراب 100 مل', '45', '39', 'Calcium supplement', 'Calcium supplement', NULL, 'Calcium carbonate+magnesium carbonate+vitamin d3+zinc', 'Praxo pharm', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, NULL, '6224001594021', 669, '2023-09-24', NULL, 0, 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.', 'Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed.', 'Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40% to 80% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Gamps agilita 30 capsules', 7167, 'جامبس اجيليتا 30 كبسولة', '333', NULL, 'Dietary supplement', 'Dietary supplement', NULL, 'Garcinia cambogia+green coffee bean extract+caffeine anhydrous+green tea extract', 'Dopamine pharma', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 953, '2025-08-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Noricept 200 mg/ml i.m. amp.', 8983, 'نوريسبت 200 مجم/مل امبول', '14', NULL, 'Synthetic progesterone', 'Synthetic progesterone', NULL, 'Norethisterone', 'Cid', 'Amp', 'أمبول', '200 mg', '1', NULL, NULL, 'about norethisterone norethisterone and its acetate and enanthate esters are synthetic progestogens given by mouth given in the treatment of abnormal uterine bleeding and endometriosis. indications for norethisterone primary & secondary amenorrhoea of lon', '6221043012650', 833, '2022-12-07', NULL, 0, 'Norethisterone is indicated as an oral contraceptive when given as monotherapy[L9527] or in combination with an estrogen component, such as [ethinylestradiol] or [estradiol].[L10313,L10307] In combination with an estrogen component, oral norethisterone is also indicated as a hormone replacement therapy in the treatment of postmenopausal osteoporosis and moderate-to-severe vasomotor symptoms arising from menopause.[L10304] When applied via transdermal patch, the combination of norethisterone and estradiol is indicated for the treatment of hypoestrogenism, vulvovaginal atrophy, and moderate-severe vasomotor symptoms.[L10301]



Norethisterone, taken in combination with intramuscular [leuprolide], is also indicated for the symptomatic treatment of endometriosis-related pain.[L10310]', 'On a molecular level, progestins like norethisterone exert their effects on target cells via binding to progesterone receptors that result in downstream changes to target genes.[L10304] Target cells are found in the reproductive tract, breast, pituitary, hypothalamus, skeletal tissue, and central nervous system.[L10304] Contraceptive efficacy is derived mainly from changes to the cervical mucus, wherein norethisterone increases the cell content and viscosity of the mucous to impede sperm transport and migration.[L9527] Norethisterone also induces a variety of changes to the endometrium - including atrophy, irregular secretion, and suppressed proliferation - that make it inhospitable for implantation.[L9527,A37129] Working via a negative feedback loop, norethisterone also acts on both the hypothalamus and anterior pituitary to suppress the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. Suppression of these hormones prevents follicular development, ovulation, and corpus luteum development.[A37129] 



When used as a component of hormone replacement therapy in menopausal women, norethisterone’s value is mainly in suppressing the growth of the endometrium.[A188156] As estrogen stimulates endometrial growth, the unopposed use of estrogen in postmenopausal women with an intact uterus can lead to endometrial hyperplasia which can increase the risk of endometrial cancer. The addition of a progestin to a hormone replacement therapy in this population protects against this endometrial hyperplasia and, therefore, lowers the risk associated with the use of hormone replacement therapies.



Norethisterone, along with other progestins and endogenous progesterone, has a low affinity for other steroid receptors, such as the androgen receptor and glucocorticoid receptor.[A10367,A188075] While affinity and agonistic activity at these receptors is minimal, it is thought that androgen receptor agonism is responsible for some of the adverse effects observed with progestin use (e.g. acne, serum lipid changes).[A10367]', 'Norethisterone is a synthetic oral progestin used for contraception or to treat other hormone-related conditions such as menopausal symptoms and endometriosis. As a synthetic progestin, norethisterone acts similarly to endogenous progesterone but with a much higher potency - it acts at the pelvic level to alter cervical and endometrial function, as well as via the inhibition of pituitary hormones that play a role in follicular maturation and ovulation.[L9527] A small increase in the risk of developing breast cancer has been observed in patients using combined oral contraceptives, with some evidence also implicating progestin-only pills - patients starting hormonal contraception should be advised of this risk and should employ routine breast self-examinations to check for evidence of any developing masses.[L9527]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Gasec 20mg 7 caps.', 19580, 'جازيك 20مجم 7 كبسولات', '26', NULL, 'Peptic ulcer.proton pump inhibitor', 'Peptic ulcer.proton pump inhibitor', NULL, 'Omeprazole', 'Mup > acino', 'Cap', 'كبسولة', '20mg', '1', NULL, NULL, NULL, NULL, 1265, '2023-04-18', NULL, 0, 'Omeprazole, according to the FDA label [FDA label] is a proton pump inhibitor (PPI) used for the following purposes:



• Treatment of active duodenal ulcer in adults 



• Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer

recurrence in adults 



• Treatment of active benign gastric ulcer in adults 



• Reduction of risk of upper gastrointestinal (GI) bleeding in critically ill adult patients.



• Treatment of symptomatic gastroesophageal reflux disease (GERD) in

patients 1 year of age and older 



• Treatment of erosive esophagitis (EE) due to acid-mediated GERD in

patients 1 month of age and older 



• Maintenance of healing of EE due to acid-mediated GERD in patients 1

year of age and older 



• Pathologic hypersecretory conditions in adults', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump [A175180], expressed in high quantities by the parietal cells of the stomach. ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid) [A174295].



Omeprazole is a member of a class of antisecretory compounds, the substituted _benzimidazoles_, that stop gastric acid secretion by selective inhibition of the _H+/K+ ATPase_ enzyme system. Proton-pump inhibitors such as omeprazole bind covalently to cysteine residues via disulfide bridges on the alpha subunit of the _H+/K+ ATPase_ pump, inhibiting gastric acid secretion for up to 36 hours [A175192].  This antisecretory effect is dose-related and leads to the inhibition of both basal and stimulated acid secretion, regardless of the stimulus [FDA label].  



**Mechanism of H. pylori eradication**



Peptic ulcer disease (PUD) is frequently associated with _Helicobacter pylori_ bacterial infection (NSAIDs) [A175195]. The treatment of H. pylori infection may include the addition of omeprazole or other proton pump inhibitors as part of the treatment regimen [FDA label], [A175198]. 

_H. pylori_ replicates most effectively at a neutral pH [A175213]. Acid inhibition in H. pylori eradication therapy, including proton-pump inhibitors such as omeprazole, raises gastric pH, discouraging the growth of H.pylori [A175198]. It is generally believed that proton pump inhibitors inhibit the _urease_ enzyme, which increases the pathogenesis of H. pylori in gastric-acid related conditions [A175216].   ', '**Effects on gastric acid secretion**



This drug decreases gastric acid secretion [FDA label]. After oral administration, the onset of the antisecretory effect of omeprazole is usually achieved within one hour, with the maximum effect occurring by 2 hours after administration. The inhibitory effect of omeprazole on acid secretion increases with repeated once-daily dosing, reaching a plateau after four days [FDA label].



**Effects on serum gastrin**



In studies of 200 or more patients, serum gastrin levels increased during the first 1-2 weeks of daily administration of therapeutic doses of omeprazole. This occurred in a parallel fashion with the inhibition of acid secretion. No further increase in serum gastrin occurred with continued omeprazole administration. Increased gastrin causes enterochromaffin-like cell hyperplasia and increased serum Chromogranin A (CgA) levels. The increased CgA levels may lead to false positive results in diagnostic studies for neuroendocrine tumors [FDA label].



**Enterochromaffin-like (ECL) cell effects**



Human gastric biopsy samples have been obtained from more than 3000 pediatric and adult patients treated with omeprazole in long-term clinical studies. The incidence of enterochromaffin-like cell hyperplasia in these studies increased with time; however, no case of ECL cell carcinoids, dysplasia, or neoplasia have been identified in these patients. These studies, however, are of insufficient in power and duration to draw conclusions on the possible influence of long-term administration of omeprazole in the development of any premalignant or malignant conditions [FDA label]. 



**Other effects**



Systemic effects of omeprazole in the central nervous system, cardiovascular and respiratory systems have not been found to date. Omeprazole, given in oral doses of 30 or 40 mg for 2-4 weeks, showed no effect on thyroid function, carbohydrate metabolism, or circulating levels of parathyroid hormone, cortisol, estradiol, testosterone, prolactin, cholecystokinin or secretin [FDA label]. 





', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Amlobenzamir 10/20mg 10 caps.', 13957, 'املوبينزامير 10/20 مجم 10 كبسولات', '16', NULL, 'Antihypertensive.combined ace with calcium channel blocker', 'Antihypertensive.combined ace with calcium channel blocker', NULL, 'Amlodipine+benazepril', 'Medizen pharmaceutical industries > mira international', 'Cap', 'كبسولة', '20mg', '1', 'علاج ارتفاع ضغط الدم', NULL, 'mechanism of action of amlodipine amlodipine is a second generation dihydropyridine ca channel blocker. it exerts it`s antihypertensive antianginal actions through blocking the influx of ca ions through voltage gated l-type ca channels to the peripheral v', NULL, 835, '2022-05-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Phytonadione 10 mg 5 amp.', 24925, 'فيتوناديون 10مجم 5 امبول', '16', NULL, 'Vitamin k', 'Vitamin k', NULL, 'Vitamin k1', 'Sedico', 'Amp', 'أمبول', '10 mg', '5', NULL, NULL, 'about vitamin k fat soluble vitamin antihemorrhagic. mechanism of action of vitamin k phytonadione (vitamin k1) is a synthetic form of vitamin k and is lipid soluble. vitamin k acts as a cofactor in the synthesis of coagulation proteins; prothrombin facto', NULL, 949, '2022-07-15', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Epidopa 250mg 30 f.c. tab.', 4254, 'ابيدوبا 250مجم 30 قرص', '23', NULL, 'Antihypertensives.centeral alpha 2 agonist', 'Antihypertensives.centeral alpha 2 agonist', NULL, 'Methyldopa', 'Eipico', 'Tab', 'أقراص', '250mg', '3', NULL, NULL, 'about methyldopa centrally acting alpha-2 agonist a phenylalanine derivative antihypertensive (pregnancy-induced hypertension). mechanism of action of methyldopa methyl dopa gets metabolized in the adrenergic neurons to alpha methyl nor adrenaline which a', '6221032118882', 923, '2022-12-05', NULL, 0, 'Methyldopa is indicated for the management of hypertension as monotherapy [L32614] or in combination with hydrochlorothiazide.[L32619] Methyldopa injection is used to manage hypertensive crises.[L32624]', 'The exact mechanism of methyldopa is not fully elucidated; however, the main mechanisms of methyldopa involve its actions on alpha-adrenergic receptor and the aromatic L-amino acid decarboxylase enzyme, to a lesser extent. The sympathetic outflow is regulated by alpha (α)-2 adrenergic receptors and imidazoline receptors expressed on adrenergic neurons within the rostral ventrolateral medulla.[A1501] Methyldopa is metabolized to α‐methylnorepinephrine via dopamine beta-hydroxylase activity and, consequently, alpha-methylepinephrine via phenylethanolamine-N-methyltransferase activity.[A232244, A232249, A232259] Mediating the therapeutic effects of methyldopa, α‐methylnorepinephrine and α-methylepinephrine active metabolites are agonists at presynaptic alpha-2 adrenergic receptors in the brainstem. Stimulating alpha-2 adrenergic receptors results in the inhibition of adrenergic neuronal outflow and attenuation of norepinephrine release in the brainstem. Consequently, the output of vasoconstrictor adrenergic signals to the peripheral sympathetic nervous system is reduced, leading to a reduction in blood pressure.[A1499]



The L-isomer of alpha-methyldopa also reduces blood pressure by inhibiting aromatic L-amino acid decarboxylase, also known as DOPA decarboxylase, which is an enzyme responsible for the syntheses of dopamine and serotonin.[L32614] Inhibiting this enzyme leads to depletion of biogenic amines such as norepinephrine. However, inhibition of aromatic L-amino acid decarboxylase plays a minimal role in the blood-pressure‐lowering effect of methyldopa.[A1501, A1505]', 'Antihypertensive effects of methyldopa are mostly mediated by its pharmacologically active metabolite, alpha-methylnorepinephrine, which works as an agonist at central inhibitory alpha-adrenergic receptors.[L32614] Stimulation of alpha-adrenergic receptors leads to decreased peripheral sympathetic tone and reduced arterial pressure.[A1505] Methyldopa causes a net reduction in the tissue concentration of serotonin, dopamine, norepinephrine, and epinephrine. Overall, methyldopa lowers both standing blood pressure and especially supine blood pressure, with infrequent symptomatic postural hypotension. Methyldopa also reduces plasma renin activity but has negligible effects on glomerular filtration rate, renal blood flow, or filtration fraction. It also has no direct effect on cardiac function but in some patients, a slowed heart rate may occur.[L32614]



Following oral administration, blood-pressure-lowering effects are observed within 12 to 24 hours in most patients, and a maximum reduction in blood pressure occurs in 4 to 6 hours. Blood pressure returns to pre-treatment levels within 24 to 48 hours following drug discontinuation.[L32614] Following intravenous administration, the blood-pressure-lowering effects of methyldopa last for about 10 to 16 hours.[A231784]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Invega 6mg 7 extended release tabs', 6545, 'انفيجا 6مجم 7 اقراص ممتدة المفعول', '300', '210', 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Paliperidone', 'Janssen cilag > soficopharm', 'Tab', 'أقراص', '6mg', '1', 'امراض نفسية -- مضاد للذهان', NULL, NULL, NULL, 2045, '2024-04-27', NULL, 0, 'As an oral extended-release tablet and a once-monthly extended-release suspension for intramuscular injection, paliperidone is indicated for the treatment of adults and adolescents with schizophrenia and in the treatment of schizoaffective disorder in combination with antidepressants or mood stabilizers.[L16168,L37744] Paliperidone is also available in both an every-three-month and twice-yearly extended-release suspension for intramuscular injection for the treatment of schizophrenia.[L4137,L37749]', 'Paliperidone is the major active metabolite of risperidone. The mechanism of action of paliperidone, as with other drugs having efficacy in schizophrenia, is unknown, but it has been proposed that the drug''s therapeutic activity in schizophrenia is mediated through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism.', 'Paliperidone is an atypical antipsychotic developed by Janssen Pharmaceutica. Chemically, paliperidone is primary active metabolite of the older antipsychotic risperidone (paliperidone is 9-hydroxyrisperidone). The mechanism of action is unknown but it is likely to act via a similar pathway to risperidone.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Immufer syrup 120 ml', 32116, 'ايميوفير شراب 120 مل', '60', '55', 'Iron supplement', 'Iron supplement', NULL, 'Elemental iron+folic acid+zinc+vitamin b12+vitamins (b1+b2+b3+b6)+vitamin c+lactoferrin', 'Maxel pharma for pharmaceuticals > louran pharma', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 1096, '2024-08-13', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sabastatin xr 40mg 10 ext. rel. f.c. tabs.', 10128, 'ساباستاتين اكس ار 40مجم 10 اقراص', '30', NULL, 'Antihyperlipidemic.statins', 'Antihyperlipidemic.statins', NULL, 'Lovastatin', 'Bioriginal international group pharma egypt > sab for trading import & export', 'Tab', 'أقراص', '40mg', '1', NULL, NULL, 'about lovastatin statin class hmg-coa reductase inhibitor hypolipidemic agent. mechanism of action of lovastatin it is a precursor lactone hydrolyzed in to active beta-hydroxy acid which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl', NULL, 777, '2023-01-16', NULL, 0, 'Lovastatin is indicated to reduce the risk of myocardial infarction, unstable angina, and the need for coronary revascularization procedures in individuals without symptomatic cardiovascular disease, average to moderately elevated total-C and LDL-C, and below average HDL-C. It is indicated as an intervention alternative in individuals presenting dyslipidemia at risk of developing atherosclerotic vascular disease. The administration of this agent should be accompanied by the implementation of a fat and cholesterol-restricted diet.[F4661]



Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Lovastatin is indicated as an adjunct to diet for the reduction of elevated total-C and LDL-C levels in patients with primary hypercholesterolemia (Types IIa and IIb2), when the response to diet restricted in saturated fat and cholesterol and to other nonpharmacological measures alone has been inadequate.[F4661,F4664]



Lovastatin is also indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower total-C and LDL-C to target levels.[F4661]



Lovastatin is indicated as an adjunct to diet to reduce total-C, LDL-C and apolipoprotein B levels in adolescent boys and girls with Heterozygous Familial Hypercholesterolemia (HeFH) who are at least one year post-menarche, 10 to 17 years of age, with HeFH if after an adequate trial of diet therapy the following findings are present: LDL-C remains greater than 189 mg/dL or LDL-C remains greater than 160 mg/dL and there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present in the adolescent patient.



Before administering lovastatin, it is important to rule out the presence of secondary causes of hypercholesterolemia and a lipid profile should be performed.



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Lovastatin is a lactone which is readily hydrolyzed _in vivo_ to the corresponding β-hydroxyacid and strong inhibitor of HMG-CoA reductase, a hepatic microsomal enzyme which catalyzes the conversion of HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A ) to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421,A174553] At therapeutic lovastatin doses, HMG-CoA reductase is not completely blocked, thereby allowing biologically necessary amounts of mevalonate to be available. Because the conversion of HMG-CoA to mevalonate is an early step in the biosynthetic pathway for cholesterol, therapy with lovastatin would not be expected to cause an accumulation of potentially toxic sterols.[F4664]



Lovastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increase hepatic uptake of LDL. Lovastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL). The overall effect is a decrease in plasma LDL and VLDL and a significant reduction in the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475]



A significant effect on LDL-C reduction was seen within 2 weeks of initiation of lovastatin, and the maximum therapeutic response occurred within 4-6 weeks. The response was maintained during continuation of therapy. Single daily doses given in the evening were more effective than the same dose given in the morning, perhaps because cholesterol is synthesized mainly at night. When therapy with lovastatin is stopped, total cholesterol has been shown to return to pre-treatment levels.[F4664]



In vitro and in vivo animal studies also demonstrate that lovastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Lovastatin has been reported to have beneficial effects on certain cancers. This includes a multi-factorial stress-triggered cell death (apoptosis) and DNA degradation response in breast cancer cells.[A181937] It has also been shown to inhibit histone deacetylase 2 (HDAC2) activity and increase the accumulation of acetylated histone-H3 and the expression of p21(WAF/CIP) in human cancer cells, suggesting that statins might serve as novel HDAC inhibitors for cancer therapy and chemoprevention.[A15235]', 'Lovastatin is an oral antilipemic agent which reversibly inhibits HMG-CoA reductase. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, lovastatin reduces the risk of cardiovascular morbidity and mortality.[A174580,A181087,A181406,A181925]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A174580,A181397,A181403] Clinical studies have shown that lovastatin reduces LDL-C and total cholesterol by 25-40%.[A174580] The 50% inhibitory dose is known to be of 46 mcg/kg which is translated into a reduction of approximately 30% of plasma cholesterol.[A174553]



**Myopathy/Rhabdomyolysis**



Lovastatin, like other inhibitors of HMG-CoA reductase, occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above ten times the upper limit of normal (ULN). Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred. The risk of myopathy is dose-related and is increased by high levels of HMG-CoA reductase inhibitory activity in plasma. In a clinical study (EXCEL)[A181925] in which patients were carefully monitored and some interacting drugs were excluded, there was one case of myopathy among 4933 patients randomized to lovastatin 20 to 40 mg daily for 48 weeks, and 4 among 1649 patients randomized to 80 mg daily.



Predisposing factors for myopathy include advanced age (≥65 years), female gender, uncontrolled hypothyroidism, and renal impairment. Chinese patients may also be at increased risk for myopathy. In most cases, muscle symptoms and CK increases resolved when treatment was promptly discontinued.



The risk of myopathy during treatment with lovastatin may be increased with concurrent administration of interacting drugs such as [fenofibrate], [niacin], [gemfibrozil], [cyclosporine], and strong inhibitors of the CYP3A4 enzyme.  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4661,F4664]



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Dysfunction**



Persistent increases (to more than 3 times the upper limit of normal) in serum transaminases occurred in 1.9% of adult patients who received lovastatin for at least one year in early clinical trials. When the drug was interrupted or discontinued in these patients, the transaminase levels usually fell slowly to pretreatment levels. The increases usually appeared 3 to 12 months after the start of therapy with lovastatin, and were not associated with jaundice or other clinical signs or symptoms.[F4661] In the EXCEL study,[A181925] the incidence of persistent increases in serum transaminases over 48 weeks was 0.1% for placebo, 0.1% at 20 mg/day, 0.9% at 40 mg/day, and 1.5% at 80 mg/day in patients on lovastatin. However, in post-marketing experience with lovastatin, symptomatic liver disease has been reported rarely at all dosages.[F4661]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pregdin-apex 300mg 20 caps.', 25172, 'بريجدين ابيكس 300مجم 20 كبسول', '134', NULL, 'Anti-epileptic.gaba analogs', 'Anti-epileptic.gaba analogs', NULL, 'Pregabalin', 'Multi-apex', 'Cap', 'كبسولة', '300mg', '2', NULL, NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', '6223003202668', 1118, '2022-12-08', NULL, 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Samalvi 30 tabs', 32315, 'سامالفي 30 قرص', '75', '65', 'Multivitamin', 'Multivitamin', NULL, 'Calcium+magnesium+vitamin d3', 'Pharma zad > samanta group', 'Tab', 'أقراص', NULL, '3', 'مكمل غذائى لدعم النمو الطبيعيى للعظام والغضاريف والوقاية من الكساح وهشاشة العظام وتقليل الشد العضلى', NULL, NULL, '6224002695031', 1444, '2024-04-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Emerita vag.douche 250 ml', 18235, 'اميريتا غسول مهبلي 250 مل', '30', NULL, 'Vaginal wash', 'Vaginal wash', NULL, NULL, 'El-helou perfumes & cosmetics > safety pharma', 'Unknown', 'غير محدد', '250 ml', '1', NULL, NULL, NULL, NULL, 777, '2022-07-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Activate 200mg 40 sugar coated tab.', 106, 'اكتيفيت 200 مجم 40 قرص', '26', NULL, 'Nootropic', 'Nootropic', NULL, 'Sulbutiamine', 'Sigma', 'Tab', 'أقراص', '200mg', '2', 'تحسين الذاكرة -- الوعي الكامل للبيئة المحيطة', NULL, 'about sulbutiamine a synthetic derivative of thiamine a centrally acting cholinergic agent nootropic antiasthenic. mechanism of action of sulbutiamine sulbutiamine is a centrally acting cholinergic agent. this drug inhibits the enzyme acetyl cholinesteras', '6221051010051', 5401, '2022-12-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Atoderm pain (soap) 150 gm', 14544, 'اتوديرم صابون 150 جم', '215', NULL, 'Moisturizing topicals', 'Moisturizing topicals', NULL, NULL, 'Bioderma dermatological laboratories > biotech egypt', 'Soap', 'صابون', '150 gm', '1', NULL, NULL, 'purifying ultra-rich soap for daily use that restores natural lipids for severe and recurrent cutaneous dryness and reactive and irritated zones. ï¿½ the atoderm ultra-rich soap formula based on extremely mild surfactants contains ultra-rich soothing and', NULL, 793, '2022-08-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Coughpent syrup 120 ml', 16856, 'كفبنت شراب 120 مل', '18', NULL, 'Anti-cough', 'Anti-cough', NULL, 'Guaiacol+pholcodine', 'Global napi pharmaceuticals > penta pharma-egypt', 'Syrup', 'شراب', '120 ml', '1', 'علاج للكحة', NULL, NULL, '6223002147175', 983, '2022-05-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vital care conditioner imperial argan 250ml', 29469, 'فيتال كير 250مل', '88', NULL, 'Hair care', 'Hair care', NULL, NULL, 'So.di.co. srl > bright star -egypt', 'Conditioner', 'بلسم', '250ml', '1', NULL, NULL, NULL, NULL, 657, '2022-07-31', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Panthovera hair shampoo 250 ml', 9602, 'بانثوفيرا شامبو للشعر 250 مل', '185', '150', 'Hair care', 'Hair care', NULL, 'L-arginine+saw palmetto ext+ginkgo biloba ext+rosemary ext+thyme ext+lavender oil+aloe vera+panthenol+jojoba', 'Hi-care > rovamed pharma', 'Amp', 'أمبول', '250 ml', '1', NULL, NULL, '** hair strengthening & revitalizing. new formula .. fortified with: l-arginine & silicone ** indications -adjuvant therapy in cases of hair loss -protect dry and damaged hair & prevent split ends -stimulate hair growth and increase its density - highly c', '6224011042239', 3150, '2025-01-14', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Repaglid 0.5mg 20 tab.', 25885, 'ريباجليد 0.5مجم 20 اقراص', '11', NULL, 'Anti-diabetic.secretagogues.glinides', 'Anti-diabetic.secretagogues.glinides', NULL, 'Repaglinide', 'Multi-apex', 'Tab', 'أقراص', '0.5mg', '2', NULL, NULL, 'about repaglinide meglitinide derivative insulin secretagogue oral anti-diabetic drug. mechanism of action of repaglinide it is a quick and short acting antidiabetic drug which exerts it`s action by stimulating insulin release from ?-cells of pancreas. it', '6223003201487', 742, '2022-12-08', NULL, 0, 'As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ', 'Repaglinide activity is dependent on the presence functioning &beta; cells and glucose. In contrast to sulfonylurea insulin secretatogogues, repaglinide has no effect on insulin release in the absence of glucose. Rather, it potentiates the effect of extracellular glucose on ATP-sensitive potassium channel and has little effect on insulin levels between meals and overnight. As such, repaglinide is more effective at reducing postprandial blood glucose levels than fasting blood glucose levels and requires a longer duration of therapy (approximately one month) before decreases in fasting blood glucose are observed. The insulinotropic effects of repaglinide are highest at intermediate glucose levels (3 to 10 mmol/L) and it does not increase insulin release already stimulated by high glucose concentrations (greater than 15 mmol/L). Repaglinide appears to be selective for pancreatic &beta; cells and does not appear to affect skeletal or cardiac muscle or thyroid tissue. ', 'Insulin secretion by pancreatic &beta; cells is partly controlled by cellular membrane potential. Membrane potential is regulated through an inverse relationship between the activity of cell membrane ATP-sensitive potassium channels (ABCC8) and extracellular glucose concentrations. Extracellular glucose enters the cell via GLUT2 (SLC2A2) transporters. Once inside the cell, glucose is metabolized to produce ATP. High concentrations of ATP inhibit ATP-sensitive potassium channels causing membrane depolarization. When extracellular glucose concentrations are low, ATP-sensitive potassium channels open causing membrane repolarization. High glucose concentrations cause ATP-sensitive potassium channels to close resulting in membrane depolarization and opening of L-type calcium channels. The influx of calcium ions stimulates calcium-dependent exocytosis of insulin granules. Repaglinide increases insulin release by inhibiting ATP-sensitive potassium channels in a glucose-dependent manner. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('La roche-posay micellar water 400 ml', 21506, 'لاروش بوزيه ماء ميسيلار 400مل', '199', NULL, 'Skin care', 'Skin care', NULL, NULL, 'La roche-posay > united company for trading & distribution', 'Unknown', 'غير محدد', '400 ml', '1', NULL, NULL, '*properties: sensitive skin physiological ph. high cleansing efficacy and cleansing surfactants selected for an optimal tolerance. no soap. no colorants. no alcohol. no parabens. use: apply to the face eyes and lips using a cotton pad. no rinsing.', NULL, 499, '2022-08-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Healthoval woman 30 tabs', 8223, 'هيلثوفال وومن للسيدات 30 قرص', '180', NULL, 'Multivitamin', 'Multivitamin', NULL, 'Vitamin a+vitamin c+vitamin d3+vitamin e+vitamin k+thiamine+riboflavin+niacin+vitamin b6+folic acid+vitamin b12+biotin+pantothenic acid+calcium+iron+phosphorus+iodine+magnesium+zinc+selenium+copper+manganese+chromium+molybdenum+chloride+potassium', 'Tetracare limited', 'Tab', 'أقراص', NULL, '1', NULL, NULL, NULL, NULL, 528, '2025-12-07', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zesperone 4mg 10 f.c. tab', 29891, 'زيسبيرون 4مجم 10 اقراص', '62', '45', 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Risperidone', 'Global napi pharmaceuticals > rexcel', 'Tab', 'أقراص', '4mg', '1', NULL, NULL, NULL, NULL, 1737, '2023-12-20', NULL, 0, 'Risperidone is indicated for the treatment of schizophrenia [L12885,L44692,L46297] and irritability associated with autistic disorder.[L12885] It is also indicated as monotherapy, or adjunctly with lithium or valproic acid, for the treatment of acute mania or mixed episodes associated with bipolar I disorder.[L12885,L44692]



Risperidone is additionally indicated in Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches.[L12906]



Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.[A177226]', 'Though its precise mechanism of action is not fully understood, current focus is on the ability of risperidone to inhibit the D2 dopaminergic receptors and 5-HT2A serotonergic receptors in the brain. Schizophrenia is thought to result from an excess of dopaminergic D2 and serotonergic 5-HT2A activity, resulting in overactivity of central mesolimbic pathways and mesocortical pathways, respectively.[A1115, A1116, A1117]



D2 dopaminergic receptors are transiently inhibited by risperidone, reducing dopaminergic neurotransmission, therefore decreasing positive symptoms of schizophrenia, such as delusions and hallucinations.[A251765] Risperidone binds transiently and with loose affinity to the dopaminergic D2 receptor, with an ideal receptor occupancy of 60-70% for optimal effect.[A1119,A31773] Rapid dissociation of risperidone from the D2 receptors contributes to decreased risk of extrapyramidal symptoms (EPS), which occur with permanent and high occupancy blockade of D2 dopaminergic receptors.[A1118,A1119] Low-affinity binding and rapid dissociation from the D2 receptor distinguish risperidone from the traditional antipsychotic drugs. A higher occupancy rate of D2 receptors is said to increase the risk of extrapyramidal symptoms and is therefore to be avoided.[A1118,A1119,A31771] 

 

Increased serotonergic mesocortical activity in schizophrenia results in negative symptoms, such as depression and decreased motivation. The high-affinity binding of risperidone to 5-HT2A receptors leads to a decrease in serotonergic activity. In addition, 5-HT2A receptor blockade results in decreased risk of extrapyramidal symptoms, likely by increasing dopamine release from the frontal cortex, and not the nigrostriatal tract. Dopamine level is therefore not completely inhibited.[A1117,A1119] Through the above mechanisms, both serotonergic and D2 blockade by risperidone are thought to synergistically work to decrease the risk of extrapyramidal symptoms. 

 

Risperidone has also been said to be an antagonist of alpha-1 (α1), alpha-2 (α2), and histamine (H1) receptors.[A37034] Blockade of these receptors is thought to improve symptoms of schizophrenia, however the exact mechanism of action on these receptors is not fully understood at this time.[L12885]', 'The primary action of risperidone is to decrease dopaminergic and serotonergic pathway activity in the brain, therefore decreasing symptoms of schizophrenia and mood disorders.[A1115,A1116]



Risperidone has a high binding affinity for serotonergic 5-HT2A receptors when compared to dopaminergic D2 receptors in the brain.[A1114,A1115] Risperidone binds to D2 receptors with a lower affinity than first-generation antipsychotic drugs, which bind with very high affinity. A reduction in extrapyramidal symptoms with risperidone, when compared to its predecessors, is likely a result of its moderate affinity for dopaminergic D2 receptors.[A1119,A1117]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Glasuchond 30 tabs', 1258, 'جلاسوكوند 30 قرص', '350', NULL, 'Anti-rheumatic. osteoarthritis. anabolic agents', 'Anti-rheumatic. osteoarthritis. anabolic agents', NULL, 'Glucosamine 500 mg+chondroitin 300 mg+avocado-soybean unsaponifiables 100 mg+vitamin c+e and managanese', 'Glimmar pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 972, '2022-08-29', NULL, 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Charcoal ki 30 capsules', 5541, 'شاركول كي آي 30 كبسولة', '117', NULL, 'anti-flatulent', 'anti-flatulent', NULL, 'Charcoal 400mg+fennel seed extract 50mg+anise seed extract 50mg.', 'Ki pharma', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 869, '2022-08-07', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Spasmin 5 paed.supp.', 10744, 'سبازمين 5 اقماع لبوس اطفال', '3', NULL, 'Antispasmodic', 'Antispasmodic', NULL, 'Hexahydro-adiphenine+propyphenazone', 'Pharco', 'Supp', 'لبوس', NULL, '1', NULL, NULL, NULL, '6223000011829', 913, '2023-04-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Panax diarrex 200mg/5ml oral 120ml susp.', 24490, 'باناكس دايركس 200مجم/5مل 120مل شراب معلق', '6', NULL, 'Antidiarrheal', 'Antidiarrheal', NULL, 'Nifuroxazide', 'Panax pharma', 'Susp', 'معلق', '200mg', '2', NULL, NULL, 'indications infectious diarrhea in children and adults chronic colitis enterocolitis as an adjunctive treatment in combined therapy of intestinal dysbiosis. contraindication hypersensitivity to 5-nitrofurane derivatives and/or other components of the drug', NULL, 985, '2022-07-11', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Chemotrim forte 10 tab.', 16231, 'كيموتريم فورت 10 اقراص', '7', NULL, 'Antibiotic', 'Antibiotic', NULL, 'Sulphamethoxazole+trimethoprim', 'Kahira', 'Tab', 'أقراص', NULL, '1', NULL, NULL, 'indication for the treatment bacterial infections causing bronchitis prostatitis and urinary tract infections. mechanism of action sulfonamides inhibit the enzymatic conversion of pteridine and p-aminobenzoic acid (paba) to dihydropteroic acid by competin', '6221068000816', 840, '2022-12-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mucoline 30mg 30 tab.', 23071, 'ميكولين 30مجم 30 قرص', '14', NULL, 'Mucolytic', 'Mucolytic', NULL, 'Ambroxol', 'T3a pharma', 'Tab', 'أقراص', '30mg', '3', NULL, NULL, NULL, NULL, 871, '2022-07-07', NULL, 0, 'Ambroxol is indicated for secretolytic therapy in bronchoplmonary disease with abnormal mucus secretion and transport. It allows the mucus to be more easily cleared and ease a patient''s breathing.', 'Ambroxol is a mucolytic agent. Excessive Nitric oxide (NO) is associated with inflammatory and some other disturbances of airways function. NO enhances the activation of soluble guanylate cyclase and cGMP accumulation. Ambroxol has been shown to inhibit the NO-dependent activation of soluble guanylate cyclase. It is also possible that the inhibition of NO-dependent activation of soluble guanylate cyclase can suppress the excessive mucus secretion, therefore it lowers the phlegm viscosity and improves the mucociliary transport of bronchial secretions.', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sensajoy acne facial cleanser 200 ml', 31335, 'سنساجوي منظف وجه لحب الشباب 200 مل', '270', '250', 'Skin care', 'Skin care', NULL, NULL, 'Egyptian co. for cosmetics > orchidia', 'Cleanser', 'منظف', '200 ml', '1', NULL, NULL, 'sensajoy is a luxurious and effective ph balanced soap free facial wash that contains antimicrobials helpful in acne prone skin care. itï-s a gentle foam effec-tively cleanses the skin of impurities and make-up. zinc pca decrease sebum secretion while hel', NULL, 668, '2025-03-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bone cal 500mg 30 tab.', 15419, 'بون كال 500مجم 30 قرص', '24', NULL, 'Calcium supplement', 'Calcium supplement', NULL, 'Calcium', 'Amoun', 'Tab', 'أقراص', '500mg', '3', NULL, NULL, 'mechanism of action of calcium calcium is essential for maintaining the functional integrity of nervous muscular and skeletal system. it controls excitability of nerves and muscles and regulates permeability of cell membrane. it also regulates cell adhesi', '6221025017581', 2439, '2022-12-03', NULL, 0, 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.', 'Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed.', 'Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40% to 80% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Alka-misr alkaline wash powder 10 sachets', 345, 'الكا-مصر غسول قلوي بودرة 10 اكياس', '28', '10.5', 'Nasal/vaginal wash', 'Nasal/vaginal wash', NULL, 'Borax+sodium bicarbonate+sodium chloride', 'Misr > al delta pharmaceuticals trading co.', 'Powder', 'بودرة', NULL, '10', 'غسول المهبل -- غسول للأنف', NULL, NULL, '6224009706037', 9369, '2025-07-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Antikramp 5mg/2ml i.v./i.m. 1 amp.', 14242, 'انتيكرامب 5 مجم / 2مل 1 امبول', '4', NULL, 'Antispasmodic', 'Antispasmodic', NULL, 'Tiemonium methylsulphate', 'El nile.', 'Amp', 'أمبول', '5mg', '1', 'مضاد للتقلصات', NULL, 'tiemonium methylsulfate - treatment of acute intense or refractory painful syndromes with a spasmodic component. the use of noramidopyrine is only justified when its activity confers a real advantage over other analgesics. indications: smooth muscle spasm', NULL, 1151, '2022-07-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Servi light 60 caps.', 27768, 'سيرفي لايت 60 كبسولة', '460', '400', 'Weight loss', 'Weight loss', NULL, 'Green coffee', 'Servilife pharma', 'Cap', 'كبسولة', NULL, '6', '1- لحالات الوزن الزائد والسمنة.', NULL, NULL, '6224001269066', 1320, '2025-03-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neo move on cream 100 gm', 4357, 'نيو موف اون كريم 100 جم', '250', '220', 'Analgesic.antirheumatic', 'Analgesic.antirheumatic', NULL, NULL, 'Neo medical co. > arab doctors', 'Cream', 'كريم', '100 gm', '1', 'الام المفاصل والعظام والعضلات', NULL, NULL, NULL, 2989, '2025-01-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dudomez 40/1100mg 10 capsules', 17947, 'ديودوميز 40/1100 مجم 10 كبسولات', '66', '46', 'Peptic ulcer.proton pump inhibitor', 'Peptic ulcer.proton pump inhibitor', NULL, 'Omeprazole+sodium bicarbonate', 'Future pharmaceutical industries (fpi) > tabuk pharmaceutical manufacturing company', 'Capsule', 'كبسولة', '1100mg', '1', 'لعلاج حالات الحموضة وقرحة المعدة -- حالات حرقان الصدر بسبب زيادة حامض المعدة', NULL, NULL, '6223004710155', 2742, '2025-04-19', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Flowdon massage cream 60 gm', 30554, 'فلودون مساج كريم 60 جم', '49', '36', 'Massage cream', 'Massage cream', NULL, 'Camphor+menthol+eucalyptus', 'Nikim special chemicals > rivera pharm', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, 'massage cream relief pain edema analgesic', NULL, 1487, '2024-10-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Protoloc 40mg 14 e.c.tabs', 25430, 'بروتولوك 40مجم 14 قرص', '82', '55', 'Peptic ulcer.proton pump inhibitor', 'Peptic ulcer.proton pump inhibitor', NULL, 'Pantoprazole', 'Eva pharma > penta pharma-egypt', 'Tab', 'أقراص', '40mg', '2', 'لعلاج قرحة المعدة', NULL, NULL, '6224007738269', 6672, '2024-11-26', NULL, 0, '

**Pantoprazole Injection**:



**Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis**



Pantoprazole for injection is indicated for short-term treatment (7-10 days) of patients having gastroesophageal reflux disease (GERD) with a history of erosive esophagitis, as an alternative to oral medication in patients who are unable to continue taking pantoprazole delayed-release tablets. _Safety and efficacy of pantoprazole injection as the initial treatment of patients having GERD with a history of erosive esophagitis have not been demonstrated at this time_.[FDA label]



**Pathological Hypersecretion Associated with Zollinger-Ellison Syndrome**



Pantoprazole for injection is indicated for the treatment of pathological hypersecretory conditions associated with Zollinger-Ellison Syndrome or other neoplastic conditions.[FDA label]



**Pantoprazole delayed-release oral suspension**:



**Short-Term Treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)**



Indicated in adults and pediatric patients five years of age and above for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis. For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been determined.[F3202]



**Maintenance of healing of erosive esophagitis**



Indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD.[F3202]



**Pathological hypersecretory conditions including Zollinger-Ellison syndrome**



Indicated for the long-term treatment of the above conditions.[F3202]', 'Hydrochloric acid (HCl) secretion into the gastric lumen is a process regulated mainly by the H(+)/K(+)-ATPase of the proton pump, expressed in high quantities by the parietal cells of the stomach.[A174295] ATPase is an enzyme on the parietal cell membrane that facilitates hydrogen and potassium exchange through the cell, which normally results in the extrusion of potassium and formation of HCl (gastric acid). 



Proton pump inhibitors such as pantoprazole are substituted _benzimidazole_ derivatives, weak bases, which accumulate in the acidic space of the parietal cell before being converted in the _canaliculi_  (small canal) of the gastric parietal cell, an acidic environment, to active _sulfenamide_ derivatives. This active form then makes disulfide bonds with important cysteines on the gastric acid pump, inhibiting its function.[A174247] Specifically, pantoprazole binds to the _sulfhydryl group_ of H+, K+-ATPase, which is an enzyme implicated in accelerating the final step in the acid secretion pathway. The enzyme is inactivated, inhibiting gastric acid secretion.[A174253] The inhibition of gastric acid secretion is stronger with proton pump inhibitors such as pantoprazole and lasts longer than with the H(2) antagonists.[A174295] ', 'This drug acts to decrease gastric acid secretion, which reduces stomach acidity. Pantoprazole administration leads to long-lasting inhibition of gastric acid secretion.[F3193]



**General Effects**



Pantoprazole has been shown to reduce acid reflux-related symptoms, heal inflammation of the esophagus, and improve patient quality of life more effectively than histamine-2 receptor antagonists (H2 blockers). This drug has an excellent safety profile and a low incidence of drug interactions. It can be used safely in various high-risk patient populations, including the elderly and those with renal failure or moderate hepatic dysfunction.[A174226]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as pantoprazole have been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]



PPIs such as pantoprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes [A177577, A177580]. 



**A note on laboratory testing abnormalities**



During treatment with antisecretory medicinal products such as pantoprazole, serum gastrin (a peptide hormone that stimulates secretion of gastric acid) increases in response to the decreased acid secretion caused by proton pump inhibition. The increased gastrin level may interfere with investigations for neuroendocrine tumors. Published evidence suggests that proton pump inhibitors should be stopped 14 days before chromogranin A (CgA) measurements. This permits chromogranin A levels, that might be falsely elevated after proton pump inhibitor treatment, to return to the normal reference range.[F3217] 



Reports have been made of false-positive results in urine screening tests for tetrahydrocannabinol (THC) in patients receiving the majority of proton pump inhibitors, including pantoprazole. A confirmatory method should be used.[F3217]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Quetiasu 100mg 30 tabs', 7518, 'كويتياسو 100 مجم 30 قرص', '167', NULL, 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Quetiapine', 'Sun pharma', 'Tab', 'أقراص', '100mg', '3', NULL, NULL, NULL, NULL, 887, '2023-04-26', NULL, 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ismn stada 60mg m.r. 20 caps.', 20981, 'اسمن ستادا 60 مجم ام ار 20 كبسولة', '18', NULL, 'Antianginal', 'Antianginal', NULL, 'Isosorbide-5-mononitrate', 'Global napi pharmaceuticals > stada', 'Cap', 'كبسولة', '60mg', '2', NULL, NULL, 'about isosorbide-5-mononitrate alkyl nitrate derivative a direct vasodilator antianginal. mechanism of action of isosorbide-5-mononitrate it is a direct smooth muscle relaxant which have a prominent action vascular smooth muscles preferentially veins than', NULL, 754, '2022-07-28', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Penduline kids hair mask 300 ml', 24659, 'بيندولين ماسك شعر للاطفال 300مل', '95', NULL, 'Hair care', 'Hair care', NULL, 'Argan oil+jojoba oil+pumpkin oil+sesame oil+almond oil+coconut oil+olive oil+panthenol+hydrolyzed pr', 'Cosmo pack > semak for cosmetics', 'Pen', 'قلم', '300 ml', '1', NULL, NULL, 'how to use: wash hair with penduline kids shampoo then dry hair with a clean towel leaving some moisture in hair then put a suitable amount on the scalp and rub it well with cream for 5 minutes then cover the rest of hair with another amount of cream then', NULL, 561, '2022-08-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefalomash 500 mg i.m./i.v. vial', 16447, 'سيفالوماش 500مجم فيال', '27', '17.5', 'Antibiotic.cephalosporin.third-generation', 'Antibiotic.cephalosporin.third-generation', NULL, 'Cefotaxime', 'Mash premiere', 'Vial', 'فيال', '500 mg', '1', 'ملطف للجلد.', NULL, NULL, NULL, 729, '2024-04-15', NULL, 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Beesline 4 in 1 whitening cleanser 150 ml', 14985, 'بيزلين منظف مبيض 4 في 1 150 مل', '270', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Beesline > pharma cruise medical', 'Cleanser', 'منظف', '150 ml', '1', NULL, NULL, 'active ingredients lumiskin kaolin clay corn flour honey lactic acid vegetable glycerin sodium lactate walnut shell powder lemon peel olive leaf vitamin b3 licorice root extract cucumber eucalyptus rosemary peppermint willow bark & vitamin c. an advanced', '5281018881330', 1024, '2022-07-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neoflex 60 tabs. (adrien gagnon)', 4315, 'نيوفليكس 60 قرص', '1,650', NULL, 'Anti-rheumatic.osteoarthritis.anabolic agents', 'Anti-rheumatic.osteoarthritis.anabolic agents', NULL, 'Glucosamine sulphate+chondroitin sulphate+methyl sulfonyl methane (msm)+devil clew+lysine', 'Egypharma', 'Tab', 'أقراص', NULL, '1', NULL, NULL, NULL, NULL, 847, '2025-06-16', NULL, 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Epirovastin 20 mg 14 f.c. tab', 18452, 'ابيروفاستين 20مجم 14 قرص', '76', '28.5', 'Antihyperlipidemic.statins', 'Antihyperlipidemic.statins', NULL, 'Rosuvastatin', 'Eipico', 'Tab', 'أقراص', '20 mg', '2', 'دواء خافض لدهون الدم', NULL, 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6221032107664', 3556, '2024-11-13', NULL, 0, 'The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia.[F4649]



The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.[F4652]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4649] The overall effect is a decrease in plasma LDL and VLDL. 



In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration.[A1807] The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts.[A1787] Rosuvastatin increases the bioavailability of nitric oxide[A1807,A1799,A1787] by upregulating NOS[A1791] and by increasing the stability of NOS through post-transcriptional polyadenylation.[A1796] It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.', 'Rosuvastatin is a synthetic, enantiomerically pure antilipemic agent. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. These risks can occur at any dose level, but are increased at the highest dose (40 mg). Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age ≥ 65 years, inadequately treated hypothyroidism, renal impairment).



The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (such as [fenofibrate] or [niacin]), [gemfibrozil], [cyclosporine], [atazanavir]/[ritonavir], [lopinavir]/ritonavir, or [simeprevir].  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors, including rosuvastatin, coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4649] 



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Enzyme Abnormalities**



Increases in serum transaminases have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. In most cases, the elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy. There were two cases of jaundice, for which a relationship to rosuvastatin therapy could not be determined, which resolved after discontinuation of therapy. There were no cases of liver failure or irreversible liver disease in these trials.[F4649]



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including rosuvastatin calcium tablets. Based on clinical trial data with rosuvastatin, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus.[F4649]



An in vitro study found that [atorvastatin], [pravastatin], [rosuvastatin], and [pitavastatin] exhibited a dose-dependent cytotoxic effect on human pancreas islet β cells, with reductions in cell viability of 32, 41, 34 and 29%, respectively, versus control]. Moreover, insulin secretion rates were decreased by 34, 30, 27 and 19%, respectively, relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and lower cholesterol levels and, as such, might theoretically blunt adrenal or gonadal steroid hormone production. Rosuvastatin demonstrated no effect upon nonstimulated cortisol levels and no effect on thyroid metabolism as assessed by TSH plasma concentration. In rosuvastatin treated patients, there was no impairment of adrenocortical reserve and no reduction in plasma cortisol concentrations. Clinical studies with other HMG-CoA reductase inhibitors have suggested that these agents do not reduce plasma testosterone concentration. The effects of HMG-CoA reductase inhibitors on male fertility have not been studied. The effects, if any, on the pituitarygonadal axis in premenopausal women are unknown.[F4652]



**Cardiovascular**



Ubiquinone levels were not measured in rosuvastatin clinical trials, however significant decreases in circulating ubiquinone levels in patients treated with other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4652]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by a concomitant increase in the Lipoprotein(a) [Lp(a)] concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease. It is thus desirable to maintain and reinforce lifestyle changes in high-risk patients placed on rosuvastatin therapy.[F4652] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Limitless ossofortin d3 (2000 i.u.) 30 tabs.', 360, 'ليمتلس اوسوفورتين د3 2000 وحدة دولية 30 قرص', '64', '58', 'Vitamin d', 'Vitamin d', NULL, 'Cholecalciferol(vitamin d3)', 'Eva pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, '6223012480682', 5098, '2024-03-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mebo c cream 25 gm', 600, 'ميبو سي كريم 25 جم', '95', '73.5', NULL, NULL, NULL, NULL, 'Company', 'Cream', 'كريم', '25 gm', '1', NULL, NULL, NULL, '9790009003492', 1791, '2025-11-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pregavalex 300mg 20 caps.', 25168, 'بريجافالكس 300مجم 20 كبسول', '134', NULL, 'Anti-epileptic.gaba analogs', 'Anti-epileptic.gaba analogs', NULL, 'Pregabalin', 'Eva pharma', 'Cap', 'كبسولة', '300mg', '2', NULL, NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, 904, '2022-07-29', NULL, 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Doxazin 4 mg 10 tab.', 3866, 'دوكسازين 4 مجم 10 اقراص', '18', NULL, 'Antihypertensive.selective alpha 1 receptor blockers', 'Antihypertensive.selective alpha 1 receptor blockers', NULL, 'Doxazosin', 'Pharopharma', 'Tab', 'أقراص', '4 mg', '1', 'علاج لمرض ارتفاع ضغط الدم', NULL, 'about doxazosin alpha-1 adrenergic antagonist quinazoline derivative antihypertensive. mechanism of action of doxazosin the drug exerts its antihypertensive action by acting as a selective alpha-1 antagonist. it dilates both arteries and veins thus it red', '6221094025906', 5733, '2023-05-29', NULL, 0, 'Doxazosin is indicated to treat the symptoms of benign prostatic hypertrophy, which may include urinary frequency, urgency, and nocturia, among other symptoms. In addition, doxazosin is indicated alone or in combination with various antihypertensive agents for the management of hypertension.[L7282] Off-label uses of doxazosin include the treatment of pediatric hypertension[A180634] and the treatment of ureteric calculi.[A180637]', 'Doxazosin selectively inhibits the postsynaptic alpha-1 receptors on vascular smooth muscle by nonselectively blocking the alpha-1a, alpha-1b, and alpha-1d subtypes[A180688,A4649]. This action on blood vessels decreases systemic peripheral vascular resistance, reducing blood pressure, exerting minimal effects on the heart rate due to its receptor selectivity.[A180649,A180676] Norepinephrine-activated alpha-1 receptors located on the prostate gland and bladder neck normally cause contraction of regional muscular tissue, obstructing urinary flow and contributing to the symptoms of benign prostatic hypertrophy.  Alpha-1 antagonism causes smooth muscle relaxation in the prostate and bladder, effectively relieving urinary frequency, urgency, weak urinary stream, and other unpleasant effects of BPH.[A180655] Recently, doxazosin was found to cause apoptosis of hERG potassium channels in an in vitro setting, possibly contributing to a risk of heart failure with doxazosin use.[A15296,A180697,A180700] ', 'Doxazosin decreases standing and supine blood pressure[A180649] and relieves the symptoms of benign prostatic hypertrophy through the inhibition of alpha-1 receptors.

Doxazosin may cause hypotension due to its pharmacological actions. This frequently occurs in the upright position, leading to a feeling of dizziness or lightheadedness. The first dose of doxazosin may lead to such effects, however, subsequent doses may also cause them. The risk of these effects is particularly high when dose adjustments occur or there are long intervals between doxazosin doses. Treatment should be started with the 1 mg dose of doxazosin, followed by slow titration to the appropriate dose.[L7282] Patients must be advised of this risk and to avoid situations in which syncope and dizziness could be hazardous following the ingestion of doxazosin.[L7282] Interestingly doxazosin exerts beneficial effects on plasma lipids. It reduces LDL (low-density lipoprotein) cholesterol and triglyceride levels and increases HDL (high-density lipoprotein) cholesterol levels.[A180649]



A note on priapism risk



In rare cases, doxazosin and other alpha-1 blockers may cause priapism, a painful occurrence of persistent and unrelievable penile erection that can lead to impotence if medical attention is not sought as soon as possible. Patients must be advised of the priapism risk associated with doxazosin and to seek medical attention immediately if it is suspected.[A180670,L7282]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vorifungin 200 mg vial(n/a yet)', 29593, 'فوريفنجين 200مجم فيال', '641', '400', 'Antifungals.triazoles', 'Antifungals.triazoles', NULL, 'Voriconazole', 'Global pharmaceutical industries (2) > eva pharma', 'Vial', 'فيال', '200 mg', '1', NULL, NULL, 'indication for the treatment of esophageal candidiasis invasive pulmonary aspergillosis and serious fungal infections caused by scedosporium apiospermum and fusarium spp. mechanism of action voriconazole binds and inhibits ergosterol synthesis by inhibiti', NULL, 950, '2024-05-06', NULL, 0, 'For the treatment of esophageal candidiasis, cadidemia, invasive pulmonary aspergillosis, and serious fungal infections caused by <i>Scedosporium apiospermum</i> and <i>Fusarium</i> spp.[L9821, L15571] ', 'Voriconazole is used to treat fungal infections caused by a variety of organisms but including _Aspergillus spp._ and _Candida spp_. Voriconazole is a triazole antifungal exhibiting fungistatic activity against fungal pathogens.[A236050, A236045, L9821] Like other triazoles, voriconazole binds to 14-alpha sterol demethylase, also known as CYP51, and inhibits the demethylation of lanosterol as part of the ergosterol synthesis pathway in yeast and other fungi. The lack of sufficient ergosterol disrupts fungal cell membrane function and limits fungal cell growth. With fungal growth limited, the host''s immune system is able to clear the invading organism.', 'Voriconazole is a fungistatic triazole antifungal used to treat infections by inhibiting fungal growth.[L9821] It is known to cause hepatotoxic and photosensitivity reactions in some patients.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Beesline deo whitening pacific islands roll-on 50 ml', 15001, 'بيزلين رول اون للتبييض 50 مل', '195', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Beesline > pharma cruise medical', 'Unknown', 'غير محدد', '50 ml', '1', NULL, NULL, 'active ingredients alum rock lumiskin teflose lactic acid wheatgerm oil sodium lactate aloe vera parsley olive leaf & propolis. an innovative safe & highly effective 48hr antiperspirant deodorant that works to fight body odour adsorb moisture & soothe the', NULL, 1046, '2022-07-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fish oil 100 softgels', 19060, 'فيش اويل 100 كبسولة', '800', NULL, 'Supplement', 'Supplement', NULL, 'Omega-3', 'Optimum nutrition > ramco', 'Gel', 'جل', NULL, '2', NULL, NULL, 'fish oils contain long-chain fatty acids including docosahexaenoic acid (dha) and eiscosapentaenoic acid (epa). dha and epa are omega-3 fatty acids with important roles in numerous metabolic functions. they are found in foods like salmon and supplements s', NULL, 729, '2022-08-02', NULL, 0, 'Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia. ', 'Omega-3 fatty acids mediate anti-inflammatory effects and increased levels of EPA or DHA has shown to decrease the levels of PGE2 and 4 series-LT. 

Eicosapentaenoic acids compete with constitutive levels of arachidonic acid in cell membranes for the same desaturation enzymes and produce 3-series prostaglandins and thromboxanes, and 5-series leukotrienes which have low pro-inflammatory potential. The alteration in leukotriene biosynthesis due to higher concentration of omega-3 fatty acids compared to arachidonic acid underlies the anti-inflammatory effects. 

EPA and DHA also give rise to resolvins and related lipid signalling molecules such as protectins via cyclooxygenase and lipoxygenase pathways, which have anti-inflammatory effects. They inhibit transendothelial migration of neutrophils and inhibit TNF and IL-1β production. Omega-3 fatty acids also decrease adhesion molecule expression on leukocytes and on endothelial cells and decrease intercellular adhesive interactions.

Omega-3 (or n-3) polyunsaturated fatty acids (PUFAs) and their metabolites are natural ligands for peroxisome proliferator-activated receptor (PPAR) gamma that regulates inflammatory gene expression and NFκB activation. PPAR alpha activation is also associated with induction of COX-2 expression. 

The role of EPA and DHA in reducing triglyceride levels include inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increased mitochondrial and peroxisomal-beta-oxidation in the liver, decreased lipogenesis in the liver, and increased plasma lipoprotein lipase activity. They also may reduce triglyceride synthesis because they are poor substrates for the enzymes responsible for TG synthesis, and EPA and DHA inhibit esterification of other fatty acids. ', 'Omega-3 fatty acids are triglycerides that get broken down into smaller fatty acid units. They act to reduce plasma triglyceride levels however increase the cholesterol levels and are thought to possess potent antiarrythmic effects. Polyunsaturated fatty acids including eicosapentaenoic and docosahexaenoic acid mediate important cellular function such as inhibition of platelet function, prolongation of bleeding time, anti-inflammatory effects and reduction of plasma fibrinogen. Polyunsaturated fatty acids are components of the phospholipids that form the structures of the cell membranes and also serve as energy source. They form eicosanoids which are important signalling molecules with wide-ranging functions in the body''s cardiovascular, pulmonary, immune and endocrine systems. DHA tends to exist in high concentrations in the retina, brain (via uptake by Mfsd2a as a transporter), and sperm.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lactomax 10 sachets', 21543, 'لاكتوماكس 10 أكياس', '75', '60', 'Lactagauge', 'Lactagauge', NULL, 'Fenugreek+fennel+anise+chamomile', 'Pharma zad > xtra med', 'Sachet', 'أكياس', NULL, '1', 'يعمل على ادرار وزيادة افراز اللبن', NULL, 'lactagauge dose: 1-2 sachets per day a sachet on a glass', '624355246465', 1380, '2025-04-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ocucarpine 4% eye drops 10 ml', 23954, 'اوكيوكاربين 4% قطرةللعين 10مل', '67', NULL, 'Anti-intra occular pressure.miosis inhancer', 'Anti-intra occular pressure.miosis inhancer', NULL, 'Pilocarpine', 'Alexandria', 'Drops', 'نقط', '4%', '1', NULL, NULL, 'about pilocarpine alkaloid cholinergic (a non-selective muscarinic) agonist antiglaucoma miotic. mechanism of action of pilocarpine pilocarpine is a direct acting cholinergic parasympathomimetic agent which acts through direct stimulation of cholinergic r', NULL, 980, '2023-04-15', NULL, 0, 'Pilocarpine oral tablets are indicated for the treatment of dry mouth caused by Sjogren''s Syndrome or radiotherapy for cancer of the head and neck.[L48566]



Pilocarpine ophthalmic formulations are used to treat presbyopia in adults,[L48556, L48631] reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, manage acute angle-closure glaucoma, prevent postoperative elevated IOP associated with laser surgery, and induce miosis.[L48561]', 'The muscarinic M3 receptor is expressed in various endocrine and exocrine glands, including the gastric and salivary glands.[A262041] It is also found in smooth muscle cells in pupillary sphincter and ciliary bodies. The M3 receptor is a G<sub>q</sub>-protein-coupled receptor that activates phospholipase C and upregulates inositol trisphosphate and intracellular calcium. M3 receptor activation has been implicated in smooth muscle contraction and the stimulation of salivary glands.[A262016] Pilocarpine is an agonist for M1 and M2 receptors,[A262041, A262086] and is a full and partial agonist at the M3 receptor.[A262016]', 'Pilocarpine is a muscarinic agent that mediates diaphoretic, miotic, and central nervous system effects. Pilocarpine stimulates the secretion of various exocrine glands, such as sweat, lacrimal, salivary, and gastrointestinal glands. Following oral administration, pilocarpine increased the mean salivary flow rate by 2- to lO-folds than placebo. Its peak levels were maintained for at least one to two hours.[A262036, L48556] Pilocarpine increases smooth muscle tone, contracts the pupillary and iris sphincter muscles, and induces miosis.[A262036, L48556, L48566, L48631]



Because pilocarpine may affect all five muscarinic receptor subtypes, it is associated with parasympathetic side effects.[A262016, A262041]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Salbovent forte 4mg 20 tab.', 10153, 'سالبوفنت فورت 4مجم 20 قرص', '18', '10', 'Bronchodilator', 'Bronchodilator', NULL, 'Salbutamol', 'Alexandria', 'Tab', 'أقراص', '4mg', '2', 'علاج لمرض الربو.', NULL, 'about salbutamol beta2-adrenergic agonist phenethylamine derivative bronchodilator(antiasthma) uterine relaxant. mechanism of action of salbutamol salbutamol is a short acting ?2 receptor agonist. it selectively stimulates ?2 receptors present in airway u', '6223000170076', 2672, '2024-09-26', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Perasafe 50% 810g powder', 24730, 'بيراسيف 50% 810جم بودر', '192', NULL, NULL, NULL, NULL, 'Sodium perborate', 'Antec international - united kingdom > t3a pharma', 'Powder', 'بودرة', '50%', '1', NULL, NULL, NULL, NULL, 603, '2022-08-02', NULL, 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Attensera 18 mg 30 caps.', 14604, 'اتنسيرا 18مجم 30 كبسولة', '120', NULL, 'Attention-deficit hyperactivity disorder', 'Attention-deficit hyperactivity disorder', NULL, 'Atomoxetine', 'Mash premiere', 'Cap', 'كبسولة', '18 mg', '3', 'علاج لمرض فرط الحركة وتشتت الذهن.', NULL, 'description: atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (adhd). dose: dosing of children and adolescents up to 70 kg body weight initial: the recommended dose is 0.5 mg/kg and increas', NULL, 1135, '2022-05-19', NULL, 0, 'Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults.', 'Atomoxetine is known to be a potent and selective inhibitor of the norepinephrine transporter (NET),[A175723] which prevents cellular reuptake of norepinephrine throughout the brain, which is thought to improve the symptoms of ADHD. More recently, positron emission tomography (PET) imaging studies in rhesus monkeys have shown that atomoxetine also binds to the serotonin transporter (SERT),[A178111] and blocks the N-methyl-d-aspartate (NMDA) receptor,[A18263] indicating a role for the glutamatergic system in the pathophysiology of ADHD. ', 'Atomoxetine is a selective norepinephrine (NE) reuptake inhibitor used for the treatment of attention deficit hyperactivity disorder (ADHD). Atomoxetine has been shown to specifically increase norepinephrine and dopamine within the prefrontal cortex, which results in improved ADHD symptoms.[A18262, A18262, F4639]



Due to atomoxetine''s noradrenergic activity, it also has effects on the cardiovascular system such as increased blood pressure and tachycardia.[T244] Sudden deaths, stroke, and myocardial infarction have been reported in patients taking atomoxetine at usual doses for ADHD. Atomoxetine should be used with caution in patients whose underlying medical conditions could be worsened by increases in blood pressure or heart rate such as certain patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease. It should not be used in patients with severe cardiac or vascular disorders whose condition would be expected to deteriorate if they experienced clinically important increases in blood pressure or heart rate. Although the role of atomoxetine in these cases is unknown, consideration should be given to not treating patients with clinically significant cardiac abnormalities. Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during atomoxetine treatment should undergo a prompt cardiac evaluation.[F4639]



In general, particular care should be taken in treating ADHD in patients with comorbid bipolar disorder because of concern for possible induction of a mixed/manic episode in patients at risk for bipolar disorder. Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by atomoxetine at usual doses. If such symptoms occur, consideration should be given to a possible causal role of atomoxetine, and discontinuation of treatment should be considered.[F4639]



Atomoxetine capsules increased the risk of suicidal ideation in short-term studies in children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). All pediatric patients being treated with atomoxetine  should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases.[F4639]



Postmarketing reports indicate that atomoxetine can cause severe liver injury. Although no evidence of liver injury was detected in clinical trials of about 6000 patients, there have been rare cases of clinically significant liver injury that were considered probably or possibly related to atomoxetine use in postmarketing experience. Rare cases of liver failure have also been reported, including a case that resulted in a liver transplant. Atomoxetine should be discontinued in patients with jaundice or laboratory evidence of liver injury, and should not be restarted. Laboratory testing to determine liver enzyme levels should be done upon the first symptom or sign of liver dysfunction (e.g., pruritus, dark urine, jaundice, right upper quadrant tenderness, or unexplained “flu like” symptoms).[F4639]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bromurex 2mg/ml 5 amp.', 1729, 'بروموريكس 2مجم/ مل امبول', '30', NULL, 'Nondepolarizing neuromuscular blocker', 'Nondepolarizing neuromuscular blocker', NULL, 'Pancuronium bromide', 'Sedico', 'Amp', 'أمبول', '2mg', '1', NULL, NULL, 'clinical pharmacology pancuronium bromide is a nondepolarizing neuromuscular blocking agent possessing all of the characteristic pharmacological actions of this class of drugs (curariform). it acts by competing for cholinergic receptors at the motor end-p', '6221042421057', 952, '2022-09-20', NULL, 0, 'Used as a muscle relaxant during anesthesia and surgical procedures.', 'Nondepolarizing neuromuscular blocking agents inhibit neuromuscular transmission by competing with acetylcholine for the cholinergic receptors of the motor end plate, thereby reducing the response of the end plate to acetylcholine. This type of neuromuscular block is usually antagonized by anticholinesterase agents.', 'Pancuronium is a non-depolarising muscle relaxant similar to curare. It acts as a competitive acetylcholine antagonist on neuromuscular junctions, displacing acetylcholine (hence competitive) from its post-synaptic nicotinic acetylcholine receptors. It is, unlike suxamethonium, a non-depolarising agent, which means, that it causes no spontaneous depolarisations upon association with the nicotinic receptor in neuromuscular junction, thus producing no muscle fasciculations upon administration. Pancuronium has no hormonal activity. It exerts slight vagolytic activity (i.e. diminishing activity of the vagus nerve) and no ganglioplegic (i.e., blocking ganglions) activity.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pregesican 75 mg 20 caps.', 13189, 'بريجيسيكان 75مجم 20 كبسولة', '46', NULL, 'Anti-epileptic.gaba analogs', 'Anti-epileptic.gaba analogs', NULL, 'Pregabalin', 'Adwia', 'Cap', 'كبسولة', '75 mg', '2', NULL, NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalin pregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, 1049, '2022-07-31', NULL, 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Avene akerat smoothing exfoliating cream 200ml', 14682, 'افين اكيرات كريم تقشير بشرة 200 مل', '299', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Pierre - fabre france > biotech egypt', 'Cream', 'كريم', '200ml', '1', NULL, NULL, 'ultra-rich targeted body care helps restore skinï¿½s comfort level and balance for smoother softer skin texture. ï¿½ minimizes rough and hardened skin ï¿½ removes thick flakes ï¿½ enhances ability to retain moisture ï¿½ smoother softer skin texture ï¿½ fr', NULL, 778, '2022-06-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Royal zad 500 mg 10 capsules', 13159, 'رويال زاد 500 مجم 10 كبسولة', '120', '80', 'Support normal body energy', 'Support normal body energy', NULL, 'Royal jelly+wheat germ oil+beeswax+tocopheryl', 'Safe life', 'Capsule', 'كبسولة', '500 mg', '1', NULL, NULL, NULL, NULL, 6383, '2024-05-22', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Becomvast 30 sublingual tabs', 13935, 'بيكومفاست 30 قرص تحت اللسان', '89', NULL, 'Multivitamin', 'Multivitamin', NULL, 'Vitamin b12 1000mcg+vitamin b6+folic 400 mcg+d-biotin', 'Medicina', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1941, '2024-05-20', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Gum-c mouth wash 120 ml', 20097, 'جم-سي غسول للفم 120 مل', '30', '24', 'Oral care', 'Oral care', NULL, 'Thyme extract+menthol+clove oil+vitamin c+glycerin', 'Hi-care > falcon group', 'Mouth wash', 'غسول للفم', '120 ml', '1', NULL, NULL, NULL, '6224000696153', 982, '2025-06-28', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Liver albumin plus 20 caps', 7450, 'ليفر البيومن بلاس 20 كبسولة', '120', '80', 'Liver support supplements', 'Liver support supplements', NULL, 'Liver support formula', 'International drug agency (idi) > novell pharma', 'Cap', 'كبسولة', NULL, '2', 'بديل ألبومين -- يستخدم لمرضى الكبد', NULL, NULL, '6223004072062', 7421, '2025-01-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mepasil 80% susp. 120 ml', 22579, 'ميباسيل 80% معلق 120 مل', '10', NULL, 'Liver support supplements', 'Liver support supplements', NULL, 'Silymarin', 'Mepaco', 'Susp', 'معلق', '80%', '1', NULL, NULL, NULL, NULL, 996, '2022-07-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fortatec children 10 gm 10 sachets', 19338, 'فورتاتيك للاطفال 10 جم 10 اكياس', '45', NULL, 'Iron supplement', 'Iron supplement', NULL, 'Ferrous fumarate+lactoferrin+folic acid+vitamin(b1+b6+b12+c)+calcium', 'Medcare > novotec pharma', 'Sachet', 'أكياس', '10 gm', '1', NULL, NULL, 'dose: 1 sachet daily to be dissolved in 100 ml of warm water or milk.', NULL, 712, '2022-07-23', NULL, 0, 'Ferrous sulfate is used for the prevention and treatment of iron deficiency anemia in adults and children.[A190804,L2240,L11800]

', 'Iron is required to maintain optimal health, particularly for helping to form red blood cells (RBC) that carry oxygen around the body. A deficiency in iron indicates that the body cannot produce enough normal red blood cells.[A32514,L11800] Iron deficiency anemia occurs when body stores of iron decrease to very low levels, and the stored iron is insufficient to support normal red blood cell (RBC) production. Insufficient dietary iron, impaired iron absorption, bleeding, pregnancy, or loss of iron through the urine can lead to iron deficiency.[A32514,L11794]  Symptoms of iron deficiency anemia include fatigue, breathlessness, palpitations, dizziness, and headache.



Taking iron in supplement form, such as ferrous sulfate, allows for more rapid increases in iron levels when dietary supply and stores are not sufficient.[L2175] Iron is transported by the divalent metal transporter 1 (DMT1) across the endolysosomal membrane to enter the macrophage. It can then can be incorporated into ferritin and be stored in the macrophage or carried of the macrophage by ferroportin. This exported iron is  oxidized by the enzyme to ceruloplasmin to Fe3+, followed by sequestration by transferrin for transport in the serum to various sites, including the bone marrow for hemoglobin synthesis or into the liver.[A32524] Iron combines with porphyrin and globin chains to form hemoglobin, which is critical for oxygen delivery from the lungs to other tissues.[L2263]', 'Ferrous sulfate replenishes iron, an essential component in hemoglobin, myoglobin, and various enzymes. It replaces the iron that is usually found in hemoglobin and myoglobin. Iron participates in oxygen transport and storage, electron transport and energy metabolism, antioxidant and beneficial pro-oxidant functions, oxygen sensing, tissue proliferation and growth, as well as DNA replication and repair.[A32524,A32514]



', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vimora vag.douche 120ml', 29357, 'فيمورا دوش مهبلي 120مل', '60', '45', 'Vaginal wash', 'Vaginal wash', NULL, 'Chamomile extract+thyme extract+aloe vera extract', 'Hi-care > rony pharma', 'Unknown', 'غير محدد', '120ml', '1', NULL, NULL, NULL, NULL, 756, '2025-08-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ocean bio-actif fluid+ nasal spray 100 ml', 22900, 'اوشن بيو اكتف فلويد سبراي انف 100 مل', '300', '275', 'Nasal decongestant', 'Nasal decongestant', NULL, NULL, 'Abbott', 'Spray', 'بخاخ', '100 ml', '1', NULL, NULL, NULL, NULL, 1794, '2025-02-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vigam-s 5 %w/v (100ml) inj.', 29301, 'فيجام اس 5% 100مل', '2,200', NULL, NULL, NULL, NULL, 'Human normal immunoglobulin', 'Bpl bio products lab. u.k. > bio care pharma group-egypt', 'Inj', 'حقن', '5 %', '1', NULL, NULL, NULL, NULL, 687, '2022-07-25', NULL, 0, 'Human immunoglobulin G is indicated for the following conditions:



### Primary Immunodeficiency

- for the treatment of primary immunodeficiency in adult and pediatric patients[L39920, L39930, L39935, L39940, L39945, L39950, L39955, L39960, L39965, L39975, L39980, L40029, L40034, L40044]

- in combination with [hyaluronidase (human recombinant)] for the treatment of primary immunodeficiency in patients ≥2 years of age.[L42760]



### Immune Thrombocytopenic Purpura (ITP)

- for the treatment of acute or chronic immune thrombocytopenic purpura in adult and pediatric patients[L39940, L39950, L39960, L39965, L39970, L39975, L39980]



### Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

- for the treatment of CIDP in adult patients[L39955, L39965, L39975, L39980, L40034]

- in combination with hyaluronidase (human recombinant) as a maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP)[L40039]



### Multifocal Motor Neuropathy (MMN)

- for maintenance therapy to improve muscle strength and disability in adult patients with MMN[L39955]



### Prophylaxis of Bacterial Infection

- for the prevention of bacterial infections in patients with hypogammaglobulinemia and/or B-cell chronic lymphocytic leukemia[L39960]



### Coronary Artery Aneurysm Associated With Kawasaki Syndrome

- for the prevention of coronary artery aneurysms in pediatric patients with Kawasaki syndrome[L39960]



### Dermatomyositis

- for the treatment of dermatomyositis in adult patients[L39970]

', 'IVIg interacts with a number of different components of the immune system, including cytokines, complement, Fc receptors and several cell surface immunocompetent molecules. IVIg also impacts different effector cells of the immune system (B and T lymphocytes, dendritic cells, etc.) and regulates a wide range of genes. Its main mechanism of actions are believed to be Fc-dependent and F(ab'')2-dependent. IVIg competitively blocks gamma Fc receptors, preventing the binding and ingestion of phagocytes and suppressing platelet depletion. IVIg contains a number of different antobodies, which prevent infection by attaching to the surface of invading pathogens and aiding in their disposal before they can infect cells. Antibodies remove pathogens via complement activation, agglutination or precipitation, pathogen receptor blocking, macrophage “tagging” or neutralization (via binding) of pathogen toxins. Intact IVIg and F(ab′)2 fragments of IVIg can also neutralize the activity of various autoantibodies. By triggering the production of interleukin-1 receptor antagonist, IVIg modulates of the production of cytokines and cytokine antagonists. It also prevents the generation of the C5b-9 membrane attack complex and subsequent complement-mediated tissue damage by binding active complement components.', 'Used as a replacement therapy in inherited humoral immunodeficiency disorders such as severe combined immunodeficiency syndrome, x-linked agammaglobulinemia, and Wiskott-Aldrich Syndrome. The immunoglobulins target, bind and kill bacterial cells as well as viral particles. IgG is the monomeric immunoglobulin of which there are four subclasses (IgG1, IgG2, IgG3 and IgG4) in differing abundances (66%, 23%, 7% and 4%). IgAs represent about 15% of the immunoglobulins in the blood. These target inhaled or ingested pathogens.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sokinal whitening cream 50 gm', 27234, 'سوكينال كريم تبييض 50جم', '90', NULL, 'Whitening topical', 'Whitening topical', NULL, 'Lactic acid+vitamins(c+e+a)+allantoin+bees honey+glycolic acid+arbutin+shea butter', 'Egyptian company for cosmetics > excellence pharm', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 745, '2022-07-13', NULL, 0, 'For use as an alkalinizing agent.', 'Lactate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cations.', 'Lactic acid produces a metabolic alkalinizing effect.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('MEDIXOACT 60 GM GEL', 1778, 'ميديكسو أكت 60 جم جل', '60', NULL, 'Massage gel', 'Massage gel', NULL, 'Menthol+cinnamomum+eucalyptus+clove oil+avocado oil+salicylic acid+magnesium sulfate', 'Medixo pharmaceutical company', 'Gel', 'جل', '60 GM', '1', NULL, NULL, NULL, NULL, 1048, '2024-12-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Levepsy 100mg/ml syrup 120 ml', 21746, 'ليفبسي 100 مجم / مل شراب 120 مل', '60', NULL, 'Anti-epileptic.pyrrolidine', 'Anti-epileptic.pyrrolidine', NULL, 'Levetiracetam', 'Eipico', 'Syrup', 'شراب', '100mg', '1', NULL, NULL, 'about levetiracetam it is s-enantiomer of etiracetam. anticonvulsant medication used to treat epilepsy. mechanism of action of levetiracetam the exact mechanism for levetiracetam is unknown. however the drug binds to a synaptic vesicle protein sv2a which', NULL, 765, '2022-07-20', NULL, 0, 'Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606]



Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]', 'The exact mechanism through which levetiracetam exerts its anti-epileptic effects is unclear, but is thought to be unique amongst other anti-epileptic medications. Current knowledge suggests that levetiracetam’s binding to synaptic vesicle protein 2A (SV2A) is a key driver of its action. SV2A is a membrane-bound protein that is found on synaptic vesicles and is ubiquitous throughout the CNS[A12546] - it appears to play a role in vesicle exocytosis[L8606,L8615] and in the modulation of synaptic transmission by increasing the available amount of secretory vesicles available for neurotransmission.[A12552] Stimulation of pre-synaptic SV2A by levetiracetam may inhibit neurotransmitter release,[A12551] but this action does not appear to affect normal neurotransmission. This has led to the suggestion that levetiracetam exclusively modulates the function of SV2A only under pathophysiological conditions.[A12546] Levetiracetam and related analogues showed a correlation between affinity for SV2A and anti-epileptic potency, further suggesting that action at this site contributes to the anti-epileptic activity of the drug.[L8606,L8615]



Levetiracetam has also been shown to indirectly affect GABAergic neurotransmission (despite having no direct effect on GABAergic or glutamatergic receptors) and modulate ionic currents.[A12552] Similarly, levetiracetam has been shown in vitro to inhibit N-type calcium channels.[A16562] How, or even if, these actions are implicated in its anti-epileptic action have yet to be elucidated.', 'Levetiracetam appears to prevent seizure activity via the selective inhibition of hypersynchronized epileptiform burst firing without affecting normal neuronal transmission, though the exact mechanism through which this occurs is unclear.[L8606,L8615] The therapeutic index of levetiracetam is wide,[L8615,A185918] making it relatively unique amongst other anti-epileptic medications.



Anti-epileptic drugs, including levetiracetam, may increase the risk of suicidal ideation or behaviour - patients taking levetiracetam should be monitored for the emergence or worsening of depressive symptoms, suicidal ideation, and behavioural abnormalities.[L8606,L8600,L8615]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefix 1000mg 8 f.c.tab', 2235, 'سيفكس 1000مجم 8 اقراص', '10', NULL, 'Antibiotic.cephalosporin.first-generation', 'Antibiotic.cephalosporin.first-generation', NULL, 'Cefadroxil', 'Sigma tec > future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '1000mg', '1', 'مضاد حيوي.', NULL, NULL, NULL, 2397, '2022-09-08', NULL, 0, 'For the treatment of the following infections (skin, UTI, ENT) caused by; <i>S. pneumoniae, H. influenzae, staphylococci, S. pyogenes</i> (group A beta-hemolytic streptococci), <i>E. coli, P. mirabilis, Klebsiella</i> sp, coagulase-negative staphylococci and <i>Streptococcus pyogenes</i>', 'Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor.', 'Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('See-lit facial cleanser 200 ml', 3405, 'سي لايت غسول منظف للوجه 200 مل', '199', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Medinza pharm', 'Cleanser', 'منظف', '200 ml', '1', NULL, NULL, NULL, NULL, 794, '2022-09-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Meloxicam 15mg 5 supp.', 7918, 'ميلوكسيكام 15مجم 5 اقماع لبوس', '9', NULL, 'Nsaid.oxicam', 'Nsaid.oxicam', NULL, 'Meloxicam', 'Amriya', 'Supp', 'لبوس', '15mg', '1', NULL, NULL, 'about meloxicam nsaid thiazole derivative oxicam class analgesic anti-inflammatory. mechanism of action of meloxicam this drug reduces the prostaglandin synthesis peripherally by inhibiting cox1 & cox2 isoenzymes. this results its antinflammatory action.', '6221075100011', 1045, '2022-12-28', NULL, 0, 'Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis.  In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above.[L11398] Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been studied in the treatment of neuropathic pain. [A190189]



Meloxicam, in combination with [bupivacaine], is indicated for postsurgical analgesia in adult patients for up to 72 hours following soft tissue surgical procedures, foot and ankle procedures, and other orthopedic procedures in which direct exposure to articular cartilage is avoided.[L50427]', 'Meloxicam inhibits prostaglandin synthetase (cylooxygenase 1 and 2) enzymes leading to a decreased synthesis of prostaglandins, which normally mediate painful inflammatory symptoms.[A176366] As prostaglandins sensitize neuronal pain receptors, inhibition of their synthesis leads to analgesic and inflammatory effects. Meloxicam preferentially inhibits COX-2, but also exerts some activity against COX-1, causing gastrointestinal irritation.[A190189,L11398]', 'Meloxicam is an anti-inflammatory, analgesic analgesic with antipyretic effects in fever.[A190189] Prostaglandins are substances that contribute to inflammation.[A176366] This drug also exerts preferential actions against COX-2[A190195], which may reduce the possible gastrointestinal effects of this drug.  



In humans, meloxicam has demonstrated the ability to decrease erythrocyte sedimentation rate(ESR) in patients with rheumatoid arthritis, and to decrease ESR, C-reactive protein (CRP), as well as  aquaporin-1 expression.[A190189] As with other NSAIDS, prolonged use of meloxicum can result in renal or cardiovascular impairment or thrombotic cardiovascular events.[L11398]



A note on gastrointestinal effects



As meloxicam preferentially inhibits COX-2, it is thought to cause less gastrointestinal irritation compared to other NSAIDS. Despite this, it still carries a risk of gastric inflammation, bleeding and ulceration.[A190201,L11398]   In one study, patients on meloxicam suffered from gastrointestinal symptoms at a rate of 13% compared to 19% of those on [diclofenac]. GI events were found to be less severe in the meloxicam-treated patients.[A190189]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Augmacillin 457mg/5ml susp. 60 ml', 14622, 'اوجماسيللين 457مجم/5 مل معلق 60 مل', '48', '32.5', 'Penicillins.penicillin with b-lactamase inhibitor', 'Penicillins.penicillin with b-lactamase inhibitor', NULL, 'Amoxicillin+clavulanic acid', 'Mepaco', 'Susp', 'معلق', '457mg', '1', NULL, NULL, 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', '6223002210428', 1052, '2024-05-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nono water syrup 120 ml', 23692, 'ماء نونو شراب 120 مل', '42', '22', 'Git disturbances', 'Git disturbances', NULL, 'Caraway oil+dill oil+sodium bicarbonate', 'Debeiky', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, 'to improve gastro-intestinal functions', '6225000005419', 1326, '2024-02-21', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Groten biotin 10000mcg 30 tab', 27948, 'جروتن بيوتين 10000 مكجم 30 قرص', '75', NULL, 'Dietary supplement.support hair skin nails', 'Dietary supplement.support hair skin nails', NULL, 'Biotin', 'Company', 'Tab', 'أقراص', '10000mcg', '3', 'كبسولات مكمل غذائي تحتوي على بيوتين 10.000 ميكروجرام يساهم في الحفاظ على الشعر والجلد الطبيعي.', NULL, NULL, NULL, 2866, '2022-07-16', NULL, 0, 'For nutritional supplementation, also for treating dietary shortage or imbalance.', 'Biotin is necessary for the proper functioning of enzymes that transport carboxyl units and fix carbon dioxide, and is required for various metabolic functions, including gluconeogenesis, lipogenesis, fatty acid biosynthesis, propionate metabolism, and catabolism of branched-chain amino acids.', 'Biotin is a water-soluble B-complex vitamin which is composed of an ureido ring fused with a tetrahydrothiophene ring, which attaches a valeric acid substituent at one of its carbon atoms. Biotin is used in cell growth, the production of fatty acids, metabolism of fats, and amino acids. It plays a role in the Kreb cycle, which is the process in which energy is released from food. Biotin not only assists in various metabolic chemical conversions, but also helps with the transfer of carbon dioxide. Biotin is also helpful in maintaining a steady blood sugar level. Biotin is often recommended for strengthening hair and nails. Consequenty, it is found in many cosmetic and health products for the hair and skin. Biotin deficiency is a rare nutritional disorder caused by a deficiency of biotin. Initial symptoms of biotin deficiency include: Dry skin, Seborrheic dermatitis, Fungal infections, rashes including erythematous periorofacial macular rash, fine and brittle hair, and hair loss or total alopecia. If left untreated, neurological symptoms can develop, including mild depression, which may progress to profound lassitude and, eventually, to somnolence; changes in mental status, generalized muscular pains (myalgias), hyperesthesias and paresthesias. The treatment for biotin deficiency is to simply start taking some biotin supplements. A lack of biotin in infants will lead to a condition called seborrheic dermatitis or "cradle cap". Biotin deficiencies are extremely rare in adults but if it does occur, it will lead to anemia, depression, hair loss, high blood sugar levels, muscle pain, nausea, loss of appetite and inflamed mucous membranes.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bobai sun screen hydro gel spf 50 - 60 ml', 15402, 'بوباي صن سكرين هيدروجيل بعامل وقاية من الشمس 50-60 مل', '275', '220', 'Sun block', 'Sun block', NULL, 'Sun protection formula', 'Egyptian company for cosmetics > parkville pharmaceuticals', 'Gel', 'جل', '60 ml', '1', NULL, NULL, NULL, NULL, 972, '2024-05-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mannitol 10% (mottahedoon) i.v. inf. 500 ml', 22251, 'مانيتول 10% المتحدون محلول وريدي 500 مل', '42', '25.5', 'Osmotic diuretic', 'Osmotic diuretic', NULL, 'Mannitol', 'Al mottahedoon pharma', 'Unknown', 'غير محدد', '10%', '1', NULL, NULL, NULL, NULL, 741, '2025-04-16', NULL, 0, 'Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.



Mannitol is also indicated as add-on maintenance therapy for improving pulmonary function in cystic fibrosis patients aged 18 and over who have passed the BRONCHITOL tolerance test (BTT). It is recommended that patients take an orally inhaled short-acting bronchodilator 5-15 minutes prior to every inhaled mannitol dose.[L20024]', 'Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. As a diurectic mannitol induces diuresis because it is not reabsorbed in the renal tubule, thereby increasing the osmolality of the glomerular filtrate, facilitating excretion of water, and inhibiting the renal tubular reabsorption of sodium, chloride, and other solutes. Mannitol promotes the urinary excretion of toxic materials and protects against nephrotoxicity by preventing the concentration of toxic substances in the tubular fluid. As an Antiglaucoma agent mannitol levates blood plasma osmolarity, resulting in enhanced flow of water from the eye into plasma and a consequent reduction in intraocular pressure. As a renal function diagnostic aid mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption. Therefore, its urinary excretion rate may serve as a measurement of glomerular filtration rate (GFR).



The exact mechanism of action of inhaled mannitol in the symptomatic maintenance treatment of cystic fibrosis remains unclear.[A223199, L20024] It is hypothesized that mannitol produces an osmotic gradient across the airway epithelium that draws fluid into the extracellular space and alters the properties of the airway surface mucus layer, allowing easier mucociliary clearance.[A223199]', 'Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is commonly used to increase urine production (diuretic). It is also used to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol is frequently given along with other diuretics (e.g., furosemide, chlorothiazide) and/or IV fluid replacement.



Inhaled mannitol has the possibility to cause bronchospasm and hemoptysis; the occurrence of either should lead to discontinuation of inhaled mannitol.[L20024]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lumiere hair solution 100 ml', 22111, 'لومير لوسيون للشعر 100مل', '50', NULL, 'Hair care', 'Hair care', NULL, 'Panthenol+aloe vera+chamomile+thyme+ethyl alcohol+salicylic acid', 'Egpi', 'Solution', 'محلول', '100 ml', '1', NULL, NULL, 'special formula that nourishes and fortifies hair roots', NULL, 721, '2022-08-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Care dipine 10mg 30 f.c. tabs', 4226, 'كير ديبين 10 مجم 30 قرص', '138', '105', 'Antihypertensive.selective calcium channel blocker', 'Antihypertensive.selective calcium channel blocker', NULL, 'Lercanidipine', 'Misr > pharmacare', 'Tab', 'أقراص', '10mg', '3', NULL, NULL, NULL, '6224001514180', 1366, '2024-07-29', NULL, 0, 'For the treatment of Hypertension, management of angina pectoris and Raynaud''s syndrome', 'By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Lercanidipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.', 'Lercanidipine, a dihydropyridine calcium-channel blocker, is used alone or with an angiotensin-converting enzyme inhibitor, to treat hypertension, chronic stable angina pectoris, and Prinzmetal''s variant angina. Lercanidipine is similar to other peripheral vasodilators. Lercanidipine inhibits the influx of extra cellular calcium across the myocardial and vascular smooth muscle cell membranes possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum. The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pentolate 1% eye drops 10 ml', 24695, 'بنتولات قطرة عين 10 مل', '8', NULL, 'Mydriatic', 'Mydriatic', NULL, 'Cyclopentolate', 'Amoun', 'Pen', 'قلم', '1%', '1', NULL, NULL, 'about cyclopentolate ophthalmic anticholinergic(anti-muscarinic) a mydriatic and cycloplegic agent for diagnostic purposes. mechanism of action of cyclopentolate cyclopentolate is a muscarinic receptor blocker. it nonselectively inhibits the muscarinic ac', '6221025017000', 1043, '2023-04-18', NULL, 0, 'Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.', 'By blocking muscarinic receptors, cyclopentolate produces dilatation of the pupil (mydriasis) and prevents the eye from accommodating for near vision (cycloplegia).', 'Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Marago 10 sashets', 33145, 'ماراجو 10 كيس', '210', '200', 'Food supplement', 'Food supplement', NULL, 'Chromium', 'Premier international', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 6865, '2025-08-04', NULL, 0, 'Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms [FDA Label].', 'Chromium is an essential nutrient involved in the metabolism of glucose, insulin and blood lipids. Its role in potentiating insulin signalling cascades has been implicated in several studies. Chromium upregulates insulin-stimulated insulin signal transduction via affecting effector molecules downstream of the insulin receptor (IR). IR-mediated signalling pathway involves phoshorylation of multiple intracellular domains and protein kinases, and downstream effector molecules [A32353]. Upon activation by ligands, intracellular β-subunit of IR autophosphorylates and activates tyrosine kinase domain of the IR, followed by activation and phosphorylation of regulatory proteins and downstream signalling effectors including phosphatidylinositol 2-kinase (PI3K). PI3K activates further downstream reaction cascades to activate protein kinase B (Akt) to ultimately promote translocation of glucose transporter-4 (Glut4)-vesicles from the cytoplasm to the cell surface and regulate glucose uptake [A32353]. Chromium enhances the kinase activity of insulin receptor β and increases the activity of downstream effectors, pI3-kinase and Akt. 



Under insulin-resistant conditions, chromium also promotes GLUT-4 transporter translocation that is independent of activity of IR, IRS-1, PI3-kinase, or Akt; chromium mediates cholesterol efflux from the membranes via increasing fluidity of the membrane by decreasing the membrane cholesterol and upregulation of sterol regulatory element-binding protein [A32353]. As a result, intracellular GLUT-4 transporters are stimulated to translocate from intracellular to the plasma membrane, leading to enhanced glucose uptake in muscle cells [L1990]. Chromium attenuates the activity of PTP-1B _in vitro,_ which is a negative regulator of insulin signaling. It also alleviates ER stress that is observed to be elevated the suppression of insulin signaling. ER stress is thought to activate c-Jun N-terminal kinase (JNK), which subsequently induces serine phosphorylation of IRS and aberration of insulin signalling [A32353]. Transient upregulation of AMPK by chromium also leads to increased glucose uptake [A32353]. ', 'Trivalent chromium is part of glucose tolerance factor, an essential activator of insulin-mediated reactions. Chromium helps to maintain normal glucose metabolism and peripheral nerve function. Chromium increases insulin binding to cells, increases insulin receptor density and activates insulin receptor kinase leading to enhanced insulin sensitivity [A32351]. In chromium deficiency, intravenous administration of chromium resulted in normalization of the glucose tolerance curve from the diabetic-like curve typical of chromium deficiency [FDA Label]. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Apricor cream 30 gm', 32436, 'ابريكور كريم 30جم', '80', '50', 'Anti acne cream', 'Anti acne cream', NULL, 'Glycolic acid+salicylic acid+lactic acid+tea tree oil+allantoin+panthenol+chamomile+olive oli+vit e+rosemary', 'Tetra pharm', 'Cream', 'كريم', '30 gm', '1', 'كريم غنى بالفيتامينات ومضادات الاكسدة لعلاج حب الشباب', NULL, NULL, '6225000502321', 1965, '2025-05-14', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Light eyes 15 ml', 21820, 'لايت ايز 15 مل لمحيط العين', '185', '175', 'Eye contour', 'Eye contour', NULL, NULL, 'Isis pharma > biotech egypt', 'Unknown', 'غير محدد', '15 ml', '1', NULL, NULL, NULL, NULL, 789, '2025-08-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Gramogar 15 ml drops', 7458, 'جراموجار نقط فم 15 مل', '75', '65', 'Agar agar liquid extract', 'Agar agar liquid extract', NULL, 'Agar agar liquid extract', 'Genio pharma', 'Drops', 'نقط', '15 ml', '1', NULL, NULL, NULL, NULL, 1054, '2025-08-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vancobact 1 gm vial for i.v. inf.', 33827, 'فانكوباكت 1 جم فيال', '204', '60.5', 'Tricyclic glycopeptide antibiotic', 'Tricyclic glycopeptide antibiotic', NULL, 'Vancomycin', 'Egypharma-egypt', 'Vial', 'فيال', '1 gm', '1', NULL, NULL, 'about vancomycin a tricyclic glycopeptide antibiotic. mechanism of action of vancomycin vancomycin binds to the terminal dipeptide sequence of peptidoglycan and inhibits the association and cross linking of peptidoglycan and as the result inhibit cell wal', NULL, 754, '2024-12-15', NULL, 0, 'Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections.[L41529] Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of _Clostridium difficile_-associated diarrhea and for enterocolitis caused by _Staphylococcus aureus_ (including methicillin-resistant strains).[L41534]', 'The bactericidal action of vancomycin results primarily from inhibition of cell-wall biosynthesis. Specifically, vancomycin prevents incorporation of N-acetylmuramic acid (NAM)- and N-acetylglucosamine (NAG)-peptide subunits from being incorporated into the peptidoglycan matrix, which forms the major structural component of Gram-positive cell walls. Vancomycin forms hydrogen bonds with the terminal D-alanyl-D-alanine moieties of the NAM/NAG-peptides, preventing the incorporation of the NAM/NAG-peptide subunits into the peptidoglycan matrix. In addition, vancomycin alters bacterial-cell-membrane permeability and RNA synthesis. There is no cross-resistance between vancomycin and other antibiotics. Vancomycin is not active in vitro against gram-negative bacilli, mycobacteria, or fungi. [FDA Label]                                                                                                                      ', 'Vancomycin is a branched tricyclic glycosylated nonribosomal peptide often reserved as the "drug of last resort", used only after treatment with other antibiotics has failed. Vancomycin has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections: <i>Listeria monocytogenes</i>, <i>Streptococcus pyogenes</i>, <i>Streptococcus pneumoniae</i> (including penicillin-resistant strains), <i>Streptococcus agalactiae</i>, <i>Actinomyces</i> species, and <i>Lactobacillus</i> species. The combination of vancomycin and an aminoglycoside acts synergistically in vitro against many strains of Staphylococcus aureus, Streptococcus bovis, enterococci, and the viridans group streptococci [FDA Label].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pharmaceris s-safe protective face cream spf50+ 50 ml', 24817, 'فارماسيرز كريم لحمايه الجسم من الشمس بتركيبه خفيفه 50مل', '299', NULL, 'Sun block', 'Sun block', NULL, NULL, 'Laboratorium kosmetyczne dr irena eris sp. z o.o. > multitrade', 'Cream', 'كريم', '50 ml', '1', NULL, NULL, NULL, NULL, 711, '2022-07-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Candesar 4mg 14 tab.', 1976, 'كانديزار 4مجم 14 قرص', '13', NULL, 'Antihypertensive.arbs', 'Antihypertensive.arbs', NULL, 'Candesartan cilexetil', 'Pharopharma', 'Tab', 'أقراص', '4mg', '2', NULL, NULL, 'about candesartan cilexetil angiotensin || antagonist antihypertensive agent mechanism of action of candesartan cilexetil it is a antagonist of angiotensin 2 at at-1 receptor.it decreases peripheral resistance and lowers bp in hypertensive individuals. it', '6221094026125', 1196, '2022-12-03', NULL, 0, 'May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Candesartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.', 'Candesartan selectively blocks the binding of angiotensin II to AT1 in many tissues including vascular smooth muscle and the adrenal glands. This inhibits the AT1-mediated vasoconstrictive and aldosterone-secreting effects of angiotensin II and results in an overall decrease in blood pressure. Candesartan is greater than 10,000 times more selective for AT1 than AT2. Inhibition of aldosterone secretion may increase sodium and water excretion while decreasing potassium excretion.', 'Candesartan cilexetil is an ARB prodrug that is rapidly converted to candesartan, its active metabolite, during absorption from the gastrointestinal tract. Candesartan confers blood pressure lowering effects by antagonizing the hypertensive effects of angiotensin II via the RAAS. RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from granular cells of the juxtaglomerular apparatus in the kidneys. Renin cleaves circulating angiotensinogen to angiotensin I, which is cleaved by angiotensin converting enzyme (ACE) to angiotensin II. Angiotensin II increases blood pressure by increasing total peripheral resistance, increasing sodium and water reabsorption in the kidneys via aldosterone secretion, and altering cardiovascular structure. Angiotensin II binds to two receptors: type-1 angiotensin II receptor (AT1) and type-2 angiotensin II receptor (AT2). AT1 is a G-protein coupled receptor (GPCR) that mediates the vasoconstrictive and aldosterone-secreting effects of angiotensin II. Studies performed in recent years suggest that AT2 antagonizes AT1-mediated effects and directly affects long-term blood pressure control by inducing vasorelaxation and increasing urinary sodium excretion. Angiotensin receptor blockers (ARBs) are non-peptide competitive inhibitors of AT1. ARBs block the ability of angiotensin II to stimulate pressor and cell proliferative effects. Unlike ACE inhibitors, ARBs do not affect bradykinin-induced vasodilation. The overall effect of ARBs is a decrease in blood pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Azathioprine rpg 50mg 100 tab', 14791, 'ازاثيوبرين ار بي جي 100 قرص', '156', '137.5', 'Immunosuppressants', 'Immunosuppressants', NULL, 'Azathioprine', 'Rpg life sciences-india > international trading office', 'Tab', 'أقراص', '50mg', '10', 'مثبط للمناعة', NULL, NULL, NULL, 2227, '2025-08-07', NULL, 0, 'Azathioprine is indicated to treat rheumatoid arthritis and prevent renal transplant rejection.[L11214]', 'Azathioprine''s mechanism of action is not entirely understood but it may be related to inhibition of purine synthesis, along with inhibition of B and T cells.[A19872]



6-thioguanine triphosphate, a metabolite of azathioprine, modulates activation of rac1 when costimulated with CD28, inducing T cell apoptosis.[A19872] This may be mediated through rac1''s action on mitogen-activated protein kinase, NF-kappaB.[A19872]', 'Azathioprine is an immunosuppressive agent which functions through modulation of rac1 to induce T cell apoptosis, as well as other unknown immunosuppressive functions.[A19872] It has a long duration of action as it is given daily, and has a narrow therapeutic index.[L11214] Patients should be counselled regarding the risk of malignancies of the skin and lymphomas.[L11214]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Honimag 20 tabs.', 20535, 'هونيماج 20 قرص', '14', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Multivitamins+minerals', 'Mepaco', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, '6223002212507', 1164, '2022-12-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Maxamika 1000mg/4ml i.m./i.v. vial', 22375, 'ماكساميكا 1000مجم/4مل فيال', '21', NULL, 'Antibiotics', 'Antibiotics', NULL, 'Amikacin', 'Chemipharm', 'Vial', 'فيال', '1000mg', '1', NULL, NULL, 'description amikacin is a semi-synthetic aminoglycoside antibiotic derived from kanamycin a. similar to other aminoglycosides amikacin disrupts bacterial protein synthesis by binding to the 30s ribosome of susceptible organisms. binding interferes with mr', NULL, 735, '2023-01-09', NULL, 0, 'The amikacin sulfate injection is indicated in the short-term treatment of serious bacterial infections due to susceptible strains of gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, as well as Acinetobacter (Mima-Herellea) species.[F1954]



Clinical studies have shown amikacin sulfate injection to be effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and postoperative infections (including post-vascular surgery).[F1954]



Clinical studies have shown amikacin also to be effective in serious, complicated, and recurrent urinary tract infections due to the above organisms. Aminoglycosides, including amikacin, are not indicated in uncomplicated first-time episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics which are less toxic.[F1954]



In September 2018, a new indication with a new dosage route was approved for this drug. Amikacin liposome inhalation suspension was approved for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease).[L4673] This indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by Month 6 of treatment. Clinical benefit has not yet been established.[Label]



**Important notes regarding Staphylococcus and Sensitivity testing:**



Staphylococcus aureus, including methicillin-resistant strains, is the principal Gram-positive organism sensitive to amikacin.

The use of amikacin in the treatment of staphylococcal infections should be restricted only to second-line therapy, and should be limited to only those patients suffering from severe infections caused by susceptible strains of staphylococcus species who have failed to show sensitivity to other available antibiotics.[F1949]



Bacteriologic studies should be performed to identify causative organisms and their susceptibilities to amikacin. Amikacin may be used as initial therapy in suspected gram-negative infections and therapy may be initiated before obtaining the results of susceptibility testing.[Label,F1949,F1954]', 'The primary mechanism of action of amikacin is the same as that for all aminoglycosides. It binds to bacterial 30S ribosomal subunits and interferes with mRNA binding and tRNA acceptor sites, interfering with bacterial growth. This leads to disruption of normal protein synthesis and production of non-functional or toxic peptides. Other actions have been postulated for drugs of this class.[Label,F1949,F1950] Amikacin, as well as the rest of the aminoglycosides, are generally bacteriocidal against gram-positive and gram-negative bacteria.[L4680,F1954]', 'Amikacin is an aminoglycoside antibiotic. Aminoglycosides bind to the bacteria, causing misreading of t-RNA, leaving bacteria unable to synthesize proteins vital to their growth. Aminoglycosides are useful mainly in the treatment infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, however, other antibiotics may be more potent and less toxic to humans.[Label,F1949]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Eye mix eye contour gel 30 gm', 18735, 'ايي ميكس جل 30 ​​جم', '295', '250', 'Eye contour', 'Eye contour', NULL, 'Caffeine+glutathion+glycolic acid+ coenzyme q10', 'Egyptian company for cosmetics > pharmix', 'Gel', 'جل', '30 gm', '1', NULL, NULL, 'for dark circles around the eye.', NULL, 753, '2025-08-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Jointdrive 30 tablets', 12326, 'جوينت درايف 30 قرص', '290', '250', 'Joint support', 'Joint support', NULL, 'Glucosamine 250 mg+avocado-soybean unsaponifiables (asu) 75 mg+undenatured collagen type ii 10 mg+hyaluronic acid 12.5 mg+boron 1.5 mg+boswellia extract 25 mg', 'Elsebaey pharma', 'Tablet', 'أقراص', NULL, '3', NULL, NULL, NULL, '6225000481558', 2020, '2024-06-20', NULL, 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Farcorelaxin 20mg i.v./i.m. 3 amp.', 18818, 'فاركوريلاكسين 20 مجم 3 امبولات', '9', NULL, 'Antimuscarinic.antispasmodic', 'Antimuscarinic.antispasmodic', NULL, 'Hyoscin-n-butylbromid', 'Pharco', 'Amp', 'أمبول', '20mg', '3', NULL, NULL, 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', '6223000012598', 767, '2022-07-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vital care serum restoring treatment imperial argan 100ml', 29471, 'فيتال كير سيرم 100مل', '160', NULL, 'Hair care', 'Hair care', NULL, NULL, 'So.di.co. srl > bright star -egypt', 'Serum', 'سيروم', '100ml', '1', NULL, NULL, 'for dry and damaged hair', NULL, 724, '2022-07-22', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zithrodose 100mg/5ml susp. 45 ml', 12886, 'زيثرودوز 100مجم معلق 45 مل', '52', '34', 'Antibiotic.macrolide', 'Antibiotic.macrolide', NULL, 'Azithromycin', 'El-obour > averroes pharma-egypt', 'Susp', 'معلق', '100mg', '1', NULL, NULL, NULL, '6224008179023', 1597, '2025-04-24', NULL, 0, 'Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin [FDA label].



Azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and "Indications" section of this drug entry for detailed information [FDA label]. 



**Adults**:



Acute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Acute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.

Uncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.



Urethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.



Genital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.



**Pediatric Patients**



Acute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.', 'In order to replicate, bacteria require a specific process of protein synthesis, enabled by ribosomal proteins [A6505]. Azithromycin binds to the 23S rRNA of the bacterial 50S ribosomal subunit. It stops bacterial protein synthesis by inhibiting the transpeptidation/translocation step of protein synthesis and by inhibiting the assembly of the 50S ribosomal subunit [FDA label], [A14179]. This results in the control of various bacterial infections [A174193], [FDA label].   The strong affinity of macrolides, including azithromycin, for bacterial ribosomes, is consistent with their broad‐spectrum antibacterial activities [A174193].





Azithromycin is highly stable at a low pH, giving it a longer serum half-life and increasing its concentrations in tissues compared to erythromycin [A174175]. 



', 'Macrolides stop bacterial growth by inhibiting protein synthesis and translation, treating bacterial infections [A174175].

Azithromycin has additional immunomodulatory effects and has been used in chronic respiratory inflammatory diseases for this purpose [A174172].



', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Adcoclindace 10mg/30ml top. soln.', 13474, 'ادكوكلينداس 10مجم/30مل محلول موضعي', '12', NULL, 'Antibiotic.lincomycins', 'Antibiotic.lincomycins', NULL, 'Clindamycin', 'Arab drug company.', 'Sol', 'محلول', '10mg', '1', NULL, NULL, NULL, NULL, 947, '2022-07-23', NULL, 0, 'In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci.[L11599,L11602] Used topically, it is indicated for the treatment of acne vulgaris[L11593,L11611,L11605] and is available in combination with [benzoyl peroxide][L11584] or [tretinoin][L11590] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene].[L48666] Clindamycin is also indicated as a vaginal cream[L11596], suppository[L11608], or gel[L39416] for the treatment of bacterial vaginosis in non-pregnant females.



Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.[L11629]', 'Clindamycin inhibits bacterial protein synthesis by binding to 23S RNA of the 50S subunit of the bacterial ribosome.[L11599] It impedes both the assembly of the ribosome and the translation process.[L11629] The molecular mechanism through which this occurs is thought to be due to clindamycin''s three-dimensional structure, which closely resembles the 3''-ends of L-Pro-Met-tRNA and deacylated-tRNA during the peptide elongation cycle - in acting as a structural analog of these tRNA molecules, clindamycin impairs peptide chain initiation and may stimulate dissociation of peptidyl-tRNA from bacterial ribosomes.[A190621]



The mechanism through which topical clindamycin treats acne vulgaris is unclear, but may be related to its activity against _Propionibacterium acnes_, a bacteria that has been associated with acne.[L11593] ', 'Clindamycin exerts its bacteriostatic effect via inhibition of microbial protein synthesis.[A190621] Clindamycin has a relatively short T<sub>max</sub> and half-life necessitating administration every six hours to ensure adequate antibiotic concentrations.[L11629] 



_Clostridium difficile_ associated diarrhea (CDAD) has been observed in patients using clindamycin, ranging in severity from mild diarrhea to fatal colitis and occasionally occurring over two months following cessation of antibiotic therapy.[L11602] Overgrowth of _C. difficile_ resulting from antibiotic use, along with its production of A and B toxins, contributes to morbidity and mortality in these patients. Because of the associated risks, clindamycin should be reserved for serious infections for which the use of less toxic antimicrobial agents are inappropriate.[L11602]



Clindamycin is active against a number of gram-positive aerobic bacteria, as well as both gram-positive and gram-negative anaerobes.[L11599] Resistance to clindamycin may develop, and is generally the result of base modification within the 23S ribosomal RNA. Cross-resistance between clindamycin and lincomycin is complete, and may also occur between clindamycin and macrolide antibiotics (e.g. [erythromycin]) due to similarities in their binding sites.[L11599]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ectomethrin 2.5 % lotion 50 ml', 3989, 'اكتومثرين 2.5% لوسيون 50 مل', '25', '15', 'Scabicide', 'Scabicide', NULL, 'Permethrin', 'Misr > apc (arab perfumes chemicals and pharmaceutical co.)', 'Lotion', 'لوشن', '2.5 %', '1', NULL, NULL, 'about permethrin synthetic pyrethroid antiparasitic pediculicide scabicide. mechanism of action of permethrin permethrin exerts its action by inhibiting sodium ion channel and delays depolarization. this will leads to (neuronal) paralysis of insects. perm', '6221035004014', 1465, '2024-12-06', NULL, 0, 'For the treatment of infestation with <i>Sarcoptes scabiei</i> (scabies).', 'Permethrin acts on the nerve cell membrane to disrupt the sodium channel current by which the polarization of the membrane is regulated. Delayed repolarization and paralysis of the pests are the consequences of this disturbance.', 'Permethrin, a pyrethroid, is active against a broad range of pests including lice, ticks, fleas, mites, and other arthropods.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nexicure 20 mg 14 f.c.tabs.', 23540, 'نيكسيكيور 20مجم 14 قرص', '64', '60', 'Peptic ulcer.proton pump inhibitor', 'Peptic ulcer.proton pump inhibitor', NULL, 'Esomeprazole', 'Atco pharma > zeta pharm', 'Tab', 'أقراص', '20 mg', '2', 'يستخدم في علاج عسر الهضم والتهاب المريء والحموضة المعوية والقضاء على بكتيريا هيليكوباكتر بيلوري (جرثومة المعدة) ومرض القرحة المعدية ومرض الارتجاع المعدي المريئي', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223015000139', 9272, '2024-09-16', NULL, 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cranberry 100 veg caps', 3136, 'كرانبري 100 كبسولة', '780', NULL, 'Uti infections', 'Uti infections', NULL, 'Cranberry extract', 'Future pharmaceutical industries (fpi) > ema pharm', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, NULL, '6224000912000', 1216, '2022-09-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Elugel oral gel 20 gm', 18213, 'ايليوجل جل للفم 20 جم', '7', NULL, 'Oral care', 'Oral care', NULL, 'Chlorhexidine', 'Global napi pharmaceuticals > pierre - fabre france', 'Gel', 'جل', '20 gm', '1', NULL, NULL, NULL, NULL, 880, '2022-07-22', NULL, 0, 'Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures.[L11518,L11521,L11527,L11533] Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis[L11512] and a slow-release "chip" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.[L11536]', 'Chlorhexidine’s broad-spectrum antimicrobial effects are due to its ability to disrupt microbial cell membranes. The positively charged chlorhexidine molecule reacts with negatively charged phosphate groups on microbial cell surfaces - this reaction both destroys the integrity of the cell, allowing leakage of intracellular material, and allows chlorhexidine to enter the cell, causing precipitation of cytoplasmic components and ultimately cell death.[L11536,A190453] The specific means of cell death is dependent on the concentration of chlorhexidine - lower concentrations are bacteriostatic and result in leakage of intracellular substances such as potassium and phosphorous, whereas higher concentrations are bactericidal and cause cytoplasmic precipitation.[A190453]', 'Chlorhexidine is a broad-spectrum antimicrobial with demonstrated activity against both gram-positive and gram-negative bacteria, yeasts, and viruses.[A190417] Antimicrobial activity is dose-dependent - chlorhexidine is bacteriostatic at lower concentrations (0.02%-0.06%) and bactericidal at higher concentrations (>0.12%).[A190417]  Pharmacokinetic studies of oral chlorhexidine rinses indicate that approximately 30% of the active ingredient is retained in the mouth following rinsing, which is subsequently slowly released into oral fluids.[L11512] This ability to adsorb to dentine, shared with tetracycline antibiotics such as [doxycycline], is known as "substantivity" and is the result of chlorhexidine''s positive charge - it is likely that this substantivity plays at least some role in chlorhexidine''s antimicrobial activity, as its persistence on surfaces such as dentine prevent microbial colonization.[A190453]



Dental chlorhexidine rinses may result in staining of oral surfaces, such as teeth. This effect is not ubiquitous and appears to be more significant with extended therapy (i.e. up to 6 months) - nevertheless, patients for whom oral staining is unacceptable should use chlorhexidine rinse with caution and for the shortest effective interval.[L11512] Allergic reactions to chlorhexidine have been associated with the development of anaphylaxis.[A190468]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Avene physiolift precision wrinkle filler 15ml', 14711, 'افين فيزيوليفت بريسشن مضاد للتجاعيد 15 مل', '519', NULL, 'Firming topical.anti-wrinkle', 'Firming topical.anti-wrinkle', NULL, NULL, 'Pierre - fabre france > biotech egypt', 'Unknown', 'غير محدد', '15ml', '1', 'اخفاء وازالة تجاعيد البشرة', NULL, '- highly-concentrated in anti-aging actives it visibly corrects the most pronounced wrinkles and deep furrows: forehead crows feet frown lines and the mouth contour. the skin benefits from the complementary action of ascofillinetm hyaluronic acid mono-oli', NULL, 2831, '2022-10-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Traveria 200 mg 10 f.c. tab.', 28403, 'ترافيريا 200 مجم 20 قرص', '63', '42.5', 'Travelers diarrhea', 'Travelers diarrhea', NULL, 'Rifaximin', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '200 mg', '2', 'علاج الاسهال لدي المسافرين نتيجة الاكل و الماء الغير مألوف -- الحفاظ علي العناصر و السوائل داخل الجسم', NULL, 'indication for the treatment of patients (?12 years of age) with travelers diarrhea caused by noninvasive strains of escherichia coli. rifaximin is also designated an orphan drug by the food and drug administration for the adjunctive treatment of hepatic', NULL, 2103, '2025-06-18', NULL, 0, 'Rifaximin has multiple indications by the FDA: for the treatment of patients (≥12 years of age) with traveller''s diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy recurrence in patients ≥18 years of age; and in May 2015 it was approved for irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women. ', 'Rifaximin acts by inhibiting RNA synthesis in susceptible bacteria by binding to the beta-subunit of bacterial deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase enzyme. This binding blocks translocation, which stops transcription.', 'Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. This non-systemic property of the drug is due to the addition of a pyridoimidazole ring, which renders it non-absorbable. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. Other studies have also shown rifaximin to be an pregnane X receptor (PXR) activator. As PXR is responsible for inhibiting the proinflammatory transcription factor NF-kappa B (NF-κB) and is inhibited in inflammatory bowel disease (IBD), rifaximin was proven to be effective for the treatment of IBS-D.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Herbaland calcium & d3 - 30 gummies', 20375, 'هيربالاند الكالسيوم & فيتامين د3- 30 قطعه', '115', NULL, 'Calcium supplement with vitamin d3', 'Calcium supplement with vitamin d3', NULL, 'Calcium+vitamin d3+phosphorus', 'Herbaland naturals inc. > pharma vision', 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 850, '2022-08-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sila bone 30 tabs', 10829, 'سيلا بون 30 قرص', '120', '60', 'Calcium supplement', 'Calcium supplement', NULL, 'Calcium+magnesium+zinc+vitamin d3+boron+copper+manganese+selenium', 'Silaj', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1331, '2025-10-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hipanthen plus cream 60 gm', 6158, 'هاي بانتين بلس كريم 60 جرام', '60', '50', 'Moisturizing topicals', 'Moisturizing topicals', NULL, 'Panthenol+zinc oxide+glycerin+cetyl alcohol+natural oils', 'Hi-care > pixel pharmaceutical company', 'Cream', 'كريم', '60 gm', '1', 'مرطب ملطف للجلد', NULL, 'indications: dermatitis - fissures and dryness of hands and feet - nipple fissure', '6224001661204', 3744, '2024-05-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cutersy lotion', 7894, 'كيوترسي لوشن', '90', NULL, 'Antifungal, antibacterial', 'Antifungal, antibacterial', NULL, 'Piroctone olamine+zinc pyrithione+tea trea extract+saw palmetto+rosemary extract+salicylic acid+panthenol', 'Versy pharmaceutical', 'Lotion', 'لوشن', NULL, '1', NULL, NULL, NULL, NULL, 875, '2025-11-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vevetona hair oil 100 ml', 29528, 'فيفيتونا زيت شعر 100 مل', '250', '199', 'Hair oil', 'Hair oil', NULL, 'Wheat germ oil+gogoba oil+sesame+vit e+vit a', 'Chemica > nova pharma', 'Hair oil', 'زيت شعر', '100 ml', '1', 'زيت شعر لعلاج حالات تساقط الشعر', NULL, 'use 2 time daily for promotions for your hair growth and to prevent dandruff plus decrease your hair loss', NULL, 2305, '2025-06-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dexiglofozin plus 10/500 mg 30 ext. rel . f.c. tabs.', 8295, 'ديكسيجلوفوزين بلس 10/500 مجم 30 قرص', '231', NULL, 'Anti-diabetic.secretagogues.sglt2 inhibitors', 'Anti-diabetic.secretagogues.sglt2 inhibitors', NULL, 'Dapagliflozin+metformin', 'Zeta pharma', 'Tab', 'أقراص', '500 mg', '3', NULL, NULL, NULL, NULL, 753, '2025-12-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefadrine 250mg/5ml 60ml susp.', 15981, 'سيفادرين 250مجم/5مل معلق 60 مل', '8', '9.5', 'Antibiotic.cephalosporin.first-generation', 'Antibiotic.cephalosporin.first-generation', NULL, 'Cephradine', 'T3a pharma', 'Susp', 'معلق', '250mg', '1', NULL, NULL, NULL, NULL, 776, '2024-11-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Maddomor whitening cream 50 gm', 6204, 'مادومور كريم تفتيح البشرة 50 جم', '130', NULL, 'Skin care.whitening', 'Skin care.whitening', NULL, 'Alpha arbutin+vitamin c+liquorice ext.+collagen+hyaluronic acid', 'Loxymore pharma', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 844, '2025-07-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fenoril gel 50 gm', 26435, 'فينوريل جل 50 جم', '49', NULL, 'Analgesic', 'Analgesic', NULL, 'Horse chestnut extract+eugenol+menthol', 'Leader > pharma vision', 'Gel', 'جل', '50 gm', '1', NULL, NULL, NULL, NULL, 792, '2022-10-22', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sugarlo plus 50/850mg 30 f.c. tabs', 285, 'شوجارلو بلس 50/850مجم 30 قرص', '132', '99', 'Anti-diabetic.combined secretagogues+sensitizers', 'Anti-diabetic.combined secretagogues+sensitizers', NULL, 'Metformin hydrochloride+vildagliptin', 'Al esraa pharmaceutical optima', 'Tab', 'أقراص', '850mg', '3', NULL, NULL, NULL, '6223004160486', 5128, '2024-08-01', NULL, 0, '**Metformin immediate-release formulations**

 

Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ≥10 years old with type 2 diabetes mellitus.[L40243]



**Metformin extended-release tablet (XR)**



The extended-release formulation of metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Safety in children has not been determined to this date.[L12207]



**Metformin combination products**



Metformin is a component of a variety of combination products with other anti-diabetic agents. It is indicated, along with diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with DPP-4 inhibitors ([sitagliptin], [linagliptin], [alogliptin], or [saxagliptin]),[L11479,L40248,L40253,L40258,L40263] in combination with SGLT2 inhibitors ([canagliflozin], [empagliflozin], [ertugliflozin], or [dapagliflozin]),[L11479,L30503,L1134,L13679,L38729] or in combination with [pioglitazone].[L11419]', 'Metformin''s mechanisms of action are unique from other classes of oral antihyperglycemic drugs. Metformin decreases blood glucose levels by decreasing hepatic glucose production (also called gluconeogenesis), decreasing the intestinal absorption of glucose, and increasing insulin sensitivity by increasing peripheral glucose uptake and utilization.[L12207] It is well established that metformin inhibits mitochondrial complex I activity, and it has since been generally postulated that its potent antidiabetic effects occur through this mechanism.[A36534, A36557]   The above processes lead to a decrease in blood glucose, managing type II diabetes and exerting positive effects on glycemic control.



After ingestion, the organic cation transporter-1 (OCT1) is responsible for the uptake of metformin into hepatocytes (liver cells). As this drug is positively charged, it accumulates in cells and in the mitochondria because of the membrane potentials across the plasma membrane as well as the mitochondrial inner membrane. Metformin inhibits mitochondrial complex I, preventing the production of mitochondrial ATP leading to increased cytoplasmic ADP:ATP and AMP:ATP ratios.[A36534] These changes activate AMP-activated protein kinase (AMPK), an enzyme that plays an important role in the regulation of glucose metabolism.[A176348] Aside from this mechanism, AMPK can be activated by a lysosomal mechanism involving other activators.  Following this process, increases in AMP:ATP ratio also inhibit _fructose-1,6-bisphosphatase_ enzyme, resulting in the inhibition of gluconeogenesis, while also inhibiting _adenylate cyclase_ and decreasing the production of cyclic adenosine monophosphate (cAMP),[A36534] a derivative of ATP used for cell signaling [A176351]. Activated AMPK phosphorylates two isoforms of acetyl-CoA carboxylase enzyme, thereby inhibiting fat synthesis and leading to fat oxidation, reducing hepatic lipid stores and increasing liver sensitivity to insulin.[A36534] 



In the intestines, metformin increases anaerobic glucose metabolism in enterocytes (intestinal cells), leading to reduced net glucose uptake and increased delivery of lactate to the liver. Recent studies have also implicated the gut as a primary site of action of metformin and suggest that the liver may not be as important for metformin action in patients with type 2 diabetes. Some of the ways metformin may play a role on the intestines is by promoting the metabolism of glucose by increasing glucagon-like peptide I (GLP-1) as well as increasing gut utilization of glucose.[A36534] 



In addition to the above pathway, the mechanism of action of metformin may be explained by other ways, and its exact mechanism of action has been under extensive study in recent years.[A36535, A36554, A36555, A36557]', '**General effects**



Insulin is an important hormone that regulates blood glucose levels.[T514] Type II diabetes is characterized by a decrease in sensitivity to insulin, resulting in elevations in blood glucose when the pancreas can no longer compensate. In patients diagnosed with type 2 diabetes, insulin is unable to exert adequate effects on tissues and cells (i.e. insulin resistance)[T514] and insulin deficiency may also be present.[L5753]



Metformin reduces hepatic production of glucose, decreases the intestinal absorption of glucose, and enhances insulin sensitivity by increasing both peripheral glucose uptake and utilization. In contrast with drugs of the sulfonylurea class, which lead to hyperinsulinemia, the secretion of insulin is unchanged with metformin use.[L12207]



**Effect on fasting plasma glucose (FPG) and Glycosylated hemoglobin (HbA1c)**



HbA1c is an important periodic measure of glycemic control used to monitor diabetic patients. Fasting plasma glucose is also a useful and important measure of glycemic control. In a 29-week clinical trial of subjects diagnosed with type II diabetes, metformin decreased the fasting plasma glucose levels by an average of 59 mg/dL from baseline, compared to an average increase of 6.3 mg/dL from baseline in subjects taking a placebo.[L12207]  Glycosylated hemoglobin (HbA1c) was decreased by about 1.4% in subjects receiving metformin, and increased by 0.4% in subjects receiving placebo only.[L12207]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ferronex plus iron lozenges 24 tabs.', 19003, 'فيرونيكس بلس 24 قرص حديد', '110', '79', 'Iron supplement.anemia', 'Iron supplement.anemia', NULL, 'Iron (ferrous fumarate)+sucrose+cellulose+cocoa powder+full cream milk', 'Pharma zad > bionil', 'Tab', 'أقراص', NULL, '2', 'مكمل غذائي بالحديد لعلاج الانيميا', NULL, 'iron fortified lozenges', '6224009569021', 5783, '2024-10-09', NULL, 0, 'For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.', 'After iron dextran is injected, the circulating iron dextran is removed from the plasma by cells of the reticuloendothelial system, which split the complex into its components of iron and dextran. The iron is immediately bound to the available protein moieties to form hemosiderin or ferritin, the physiological forms of iron, or to a lesser extent to transferrin. This iron which is subject to physiological control replenishes hemoglobin and depleted iron stores.', 'Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Floreen 100 mg lactofern 10 sachet', 32020, 'فلورين 100مجم لاكتوفرين 10 أكياس', '150', '120', 'Multi vitamins', 'Multi vitamins', NULL, 'Lactoferen+folic acid+zinc+vitc+vit b complex', 'Pharma zad egypt > challenge pharmaceutical', 'Sachet', 'أكياس', '100 mg', '1', 'مكمل غذائى علاج حالات فقر الدم ودعم الجهاز العصبى والمناعى وامداد الجسم بالطاقة', NULL, 'to enhance immune system &cases of upper respiratory tract infections &cases of diareah &cases of recurrent infections', NULL, 1740, '2025-07-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pantex hair shampoo 120 ml', 24512, 'بانتيكس شامبو للشعر 125 مل', '60', '50', 'Hair care', 'Hair care', NULL, 'Salicylic acid+octopirox', 'Weiser', 'Amp', 'أمبول', '120 ml', '1', NULL, NULL, NULL, NULL, 1135, '2024-06-15', NULL, 0, 'Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.', 'Salicylic acid directly irreversibly inhibits COX-1 and COX-2 to decrease conversion of arachidonic acid to precursors of prostaglandins and thromboxanes. Salicylate''s use in rheumatic diseases is due to it''s analgesic and anti-inflammatory activity. Salicylic acid is a key ingredient in many skin-care products for the treatment of acne, psoriasis, calluses, corns, keratosis pilaris, and warts. Salicylic acid allows cells of the epidermis to more readily slough off. Because of its effect on skin cells, salicylic acid is used in several shampoos used to treat dandruff. Salicylic acid is also used as an active ingredient in gels which remove verrucas (plantar warts). Salicylic acid competitively inhibits oxidation of uridine-5-diphosphoglucose (UDPG) with nicotinamide adenosine dinucleotide (NAD) and noncompetitively with UDPG. It also competitively inhibits the transferring of the glucuronyl group of uridine-5-phosphoglucuronic acid (UDPGA) to a phenolic acceptor. Inhibition of mucopoly saccharide synthesis is likely responsible for the slowing of wound healing with salicylates.', 'Salicylic acid treats acne by causing skin cells to slough off more readily, preventing pores from clogging up. This effect on skin cells also makes salicylic acid an active ingredient in several shampoos meant to treat dandruff. Use of straight salicylic solution may cause hyperpigmentation on unpretreated skin for those with darker skin types (Fitzpatrick phototypes IV, V, VI), as well as with the lack of use of a broad spectrum sunblock. Subsalicylate in combination with bismuth form the popular stomach relief aid known commonly as Pepto-Bismol. When combined the two key ingredients help control diarrhea, nausea, heartburn, and even gas. It is also very mildly anti-biotic.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Glitazen 30 mg 30 tabs.', 19862, 'جليتازين 30 مجم 30 قرص', '33', NULL, 'Anti-diabetic.sensitizers.glitazone', 'Anti-diabetic.sensitizers.glitazone', NULL, 'Pioglitazone', 'El-obour modern pharm. ind. > hygint pharmaceuticals', 'Tab', 'أقراص', '30 mg', '3', NULL, NULL, 'about pioglitazone thiazolidinedione (tzd) derivative insulin sensitizer oral anti diabetic. mechanism of action of pioglitazone the drug exerts antidiabetic action by acting as a selective agonist for the nuclear peroxisome proliferator-activated recepto', NULL, 809, '2022-07-23', NULL, 0, 'Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.[L11416] It is also available in combination with [metformin],[L11419] [glimepiride],[L11422] or [alogliptin][L11425] for the same indication.', 'Pioglitazone is a selective agonist at peroxisome proliferator-activated receptor-gamma (PPARγ) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver.[L11416,A19759] Activation of PPARγ increases the transcription of insulin-responsive genes involved in the control of glucose and lipid production, transport, and utilization.[A19759] Through this mechanism, pioglitazone both enhances tissue sensitivity to insulin and reduces the hepatic production of glucose (i.e. gluconeogenesis) - insulin resistance associated with type 2 diabetes mellitus is therefore improved without an increase in insulin secretion by pancreatic beta cells.[L11416,A19759]', 'Pioglitazone enhances cellular responsiveness to insulin, increases insulin-dependent glucose disposal, and improves impaired glucose homeostasis.[A19757] In patients with type 2 diabetes mellitus, these effects result in lower plasma glucose concentrations, lower plasma insulin concentrations, and lower HbA1c values.[A19757]

 

Significant fluid retention leading to the development/exacerbation of congestive heart failure has been reported with pioglitazone - avoid its use in patients in heart failure or at risk of developing heart failure.[L11416] There is some evidence that pioglitazone may be associated with an increased risk of developing bladder cancer. Pioglitazone should not be used in patients with active bladder cancer and should be used with caution in patients with a history of bladder cancer.[L11416]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Diabolka 30 tabs', 12165, 'ديابولكا 30 قرص', '137', NULL, NULL, NULL, NULL, NULL, 'Biomed', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 768, '2024-07-11', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Avinox spray oral spray 60 ml', 256, 'افينوكس بخاخ للفم 60 مل', '70', '35', 'Mouth healing ulcers', 'Mouth healing ulcers', NULL, 'Cetrimonium bromide', 'S.l. fastners private limited', 'Spray', 'بخاخ', '60 ml', '1', 'اسبراي للفم للتخلص من الرائحة الكريهة -- علاج تقرحات الفم واللثة -- علاج الاالم الفم واللثة', NULL, NULL, NULL, 3839, '2024-06-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ossofortin original d2 (10.000 i.u.) 30 tabs', 10047, 'اوسوفورتين اوريجينال دي2 10.000 وحدة دولية 30 قرص', '84', NULL, 'Vitamin d', 'Vitamin d', NULL, 'Ergocalciferol', 'Eva pharma', 'Tab', 'أقراص', NULL, '3', '* تعويض نقص فيتامين دال', NULL, NULL, '6223002453900', 9834, '2023-04-21', NULL, 0, 'Ergocalciferol is indicated for the treatment of hypoparathyroidism, refractory rickets, and familial hypophosphatemia.[FDA label]



Hypoparathyroidism is the result of inadequate parathyroid hormone production that occurs due to the presence of damage or removal of the parathyroid glands. This condition produces decreased calcium and increased phosphorus levels.[L6082]



Rickets is a condition produced due to a deficiency in vitamin D, calcium or phosphorus. However, this condition can also be related to renal diseases. It is characterized to present weak or soft bones.[A177664]



Familial hypophosphatemia is characterized by the impaired transport of phosphate and an altered vitamin D metabolism in the kidneys. The presence of this condition can derive in the presence of osteomalacia, bone softening and rickets.[L6085]', 'For its activity, ergocalciferol is required to be transformed to its major active circulating hydroxylated metabolite and transported to the target organs in order to bind to its target, the vitamin D receptor.[T580]



The activation of the vitamin D receptor is part of the vitamin D endocrine system and it is described by the production of a change in the transcription rates of the vitamin D receptor target genes.[T580] The target genes in the DNA affected by the presence of ergocalciferol are called vitamin D response elements which are dependent on co-modulators.[A177637]



The vitamin D receptor is a transcription factor and member of the steroid hormone nuclear receptor family. It presents a DNA binding domain (VDRE) that, when activated, recruits coregulatory complexes to regulate the genomic activity.[A177637]



Additionally, ergocalciferol presents nongenomic effects such as the stimulation of intestinal calcium transport via transcaltachia.[A177637]', 'After the activation of the vitamin D receptor, some of the biological changes produced by ergocalciferol include mobilization and accretion of calcium and phosphorus in the bone, absorption of calcium and phosphorus in the intestine, and reabsorption of calcium and phosphorus in the kidney.[T580] 



Some other effects known to be produced due to the presence of vitamin D are osteoblast formation, fetus development, induction of pancreatic function, induction of neural function, improvement of immune function, cellular growth and cellular differentiation.[T580]



When compared to its vitamin D counterpart [cholecalciferol], ergocalciferol has been shown to present a reduced induction of calcidiol and hence, it is less potent.[A177529]



Ergocalciferol supplementation in patients with end-stage renal disease has been shown to generate a significant benefit in lab parameters of bone and mineral metabolism as well as improvement in glycemic control, serum albumin levels and reduced levels of inflammatory markers.[A177526]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Futacoxib 60 mg 30 f.c.tabs.', 30573, 'فيوتاكوكسيب 60مجم 30 قرص', '231', '195', 'Nsaid.selective cox-2 inhibitors', 'Nsaid.selective cox-2 inhibitors', NULL, 'Etoricoxib', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '60 mg', '3', 'يستخدم لعلاج الآلام بعد إجراءات الأسنان البسيطة وجراحة أمراض النساء والألم المرتبط بعسر الطمث الأولي', NULL, 'etoricoxib is indicated for the treatment of rheumatoid arthritis psoriatic arthritis osteoarthritis ankylosing spondylitis chronic low back pain acute pain and gout. like any other selective cox-2 inhibitor (coxib) etoricoxib selectively inhibits isoform', '6223004191268', 5673, '2024-09-16', NULL, 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.', 'Like any other COX-2 selective inhibitor Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2), preventing production of prostaglandins (PGs) from arachidonic acid.', 'Etoricoxib is a COX-2 selective inhibitor (approximately 106 times more selective for COX-2 inhibition over COX-1).', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Glucose 25% (el nasr) i.v. inf. 500 ml (rubber cap)', 5624, 'جلوكوز 25% النصر محلول وريدي 500 مل زجاجة بغطاء مطاطي', '17', NULL, 'Antihypoglycemic', 'Antihypoglycemic', NULL, 'Glucose (dextrose)', 'El nasr', 'Cap', 'كبسولة', '25%', '1', 'محلول جلوكوز ملحي', NULL, NULL, NULL, 3213, '2023-05-14', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Irbefutal co 300/25 mg 30 tab.', 5236, 'اربيفيوتال كو 300/25مجم 30 قرص', '117', NULL, 'Anti-hypertensive.angiotensin blocker', 'Anti-hypertensive.angiotensin blocker', NULL, 'Hydrochlorothiazide+irbesartan', 'Future pharmaceutical industries (fpi)', 'Tab', 'أقراص', '25 mg', '3', NULL, NULL, NULL, NULL, 1032, '2022-10-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefaxoral 500mg 8 caps.', 16000, 'سيفاكسورال 500 مجم 8 اقراص', '10', NULL, 'Antibiotic.cephalosporin.first-generation', 'Antibiotic.cephalosporin.first-generation', NULL, 'Cefadroxil', 'T3a pharma', 'Cap', 'كبسولة', '500mg', '1', NULL, NULL, NULL, NULL, 811, '2022-07-24', NULL, 0, 'For the treatment of the following infections (skin, UTI, ENT) caused by; <i>S. pneumoniae, H. influenzae, staphylococci, S. pyogenes</i> (group A beta-hemolytic streptococci), <i>E. coli, P. mirabilis, Klebsiella</i> sp, coagulase-negative staphylococci and <i>Streptococcus pyogenes</i>', 'Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor.', 'Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Jadenu 180mg 30 f.c. tabs.', 21118, 'جادينو 180 مجم 30 قرص', '4,640', '3680', 'Iron chelating agents', 'Iron chelating agents', NULL, 'Deferasirox', 'Novartis', 'Tab', 'أقراص', '180mg', '3', NULL, NULL, 'about deferasirox a synthetic achiral tridentate triazole derived from salicylic acid oral iron chelating agents. indication for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and', NULL, 1509, '2024-06-04', NULL, 0, 'For the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.', 'Two molecules of deferasirox are capable of binding to 1 atom of iron. Deferasirox works in treating iron toxicity by binding trivalent (ferric) iron (for which it has a strong affinity), forming a stable complex which is eliminated via the kidneys.', 'Deferasirox is an orally active chelator that is selective for iron (as Fe3+). It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio. Although deferasirox has very low affinity for zinc and copper there are variable decreases in the serum concentration of these trace metals after the administration of deferasirox. The clinical significance of these decreases is uncertain.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cefbiolor 250 mg 10 caps.', 16003, 'سيفبيولور 250 مجم 10 كبسولات', '16', NULL, 'Antibiotic.cephalosporin.second-generation', 'Antibiotic.cephalosporin.second-generation', NULL, 'Cefaclor', 'Sigma > sabaa', 'Cap', 'كبسولة', '250 mg', '1', NULL, NULL, 'about cefaclor a second-generation cephalosporin antibiotic oral broad-spectrum antibiotics. mechanism of action cefaclor is a 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibi', NULL, 814, '2022-07-18', NULL, 0, 'For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.', 'Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor.', 'Cefaclor is a second generation cephalosporin antibiotic with a spectrum resembling first-generation cephalosporins. <i>In vitro</i> tests demonstrate that the bactericidal action of the cephalosporins results from inhibition of cell-wall synthesis. As indicated by _in vitro_ and _in vivo_ clinical studies, cefaclor was shown to be effective against most strains of Gram positive aerobes - Staphylococci (including coagulase-positive, coagulase-negative, and penicillinase-producing strains), <i>Streptococcus pneumoniae</i>, <i>Streptococcus pyogenes</i> (group A &szlig;-hemolytic streptococci), as well as Gram-negative aerobes - <i>Escherichia coli</i>, <i>Haemophilus influenzae</i> (including &szlig;-lactamase-producing ampicillin-resistant strains), <i>Klebsiella sp</i>, and <i>Proteus mirabilis</i>.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pharmavildamin 50/850mg 30 tab', 17567, 'فارمافيلدامين 50/1000مجم 30 قرص', '159', '121.5', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', NULL, 'Vildagliptin+metformin', 'Pharma care', 'Tab', 'أقراص', '850mg', '3', NULL, NULL, NULL, '6224009003501', 1123, '2025-07-30', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Delpedox 875mg 10 f.c.tab.', 17217, 'ديلبيدوكس 875 مجم 10 اقراص', '12', NULL, 'Penicillins.monocomponent', 'Penicillins.monocomponent', NULL, 'Amoxicillin', 'Sedico > pioneer pharmaceutical industries', 'Tab', 'أقراص', '875mg', '1', NULL, NULL, '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', '6223004000539', 765, '2022-07-26', NULL, 0, 'Amoxicillin alone is indicated to treat susceptible bacterial infections of the ear, nose, throat, genitourinary tract, skin, skin structure, and lower respiratory tract.[L11656,L11659] Amoxicillin is given with calvulanic acid to treat acute bacterial sinusitis, community acquired pneumonia, lower respiratory tract infections, acute bacterial otitis media, skin and skin structure infections, and urinary tract infections.[L11650,L7880,L11653] Amoxicillin is given with omeprazole in the treatment of _Helicobacter pylori_ (_H. pylori_) infection.[L9743,L11647]



Amoxicillin is used in combination with [vonoprazan] and [clarithromycin] as co-packaged triple therapy or in combination with [vonoprazan] as co-packaged dual therapy to treat _H. pylori_ infection in adults.[L41695]', 'Amoxicillin competitively inhibits penicillin-binding protein 1 and other high molecular weight penicillin binding proteins.[A6205,A190678]  Penicillin bind proteins are responsible for glycosyltransferase and transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls.[A190678] Without the action of penicillin binding proteins, bacteria upregulate autolytic enzymes and are unable to build and repair the cell wall, leading to bacteriocidal action.[A190642,A190678]', 'Amoxicillin competitively inhibit penicillin binding proteins, leading to upregulation of autolytic enzymes and inhibition of cell wall synthesis.[A6205,A190678,A190642] Amoxicillin has a long duration of action as it is usually given twice daily.[L7880] Amoxicillin has a wide therapeutic range as mild overdoses are not associated with significant toxicity.[L11650] Patients should be counselled regarding the risk of anaphylaxis, _Clostridium difficile_ infections, and bacterial resistance.[L11656]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Orastatin 100.000 i.u/ml oral susp. 30 ml', 24223, 'اوراستاتين نقط للفم مضاد للفطريات', '19', '10.5', 'Antifungal.polyene', 'Antifungal.polyene', NULL, 'Nystatin', 'Mepaco > hi-pharm', 'Susp', 'معلق', '30 ml', '1', 'مضاد للفطريات للفم', NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', '6224001050343', 2850, '2023-08-18', NULL, 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hi-glitazone 15mg 30 tab.', 6147, 'هاي جليتازون 15 مجم 30 قرص', '75', NULL, 'Anti-diabetic.sensitizers.glitazone', 'Anti-diabetic.sensitizers.glitazone', NULL, 'Pioglitazone', 'Hi-pharm', 'Tab', 'أقراص', '15mg', '3', NULL, NULL, 'about pioglitazone thiazolidinedione (tzd) derivative insulin sensitizer oral anti diabetic. mechanism of action of pioglitazone the drug exerts antidiabetic action by acting as a selective agonist for the nuclear peroxisome proliferator-activated recepto', '6224001050206', 1182, '2023-08-03', NULL, 0, 'Pioglitazone is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.[L11416] It is also available in combination with [metformin],[L11419] [glimepiride],[L11422] or [alogliptin][L11425] for the same indication.', 'Pioglitazone is a selective agonist at peroxisome proliferator-activated receptor-gamma (PPARγ) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver.[L11416,A19759] Activation of PPARγ increases the transcription of insulin-responsive genes involved in the control of glucose and lipid production, transport, and utilization.[A19759] Through this mechanism, pioglitazone both enhances tissue sensitivity to insulin and reduces the hepatic production of glucose (i.e. gluconeogenesis) - insulin resistance associated with type 2 diabetes mellitus is therefore improved without an increase in insulin secretion by pancreatic beta cells.[L11416,A19759]', 'Pioglitazone enhances cellular responsiveness to insulin, increases insulin-dependent glucose disposal, and improves impaired glucose homeostasis.[A19757] In patients with type 2 diabetes mellitus, these effects result in lower plasma glucose concentrations, lower plasma insulin concentrations, and lower HbA1c values.[A19757]

 

Significant fluid retention leading to the development/exacerbation of congestive heart failure has been reported with pioglitazone - avoid its use in patients in heart failure or at risk of developing heart failure.[L11416] There is some evidence that pioglitazone may be associated with an increased risk of developing bladder cancer. Pioglitazone should not be used in patients with active bladder cancer and should be used with caution in patients with a history of bladder cancer.[L11416]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Progest 400mg 15 caps', 7361, 'بروجيست 400مجم 15 كبسولة', '255', NULL, 'Progesterone replacement', 'Progesterone replacement', NULL, 'Progesterone', 'Pharco', 'Cap', 'كبسولة', '400mg', '1', NULL, NULL, NULL, '6221151574507', 878, '2022-07-12', NULL, 0, '**Gelatinized capsules**



The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea [FDA label]. 



**Vaginal gel**



Progesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (“ART”) treatment for infertile women with progesterone deficiency.  The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel [F3898].



**Vaginal insert**



This form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women [F3901].



**Injection (intramuscular)**



This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer [F3907]. 



**Tablets, contraceptive**



The tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy [F3904]. ', 'Progesterone binds and activates its nuclear receptor, _PR_, which plays an important part in the signaling of stimuli that maintain the endometrium during its preparation for pregnancy.



Progesterone receptor (PR) is a member of the nuclear/steroid hormone receptor (SHR) family of ligand-dependent transcription factors that is expressed primarily in female reproductive tissue as well as the central nervous system. As a result of its binding its associated steroid hormone, progesterone, the progesterone receptor (PR) modulates the expression of genes that regulate the development, differentiation, and proliferation of target tissues [A175666]. In humans, PR is found to be highly expressed in the stromal (connective tissue) cells during the secretory phase and during pregnancy [A175651]. 



Progesterone may prevent pregnancy by changing the consistency of cervical mucus to be unfavorable for sperm penetration, and by inhibiting follicle-stimulating hormone (FSH), which normally causes ovulation.  With perfect use, the first-year failure rate for progestin-only oral contraceptives is approximately 0.5%. The typical failure rate, however, is estimated to be approximately 5%, due to late or missed pills [F3904].', 'Progesterone, depending on concentration and dosage form, and timing of exposure may have several pharmacodynamic effects.  These actions, according, to various preparations, are listed below:



General effects



Progesterone is the main hormone of the corpus luteum and the placenta. It acts on the uterus by changing the proliferative phase to the secretory phase of the endometrium (inner mucous lining of the uterus).   This hormone, stimulated by a hormone called _luteinizing hormone_ (LH) is the main hormone during the secretory phase to prepare the corpus luteum and the endometrium for implantation of a fertilized ovum. As the luteal phase concludes, the progesterone hormone sends negative feedback to the anterior pituitary gland in the brain to decrease FSH (follicle stimulating hormone) and LH (luteinizing hormone) levels. This prevents ovulation and maturation of oocytes (immature egg cells). The endometrium then prepares for pregnancy by increasing its vascularity (blood vessels) and stimulating mucous secretion. This process occurs by progesterone stimulating the endometrium to decrease endometrial proliferation, leading to a decreased uterine lining thickness, developing more complex uterine glands, collecting energy in the form of glycogen, and providing more uterine blood vessel surface area suitable for supporting a growing embryo. As opposed to cervical mucous changes observed during the proliferative phase and ovulation, progesterone decreases and thickens the cervical mucus, rendering it less elastic. This change occurs because the fertilization time period has passed, and a specific consistency of mucous amenable to sperm entry is no longer required [T490].



**Gelatinized capsules**



Progesterone capsules are an oral dosage form of micronized progesterone which, chemically identical to progesterone of ovarian origin. Progesterone capsules have all the properties of endogenous progesterone with induction of a secretory phase endometrium with gestagenic, antiestrogenic, slightly antiandrogenic and anti-aldosterone effects [F3913]. Progesterone opposes the effects of estrogen on the uterus, and is beneficial in women with unopposed estrogen exposure, which carries an increased risk of malignancy [F3913].





**Vaginal gel and vaginal insert**



 The gel preparation mimics the effects of naturally occurring progesterone. In the presence of adequate levels of estrogen, progesterone converts a proliferative endometrium into secretory endometrium. This means that the endometrium changes from a growing and thickening stage into a subsequent preparation stage for pregnancy, which involves further preparatory changes. Progesterone is necessary for the development of decidual tissue (specialized tissue amenable to supporting a possible pregnancy). Progesterone is required to increase endometrial receptivity for the implantation of a fertilized embryo. Once an embryo is implanted, progesterone helps to maintain the pregnancy [F3898]. 





**Injection (intramuscular)**



 Intramuscularly injected progesterone increases serum progesterone and aids in the prevention of endometrial tissue overgrowth due to unopposed estrogen (which leads to abnormal uterine bleeding and sometimes uterine cancer) [L5638], [F3916]. In the absence or deficiency of progesterone, the endometrium continually proliferates, eventually outgrowing its limited blood supply, shedding incompletely, and leading to abnormal and/or profuse bleeding as well as malignancy [L5638].



**Tablets, contraceptive**



Progesterone-only contraceptive tablets prevent conception by suppressing ovulation in about half of users, causing a thickening of cervical mucus to inhibit sperm movement, lowering the midcycle LH and FSH hormone peaks, slowing the movement of the ovum through the fallopian tubes, and causing secretory changes in the endometrium as described above [F3904].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Relaxycool 80ml spray', 4574, 'ريلاكس كول 80 مل بخاخ', '69', NULL, 'Massage spray', 'Massage spray', NULL, 'Menthol+clove+eucalyptus+peppermint+camphor+tea tree+canola', 'Life pharma international', 'Spray', 'بخاخ', '80ml', '1', NULL, NULL, NULL, NULL, 704, '2025-06-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Uremel 100ml cream', 4664, 'يوريميل كريم 100 مل', '240', NULL, 'Moisturizer', 'Moisturizer', NULL, 'Urea', 'Melano pharma', 'Cream', 'كريم', '100ml', '1', NULL, NULL, NULL, '6223013790704', 1251, '2023-05-01', NULL, 0, 'Urea is used topically for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.[L41484]', NULL, 'Urea is a keratolytic emollient that works to treat or prevent dry, rough, scaly, itchy skin.[L41484]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bobai sunscreen tinted cream spf 80 - 60 gm', 15400, 'بوباي صن بلوك تينتد كريم بمعامل حماية 80 - 60 جم', '225', '195', 'Sun block', 'Sun block', NULL, 'Sun protection formula', 'Egyptian company for cosmetics > parkville pharmaceuticals', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, 'integrated system with organic and inorganic ingredients anti-oxidant and soothing power broad spectrum protection (uva/ uvb) photo stable long-lasting protection water proof /sweat proof and suitable for all skin types. apply 20 minutes before sun exposu', NULL, 1006, '2025-07-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nanobee iron 20 tablet', 3530, 'نانوبي حديد 20 قرص', '130', NULL, 'Iron source +multivitamin', 'Iron source +multivitamin', NULL, 'Liposomal iron+folic acid+vitamin b12+vitamin b6+zinc+copper', 'Hexagonpharm', 'Tablet', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 904, '2025-04-12', NULL, 0, 'Investigated for use/treatment in neuropathy (diabetic) and peripheral vascular disease.', 'The encapsulated formulation (Liprostin) has been shown to improve the therapeutic index of PGE-1, positively impacting many areas of treatment, such as heart attacks, occlusive disease, ischemic ulcers, critical limb salvage, claudicants, and arthritis.', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Feldene 20mg/ml i.m. 6 amp.', 4760, 'فلدين 20مجم 6 امبولات حقن عضل', '90', '63', 'Nsaid.oxicam', 'Nsaid.oxicam', NULL, 'Piroxicam', 'Pfizer', 'Amp', 'أمبول', '20mg', '6', 'مسكن.', NULL, 'about piroxicam nsaid oxicam derivative analgesic antiinflammatory. mechanism of action of piroxicam drug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. in this way it reduces the pg (pr', '6221180000428', 12101, '2024-09-29', NULL, 0, 'For treatment of osteoarthritis and rheumatoid arthritis.', 'The antiinflammatory effect of Piroxicam may result from the reversible inhibition of cyclooxygenase, causing the peripheral inhibition of prostaglandin synthesis. The prostaglandins are produced by an enzyme called Cox-1. Piroxicam blocks the Cox-1 enzyme, resulting into the disruption of production of prostaglandins. Piroxicam also inhibits the migration of leukocytes into sites of inflammation and prevents the formation of thromboxane A2, an aggregating agent, by the platelets.', 'Piroxicam is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Piroxicam works by reducing hormones that cause inflammation and pain in the body. Piroxicam is used to reduce the pain, inflammation, and stiffness caused by rheumatoid arthritis and osteoarthritis.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Concor 10mg 30 f.c. tablets', 2973, 'كونكور 10مجم 30 قرص', '99', '70.5', 'Antihypertensive.beta blocker.selective b1', 'Antihypertensive.beta blocker.selective b1', NULL, 'Bisoprolol fumarate', 'Amoun > merck kgaa f.r.germany', 'Tablet', 'أقراص', '10mg', '3', 'لمرضى ضغط الدم المرتفع', NULL, NULL, '6221025032362', 7533, '2024-07-07', NULL, 0, 'Bisoprolol is indicated for the treatment of mild to moderate hypertension.[L7219] It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.[A180460,A180463]', 'Though the mechanism of action of bisoprolol has not been fully elucidated in hypertension, it is thought that therapeutic effects are achieved through the antagonism of β-1adrenoceptors to result in lower cardiac output. Bisoprolol is a competitive, cardioselective β1-adrenergic antagonist. When β1-receptors (located mainly in the heart)[T640] are activated by adrenergic neurotransmitters such as epinephrine, both the blood pressure and heart rate increase, leading to greater cardiovascular work, increasing the demand for oxygen.  Bisoprolol reduces cardiac workload by decreasing contractility and the need for oxygen through competitive inhibition of β1-adrenergic receptors.[A180502,T640]



Bisoprolol is also thought to reduce the output of renin in the kidneys, which normally increases blood pressure. Additionally, some central nervous system effects of bisoprolol may include diminishing sympathetic nervous system output from the brain, decreasing blood pressure and heart rate.[L7219]', 'Bisoprolol decreases heart rate (chronotropy), decreases contractility (inotropy), and reduces blood pressure.[T640,L7219] The results of various clinical studies indicate that bisoprolol reduces cardiovascular mortality and all-cause mortality in patients with heart failure and decreased cardiac ejection fraction (EF).[A180466,A180505] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Grasp 50mg 20 tab', 7605, 'جراسب 50مجم 20 قرص', '59', NULL, NULL, NULL, NULL, NULL, NULL, 'Tab', 'أقراص', '50mg', '2', NULL, NULL, NULL, NULL, 770, '2025-10-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ophtatrov plus 0.004%/0.5% eye drops 2.5 ml', 24140, 'اوفتاتروف بلس قطرة 0.004%/0.5% 2.5 مل', '97', '72', 'Antiglaucoma', 'Antiglaucoma', NULL, 'Timolol+travoprost', 'Mina pharm', 'Drops', 'نقط', '0.004%', '1', NULL, NULL, 'about timolol nonselective beta adrenergic blocker ophthalmic- antiglaucoma antimigraine. mechanism of action of timolol timolol is a non selective beta blocker. it inhibits the beta receptors (?2) present in the eye such as in the ciliary body epithelium', NULL, 1510, '2024-04-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fertitonex 30 caps', 11309, 'فرتيتونكس 30 كبسولة', '300', '225', 'Antioxidant', 'Antioxidant', NULL, 'L-carnitine+l-arginine+vitamin b6+vitamin b12+vitamin d3+vitamin e+vitamin c+selenium+zinc+folic acid+co q10 enzyme', 'Copad egypt > integra pharm', 'Cap', 'كبسولة', NULL, '3', '1- زيادة ودعم الخصوبة والتكاثر للرجال.', NULL, 'supports male and female infertility & antioxidants', '6224009369430', 131656, '2024-04-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Aspain 300mg 20*10 tab.', 14472, 'اسبان 300 مجم 20-10 قرص', '24', NULL, 'Nsaid.salicylates', 'Nsaid.salicylates', NULL, 'Acetylsalicylic acid', 'Alexandria', 'Tab', 'أقراص', '300mg', '20', NULL, NULL, 'description: belongs to a group of medicines called non-steroidal anti-inflammatory drugs (nsaids) indication: mild to moderate pain including headache migraine nerve pain (neuralgia) toothache sore throat period pain. relieving aches pains and fever asso', NULL, 834, '2022-07-13', NULL, 0, '**Pain, fever, and inflammation**



Acetylsalicylic acid (ASA), in the regular tablet form (immediate-release), is indicated to relieve pain, fever, and inflammation associated with many conditions, including the flu, the common cold, neck and back pain, dysmenorrhea, headache, tooth pain, sprains, fractures, myositis, neuralgia, synovitis, arthritis, bursitis, burns, and various injuries. It is also used for symptomatic pain relief after surgical and dental procedures [FDA label]. 



The _extra strength_ formulation of acetylsalicylic acid is also indicated for the management migraine pain with photophobia (sensitivity to light) and phonophobia (sensitivity to sound)[FDA label].



**Other indications**



ASA is also indicated for various other purposes, due to its ability to inhibit platelet aggregation. These include: 



Reducing the risk of cardiovascular death in suspected cases of myocardial infarction (MI) [FDA label]. 



Reducing the risk of a first non-fatal myocardial infarction in patients, and for reducing the risk of morbidity and mortality in cases of unstable angina and in those who have had a prior myocardial infarction [FDA label].



For reducing the risk of transient ischemic attacks (TIA) and to prevent atherothrombotic cerebral infarction (in conjunction with other treatments) [FDA label].



For the prevention of thromboembolism after hip replacement surgery [FDA label]. 



For decreasing platelet to platelet adhesion following carotid endarterectomy, aiding in the prevention of transient ischemic attacks (TIA) [FDA label].



Used for patients undergoing hemodialysis with a silicone rubber arteriovenous cannula inserted to prevent thrombosis at the insertion site [FDA Label]. 



**Important note regarding use of the extended-release formulation [F4405]**



In the setting of acute myocardial infarction, or before percutaneous interventions, the extended-release form of acetylsalicylic acid should not be used. Use immediate-release formulations in scenarios requiring rapid onset of action [Label, F4405]. The extended-release form is taken to decrease the incidence of mortality and myocardial infarction (MI) for individuals diagnosed with chronic coronary artery disease (CAD), including patients with previous myocardial infarction (MI) or unstable angina or with chronic stable angina. Additionally, the extended-release form is used to decrease the risk of death and recurrent episodes of stroke in patients with a history of stroke or TIA [F4405].





 ', 'Acetylsalicylic acid (ASA) blocks prostaglandin synthesis. It is non-selective for COX-1 and COX-2 enzymes [A177241, A10989, A32682]. Inhibition of COX-1 results in the inhibition of platelet aggregation for about 7-10 days (average platelet lifespan). The acetyl group of acetylsalicylic acid binds with a serine residue of the cyclooxygenase-1 (COX-1) enzyme, leading to irreversible inhibition. This prevents the production of pain-causing prostaglandins. This process also stops the conversion of arachidonic acid to thromboxane A2 (TXA2), which is a potent inducer of platelet aggregation [FDA label].  Platelet aggregation can result in clots and harmful venous and arterial thromboembolism, leading to conditions such as pulmonary embolism and stroke. 



It is important to note that there is 60% homology between the protein structures of COX-1 and COX-2. ASA binds to serine 516 residue on the active site of COX-2 in the same fashion as its binding to the serine 530 residue located on the active site of COX-1. The active site of COX-2 is, however, slightly larger than the active site of COX-1, so that arachidonic acid (which later becomes prostaglandins) manages to bypass the aspirin molecule inactivating COX-2 [A32682, A177256].  ASA, therefore, exerts more action on the COX-1 receptor rather than on the COX-2 receptor [A177268]. A higher dose of acetylsalicylic acid is required for COX-2 inhibition [A177325]. ', '**Effects on pain and fever**



Acetylsalicylic acid disrupts the production of prostaglandins throughout the body by targeting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) [A177241, A10989, A32682]. Prostaglandins are potent, irritating substances that have been shown to cause headaches and pain upon injection into humans.  Prostaglandins increase the sensitivity of pain receptors and substances such as histamine and bradykinin. Through the disruption of the production and prevention of release of prostaglandins in inflammation, this drug may stop their action at pain receptors, preventing symptoms of pain. Acetylsalicylic acid is considered an antipyretic agent because of its ability to interfere with the production of brain prostaglandin E1. Prostaglandin E1 is known to be an extremely powerful fever-inducing agent [FDA label]. 



**Effects on platelet aggregation**



The inhibition of platelet aggregation by ASA occurs because of its interference with thromboxane A2 in platelets, caused by COX-1 inhibition. Thromboxane A2 is an important lipid responsible for platelet aggregation, which can lead to clot formation and future risk of heart attack or stroke  [FDA label]. 



**A note on cancer prevention**



ASA has been studied in recent years to determine its effect on the prevention of various malignancies [A177325]. In general, acetylsalicylic acid is involved in the interference of various cancer signaling pathways, sometimes inducing or upregulating tumor suppressor genes [A177325, A177403]. Results of various studies suggest that there are beneficial effects of long-term ASA use in the prevention of several types of cancer, including stomach, colorectal, pancreatic, and liver cancers [A177400].   Research is ongoing.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Isomil (similac soy) powder 352 gm', 21010, 'ايسوميل (سيميلاك صويا) بودرة 352 جم', '141', NULL, 'Soy milk', 'Soy milk', NULL, NULL, 'Abbott laboratories > ibn sina', 'Powder', 'بودرة', '352 gm', '1', NULL, NULL, 'soy infants formula made without milk and lactose free. for infants from birth to 12 months age. to be used within 3 weeks from opening.', NULL, 776, '2022-08-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vichy aqualia thermal soothing lip balm 4.7 ml', 29245, 'فيتشي اكواليا 4.7 مل', '149', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Vichy laboratories > united company for trading & distribution', 'Unknown', 'غير محدد', '4.7 ml', '1', NULL, NULL, 'hydrating and nourishing care that effectively restores the lips. for women with dehydrated dry or chapped lips. application: apply throughout the day especially when you feel a sense of discomfort. aqualia lip balm can be layered under makeup. for sublim', NULL, 585, '2022-08-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pentaburn 0.25% top. oint. 15 gm', 24669, 'بنتابيرن 0.25% مرهم 15 جرام', '64', '43', 'Healing topical', 'Healing topical', NULL, 'Beta-sitosterol', 'Eva pharma > penta pharma-egypt', 'Tab', 'أقراص', '0.25%', '1', NULL, NULL, 'pentaburn topical ointment for treatment of burns wounds &cracked skin. composition: beta-sitosterol 0.25 gm/100 gm with base of bees wax & sesame oil. indication: used in treatment of: -first degree burns for pain relief & remarkable fast healing. -secon', '6224007738139', 4821, '2024-09-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vinporal 5 mg 20 tab', 12316, 'فينبورال 5 مجم 20 قرص', '17', NULL, 'Nootropic', 'Nootropic', NULL, 'Vinpocetine', 'Amriya', 'Tab', 'أقراص', '5 mg', '2', 'تحسين وظائف الدماغ و المخ -- تحسين الذاكرة -- تحسين حالات الدوار و الصداع النصفي', NULL, NULL, '6221075010402', 2994, '2022-05-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Strakopina 5 mg 30 f.c.tabs.', 31410, 'ستراكوبينا 5مجم 30 قرص', '444', '336', 'Anticoagulant', 'Anticoagulant', NULL, 'Apixaban', 'Global napi pharmaceuticals > global advanced pharmaceutical (gap)', 'Tab', 'أقراص', '5 mg', '3', NULL, NULL, 'apixaban is an anticoagulant for the treatment of venous thromboembolic events. it is taken by mouth. it is a direct factor xa inhibitor. apixaban was approved in the u.s. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (dvt) and p', NULL, 6071, '2024-07-20', NULL, 0, 'Apixaban is indicated for reducing the risk of stroke and systemic embolism in patients who have nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis(DVT) leading to pulmonary embolism(PE) in patients after a hip or knee replacement surgery, and treatment of DVT and PE to reduce the risk of recurrence[Label,A177565,A6897].', 'Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III[Label]. Apixaban also inhibits prothrominase[Label]. These effects prevent the formation of a thrombus[Label].', 'Apixaban selectively inhibits factor Xa in its free and bound forms, independant of antithrombin III[Label]. Apixaban also inhibits prothrominase[Label]. These effects prevent the formation of a thrombus[Label].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Candy menthol 24 lozenges', 1997, 'كاندي بالنعناع 24 قرص', '73', '60', 'Sore throat', 'Sore throat', NULL, 'Menthol', 'Pharos trade > brother pharma', 'Lozenges', 'استحلاب', NULL, '2', 'أقراص إستحلاب', NULL, NULL, NULL, 2848, '2024-05-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Remo moisturizing cream 120 ml', 8044, 'ريمو كريم ترطيب 120 مل', '280', '255', 'Moisturizing topicals', 'Moisturizing topicals', NULL, 'Shea butter+cocoa butter+vitamin e+d-panthenol+mineral oil+almond oil+gms-se+allantoin+promulgen-d+g', 'Nikim co. > bluebell pharmaceuticals', 'Cream', 'كريم', '120 ml', '1', NULL, NULL, NULL, NULL, 568, '2025-02-14', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Liporegistate 5mg 14 f.c. tabs.', 21912, 'ليبوريجيستات 5مجم 14 قرص', '22', NULL, 'Antihyperlipidemic.statins', 'Antihyperlipidemic.statins', NULL, 'Rosuvastatin', 'Egpi > advance pharma-egypt', 'Tab', 'أقراص', '5mg', '2', NULL, NULL, 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', NULL, 1096, '2022-06-28', NULL, 0, 'The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia.[F4649]



The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.[F4652]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Rosuvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A181421] Rosuvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low density lipoprotein (LDL) receptors which increases hepatic uptake of LDL. Rosuvastatin also inhibits hepatic synthesis of very low density lipoprotein (VLDL).[F4649] The overall effect is a decrease in plasma LDL and VLDL. 



In vitro and in vivo animal studies also demonstrate that rosuvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] This includes improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response.



Statins have also been found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an important role in leukocyte trafficking and in T cell activation.[A181559]



Rosuvastatin exerts an anti-inflammatory effect on rat mesenteric microvascular endothelium by attenuating leukocyte rolling, adherence and transmigration.[A1807] The drug also modulates nitric oxide synthase (NOS) expression and reduces ischemic-reperfusion injuries in rat hearts.[A1787] Rosuvastatin increases the bioavailability of nitric oxide[A1807,A1799,A1787] by upregulating NOS[A1791] and by increasing the stability of NOS through post-transcriptional polyadenylation.[A1796] It is unclear as to how rosuvastatin brings about these effects though they may be due to decreased concentrations of mevalonic acid.', 'Rosuvastatin is a synthetic, enantiomerically pure antilipemic agent. It is used to lower total cholesterol, low density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apoB), non-high density lipoprotein-cholesterol (non-HDL-C), and trigleride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease and high ratios are associated with higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, rosuvastatin reduces the risk of cardiovascular morbidity and mortality.[A181087, A181406]



Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]



**Skeletal Muscle Effects**



Cases of myopathy and rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. These risks can occur at any dose level, but are increased at the highest dose (40 mg). Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy (e.g., age ≥ 65 years, inadequately treated hypothyroidism, renal impairment).



The risk of myopathy during treatment with rosuvastatin may be increased with concurrent administration of some other lipid-lowering therapies (such as [fenofibrate] or [niacin]), [gemfibrozil], [cyclosporine], [atazanavir]/[ritonavir], [lopinavir]/ritonavir, or [simeprevir].  Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors, including rosuvastatin, coadministered with [colchicine], and caution should therefore be exercised when prescribing these two medications together.[F4649] 



Real-world data from observational studies has suggested that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Enzyme Abnormalities**



Increases in serum transaminases have been reported with HMG-CoA reductase inhibitors, including rosuvastatin. In most cases, the elevations were transient and resolved or improved on continued therapy or after a brief interruption in therapy. There were two cases of jaundice, for which a relationship to rosuvastatin therapy could not be determined, which resolved after discontinuation of therapy. There were no cases of liver failure or irreversible liver disease in these trials.[F4649]



**Endocrine Effects**



Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including rosuvastatin calcium tablets. Based on clinical trial data with rosuvastatin, in some instances these increases may exceed the threshold for the diagnosis of diabetes mellitus.[F4649]



An in vitro study found that [atorvastatin], [pravastatin], [rosuvastatin], and [pitavastatin] exhibited a dose-dependent cytotoxic effect on human pancreas islet β cells, with reductions in cell viability of 32, 41, 34 and 29%, respectively, versus control]. Moreover, insulin secretion rates were decreased by 34, 30, 27 and 19%, respectively, relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and lower cholesterol levels and, as such, might theoretically blunt adrenal or gonadal steroid hormone production. Rosuvastatin demonstrated no effect upon nonstimulated cortisol levels and no effect on thyroid metabolism as assessed by TSH plasma concentration. In rosuvastatin treated patients, there was no impairment of adrenocortical reserve and no reduction in plasma cortisol concentrations. Clinical studies with other HMG-CoA reductase inhibitors have suggested that these agents do not reduce plasma testosterone concentration. The effects of HMG-CoA reductase inhibitors on male fertility have not been studied. The effects, if any, on the pituitarygonadal axis in premenopausal women are unknown.[F4652]



**Cardiovascular**



Ubiquinone levels were not measured in rosuvastatin clinical trials, however significant decreases in circulating ubiquinone levels in patients treated with other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4652]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by a concomitant increase in the Lipoprotein(a) [Lp(a)] concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease. It is thus desirable to maintain and reinforce lifestyle changes in high-risk patients placed on rosuvastatin therapy.[F4652] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ramacein 2.5mg 7 tab.', 25634, 'راماسين 2.5مجم 7 اقراص', '10', NULL, 'Antihypertensive.ace', 'Antihypertensive.ace', NULL, 'Ramipril', 'T3a pharma', 'Tab', 'أقراص', '2.5mg', '1', NULL, NULL, NULL, NULL, 735, '2022-07-24', NULL, 0, 'For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. [FDA Label] To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy. [T116] ', 'Ramipril inhibits the RAAS system by binding to and inhibiting ACE thereby preventing the conversion of angiotensin I to angiotensin II. [T116] As plasma levels of angiotensin II fall, less activation of the G-protein coupled receptors angiotensin receptor I (AT<sub>1</sub>R) and angiotensin receptor II (AT<sub>2</sub>R) occurs. 



AT<sub>1</sub>R mediates vasoconstriction, inflammation, fibrosis, and oxidative stress through a variety of signaling pathways. [T116] These include G<sub>q</sub> coupling to the inositol triphosphate pathway, activation of phospholipases C, A<sub>2</sub>, and D which contribute to eicosanoid production, activation of Ca<sup>2+</sup>-dependent and MAP kinases, G<sub>i</sub> and G<sub>12/13</sub>, and eventual activation of the Jak/STAT pathway leading to cell growth and production of extracellular matrix components. AT<sub>1</sub>R activation also leads to increased activity of membrane-bound NADH/NADPH oxidase which contributes to production of reactive oxygen species. Decreased activation of this receptor mediates the renoprotective, antihypertensive, and cardioprotective effects of ramipril by reducing inflammation and vasoconstriction.



AT<sub>2</sub>R acts in opposition to the effects of AT<sub>1</sub>R by activating phosphotyrosine phosphatases which inhibit MAP kinases, inhibiting Ca<sup>2+</sup> channel opening, and stimulating cGMP and nitric oxide production leading to vasodilation. [T116] These counteracting effects are shared by the Mas receptor which is activated by Ang(1-7), a subtype of angiotensin produced by plasma esterases from AngI or by ACE2 from AngII produced through a secondary pathway by tonin and cathepsin G. Ang(1-7) also activates AT<sub>2</sub>R although the bulk of its effect is mediated by MasR.



ACE is also responsible for the breakdown of bradykinin. [T116] The resulting buildup of bradykinin due to ACE inhibition is thought to mediate the characteristic dry-cough as a side effect of ACE inhibitor medications.



', 'Ramipril is an ACE inhibitor similar to benazepril, fosinopril and quinapril. [T116] It is an inactive prodrug that is converted to ramiprilat in the liver, the main site of activation, and kidneys. Ramiprilat confers blood pressure lowing effects by antagonizing the effect of the RAAS. The RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from the granular cells of the juxtaglomerular apparatus in the kidneys. In the blood stream, renin cleaves circulating angiotensinogen to ATI, which is subsequently cleaved to ATII by ACE. ATII increases blood pressure using a number of mechanisms. First, it stimulates the secretion of aldosterone from the adrenal cortex. Aldosterone travels to the distal convoluted tubule (DCT) and collecting tubule of nephrons where it increases sodium and water reabsorption by increasing the number of sodium channels and sodium-potassium ATPases on cell membranes. Second, ATII stimulates the secretion of vasopressin (also known as antidiuretic hormone or ADH) from the posterior pituitary gland. ADH stimulates further water reabsorption from the kidneys via insertion of aquaporin-2 channels on the apical surface of cells of the DCT and collecting tubules. Third, ATII increases blood pressure through direct arterial vasoconstriction. Stimulation of the Type 1 ATII receptor on vascular smooth muscle cells leads to a cascade of events resulting in myocyte contraction and vasoconstriction. In addition to these major effects, ATII induces the thirst response via stimulation of hypothalamic neurons. ACE inhibitors inhibit the rapid conversion of ATI to ATII and antagonize RAAS-induced increases in blood pressure. ACE (also known as kininase II) is also involved in the enzymatic deactivation of bradykinin, a vasodilator. Inhibiting the deactivation of bradykinin increases bradykinin levels and may sustain the effects of ramiprilat by causing increased vasodilation and decreased blood pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lentra 14 sachets 2 gm', 7199, 'لنترا 14 اكياس 2 جم', '225', '160', 'Dietary supplement', 'Dietary supplement', NULL, 'Lactium-150 (milk protein hydrolysate-alpha-casozepine)+whey protein isolate', 'Pharmed healthcare > hygint pharmaceuticals', 'Sachet', 'أكياس', '2 gm', '1', 'مكمل غذائي لتقوية المناعة -- تخفيف القلق والتوتر -- علاج اعراض الاقلاع عن التدخين', NULL, '* therapeutic indications: lactium is used to regulate stress symptoms and to help people coping with stress and overcoming stressful events. *lactium has a high affinity with some receptors of the snc defined as gaba-a receptors. this mechanism stimulate', '6224008622376', 14213, '2025-01-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lipitrin 10/40 mg 7 tab.', 7379, 'ليبترين 10/40مجم 7 اقراص', '70', NULL, 'Antihyperlipidemic.cholesterol absorption inhibitors.combined with statin', 'Antihyperlipidemic.cholesterol absorption inhibitors.combined with statin', NULL, 'Ezetimibe+simvastatin', 'Chemipharm', 'Tab', 'أقراص', '40 mg', '1', 'يعمل على خفض الدهون والكوليسترول بالجسم', NULL, 'about ezetimibe cholesterol absorption inhibitor 2-azetidinone derivative hypolipidemic agent. mechanism of action of ezetimibe it reduces the absorption of cholesterol from the intestine by localising at the brush border of the small intestine where it i', '6222006500375', 1789, '2022-12-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Relee emollient cream 60 gm', 25840, 'ريلي كريم مرطب 60 جرام', '159', '85', 'Moisturizing topicals', 'Moisturizing topicals', NULL, 'Vitamin e+propolis+chamomile+olive+castor+allantoin+pro-vitamin b5+aloe vera+jojoba+glycerin+honey', 'Egyptian company for cosmetics > derma sun', 'Cream', 'كريم', '60 gm', '1', 'كريم مرطب وملطف للجلد موضعيا', NULL, 'skin emollient cream - effective formula ph 5.5 ** also contains: sesame oil + bees wax + cocoa ext + shea butter + citric acid + caviar ext', NULL, 2136, '2025-08-19', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Angiflash sore throat spray 20 ml', 30142, 'انجيفلاش بخاخ للحلق 20 مل', '270', '150', 'Oral care', 'Oral care', NULL, 'Hypertonic seawater 2.2%+vegetable glycerine+acacia honey+propolis extract', 'Laboratoire de la mer > star international company', 'Spray', 'بخاخ', '20 ml', '1', 'بخاخ سريع المفعول لإحتقان وآللام الحلق', NULL, 'a triple-action spray that provides a sore throat fast-acting relief 1. pain relief action 2. soothing action 3. purifying action for adults - children from 6 years old', '6222003702871', 2844, '2024-09-26', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Speczil 250mg/5ml susp. 60 ml', 27382, 'سبيكزيل 250مجم/5مل شراب معلق 60مل', '21', NULL, 'Antibiotic.cephalosporin.second-generation', 'Antibiotic.cephalosporin.second-generation', NULL, 'Cefprozil', 'Adwia', 'Susp', 'معلق', '250mg', '1', NULL, NULL, 'about cefprozil second generation cephalosporin antibiotic oral antibiotic. mechanism of action of cefprozil cefprozil is a short acting 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms', NULL, 976, '2022-07-23', NULL, 0, 'For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph', 'Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor.', 'Cefprozil, a semisynthetic, second-generation cephalosporin, is used to treat otitis media, soft-tissue infections, and respiratory tract infections.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bio balance organic pomegranate shampoo 180 ml', 15219, 'بيو بالانس شامبو الصبار العضوي 180 مل', '177', NULL, 'Hair care', 'Hair care', NULL, NULL, 'Alpaya dermaceuticals > vamer pharma', 'Amp', 'أمبول', '180 ml', '1', NULL, NULL, 'product details organic pomegranate shampoo perfect for weak damaged & colour-treated hair regenarating & color-enhancing anti-oxidant rich protection hair can be damaged from combing brushing sun rays perming coloring straightening relaxing or bleaching.', NULL, 762, '2022-07-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Jenfunga 150 mg 1 caps.', 21162, 'جينفانجا 150مجم كبسولة واحدة', '5', NULL, 'Antifungals.triazoles', 'Antifungals.triazoles', NULL, 'Fluconazole', 'Egpi > jeniko medicine pharmaceuticals', 'Cap', 'كبسولة', '150 mg', '1', NULL, NULL, 'about fluconazole a triazole derivative a board range antifungal. mechanism of action of fluconazole fluconazole is fungicidal or fungistatic depending on the drug concentrations. i t inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhi', NULL, 1038, '2022-08-03', NULL, 0, 'Fluconazole can be administered in the treatment of the following fungal infections[L11043]:



 1) Vaginal yeast infections caused by Candida

 2) Systemic Candida infections

 3) Both esophageal and oropharyngeal candidiasis 

 4) Cryptococcal meningitis

 5) UTI (urinary tract infection) by Candida

 6) Peritonitis (inflammation of the peritoneum) caused by Candida



**A note on fungal infection prophylaxis**



Patients receiving bone marrow transplantation who are treated with cytotoxic chemotherapy and/or radiation therapy may be predisposed to candida infections, and may receive fluconazole as prophylactic therapy.[L11043]



**A note on laboratory testing**



Obtaining specimens for fungal culture and other important laboratory studies such as serology or pathology is advised before starting fluconazole therapy in order to isolate the organisms to be eliminated through treatment. It is permissible to start therapy before the results are available, however, adjusting the therapy once laboratory results confirm the causative organism may be necessary.[L11043]

', 'Fluconazole is a very selective inhibitor of fungal cytochrome P450 dependent enzyme _lanosterol 14-α-demethylase_. This enzyme normally works to convert _lanosterol_ to _ergosterol_, which is necessary for fungal cell wall synthesis.  The free nitrogen atom located on the azole ring of fluconazole binds with a single iron atom located in the heme group of lanosterol 14-α-demethylase.[A178774] This prevents oxygen activation and, as a result, inhibits the demethylation of lanosterol, halting the process of ergosterol biosynthesis.[A178777]  Methylated sterols are then found to accumulate in the fungal cellular membrane, leading to an arrest of fungal growth.[A178774] These accumulated sterols negatively affect the structure and function of the fungal cell plasma membrane.[A16632]



Fluconazole resistance may arise from an alteration in the amount or function of the target enzyme (lanosterol 14-α-demethylase), altered access to this enzyme, or a combination of the above.[A16632] Other mechanisms may also be implicated, and studies are ongoing.[A178783]', 'Fluconazole has been demonstrated to show fungistatic activity against the majority of strains of the following microorganisms, curing fungal infections[L11043]:



_Candida albicans, Candida glabrata (Many strains are intermediately susceptible), Candida parapsilosis, Candida tropicalis, Cryptococcus neoformans_



This is achieved through steroidal inhibition in fungal cells, interfering with cell wall synthesis and growth as well as cell adhesion, thereby treating fungal infections and their symptoms.[L11043,A174325,A174343]



The fungistatic activity of fluconazole has also been shown in normal and immunocompromised animal models with both systemic and intracranial fungal infections caused by _Cryptococcus neoformans_ and for systemic infections caused by Candida albicans.[L11043]  It is important to note that resistant organisms have been found against various strains of organisms treated with fluconazole.[A178759,A178762,A178765] This further substantiates the need to perform susceptibility testing when fluconazole is considered as an antifungal therapy.[A178768,A178786] 





**A note on steroidal effects of fluconazole**



There has been some concern that fluconazole may interfere with and inactivate human steroids/hormones due to the inhibition of hepatic cytochrome enzymes.[L11034]  Fluconazole has demonstrated to be more selective for _fungal_ cytochrome P-450 enzymes than for a variety of mammalian cytochrome P-450 enzymes. Fluconazole 50 mg administered daily for up to 28 days in individuals of reproductive age has been show to have no effect on testosterone plasma concentrations of males and plasma concentrations of steroids in females. A 200-400 mg dose of fluconazole showed no clinically relevant effect on steroid levels or on ACTH-stimulated steroid response in healthy males, in one clinical study mentioned on the European Medicines Agency label.[L11034] Other studies have shown no significant effects of fluconazole on steroid levels, further confirming these data.[A174358,A178780]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zyrovazet 5/10mg 30 tablets', 11308, 'زيروفازيت 5/10مجم 30 قرص', '132', '97.5', 'Antihyperlipidemic.statins', 'Antihyperlipidemic.statins', NULL, 'Rosuvastatin+ezetimibe', 'Marcyrl > xeedia pharma', 'Tablet', 'أقراص', '10mg', '3', NULL, NULL, NULL, NULL, 1892, '2024-06-13', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Kemagel silicone dispenser 15 ml', 21286, 'كيماجل سيليكون ديسبنسر 15 مل', '335', NULL, 'Scar therapy', 'Scar therapy', NULL, 'Polysiloxane', 'Multipharma', 'Pen', 'قلم', '15 ml', '1', NULL, NULL, 'kemagelï-silicone is medical grade advanced topical silicone gel used to improve the physiological and cosmetic appearance of the scar. silicone gel has been shown to flatten soften and smooth scars as well as reduce the discoloration associated with scar', NULL, 1189, '2022-06-28', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lentojeston 250mg/ml i.m. amp.', 21698, 'لنتوجيستون 250مجم/مل حقن عضل امبول', '27', '18.50', 'Gynecology.hormone', 'Gynecology.hormone', NULL, 'Hydroxyprogesterone caproate', 'Marcyrl co.', 'Amp', 'أمبول', '250mg', '1', 'بروجيسترون', NULL, NULL, '6223003571429', 25414, '2024-10-02', NULL, 0, 'Hydroxyprogesterone caproate was previously indicated in the US for the prevention of spontaneous preterm births in singleton pregnancies in women with a history of spontaneous preterm birth. This indication was revoked by the FDA in April 2023.[L46113]



Hydroxyprogesterone caproate remains indicated in other jurisdictions for the management of primary and secondary amenorrhea, corpus luteum insufficiency, and for the prevention of preterm birth.[L46123,L46128]', 'The mechanism by which progesterone prevents preterm birth is not well understood, but many pathways are likely involved. Progesterone plays a vital role in regulation of the female reproductive system and is important for successful implantation of the embryo and maintenance of pregnancy. It acts by binding to progesterone receptors in the uterus, ovaries, breasts and in the central nervous system. These receptors exist in 2 isoforms, PR-A and PR-B. Progesterone binding to these receptors ultimately leads to regulation of gene transcription. This results in an anti-inflammatory effect which blunts the proinflammatory state that occurs with initiation of labor, and maintains uterine queiscence by stabilizing progesterone acting on the myometrium.', 'No specific pharmacodynamic studies have been performed to assess hydroxyprogesterone caproate injections. However, the mechanism of action is likely related to increased interaction between progesterone and progesterone receptors.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Xemose face cream 40 ml', 29733, 'زيموس كريم للوجه 40 مل', '265', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Uriage dermatological laboratories > biotech egypt', 'Cream', 'كريم', '40 ml', '1', NULL, NULL, 'dry fragile and delipidated skin. skin prone to atopy. babies children adults. properties rich in uriage thermal water known for its hydrating soothing and anti-free radical properties this cream nourishes the skins that are dry fragile and delipidated. f', NULL, 437, '2022-11-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Earo-cure drops', 17999, 'ايرو كير نقط', '6', NULL, NULL, NULL, NULL, 'Antipyrine+benzocaine+oxyquinoline sulphate', 'Hi-pharm', 'Drops', 'نقط', NULL, '1', NULL, NULL, 'indication antipyrine is an analgesic often used to test effects of other drugs on liver enzymes.. pharmacodynamics antipyrine is an analgesic and antipyretic that has been given by mouth and as ear drops. antipyrine is often used in testing the effects o', NULL, 810, '2022-07-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Technomer 0.9% nasal spray 70 ml', 3138, 'تكنومير 0.9% سبراي للانف 70 مل', '110', NULL, 'Nasal spray', 'Nasal spray', NULL, 'Sea water - aloe vera extract - panthenol - vit a - vit e', 'Nexamed', 'Spray', 'بخاخ', '0.9%', '1', NULL, NULL, NULL, NULL, 1364, '2025-02-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lamotrine 2mg 30 chew. tab.', 7089, 'لاموترين 2مجم 30 قرص مضغ', '17', NULL, 'Anti-epileptic.triazine', 'Anti-epileptic.triazine', NULL, 'Lamotrigine', 'Multi-apex', 'Tab', 'أقراص', '2mg', '3', NULL, NULL, 'about lamotrigine phenyltriazine derivative anticonvulsant mood stabilizer. mechanism of action of lamotrigine lamotrigine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the in', '6223003200312', 980, '2023-05-19', NULL, 0, 'Lamotrigine is indicated as adjunctive therapy for the following seizure types in patients ≥2 years of age: partial seizures, primary generalized tonic-clonic seizures, and generalized seizures due to Lennox-Gastaut syndrome.[L9404]



It is also indicated for the process of conversion to drug monotherapy for those at least 16 years of age or older with partial seizures and currently are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED).[L9404]



In addition to the above, lamotrigine is also indicated for the maintenance treatment of bipolar I disorder, delaying the time to mood episodes (which may include mania, hypomania, depression, mixed episodes) in adults at least 18 years or older, who have been treated for acute mood symptoms with standard therapy.[L9404]



Limitations of use



It is important to note that lamotirigine should not be used in the treatment of acute mood episodes, as efficacy has not been established in this context.[L9404]', 'The exact mechanism of action of lamotrigine is not fully elucidated, as it may exert cellular activities that contribute to its efficacy in a range of conditions. Although chemically unrelated, lamotrigine actions resemble those of phenytoin and carbamazepine, inhibiting voltage-sensitive sodium channels, stabilizing neuronal membranes, thereby modulating the release of presynaptic excitatory neurotransmitters.[A191335,A191350,L9404] 



Lamotrigine likely acts by inhibiting sodium currents by selective binding to the inactive sodium channel, suppressing the release of the excitatory amino acid, glutamate. The mechanism of action of lamotrigine in reducing anticonvulsant activity is likely the same in managing bipolar disorder. Studies on lamotrigine have identified its binding to sodium channels in a fashion similar to local anesthetics, which could explain the demonstrated clinical benefit of lamotrigine in some neuropathic pain states.[T28] 



Lamotrigine displays binding properties to several different receptors. In laboratory binding assays, it demonstrates weak inhibitory effect on the serotonin 5-HT3 receptor. Lamotrigine also weakly binds to Adenosine A1/A2 receptors, α1/α2/β adrenergic receptors, dopamine D1/D2 receptors, GABA A/B receptors, histamine H1 receptors, κ-opioid receptor (KOR), mACh receptors and serotonin 5-HT2 receptors with an IC50>100 µM. Weak inhibitory effects were observed at sigma opioid receptors.[L9404] An in vivo study revealed evidence that lamotrigine inhibits Cav2.3 (R-type) calcium currents, which may also contribute to its anticonvulsant effects.[A31737] ', 'Lamotrigine likely prevents seizures and prevents mood symptoms via stabilizing presynaptic neuronal membranes and preventing the release of excitatory neurotransmitters such as glutamate, which contribute to seizure activity.[A191350,L9404] 



A note on cardiovascular effects



The metabolite of lamotrigine, 2-N-methyl metabolite (formed by glucuronidation), is reported to cause dose-dependent prolongations of the PR interval, widening of the QRS complex, and at higher doses, complete AV block. Although this harmful metabolite is only found in trace amounts in humans, plasma concentrations may increase in conditions that cause decreased drug glucuronidation, such as liver disease.[A191335,L9404,L12183]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sulfax optima formula cream 120 gm', 27627, 'سولفاكس اوبتيما فورميلا كريم 120', '125', '125', 'Massage cream', 'Massage cream', NULL, NULL, 'Egyptian company for cosmetics > parkville pharmaceuticals', 'Cream', 'كريم', '120 gm', '1', 'كريم مساج لآلام العضلات', NULL, 'joint care', '6224008073536', 2420, '2023-09-21', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Coxtori 90 mg 14 f.c. tabs.', 7137, 'كوكستوري 90مجم 14 قرص', '97', NULL, 'Nsaid.selective cox-2 inhibitors', 'Nsaid.selective cox-2 inhibitors', NULL, 'Etoricoxib', 'Minapharm', 'Tab', 'أقراص', '90 mg', '2', NULL, NULL, NULL, NULL, 1138, '2025-08-24', NULL, 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.', 'Like any other COX-2 selective inhibitor Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2), preventing production of prostaglandins (PGs) from arachidonic acid.', 'Etoricoxib is a COX-2 selective inhibitor (approximately 106 times more selective for COX-2 inhibition over COX-1).', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Corta balm 50 gm', 16820, 'كورتا بلسم 50 جم', '20', NULL, 'Skin care', 'Skin care', NULL, 'Olive oil+soybean oil+vitamin e+paraffin oil+petrolatum', 'Macro group pharmaceuticals', 'Unknown', 'غير محدد', '50 gm', '1', NULL, NULL, '-a synergistic blend for after male circumcision care. -keeps skin lubricated & promotes good healing. -lubricates the skin against friction. -prevents discomfort. -protects the skin against invasion by micro-organisms by enhancing skin barrier functions.', NULL, 798, '2022-07-13', NULL, 0, 'In a clinical context, olive oil is used as a source of calories and fatty acids in patients requiring parenteral nutrition. A formulation called Clinolipid, comprising olive oil and [soybean oil], is indicated in all age groups, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.[L51013]', 'Fatty acids act as a substrate in energy production through beta-oxidation as well as important components of cell membrane structures and prescursors for bioactive molecules like prostaglandins.', 'Provides a source of calories and fatty acids.[L51013]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Aspin mix 10 sachets (chocolate)', 14481, 'اسبين ميكس 10 اكياس شيكولاتة', '70', NULL, 'Dietary supplement', 'Dietary supplement', NULL, NULL, 'Future pharmaceutical industries (fpi) > aspin pharmaceutical', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, NULL, NULL, 927, '2022-07-28', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neuth anti-acne revitalizing facial wash 200 ml (step 2)', 23492, 'نيوث لعلاج حب الشباب غسول للوجه 200مل', '198', NULL, 'Skin care', 'Skin care', NULL, 'Saw palmetto extract+silver citrate+niacinamide+salicylic acid', 'Neuth > eva pharma', 'Facial wash', 'غسول للوجه', '200 ml', '1', NULL, NULL, 'ultra gentle soap free gel that effectively dissolves and eliminates impurities excess sebum and acne-causing substances leaving skin clean and protected. it provides long lasting sebum secretion control that lasts for hours with deep moisturizing for a s', NULL, 804, '2022-07-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lingazym d3 5ml drops', 1399, 'لينجازيم د3 نقط فم 5 مل', '39', NULL, 'Vitamin', 'Vitamin', NULL, 'Vitamin d3', 'Zyma beauty pharma', 'Drops', 'نقط', '5ml', '1', NULL, NULL, NULL, '6224011767026', 943, '2024-12-12', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Normelan body whitening lotion 100 ml', 4337, 'نورميلان لوشن 100 مل', '440', NULL, 'Skin care.whitening', 'Skin care.whitening', NULL, NULL, 'Green pharmaceutical', 'Lotion', 'لوشن', '100 ml', '1', NULL, NULL, NULL, NULL, 771, '2025-06-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ponagic forte 500mg 10 f.c. tab.', 25061, 'بوناجك فورت 500مجم 10 اقراص', '3', NULL, 'Nsaid.fenamates', 'Nsaid.fenamates', NULL, 'Mefenamic acid', 'Rameda', 'Tab', 'أقراص', '500mg', '1', NULL, NULL, 'about mefenamic acid nsaid analgesic antiinflammatory. mechanism of action of mefenamic acid mefenamic acid has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and their release at the site of injury', NULL, 821, '2022-07-13', NULL, 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, dysmenorrhea, and mild to moderate pain, inflammation, and fever.', 'Mefenamic acid binds the prostaglandin synthetase receptors COX-1 and COX-2, inhibiting the action of prostaglandin synthetase. As these receptors have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity, the symptoms of pain are temporarily reduced.', 'Mefenamic acid, an anthranilic acid derivative, is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs). It exhibits anti-inflammatory, analgesic, and antipyretic activities. Similar to other NSAIDs, mefenamic acid inhibits prostaglandin synthetase.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lodipine 2mg 7 f.c.tab.', 21987, 'لوديبين 2مجم 7 أقراص', '9', NULL, 'Antihypertensive.selective calcium channel blocker', 'Antihypertensive.selective calcium channel blocker', NULL, 'Lacidipine', 'Egyphar', 'Tab', 'أقراص', '2mg', '1', NULL, NULL, 'about lacidipine selective calcium channel blocker dihydropyridine derivative antihypertensive. mechanism of action of lacidipine lacidipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive action through block', '6224001026126', 821, '2023-01-14', NULL, 0, 'Indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including β-adrenoceptor antagonists, diuretics, and ACE-inhibitors [L1126].', 'By blocking the voltage-dependent L-type calcium channels, it prevents the transmembrane calcium influx [A31537]. Normally, calcium ions serve as intracellular messengers or activators in exictable cells including vascular smooth muscles. The influx of calcium ultimately causes the excitation and depolarization of the tissues. Lacidipine inhibits the contractile function in the vascular smooth muscle and reduce blood pressure. Due to its high membrane partition coefficient, some studies suggest that lacidipine may reach the receptor via a two-step process; it first binds and accumulates in the membrane lipid bilayer and then diffuses within the membrane to the calcium channel receptor [A31543]. It is proposed that lacidipine preferentially blocks the inactivated state of the calcium channel [A31543].



Through its antioxidant properties shared amongst other dihydropyridine calcium channel blockers, lacidipine demonstrates an additional clinical benefit. Its antiatherosclerotic effects are mediated by suppressing the formation of reactive oxygen species (ROS) and subsequent inflammatory actions by chemokines, cytokines and adhesion molecules, thus reducing atherosclerotic lesion formation [A31540]. Lacidipine may also suppress cell proliferation and migration in smooth muscle cells and suppress the expression of matrix metalloproteinases, which affects the stability of atheromatous plaques [A31540]. ', 'acidipine is a specific and potent calcium antagonist with a predominant selectivity for calcium channels in the vascular smooth muscle. Its main action is to dilate predominantly peripheral and coronary arteries, reducing peripheral vascular resistance and lowering blood pressure [L1126]. 



Following the oral administration of 4 mg lacidipine to volunteer subjects, a minimal prolongation of QTc interval has been observed (mean QTcF increase between 3.44 and 9.60 ms in young and elderly volunteers) [L1126].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Chamopect susp. 200 ml', 2469, 'كاموبكت معلق', '10', NULL, 'Antidiarrheal', 'Antidiarrheal', NULL, 'Pectin+chamomile extract', 'Atos pharma', 'Susp', 'معلق', '200 ml', '1', NULL, NULL, 'properties and actions: chamopect reduces duration of diarrhea. it contains pectin which improves with its swelling ability the passage of well formed stools adsorbs toxins and mucosal irritating substances in the intestinal lumen and forms a protective f', '6223000470985', 1252, '2022-12-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ceclor 250mg/5ml susp. 75ml', 2181, 'سيكلور 250 مجم 75مل معلق', '156', '66.5', 'Antibiotic.cephalosporin.second-generation', 'Antibiotic.cephalosporin.second-generation', NULL, 'Cefaclor', 'Epci', 'Susp', 'معلق', '250mg', '1', NULL, NULL, 'about cefaclor a second-generation cephalosporin antibiotic oral broad-spectrum antibiotics. mechanism of action cefaclor is a 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibi', '6224007321034', 2877, '2025-05-04', NULL, 0, 'For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.', 'Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor.', 'Cefaclor is a second generation cephalosporin antibiotic with a spectrum resembling first-generation cephalosporins. <i>In vitro</i> tests demonstrate that the bactericidal action of the cephalosporins results from inhibition of cell-wall synthesis. As indicated by _in vitro_ and _in vivo_ clinical studies, cefaclor was shown to be effective against most strains of Gram positive aerobes - Staphylococci (including coagulase-positive, coagulase-negative, and penicillinase-producing strains), <i>Streptococcus pneumoniae</i>, <i>Streptococcus pyogenes</i> (group A &szlig;-hemolytic streptococci), as well as Gram-negative aerobes - <i>Escherichia coli</i>, <i>Haemophilus influenzae</i> (including &szlig;-lactamase-producing ampicillin-resistant strains), <i>Klebsiella sp</i>, and <i>Proteus mirabilis</i>.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hanzacal 30 f.c. tabs.', 6598, 'هانزاكال 30 قرص', '150', NULL, 'Calcium supplement', 'Calcium supplement', NULL, 'Calcium+magnesium+vitamin d3+vitamin k1+zinc+manganese+copper', 'Hanza pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 843, '2025-08-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neuro strong 30 f.c. tabs.', 33269, 'نيورو سترونج 30 قرص', '120', '105', 'Vitamin b', 'Vitamin b', NULL, 'Vitamin b1+vitamin b6+vitamin b12', 'Napco', 'Tab', 'أقراص', NULL, '3', NULL, NULL, 'vitamin b1 ... 100 mg vitamin b6 ... 100 mg vitamin b12 .. 150 mcg dose: once daily. about vit b1 physiological functions: thiamine pyrophosphate is a coenzyme and the active form of vitamin b. it functions as coenzyme in decarboxylation of a-keto acid an', NULL, 1693, '2025-08-03', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lifo 20 sachets', 21819, 'ليفو 20 كيس', '45', NULL, 'Weight loss', 'Weight loss', NULL, 'Artichoke+chicory+turmeric+parsely', 'Nutrixia > true international pharma', 'Sachet', 'أكياس', NULL, '1', 'تعمل على فقدان الوزن.', NULL, NULL, NULL, 736, '2022-05-19', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Clomifert 50mg 10 tab.', 16545, 'كلوميفيرت 50مجم 10 اقراص', '9', NULL, 'Infertility drugs.ovulation inducer', 'Infertility drugs.ovulation inducer', NULL, 'Clomiphene', 'Misr', 'Tab', 'أقراص', '50mg', '1', 'يستخدم للعقم.', NULL, 'about clomiphene a selective estrogen receptor modulator (serm) chlorotrianisene derivative ovulation stimulator fertility agent. mechanism of action of clomiphene the drug is an estrogen antagonist which exerts it`s pharmacological action by inducing ovu', NULL, 1447, '2022-05-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Falconacea plus 36 caps', 18776, 'فالكوناشيا بلس 36 كبسولة', '65', NULL, 'Immunity inhancer', 'Immunity inhancer', NULL, 'Echinacea root powder extract+black seed oil', 'Sigma > falcon group', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 1351, '2022-06-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Celadrex cream 60 gm', 16083, 'سيلادركس كريم 60 جم', '19', NULL, 'Massage', 'Massage', NULL, 'Massage cream formula', 'Kempetro > diamond pharma', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, 'natural massage cream', '6224000486204', 907, '2022-07-10', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cancidas 70mg powder vial for inf.', 15739, 'كانسيداس 70 مجم بودرة فيال', '2,500', NULL, 'Antifungals.miscellaneous', 'Antifungals.miscellaneous', NULL, 'Caspofungin', 'Merck sharp & dohme > soficopharm', 'Vial', 'فيال', '70mg', '1', NULL, NULL, 'indications and usage cancidas is an echinocandin antifungal drug indicated in adults and pediatric patients (3 months and older) for: * empirical therapy for presumed fungal infections in febrile neutropenic patients. * treatment of candidemia and the fo', NULL, 926, '2022-08-03', NULL, 0, 'For the treatment of esophageal candidiasis and invasive aspergillosis in patients who are refractory to or intolerant of other therapies.', 'Caspofungin inhibits the synthesis of beta-(1,3)-D-glucan, an essential component of the cell wall of <i>Aspergillus</i> species and <i>Candida</i> species. beta-(1,3)-D-glucan is not present in mammalian cells. The primary target is beta-(1,3)-glucan synthase.', 'Caspofungin is an antifungal drug, and belongs to a new class termed the echinocandins. It is used to treat <i>Aspergillus</i> and <i>Candida</i> infection, and works by inhibiting cell wall synthesis. Antifungals in the echinocandin class inhibit the synthesis of glucan in the cell wall, probably via the enzyme 1,3-beta glucan synthase. There is a potential for resistance development to occur, however <i>in vitro</i> resistance development to Caspofungin by Aspergillus species has not been studied.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Phytomenadione 10mg/ml 100 amps', 24923, 'فيتوميناديون 10مجم/مل 100 امبولة', '46', NULL, 'Vitamin k', 'Vitamin k', NULL, 'Vitamin k1', 'Memphis', 'Amp', 'أمبول', '10mg', '100', 'علاج النزيف الناتج عن الجرعة الزائدة من دواء الوارفرين ونقص فيتامين ك', NULL, NULL, NULL, 1641, '2022-05-15', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Oromap spray 60ml', 33341, 'اوروماب سبراى 60 مل', '59', '55', 'Oral fresh', 'Oral fresh', NULL, 'Clove oil+hayaluronic acid+menthol+eucalyptus oil+cholorohexidin', 'Sms pharma', 'Spray', 'بخاخ', '60ml', '1', NULL, NULL, 'oral fresh', '6229810620343', 491, '2025-08-03', NULL, 0, 'Clove oil is primarily indicated in conditions like colic, flatulence, and toothache [L2849].', 'The chief constituent present in clove oil is the phenol "_eugenol_" which is present in amounts up to 85%. Clove oil acts as a germicide [L2849] to Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [A24841]. 



Clove oil is thought to inhibit prostaglandin synthesis, thereby reducing painful symptoms [A33145].



Eugenol, the main constituent of clove oil is purported to have anticancer action. In one study, eugenol-treated HL-60 cells showed features of apoptosis including DNA fragmentation and formation of DNA ladders in agarose gel electrophoresis. It was observed that eugenol transduced the apoptotic signal via reactive oxygen species (ROS) generation, inducing mitochondrial permeability transition (MPT), decreasing anti-apoptotic protein _bcl-2_ level, inducing _cytochrome c_ release to the cytosol, and subsequent apoptotic cell death. When taken together, the study showed that ROS plays a critical role in eugenol-induced apoptosis in _HL-60_, and this is the first report on the mechanism of the anticancer effect of eugenol [A33146].', 'Clove (Eugenia caryophyllata Thunb. [Myrtaceae]) essential oil (CEO) has been demonstrated to possess antimicrobial, antifungal, antiviral, antioxidant, anti-inflammatory, anti-histamine, and anticancer properties. However, few studies have focused on its topical use [A33133], [L2850].



Clove essential oil, used as an antiseptic in oral infections, inhibits gram-negative and gram-positive bacteria as well as yeast [A24841].



', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Innovifen 400 mg 20 f.c. tabs.', 20854, 'انوفيفين 400 مجم 20 قرص', '20', NULL, 'Nsaid.propionic acid derivatives', 'Nsaid.propionic acid derivatives', NULL, 'Dexibuprofen', 'Marcyrl co.', 'Tab', 'أقراص', '400 mg', '2', NULL, NULL, 'a type of medicine called a non-steroidal anti-inflammatory drug (nsaid). nsaids are used to relieve pain and inflammation. what is it used for? osteoarthritis. pain in the muscles bones or joints. period pain (dysmenorrhea). toothache. warning! this medi', NULL, 982, '2022-07-25', NULL, 0, 'For more information, refer to [ibuprofen].', 'Like common NSAIDs, dexibuprofen is an active enantiomer of [ibuprofen] that suppresses the prostanoid synthesis in the inflammatory cells via inhibition of the COX-2 isoform of the arachidonic acid COX.[T28] For more information, refer to [ibuprofen].', 'For more information, refer to [ibuprofen].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mannitol 20% (mottahedoon) i.v. inf. 500 ml', 22266, 'مانيتول 20% المتحدون محلول وريدي 500 مل', '56', '30.5', 'Osmotic diuretic', 'Osmotic diuretic', NULL, 'Mannitol', 'Al mottahedoon pharma', 'Unknown', 'غير محدد', '20%', '1', NULL, NULL, 'about mannitol a polyol (sugar alcohol) low molecular weight non electrolyte osmotic diuretic. mechanism of action of mannitol it is a non electrolyte of low molecular weight which limit the tubular water and electrolyte reabsorption in a variety of ways', NULL, 2313, '2025-04-16', NULL, 0, 'Used for the promotion of diuresis before irreversible renal failure becomes established, the reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.



Mannitol is also indicated as add-on maintenance therapy for improving pulmonary function in cystic fibrosis patients aged 18 and over who have passed the BRONCHITOL tolerance test (BTT). It is recommended that patients take an orally inhaled short-acting bronchodilator 5-15 minutes prior to every inhaled mannitol dose.[L20024]', 'Mannitol is an osmotic diuretic that is metabolically inert in humans and occurs naturally, as a sugar or sugar alcohol, in fruits and vegetables. Mannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. As a diurectic mannitol induces diuresis because it is not reabsorbed in the renal tubule, thereby increasing the osmolality of the glomerular filtrate, facilitating excretion of water, and inhibiting the renal tubular reabsorption of sodium, chloride, and other solutes. Mannitol promotes the urinary excretion of toxic materials and protects against nephrotoxicity by preventing the concentration of toxic substances in the tubular fluid. As an Antiglaucoma agent mannitol levates blood plasma osmolarity, resulting in enhanced flow of water from the eye into plasma and a consequent reduction in intraocular pressure. As a renal function diagnostic aid mannitol is freely filtered by the glomeruli with less than 10% tubular reabsorption. Therefore, its urinary excretion rate may serve as a measurement of glomerular filtration rate (GFR).



The exact mechanism of action of inhaled mannitol in the symptomatic maintenance treatment of cystic fibrosis remains unclear.[A223199, L20024] It is hypothesized that mannitol produces an osmotic gradient across the airway epithelium that draws fluid into the extracellular space and alters the properties of the airway surface mucus layer, allowing easier mucociliary clearance.[A223199]', 'Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is commonly used to increase urine production (diuretic). It is also used to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol is frequently given along with other diuretics (e.g., furosemide, chlorothiazide) and/or IV fluid replacement.



Inhaled mannitol has the possibility to cause bronchospasm and hemoptysis; the occurrence of either should lead to discontinuation of inhaled mannitol.[L20024]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Loratin-d 14 repetabs', 7531, 'لوراتين دى 14 قرص', '13', NULL, 'Antihistamine.antiallergy.combined with vasoconstrictor agent', 'Antihistamine.antiallergy.combined with vasoconstrictor agent', NULL, 'Loratadine+pseudoephedrine', 'Sigma', 'Tab', 'أقراص', NULL, '2', 'علاجٌ مؤقت لأعراض حمى القش -- علاج حساسية الجهاز التنفسي العلوي مثل سيلان الأنف والحكة واستمرار العين في إفراز الدموع', NULL, 'about loratadine second generation h1 antagonist antihistamine. mechanism of action of loratadine loratadine blocks one type of receptor for histamine (the h1 receptor) and thus prevents activation (activation releasing other chemicals which produce the s', '6221051010563', 1585, '2022-12-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nuxe white brightening bb cream 30 ml', 23908, 'نوكس كريم تفتيح 30مل', '359', NULL, 'Eye contour', 'Eye contour', NULL, NULL, 'Nuxe laboratory > biotech egypt', 'Cream', 'كريم', '30 ml', '1', NULL, NULL, 'beautifier skincare that offers a dual perfecting and brightening action for a radiant transparent complexion. - oil-free. use apply in the morning to the face and neck after your dual cream or use for retouching during the day. ideal as a make-up base.', NULL, 608, '2022-07-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Clearogen acne lotion 55 ml step 3', 2741, 'كليروجين لوشن حب الشباب 55 مل المرحلة الثالثة', '454', NULL, 'Anti-acne', 'Anti-acne', NULL, 'Sulfur', 'Vamer pharma', 'Lotion', 'لوشن', '55 ml', '1', NULL, NULL, NULL, NULL, 877, '2022-08-27', NULL, 0, 'Echocardiography: Sulfur hexafluoride is indicated for use in adult patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricularendocardial border. 

Ultrasonography of the Liver: Sulfur hexafluoride is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.', 'Within the blood, the acoustic impedance of Lumason microspheres is lower than that of the surrounding non-aqueous tissue.  Therefore, an ultrasound beam is reflected from the interface between the microspheres and the surrounding tissue. The reflected ultrasound signal provides a visual image that shows a contrast between the blood and the surrounding tissues. ', 'Sulfur hexafluoride provides useful echocardiographic signal intensity for two minutes after the injection. Sulfur hexafluoride microspheres are destroyed and contrast enhancement decreases as the mechanical index increases (values of 0.8 or less are recommended). 

For ultrasonography of the liver, Sulfur hexafluoride provides dynamic patterns of differential signal intensity enhancement between focal liver lesions and liver parenchyma during the arterial, portal venous, and late phase of signal intensity enhancement of the microvasculature. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Popomix cream 50 gm', 25066, 'بوبوميكس كريم 50 جرام', '29', NULL, 'Skin care', 'Skin care', NULL, 'Olive oil+chamomile oil+beeswax+panthenol+zinc oxide+wheat germ oil+lanolin', 'Egyptian co. for cosmetics > medix pharm', 'Cream', 'كريم', '50 gm', '1', 'للعناية وترطيب الجلد', NULL, 'emollient moisturizer', NULL, 1224, '2022-03-03', NULL, 0, 'In a clinical context, olive oil is used as a source of calories and fatty acids in patients requiring parenteral nutrition. A formulation called Clinolipid, comprising olive oil and [soybean oil], is indicated in all age groups, including term and preterm neonates, as a source of calories and essential fatty acids for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated.[L51013]', 'Fatty acids act as a substrate in energy production through beta-oxidation as well as important components of cell membrane structures and prescursors for bioactive molecules like prostaglandins.', 'Provides a source of calories and fatty acids.[L51013]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Immurave one 30 caps.', 30680, 'اميوراف وان 30 كبسولة', '120', '90', 'Multivitamins', 'Multivitamins', NULL, 'Vitamin c+vitamin d+zinc', '> nexus international pharmaceuticals', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, 'vitamin c ... 1000 mg vitamin d3 ... 1000 mg zinc ... 20 mg', '6225000359833', 1878, '2024-04-28', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Star light cream 60 gm', 27458, 'ستارلايت كريم 60جم', '48', NULL, 'Whitening topical', 'Whitening topical', NULL, NULL, 'Egyptian company for cosmetics > excel pharma', 'Cream', 'كريم', '60 gm', '1', NULL, NULL, 'whitening cream', '6224007690031', 700, '2022-08-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Quitapex 100mg 30 f.c. tab.', 25558, 'كويتابيكس 100مجم 30 قرص', '186', '166', 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Quetiapine', 'Multi-apex', 'Tab', 'أقراص', '100mg', '3', NULL, NULL, NULL, '6223003204105', 4951, '2024-07-27', NULL, 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cludalost 100 mg 30 tabs.', 31976, 'كلودالوست 100مجم 30 قرص', '90', NULL, 'Antiplatlet.phosphodiesterase 3 inhibitor', 'Antiplatlet.phosphodiesterase 3 inhibitor', NULL, 'Cilostazol', 'Egpi > pharma three', 'Tab', 'أقراص', '100 mg', '3', NULL, NULL, 'description cilostazol is a medication used in the alleviation of the symptom of intermittent claudication in individuals with peripheral vascular disease. it is manufactured by otsuka pharmaceutical co. under the trade name pletal. although drugs similar', NULL, 739, '2023-05-04', NULL, 0, 'Indicated for the alleviation of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest).', 'Cilostazol and several of its metabolites are cyclic AMP (cAMP) phosphodiesterase III inhibitors (PDE III inhibitors), inhibiting phosphodiesterase activity and suppressing cAMP degradation with a resultant increase in cAMP in platelets and blood vessels, leading to inhibition of platelet aggregation and vasodilation.', 'Cilostazol reduces the symptoms of intermittent claudication, as indicated by an increased walking distance. Intermittent claudication is pain in the legs that occurs with walking and disappears with rest. The pain occurs due to reduced blood flow to the legs.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Avantgarde baby cream 75 gm', 15982, 'افانتجاردي بيبي كريم 75 جم', '65', NULL, 'Sweet almonde oil chamomile oil lavander oil caraway oil', 'Sweet almonde oil chamomile oil lavander oil caraway oil', NULL, 'Sweet almonde oil+chamomile oil+lavander oil+caraway oil', 'Avantgarde pharma', 'Cream', 'كريم', '75 gm', '1', NULL, NULL, NULL, NULL, 866, '2024-05-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Linkafer 10 sachet', 6202, 'لينكافير 10 اكياس', '75', NULL, 'Multivitamin', 'Multivitamin', NULL, 'Lactoferen', 'Royal link pharma', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, NULL, NULL, 569, '2025-07-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Avene cleanance cleansing water 400ml', 14685, 'افين ماء منظف 400 مل', '245', '209', 'Skin care', 'Skin care', NULL, NULL, 'Pierre - fabre france > biotech egypt', 'Unknown', 'غير محدد', '400ml', '1', NULL, NULL, 'specially formulated for blemish-prone skin it cleanses and removes all traces of make-up from the face and eyes. contains sebum-regulating and purifying agents leaving the skin feeling fresh and clean. no-rinse formula. paraben and alcohol free. how to u', NULL, 648, '2023-09-05', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bengiride 0.5 mg 30 caps.', 15070, 'بينيجرايد 0.5 مجم 30 كبسولة', '162', '123', '10 alpha-reductase inhibitor', '10 alpha-reductase inhibitor', NULL, 'Dutasteride', 'Medizen pharmaceutical industries > al esraa pharmaceutical optima', 'Cap', 'كبسولة', '0.5 mg', '3', 'علاج اورام البروستاتا', NULL, 'about dutasteride a 5-alpha-reductase inhibitor in benign prostatic hyperplasia(bph) male baldness. mechanism of action of dutasteride this is a selective inhibitor of both type 1 and type 2 isoforms of steroid 5alpha-reductase (an intracellular enzyme th', '6223004160301', 5631, '2025-02-11', NULL, 0, 'Indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland to improve symptoms, and reduce the risk of acute urinary retention and the need for BPH-related surgery alone or in combination with [tamsulosin].[L10568]', 'The 5α-reductase is a nuclear-bound steroid intracellular enzyme primarily located in the prostatic stromal cell that converts the androgen testosterone into the more active metabolite, 5α-dihydrotestosterone (DHT).[A2132] DHT is considered to be the primary androgen playing a role in the initial development and subsequent enlargement of the prostate gland. It serves as the hormonal mediator for the hyperplasia upon accumulation within the prostate gland.[A178270] DHT displays a higher affinity towards androgen receptors in the prostate gland compared to testosterone[T28] and by acting on the androgen receptors, DHT modulates genes that are responsible for cell proliferation.[A178279] Responsible for the synthesis of approximately one-third of circulating DHT, type I 5α-reductase is predominant in the sebaceous glands of most regions of skin, including the scalp, and liver. The type II 5a-reductase isozyme is primarily found in the prostate, seminal vesicles, epididymides, and hair follicles as well as liver, and is responsible for two-thirds of circulating DHT.[L10568] Due to its dual inhibition of both isoenzymes of 5α-reductase, dutasteride causes a near-complete suppression of DHT.[A178348] Compared to a 70% reduction of serum DHT levels caused by [finasteride], a near-complete suppression of serum DHT-more than 90% is seen with dutasteride.[A178378]



By forming a stable complex with both type II and type II 5α-reductase, dutasteride inhibits its enzymatic action of converting testosterone to 5α-dihydrotestosterone (DHT), which is the androgen primarily responsible for the initial development and subsequent enlargement of the prostate gland. It is proposed that DHT is the principal androgen responsible for prostatic growth in later life-normal masculinization of the external genitalia and maturation of the prostate gland during development-thus reducing the serum DHT levels results in reduced prostatic volume and increased epithelial apoptosis.[A178375] Dutasteride is a competitive and specific inhibitor of both Type I and Type II 5α-reductase isoenzymes and when evaluated under _in vitro_ and _in vivo_ conditions, the dissociation of the drug from the drug-enzyme complex is reported to be extremely slow.[L10568] Dutasteride does not bind to the human androgen receptor.[L10568]', 'Dutasteride is a synthetic 4-azasteroid compound that selectively inhibits both the type I and type II isoforms of steroid 5α-reductase, an intracellular enzyme that converts testosterone to 5α-dihydrotestosterone (DHT). Dutasteride works by reducing the levels of circulating DHT. It was also shown to reduce the size of the prostate gland, improve urinary flow, and symptoms of benign prostatic hyperplasia alone or in combination with tamsulosin.[L6256] The effect of the reduction of DHT by dutasteride is dose-dependent, with the maximum effect observed within 1-2 weeks following initial administration.[L10568] 



After 1 and 2 weeks of daily dosing with dutasteride 0.5 mg, median serum DHT concentrations were reduced by 85% and 90%, respectively.[L10568] The serum concentrations of DHT were maintained to be decreased by more than 90% in 85% of patients following 1 years'' administration of oral dutasteride 0.5 mg/day.[A178345] As evident from the clinical studies, dutasteride may also cause decreases in serum PSA in the presence of prostate cancer.[L10568] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fusiderm 2% cream 15 gm', 19502, 'فيوسيديرم 2% كريم 15جم', '44', '30', 'Antibiotic topical', 'Antibiotic topical', NULL, 'Fusidic acid', 'Eva pharma', 'Cream', 'كريم', '2%', '1', NULL, NULL, 'about fusidic acid a bacteriostatic steroid antibiotic systemic antibacterial anti-infective. mechanism of action of fusidic acid fusidic acid is a bactericidal or bacteriostatic drug depending upon the concentration. it inhibits the transfer of aminoacid', '6223002450251', 1577, '2025-07-30', NULL, 0, 'For the treatment of bacterial infections.', 'Fusidic acid works by interfering with bacterial protein synthesis, specifically by preventing the translocation of the elongation factor G (EF-G) from the ribosome. It also can inhibit chloramphenicol acetyltransferase enzymes.', 'Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tricovel 30 tabs.', 28498, 'تريكوفيل 30 قرص', '299', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Biogenina+biotin+zinc+copper+vitamin(c+e)', 'Giuliani > spring', 'Tab', 'أقراص', NULL, '3', NULL, NULL, 'tricovelï- with biogenina triple action: 1. reduces hair loss: biogeninaï- (registered patent) it brings nourishment and energy to hair bulb cells. 2. increases hair growth: tricovelï- prolongs and increases the growth phase of the hair cycle. by increasi', NULL, 1873, '2022-07-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Flustop 20 tabs.(n/a', 5036, 'فلوستوب 20 قرص', '5', NULL, 'Cold drugs', 'Cold drugs', NULL, 'Caffeine+chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine', 'Glaxo smithkline', 'Tab', 'أقراص', NULL, '2', 'نزلات البرد -- رشح وانسداد الانف -- الصداع بسبب دور البرد', NULL, NULL, NULL, 2412, '2023-03-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Core white eye contour serum 30 ml', 16798, 'كور وايت اي كونتور سيرم 30 مل', '180', NULL, 'Eye contour', 'Eye contour', NULL, 'Caffeine+green tea extract', 'Hi-care > pharma zone', 'Serum', 'سيروم', '30 ml', '1', 'حالات الهالات السوداء تحت العين.', NULL, 'skin lightening cream', NULL, 2369, '2022-07-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Floxia regenia - regenerating and redness control cream 40 ml', 19178, 'فلوكسيا ريجينيا - كريم تجديد 40 مل', '85', NULL, 'Healing topical', 'Healing topical', NULL, NULL, 'Floxia international sarl > bio-earth egypt', 'Cream', 'كريم', '40 ml', '1', NULL, NULL, 'regenia the new anti redness cream new formulation helping to : - reinforce blood capillaries - boost microcirculation - inhibit the propagation of inflammatory reactions - diminish redness - protect the epidermis from external aggression. clinical study', NULL, 1013, '2022-07-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Normelan sunscreen spf +50 cream gel 50 ml', 22354, 'نورميلان صن سكرين اس بي اف 50 جل 50 مل', '420', '240', 'Sun block', 'Sun block', NULL, NULL, 'Green pharmaceutical', 'Cream', 'كريم', '50 ml', '1', NULL, NULL, NULL, NULL, 990, '2025-07-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mucocycline s.r. 10 caps.', 23066, 'ميوكوسيكلين اس.ار. 10كبسولات', '12', NULL, 'Antibiotic with mucolytic', 'Antibiotic with mucolytic', NULL, 'Ambroxol+doxycycline', 'Unipharma co.', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, 'mechanism of action of doxycycline doxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. it exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein a', '6223002145324', 930, '2022-07-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Organo-orlistat 120 mg 20 capsules', 9366, 'اورجانو- اورليستات 120 مجم 20 كبسولة', '67', NULL, 'Weight loss', 'Weight loss', NULL, 'Orlistat', 'Organopharma', 'Capsule', 'كبسولة', '120 mg', '2', NULL, NULL, NULL, '6224000908249', 1521, '2022-07-09', NULL, 0, 'Orlistat is indicated for obesity management including weight loss and weight maintenance when used in combination with calorie reduction in overweight and obese adults; this indication applies to both the prescription formulation of 120 mg[L11130] and the over-the-counter formulation of 60 mg.[L31963] Orlistat in the 120 mg prescription formulation is also indicated to reduce the risk of weight regain following weight loss.[L11130]', 'Orlistat is a potent and selective inhibitor of various lipase enzymes responsible for the metabolism of fat. It acts in the gastrointestinal (GI) tract via covalent binding to the serine residues located on the active site of both gastric and pancreatic lipase. When orlistat is taken with food containing fat, it partially inhibits the hydrolysis of triglycerides. This decreases absorption of monoaclglycerides and free fatty acids, contributing to weight maintenance and weight loss.[A37653,L11130]', 'Orlistat helps with weight reduction and maintenance by inhibiting the absorption of dietary fats via the inhibition of lipase enzymes.[A1734,A1735]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Umbrella sunscreen lotion spf 50+ 75 ml', 28706, 'امبريلا صان سكرين لوشن 200 مل (معامل حماية 50)', '195', '165', 'Sun block', 'Sun block', NULL, NULL, 'Leader cosmetics > original pharma group', 'Lotion', 'لوشن', '75 ml', '1', 'واقي من الشمس', NULL, 'apply 20 minutes before sun exposure', NULL, 862, '2025-01-19', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Prinu 10sachet', 31132, 'برينو 10 اكياس', '120', '39', 'Peribiotic inulin', 'Peribiotic inulin', NULL, 'Perbiotic inulin+cereal+loctus bean gum', 'Swivel nutrient > prosperity company', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, 'probiotics+cereal for diarhea+loctus bean gum powder', NULL, 741, '2025-04-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cibinqo 50 mg 28 f.c.tabs', 3166, 'سيبينكو 50 مجم 28 قرص', '12,497', NULL, 'dermatological drugs', 'dermatological drugs', NULL, 'Abrocitinib', 'Pfizer biopharmaceuticals egypt', 'Tab', 'أقراص', '50 mg', '1', NULL, NULL, NULL, NULL, 1132, '2025-02-26', NULL, 0, 'Abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.[L39774] In the US, it is indicated to treat refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when the use of those therapies is inadvisable.[L39769]



Abrocitinib is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, or other immunosuppressants.[L39769]', 'Janus kinases (JAKs) are a family consisting of four receptor-associated kinases - JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2). Upon ligand binding and subsequent dimerization of cytokine and hormone receptors, receptor-associated JAKs are activated and phosphorylated. This allows the binding of Signal Transducers and Activators of Transcription (STATs), which are transcription factors. STAT binds to the receptor, and JAK phosphorylates and activates STAT to create a STAT dimer. The STAT dimer translocates to the nucleus to upregulate the gene transcription of pro-inflammatory cytokines and growth factors implicated in atopic dermatitis.[A183188,A244549] Blocking the JAK-STAT pathway is advantageous, as it is an intracellular signalling pathway where many pro-inflammatory pathways converge.[A244554]



Each JAK plays a role in the signalling and regulation of different cytokines and immune cells. In atopic dermatitis, JAK1 is the therapeutic target of focus as it is involved in the signalling of the γc family of cytokines involved in immune responses and disease pathophysiology, including IL-2, IL-4, IL-7, IL-9, and IL-15.[A244549] Abrocitinib reversibly inhibits JAK1 by blocking the adenosine triphosphate (ATP) binding site. Biochemical assays demonstrate that abrocitinib is selective for JAK1 over JAK2 (28-fold), JAK3 (>340-fold), and tyrosine kinase (TYK) 2 (43-fold), as well as the broader kinome.[L39769] Similarly, in cellular settings, abrocitinib preferentially inhibited cytokine-induced STAT phosphorylation by signalling pairs involving JAK1, while sparing signalling by JAK2/JAK2, or JAK2/TYK2 pairs.[L39774] The relevance of inhibition of specific JAK enzymes to the drug''s therapeutic effectiveness is currently unknown.[L39769]', 'Abrocitinib mediates anti-inflammatory effects by blocking the signalling of pro-inflammatory cytokines implicated in atopic dermatitis.[A244554] It dose-dependently reduces the serum markers of inflammation in atopic dermatitis, including high sensitivity C-reactive protein (hsCRP), interleukin-31 (IL-31), and thymus and activation regulated chemokine (TARC). These changes returned to near baseline within four weeks following drug discontinuation.[L39769] At two weeks of treatment, the mean absolute lymphocyte count increased, which returned to baseline by nine months of treatment. Treatment with abrocitinib was associated with a dose-related increase in B cell counts and a dose-related decrease in NK cell counts: the clinical significance of these changes is unknown.[L39774]



Treatment with 200 mg abrocitinib once-daily was associated with a transient, dose-dependent decrease in platelet count with the nadir occurring at a median of 24 days. Recovery of platelet count (~40% recovery by 12 weeks) occurred without discontinuation of the treatment.[L39769]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Effox 25mg 10 tab', 4019, 'ايفوكس 25مجم 10 اقراص', '7', NULL, 'Anti-ischemic', 'Anti-ischemic', NULL, 'Isosorbide mononitrate', 'Minapharm', 'Tab', 'أقراص', '25mg', '1', 'علاج الذبحات الصدرية --علاج تجلطات الدم', NULL, NULL, NULL, 912, '2022-10-19', NULL, 0, 'For the prevention of angina pectoris due to coronary artery disease.', 'Isosorbide dinitrate is converted to the active nitric oxide to activate guanylate cyclase. This activation increases levels of cyclic guanosine 3'',5''-monophosphate (cGMP). cGMP activates protein kinases and causes a series of phosphorylation reactions which leads to dephosphorylation of myosin light chains of smooth muscle fibres. Finally there is a release of calcium ions which causes smooth muscle relaxation and vasodilation.', 'Isosorbide Dinitrate is a moderate to long acting oral organic nitrate used for the relief and prophylactic management of angina pectoris. It relaxes the vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter. Dilatation of the veins promotes peripheral pooling of blood and decreases venous return to the heart, thereby reducing left ventricular end- diastolic pressure and pulmonary capillary wedge pressure (preload). Arteriolar relaxation reduces systemic vascular resistance, systolic arterial pressure, and mean arterial pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sonakto cream 50 gm', 27290, 'سوناكتو كريم 50 جم', '89', '74.5', 'Moisturizing topicals', 'Moisturizing topicals', NULL, 'Chamomile extract+panthenol+soya protein+olive oil+vitamin e', 'Leader cosmetics > sonesta pharma', 'Cream', 'كريم', '50 gm', '1', 'علاج البواسير -- مرطب', NULL, 'moisturizing cream', '6225000146013', 2352, '2025-11-26', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('4 wet intimate gel 100 ml', 13247, 'فور ويت انتيميت جل 100 مل', '40', NULL, 'Lubricant', 'Lubricant', NULL, NULL, 'Turkuaz medical co. > brother pharma', 'Gel', 'جل', '100 ml', '1', 'تخفيف وتهدئة الإحساس بعدم الراحة بسرعة، مما يساعد على استعادة التوازن الطبيعي للسيدات بسرعة', NULL, 'non-sterile transparent greaseless and light amber in colour water soluble jelly. condom safe', NULL, 1274, '2022-08-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Colitra plus 30 tab', 32058, 'كوليترا بلس 30 قرص', '345', '280', 'Multivitamin', 'Multivitamin', NULL, 'Glucosamine .collagen. chondroitin .vit d. vit c .b12 .vit e .ginger', 'Dawa egypt international > dawa egypt', 'Tab', 'أقراص', NULL, '3', 'يدعم مرونة المفاصل ويساهم فى الحفاظ على الوظيفة الطبيعية للمفاصل والغضاريف', NULL, 'chondroitin', '6224011019217', 1777, '2025-08-25', NULL, 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Depretreve 20mg 20 caps.', 30397, 'ديبريتريف 20مجم 20 كبسولة', '62', '44', 'Psychiatric.antidepressants', 'Psychiatric.antidepressants', NULL, 'Duloxetine', 'International drug industries > andalous pharma', 'Cap', 'كبسولة', '20mg', '2', NULL, NULL, 'about duloxetine a serotonin-norepinephrine reuptake inhibitor thiophene derivative antidepressant. mechanism of action of duloxetine duloxetine preferentially inhibits the re-uptake of noradrenaline and serotonin (5 ht) in the cns nerve terminals .this w', '6223004691331', 1297, '2025-04-11', NULL, 0, '**Indicated** for:



1) Management of Major Depressive Disorder.[label]



2) Management of Generalized Anxiety Disorder.[label]



3) Management of diabetic peripheral neuropathy.[label]



4) Management of fibromyalgia.[label]



5) Management of chronic musculoskeletal pain.[label]



6) Management of osteoarthritis of the knee in adults.[L6364]



7) Management of chronic lower back pain in adults.[L6364]



8) Management of stress urinary incontinence in adult women.[L6367]



**Off-label** uses include:



1) Management of chemotherapy-induced peripheral neuropathy.[A178603]



2) Management of stress urinary incontinence in adult men after prostatectomy until recovery is complete.[L6370]', 'Duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake.[A178714] Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors.



Action on the external urinary sphincter is mediated via duloxetine''s CNS effects. Increased serotonin and norepinephrine concentrations in Onuf''s nucleus leads to increased activation of 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and α<sub>1</sub> adrenergic receptors.[A178663,A178666] 5-HT<sub>2</sub> and α<sub>1</sub> are both G<sub>q</sub> coupled and their activation increases the activity of the inositol trisphosphate/phospholipase C (IP<sub>3</sub>/PLC) pathway.[T116] This pathway leads to release of intracellular calcium stores, increasing intracellular calcium concentrations, and facilitating neuronal excitability. 5-HT<sub>3</sub> functions as a ligand-gated sodium channel which allows sodium to flow into the neuron when activated. Increased flow of sodium into the neuron contributes to depolarization and activation of voltage gated channels involved in action potential generation. The combined action of these three receptors contributes to increased excitability of the pudendal motor nerve in response to glutamate.



Also related to duloxetine''s action at the spinal cord is its modulation of pain. Increasing the concentration of serotonin and norepinephrine in the dorsal horn of the spinal cord increases descending inhibition of pain through activation of 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, α<sub>1</sub>-adrenergic, and α<sub>2</sub>-adrenergic receptors.[A178705] 5-HT<sub>2</sub>, 5-HT<sub>3</sub>, and α<sub>1</sub>-adrenergic mediate neuronal activation as described above. The activated neuron in this case is the GABAergic inhibitory interneuron which synapses onto the nociceptive projection neuron to inhibit the transmission of painful stimuli to the brain. The 5-HT<sub>1</sub> and α<sub>2</sub> receptors are G<sub>i</sub>/G<sub>o</sub> coupled and their activation leads to increased potassium current through inward rectifier channels and decreased adenylyl cyclase/protein kinase A signaling which contributes to neuronal inhibition.[A178705,T116] These inhibitory receptors are present on the projection neuron itself as well as the dorsal root ganglion which precedes it and serves to directly suppress the transmission of painful stimuli.



The mechanisms involved in duloxetine''s benefits in depression and anxiety have not been fully elucidated. Dysfunctional serotonin and norepinephrine signaling are thought to be involved and increases in the availability of these neurotransmitters at the synaptic cleft thought to mediate a therapeutic effect.[A178666] It is postulated that the involvement of serotonin and norepinephrine in area responsible for emotional modulation such as the limbic system contributes to the effects in mood disorders specifically but this has yet to be confirmed.



Duloxetine''s hypertensive effect is related to its intended pharmacological effect. Increased availability of norepinephrine leads to activation of adrenergic receptors on the vascular endothelium. Since the action of α<sub>1</sub> receptors predominates, vasoconstriction results as the G<sub>q</sub> coupled receptor mediates calcium release from the sarcoplasmic reticulum to facilitate smooth muscle contraction.[T116]', 'Duloxetine, through increasing serotonin and norepinephrine concentrations in Onuf''s nucleus, enhances glutamatergic activation of the pudendal motor nerve which innervates the external urethral sphinter.[A178663,A178666] This enhanced signaling allows for stronger contraction. Increased contraction of this sphincter increases the pressure needed to produce an incontinence episode in stress urinary incontinence. Duloxetine has been shown to improve Patient Global Impression of Improvement and Incontinence Quality of Life scores.[A178669] It has also been shown to reduce the median incontinence episode frequency at doses of 40 and 80 mg.



Action at the dorsal horn of the spinal cord allows duloxetine to strengthen the the serotonergic and adrenergic pathways involved in descending inhibition of pain.[A178666,A178705] This results in an increased threshold of activation necessary to transmit painful stimuli to the brain and effective relief of pain, particularly in neuropathic pain. Pain relief has been noted in a variety of painful conditions including diabetic peripheral neuropathy, fibromyalgia, and osteoarthritis using a range of pain assessment surveys.[A178711]



While duloxetine has been shown to be effective in both animal models of mood disorders and in clinical trials for the treatment of these disorders in humans, the broad scope of its pharmacodynamic effects on mood regulation in the brain has yet to be explained.[A178714]



Increased blood pressure is a common side effect with duloxetine due to vasoconstriction mediated by the intended increase in norepinephrine signaling.[label,T116]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sominaletta 15mg/5ml elixir 120 ml', 27288, 'سوميناليتا 15مجم/5مل 120 مل شراب', '31', '23.5', 'Anti-epileptic.barbiturates', 'Anti-epileptic.barbiturates', NULL, 'Phenobarbitone', 'Alexandria', 'Unknown', 'غير محدد', '15mg', '1', 'علاج لمرض الصرع', NULL, 'about phenobarbitone barbiturate derivative sedative-hypnotic anticonvulsant. mechanism of action of phenobarbitone sedative and antiepileptic actions: phenobarbitone mainly acts on picrotoxin site of gaba -bzd receptor cl- (chloride ion) channel complex.', '6223000171233', 1595, '2025-05-11', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nexium 20 mg 14 f.c.tabs. (n/a)', 23549, 'نيكسيوم 20مجم 14 قرص', '98', NULL, 'Peptic ulcer.proton pump inhibitor', 'Peptic ulcer.proton pump inhibitor', NULL, 'Esomeprazole', 'Astra zeneca', 'Tab', 'أقراص', '20 mg', '2', 'قرحة المعدة والحموضة', NULL, NULL, '6223003270308', 1782, '2023-08-02', NULL, 0, 'Esomeprazole is indicated for the treatment of acid-reflux disorders including healing and maintenance of erosive esophagitis, and symptomatic gastroesophageal reflux disease (GERD), peptic ulcer disease, H. pylori eradication, prevention of gastrointestinal bleeds with NSAID use, and for the long-term treatment of pathological hypersecretory conditions including Zollinger-Ellison Syndrome. ', 'Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect that persists longer than 24 hours.[FDA Label]

', 'Esomeprazole is a compound that inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and <i>H. pylori</i> eradication to reduce the risk of duodenal ulcer recurrence. Esomeprazole belongs to a new class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonistic properties, but that suppress gastric acid secretion by specific inhibition of the H<sup>+</sup>/K<sup>+</sup> ATPase at the secretory surface of the gastric parietal cell. By doing so, it inhibits acid secretion into the gsatric lumen. This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus.



Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 



PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]



Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients including iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Swacave mouth spray 30 ml', 4954, 'سواكاف سبراي للفم 30 مل', '100', NULL, 'Anti bacterial anti fungal local anesthetic', 'Anti bacterial anti fungal local anesthetic', NULL, 'Hyaluronic acid+chlorhexidine+lidocaine+menthol+camphor+vitamin c+vitamin e+ecalyptus', 'Swa pharma for pharmaceuticals', 'Spray', 'بخاخ', '30 ml', '1', NULL, NULL, NULL, NULL, 852, '2025-06-22', NULL, 0, 'The intra-articular preparations of hyaluronic acid are indicated for knee pain associated with osteoarthritis.[L32228] Hyaluronic acid is used in cosmetic applications to prevent and reduce the appearance of wrinkles on the face, and as a dermal filler to correct facial imperfections or other imperfections on other parts of the body.[L32208,L32223] It is frequently an ingredient in topical applications for wound healing and symptomatic treatment of skin irritation from various causes.[L32198] Hyaluronic acid may also be indicated in ophthalmological preparations or oral capsules to treat discomfort caused by dry eyes or conjunctivitis and for its protective qualities during and before eye surgery.[A230128,L32213] Finally, hyaluronic acid can be used off-label to coat the bladder for relief of interstitial cystitis symptoms.[A230533]', 'General principles and hyaluronic acid receptor binding 



Hyaluronic acid works by two basic mechanisms: serving as a passive structural molecule or serving as signaling molecule, depending on the molecule size. The physicochemical properties of high molecular weight HA contribute to passive structural effects, demonstrating hygroscopicity and viscoelasticity and improving hydration, water balance, and structural integrity. As a signalling  molecule interacting with proteins, HA causes several opposing effects based on molecular weight: pro- or anti-inflammatory effects, promotion or inhibition of cell migration, and activating or inhibiting cell division.[A230133] 



Hyaluronic acid exerts its therapeutic effects through binding to three primary types of cell surface receptors: CD44 (a membrane glycoprotein), the receptor for hyaluronate-mediated motility (RHAMM), and the Intercellular Adhesion Molecule 1 (ICAM-1). CD44 is considered the most widely distributed receptor for hyaluronic acid, demonstrating cellular interactions with osteopontin, collagen, and matrix metalloproteinases (MMPs).  High and low molecular weight hyaluronic acids demonstrate differing molecular and cellular mechanisms in their interaction with CD44 receptors. Some examples of these effects include modification of chondrocyte survival pathways in addition to alteration of apoptosis pathways.  Lymphatic vessel endothelial hyaluronan receptor (LYVE-1), and hyaluronic acid receptor for endocytosis (HARE), (also known as Stabilin-2) also bind to hyaluronic acid.[A230128] 



Hyaluronic acid for skin conditions and cosmetics



Hyaluronic acid''s anionic proprieties cause it to attract water and induce swelling, increasing tissue volume and skin structural integrity. The aging process is associated with reduced production of skin hyaluronic acid and collagen, causing the appearance of wrinkles and the loss of facial volume. Dermal fillers of hyaluronic acid replace lost tissue volume, imparting a full and youthful appearance to skin that has lost its elasticity. Hyaluronic acid fillers contain cross-linked hyaluronic acid particles, rendering a concentrated substance with resistance to various forms of physical and chemical breakdown. The cosmetic benefits of hyaluronic acid filler may last up to 6 months, depending on the brand and technique used for injection.[L32193] Additionally, dermal hyaluronic acid fillers are known to increase the production of fibroblasts[L32193], supporting wound healing and offering relief from irritating and inflammatory skin conditions.[A230118]





Hyaluronic acid for joint pain



Most cells in the human body are capable of synthesizing HA. It is a primary component of the extracellular matrix (ECM) and can be found in bone marrow, cartilage, and synovial fluid in joints.[A230128] In osteoarthritis, the concentration of naturally occurring hyaluronic acid gradually decreases, lowering the viscosity of synovial fluid that protects joints from excess friction. Administration of intra-articular hyaluronic acid increases viscosity of synovial joint fluid, reducing friction and subsequently relieving painful arthritic symptoms.[L32193]





Hyaluronic acid for ophthalmic conditions and ophthalmological procedures



Solutions of hyaluronic acid with a concentration greater than 0.1% moisturize the surface of the eyes to treat symptoms of dry eye while improving the stabilization of tear film, replenishing deficiencies of HA, reducing friction, and preventing binding of foreign substances to the ocular tissue.[A230128,L32193] Hyaluronic acid is frequently used during and after ophthalmological surgeries and plays important roles by virtue of its moisturizing, viscoelastic, and protective properties. It promotes tissue healing of the corneal epithelium and other parts of the eye following ophthalmological surgery, minimizing the risk of adhesions and free radical formation.[A230128]

', 'HA has long-acting lubricant, shock absorbing, joint stabilizing, and water balancing properties.[A230128,L32193] It is similar to the naturally occurring glycosaminoglycan (GAG) in joints. Hyaluronic acid works by acting as a lubricant and shock absorber, facilitating joint mobility and thereby reducing osteoarthritic pain.  Hyaluronic acid has antioxidative, anti-inflammatory, and analgesic effects.[A230128] The water-balancing properties and viscoelasticity of hyaluronic acid are beneficial in cosmetic injections, imparting volume and reducing the appearance of imperfections and wrinkles.[L32193] Due to the abovementioned properties, HA has a protective effect on the eyes and cornea.[A230133]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Andopentene xr 300 mg 20 f.c. tabs.', 3844, 'اندوبنتين اكس ار 300مجم 20 قرص', '90', NULL, 'Anti-epileptic.gaba analogs', 'Anti-epileptic.gaba analogs', NULL, 'Gabapentin', 'Andalous pharma', 'Tab', 'أقراص', '300 mg', '2', NULL, NULL, NULL, '6223004693175', 1488, '2022-12-04', NULL, 0, 'In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]', 'The precise mechanism through which gabapentin exerts its therapeutic effects is unclear.[L8717,L8720] The primary mode of action appears to be at the auxillary α2δ-1 subunit of voltage-gated calcium channels (though a low affinity for the α2δ-2 subunit has also been reported).[A186179,A14097,A186277] The major function of these subunits is to facilitate the movement of pore-forming α1 subunits of calcium channels from the endoplasmic reticulum to the cell membrane of pre-synaptic neurons.[A186179] There is evidence that chronic pain states can cause an increase in the expression of α2δ subunits and that these changes correlate with hyperalgesia.[A14097] Gabapentin appears to inhibit the action of α2δ-1 subunits, thus decreasing the density of pre-synaptic voltage-gated calcium channels and subsequent release of excitatory neurotransmitters.[A186179] It is likely that this inhibition is also responsible for the anti-epileptic action of gabapentin.[A186277]



There is some evidence that gabapentin also acts on adenosine receptors[A11009, A186209] and voltage-gated potassium channels,[A186212] though the clinical relevance of its action at these sites is unclear.', 'Gabapentin is an anti-convulsant medication that inhibits the release of excitatory neurotransmitters, allowing for its use against pathologic neurotransmission such as that seen in neuropathic pain and seizure disorders.[L8717,L8732] It has a wide therapeutic index, with doses in excess of 8000 mg/kg failing to cause a fatal reaction in rats.[L8765]



Gabapentin is ineffective in absence seizures and should be used in caution in patients with mixed seizure disorders involving absence seizures. Gabapentin has been associated with drug reaction with eosinophilia and systemic symptoms (DRESS), otherwise known as multi-organ hypersensitivity. This reaction can prove fatal and early symptoms such as fever, lymphadenopathy, and rash should be promptly investigated.[L8717,L8720,L8732]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Anaforten hair serum 120 ml', 30129, 'انافورتين سيرم للشعر 120 مل', '290', '250', 'Hair care', 'Hair care', NULL, NULL, '> bio geneca pharmaceuticals', 'Serum', 'سيروم', '120 ml', '1', NULL, NULL, NULL, NULL, 1778, '2025-04-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sensoderm soap 80 gm', 26794, 'سنسوديرم صابونة 80 جرام', '50', '45', 'Soap', 'Soap', NULL, 'Triclosan+boric acid+zinc oxide+glycerin+betaine+paraffin oil+titanium dioxide', 'Hi-care > novex', 'Soap', 'صابون', '80 gm', '1', 'صابون تنظيف لطيفة للبشرة الحساسة، غنية بالمكونات الطبيعية لتهدئة وترطيب البشرة.مناسبة للاستخدام اليومي على الوجه والجسم.', NULL, 'indications : sensitive skin . neonates and babies skin hygiene . contact dermatitis and sweat rash .', '769503325101', 2960, '2025-07-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Borgalendro 70 mg oral soln. 75 ml', 15438, 'بورجاليندرو 70 مجم محلول 75 مل', '26', '18', 'Osteoporosis.bisphosphonates', 'Osteoporosis.bisphosphonates', NULL, 'Alendronate', 'Borg', 'Sol', 'محلول', '70 mg', '1', NULL, NULL, 'indication for the treatment and prevention of osteoporosis in women and paget s disease of bone in both men and women. mechanism of action the action of alendronate on bone tissue is based partly on its affinity for hydroxyapatite which is part of the mi', '6223002570829', 1215, '2025-08-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Anika hair conditioner 250 ml', 14185, 'انيكا بلسم 250 مل', '89', NULL, 'Hair care', 'Hair care', NULL, 'Pumpkin oil+silicon oil+panthenol+lanolin+keratin+jojoba oil+sesame oil+almond oil', 'Cosmopack for cosmetics > care mid-east pharma', 'Conditioner', 'بلسم', '250 ml', '1', NULL, NULL, 'use: apply on the whole scalp then rinse well with water', NULL, 830, '2022-07-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Verdex prime hair forte lotion 200 ml', 31566, 'فيردكس بريمي هير فورت لوسيون 200 مل', '600', '450', 'Hair care', 'Hair care', NULL, NULL, 'Egoteck srl > macro group pharmaceuticals', 'Lotion', 'لوشن', '200 ml', '1', NULL, NULL, 'a synergistic blend of natural ingredients for treatment of hair loss and promotion of healthy hair growth enriched with saw pametto and green tea extract. special formula designed for management of androgenic and chronic hair falling with the help of 5-a', NULL, 740, '2025-06-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Articulus capsule', 5185, 'ارتيكيولاس كبسول', '190', NULL, 'Osteoarthritis', 'Osteoarthritis', NULL, 'Glucosamine sulfate+hydrolyzed collagen+vitamin c', 'Celenova pharmaceutical', 'Capsule', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 954, '2025-06-23', NULL, 0, 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-κB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Nostifix 0.5mg 2 tablets', 23755, 'نوستيفيكس 0.5مجم 2 قرص', '68', '45.5', 'Dopamine agonist and prolactin inhibitor', 'Dopamine agonist and prolactin inhibitor', NULL, 'Cabergoline', 'Marcyrl co.', 'Tablet', 'أقراص', '0.5mg', '1', 'تنشيف اللبن و بعض حالات تأخر الحمل', NULL, NULL, '6223003573683', 5381, '2024-09-26', NULL, 0, 'For the treatment of hyperprolactinemic disorders, either idiopathic or due to prolactinoma (prolactin-secreting adenomas). May also be used to manage symptoms of Parkinsonian Syndrome as monotherapy during initial symptomatic management or as an adjunct to levodopa therapy during advanced stages of disease. ', 'The dopamine D<sub>2</sub> receptor is a 7-transmembrane G-protein coupled receptor associated with G<sub>i</sub> proteins. In lactotrophs, stimulation of dopamine D<sub>2</sub> causes inhibition of adenylyl cyclase, which decreases intracellular cAMP concentrations and blocks IP3-dependent release of Ca<sup>2+</sup> from intracellular stores. Decreases in intracellular calcium levels may also be brought about via inhibition of calcium influx through voltage-gated calcium channels, rather than via inhibition of adenylyl cyclase. Additionally, receptor activation blocks phosphorylation of p42/p44 MAPK and decreases MAPK/ERK kinase phosphorylation. Inhibition of MAPK appears to be mediated by c-Raf and B-Raf-dependent inhibition of MAPK/ERK kinase. Dopamine-stimulated growth hormone release from the pituitary gland is mediated by a decrease in intracellular calcium influx through voltage-gated calcium channels rather than via adenylyl cyclase inhibition. Stimulation of dopamine D<sub>2</sub> receptors in the nigrostriatal pathway leads to improvements in coordinated muscle activity in those with movement disorders. Cabergoline is a long-acting dopamine receptor agonist with a high affinity for D2 receptors. Receptor-binding studies indicate that cabergoline has low affinity for dopamine D1, &alpha;<sub>1</sub>,- and &alpha;<sub>2</sub>- adrenergic, and 5-HT<sub>1</sub>- and 5-HT<sub>2</sub>-serotonin receptors.', 'Cabergoline stimulates centrally-located dopaminergic receptors resulting in a number of pharmacologic effects. Five dopamine receptor types from two dopaminergic subfamilies have been identified. The dopaminergic D1 receptor subfamily consists of D<sub>1</sub> and D<sub>5</sub> subreceptors, which are associated with dyskinesias. The dopaminergic D2 receptor subfamily consists of D<sub>2</sub>, D<sub>3</sub> and D<sub>4</sub> subreceptors, which are associated with improvement of symptoms of movement disorders. Thus, agonist activity specific for D2 subfamily receptors, primarily D<sub>2</sub> and D<sub>3</sub> receptor subtypes, are the primary targets of dopaminergic antiparkinsonian agents. It is thought that postsynaptic D2 stimulation is primarily responsible for the antiparkinsonian effect of dopamine agonists, while presynaptic D2 stimulation confers neuroprotective effects. This semisynthetic ergot derivative exhibits potent agonist activity on dopamine D<sub>2</sub>- and D<sub>3</sub>-receptors. It also exhibits: agonist activity (in order of decreasing binding affinities) on 5-hydroxytryptamine (5-HT)<sub>2B</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>1D</sub>, dopamine D<sub>4</sub>, 5-HT<sub>1A</sub>, dopamine D<sub>1</sub>, 5-HT<sub>1B</sub> and 5-HT<sub>2C</sub> receptors and antagonist activity on &alpha;<sub>2B</sub>, &alpha;<sub>2A</sub>, and &alpha;<sub>2C</sub> receptors. Parkinsonian Syndrome manifests when approximately 80% of dopaminergic activity in the nigrostriatal pathway of the brain is lost. As this striatum is involved in modulating the intensity of coordinated muscle activity (e.g. movement, balance, walking), loss of activity may result in dystonia (acute muscle contraction), Parkinsonism (including symptoms of bradykinesia, tremor, rigidity, and flattened affect), akathesia (inner restlessness), tardive dyskinesia (involuntary muscle movements usually associated with long-term loss of dopaminergic activity), and neuroleptic malignant syndrome, which manifests when complete blockage of nigrostriatal dopamine occurs. High dopaminergic activity in the mesolimbic pathway of the brain causes hallucinations and delusions; these side effects of dopamine agonists are manifestations seen in patients with schizophrenia who have overractivity in this area of the brain. The hallucinogenic side effects of dopamine agonists may also be due to 5-HT<sub>2A</sub> agonism. The tuberoinfundibular pathway of the brain originates in the hypothalamus and terminates in the pituitary gland. In this pathway, dopamine inhibits lactotrophs in anterior pituitary from secreting prolactin. Increased dopaminergic activity in the tuberoinfundibular pathway inhibits prolactin secretion. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ramdeep 40mg 10 f.c. tab.', 13055, 'رامديب 40مجم 10 اقراص', '43', '31.2', 'Psychiatric.antidepressants', 'Psychiatric.antidepressants', NULL, 'Citalopram', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '40mg', '1', NULL, NULL, 'about citalopram selective serotonin reuptake inhibitor (ssris) antidepressant. mechanism of action of citalopram citalopram blocks the re-uptake of neurotransmitter serotonin from the synapse to the presynaptic nerve terminal in the cns. this potentiates', '6224007308073', 1182, '2025-08-23', NULL, 0, 'Citalopram is approved by the FDA for treating adults with major depressive disorder.[L47941] It has also been used off-label to treat various diseases, including but not limited to sexual dysfunction, ethanol abuse, psychiatric conditions such as obsessive-compulsive disorder (OCD), social anxiety disorder, panic disorder, and diabetic neuropathy.[L5224,A321,A322,A261296] ', 'The mechanism of action of citalopram is unclear but is presumed to be related to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT), potentially through the inhibition of the serotonin transporter (solute carrier family 6 member 4, _SLC6A4_).[L47941,A37688] 



Citalopram binds with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs. Particularly, citalopram has no or very low affinity for 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, dopamine D<sub>1</sub> and D<sub>2</sub>, α<sub>1</sub>-, α<sub>2</sub>-, and β-adrenergic, histamine H<sub>1</sub>, gamma aminobutyric acid (GABA), muscarinic cholinergic, and benzodiazepine receptors.[L47941]', 'Citalopram belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It has been found to relieve or manage symptoms of depression, anxiety, eating disorders and obsessive-compulsive disorder among other mood disorders. The antidepressant, anti-anxiety, and other actions of citalopram are linked to its inhibition of CNS central uptake of serotonin.[L47941] Serotonergic abnormalities have been reported in patients with mood disorders. Behavioral and neuropsychological effects of serotonin include the regulation of mood, perception, reward, anger, aggression, appetite, memory, sexuality, and attention, as examples. The onset of action for depression is approximately 1 to 4 weeks. The complete response may take 8-12 weeks after initiation of citalopram.[L5224]



 <i>In vitro</i> studies demonstrate that citalopram is a strong and selective inhibitor of neuronal serotonin reuptake and has weak effects on norepinephrine and dopamine central reuptake. The chronic administration of citalopram has been shown to downregulate central norepinephrine receptors, similar to other drugs effective in the treatment of major depressive disorder. Citalopram does not inhibit monoamine oxidase.[A325]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Feronutrillion 30 tabs', 7395, 'فيرونوتريليون 30 قرص', '165', NULL, 'Iron', 'Iron', NULL, 'Iron+vitamin c+folic acid+vitamin b12', 'Nutrillion international for pharmaceutical and food supplement', 'Tab', 'أقراص', NULL, '1', NULL, NULL, NULL, NULL, 869, '2025-09-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Injoceph 1 gm i.m. / i.v. vial', 6385, 'انجوسيف 1 جم فيال', '22', NULL, 'Antibiotic.cephalosporin.third-generation', 'Antibiotic.cephalosporin.third-generation', NULL, 'Cefoperazone', 'Chemipharm', 'Inj', 'حقن', '1 gm', '1', NULL, NULL, NULL, NULL, 771, '2023-01-13', NULL, 0, 'Indicated for the treatment of following infections caused by susceptible bacteria:[label]



1) Respiratory tract infections caused by _S. pneumoniae_, _H. influenzae_, _S. aureus_ (penicillinase and non-penicillinase producing strains), _S. pyogenes_ (Group A beta-hemolytic streptococci), _P. aeruginosa_, _Klebsiella pneumoniae_, _E. coli_, _Proteus mirabilis_, and Enterobacter species.



2) Peritonitis and other intra-abdominal infections caused by _E. coli_, _P. aeruginosa_, and anaerobic gram-negative bacilli (including _Bacteroides fragilis_).



3) Bacterial septicemia caused by _S. pneumoniae_, _S. agalactiae_, _S. aureus_, _Pseudomonas aeruginosa_, _E. coli_, _Klebsiella_ spp., _Klebsiella pneumoniae_, Proteus species (indole-positive and indole-negative), _Clostridium_ spp. and anaerobic gram-positive cocci.



4) Infections of the skin and skin structures caused by S. aureus (penicillinase and non-penicillinase producing strains), S. pyogenes, and P. aeruginosa.



5) Pelvic Inflammatory Disease, Endometritis, and Other Infections of the Female Genital Tract caused by N. gonorrhoeae, S. epidermidis, S. agalactiae, E. coli, Clostridium spp., Bacteroides species (including Bacteroides fragilis), and anaerobic gram-positive cocci.



6) Urinary tract infections caused by Escherichia coli and Pseudomonas aeruginosa.



7) Enterococcal Infections. Although cefoperazone has been shown to be clinically effective in the treatment of infections caused by enterococci in cases of peritonitis and other intra-abdominal infections, infections of the skin and skin structures, pelvic inflammatory disease, endometritis and other infections of the female genital tract, and urinary tract infections, the majority of clinical isolates of enterococci tested are not susceptible to cefoperazone but fall just at or in the intermediate zone of susceptibility, and are moderately resistant to cefoperazone. However, _in vitro_ susceptibility testing may not correlate directly with _in vivo_ results. Despite this, cefoperazone therapy has resulted in clinical cures of enterococcal infections, chiefly in polymicrobial infections. Cefoperazone should be used in enterococcal infections with care and at doses that achieve satisfactory serum levels of cefoperazone.', 'Like all beta-lactam antibiotics, cefoperazone binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins.', 'Cefoperazone is a third generation cephalosporin antibiotic. Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Myth sun screen lotion 60 ml spf 50+', 4311, 'ميث صن سكرين لوشن 60 مل بمعامل حماية من الشمس 50+', '220', NULL, 'Lotion', 'Lotion', NULL, 'Sun protection formula', 'Myth', 'Lotion', 'لوشن', '60 ml', '1', NULL, NULL, NULL, NULL, 838, '2025-06-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Coversyl 5mg 30 f.c. tab', 3125, 'كوفرسيل 5مجم 30 قرص', '79', '79', 'Antihypertensive.ace', 'Antihypertensive.ace', NULL, 'Perindopril', 'Servier', 'Tab', 'أقراص', '5mg', '1', NULL, NULL, NULL, '6223003960162', 4053, '2024-11-26', NULL, 0, 'For the treatment of mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease. ', 'There are two isoforms of ACE: the somatic isoform, which exists as a glycoprotein comprised of a single polypeptide chain of 1277; and the testicular isoform, which has a lower molecular mass and is thought to play a role in sperm maturation and binding of sperm to the oviduct epithelium. Somatic ACE has two functionally active domains, N and C, which arise from tandem gene duplication. Although the two domains have high sequence similarity, they play distinct physiological roles. The C-domain is predominantly involved in blood pressure regulation while the N-domain plays a role in hematopoietic stem cell differentiation and proliferation. ACE inhibitors bind to and inhibit the activity of both domains, but have much greater affinity for and inhibitory activity against the C-domain. Perindoprilat, the active metabolite of perindopril, competes with ATI for binding to ACE and inhibits and enzymatic proteolysis of ATI to ATII. Decreasing ATII levels in the body decreases blood pressure by inhibiting the pressor effects of ATII as described in the Pharmacology section above. Perindopril also causes an increase in plasma renin activity likely due to a loss of feedback inhibition mediated by ATII on the release of renin and/or stimulation of reflex mechanisms via baroreceptors. ', 'Perindopril is a nonsulfhydryl prodrug that is metabolized via first pass effect (62%) and systemic hydrolysis (38%) to perindoprilat, its active metabolite, following oral administration. Perindoprilat lowers blood pressure by antagonizing the effect of the RAAS. The RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from the granular cells of the juxtaglomerular apparatus in the kidneys. In the blood stream, renin cleaves circulating angiotensinogen to ATI, which is subsequently cleaved to ATII by ACE. ATII increases blood pressure using a number of mechanisms. First, it stimulates the secretion of aldosterone from the adrenal cortex. Aldosterone travels to the distal convoluted tubule (DCT) and collecting tubule of nephrons where it increases sodium and water reabsorption by increasing the number of sodium channels and sodium-potassium ATPases on cell membranes. Second, ATII stimulates the secretion of vasopressin (also known as antidiuretic hormone or ADH) from the posterior pituitary gland. ADH stimulates further water reabsorption from the kidneys via insertion of aquaporin-2 channels on the apical surface of cells of the DCT and collecting tubules. Third, ATII increases blood pressure through direct arterial vasoconstriction. Stimulation of the Type 1 ATII receptor on vascular smooth muscle cells leads to a cascade of events resulting in myocyte contraction and vasoconstriction. In addition to these major effects, ATII induces the thirst response via stimulation of hypothalamic neurons. ACE inhibitors inhibit the rapid conversion of ATI to ATII and antagonize RAAS-induced increases in blood pressure. ACE (also known as kininase II) is also involved in the enzymatic deactivation of bradykinin, a vasodilator. Inhibiting the deactivation of bradykinin increases bradykinin levels and may sustain the effects of perindoprilat by causing increased vasodilation and decreased blood pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Epicocillin 125mg/5ml 100ml susp.', 18376, 'ابيكوسيللين 125مجم/5مل معلق 100 مل', '7', NULL, 'Penicillins.monocomponent', 'Penicillins.monocomponent', NULL, 'Ampicillin', 'Eipico', 'Susp', 'معلق', '125mg', '1', NULL, NULL, 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032150509', 958, '2023-01-07', NULL, 0, 'For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc', 'By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Ampicillin interferes with an autolysin inhibitor.', 'Ampicillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Ampicillin has <i>in vitro</i> activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Ampicillin results from the inhibition of cell wall synthesis and is mediated through Ampicillin binding to penicillin binding proteins (PBPs). Ampicillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Karmastin 0.05% eye dps. 5 ml', 21256, 'كارماستين 0.05% قطرة 5 مل', '19', NULL, 'H1- and h2-receptors blocker', 'H1- and h2-receptors blocker', NULL, 'Epinastine', 'Kahira > beta pharma-egypt', 'Unknown', 'غير محدد', '0.05%', '1', NULL, NULL, 'description epinastine is used for the prevention of itching associated with allergic conjunctivitis. it has a multi-action effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the', NULL, 680, '2022-07-16', NULL, 0, 'For the prevention of itching associated with allergic conjunctivitis.', 'Epinastine has a multiaction effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding to both the H1- and H<sub>2</sub>-receptors to stop itching and provide lasting protection, and 3. prevents the release of proinflammatory chemical mediators from the blood vessel to halt progression of the allergic response.', 'Epinastine is an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes. Epinastine is indicated for the prevention of itching associated with allergic conjunctivitis. Epinastine is a topically active, direct H<sub>1</sub>-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Epinastine is selective for the histamine H<sub>1</sub>-receptor and has affinity for the histamine H2 receptor. Epinastine also possesses affinity for the a1-, a2-, and 5-HT<sub>2</sub> -receptors. Epinastine does not penetrate the blood/brain barrier and, therefore, is not expected to induce side effects of the central nervous system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Colchiopo 1mg 20 f.c.tabs', 7714, 'كولشوبو 1مجم 20 قرص', '61', NULL, 'Antigout preparation', 'Antigout preparation', NULL, 'Colchicine', 'Borg pharmaceutical industries', 'Tab', 'أقراص', '1mg', '2', NULL, NULL, NULL, NULL, 1007, '2025-10-16', NULL, 0, 'Colchicine is indicated for the prophylaxis and treatment of gout flares. It is also indicated in Familial Mediterranean fever (FMF) in children and adults of four years of age and older.[L8138] It is also indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease.[L47591] 



Some off-label uses of colchicine include the treatment of the manifestations of Behcet''s syndrome, pericarditis, and postpericardiotomy syndrome.[A183932,A183935]', 'The exact mechanism of action of colchicine has not been fully established; however, colchicine likely interferes with the intracellular assembly of the inflammasome complex present in neutrophils and monocytes that mediates activation of interleukin-1β, an inflammatory mediator.[A183602,A183605,L8138] Colchicine also attenuates neutrophil adhesion and recruitment, as well as superoxide production.[A183611] Clinical data demonstrate that colchicine reduces high-sensitivity C- reactive protein (hs-CRP).[L47591]



Colchicine is an anti-mitotic drug that disrupts cytoskeletal functions by inhibiting β-tubulin polymerization into microtubules. Consequently, it prevents the activation, degranulation, and migration of neutrophils. This pharmacological action is thought to be related to colchicine ameliorating gout symptoms and preventing major cardiovascular events.[L8138,L47591] Colchicine blocks microtubule growth at low concentrations and causes the depolymerization of microtubules at high concentrations.[A183602]', 'Colchicine ameliorates the symptoms of gout and Familial Mediterranean fever.[A183602,L8138] It possesses anti-inflammatory, anti-fibrotic, and cardiovascular protective effects. Colchicine was shown to exhibit anticancer properties, such as the inhibition of cancer cell migration and angiogenesis. Colchicine has a narrow therapeutic window.[A183602]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Q-sorb co q-10 100 mg 60 softgels (illegal import)', 25522, 'كيو سورب 100مجم', '0', NULL, 'Antioxidant', 'Antioxidant', NULL, 'Coenzyme q-10', 'Puritans pride', 'Gel', 'جل', '100 mg', '1', NULL, NULL, 'made with a natural highly bioavailable form of co q 10 ï- q-sorb.ï-important for statin drug users++ ï- taking q-sorbï- co q 10 can help replenish what statin drugs can deplete. coenzyme q-10 provides powerful antioxidant support.** good oral health is l', NULL, 917, '2022-07-15', NULL, 0, 'Mesna is a uroprotective agent and is used prophylactically to reduce ifosfamide and cyclophosphamide induced hemorrhagic cystitis.[A18572]', 'A metabolite called acrolein is produced when ifosfamide and cyclophosphamide are metabolized. This metabolite concentrates in the bladder and causes cell death via upregulation of reactive oxygen species (ROS), and activates inducible nitric oxide synthase (iNOS) which leads to production of nitric oxide (NO). Both ROS and NO produce products which are detrimental to lipids, proteins and DNA strands. Furthermore, ROS stimulate gene expression of pro-inflammatory cytokines such as TNF-α AND IL-1β. Acrolein may also lead to ulceration of the bladder urothelium. Mesna protects against cyclophosphamide and ifosfamide induced hemorrhagic cystitis by binding to their toxic metabolites. Mesna is metabolized to dimesna and excreted by the kidneys. Glutathione dihydrogenase acts on the reabsorbed portion and produces free sulfhydryl groups. These free sulfhydryl  groups bind acrolein in the bladder, allowing effective excretion and prevention  of toxic effects.[A18570] In addition, Mesna binds to and detoxifies a urotoxic ifosfamide metabolite called 4-hydroxy-ifosfamide.', 'Mesna binds to and inactivates acrolein there by preventing or reducing bladder problems', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tajucal-d liquid 100 ml', 6048, 'تاجوكال دي شراب ليكويد 100 مل', '55', '45', 'Multivitamin', 'Multivitamin', NULL, 'Calcium+vitamin d+magnesium+zinc', 'Organix - nali pharma', 'Unknown', 'غير محدد', '100 ml', '1', NULL, NULL, NULL, '6225000577633', 915, '2025-07-19', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lidoged 5% topical gel 15 gm', 21815, 'ليدوجيد 5% جل موضعي 15 جم', '5', NULL, 'Analgesic.local anesthetic', 'Analgesic.local anesthetic', NULL, 'Lidocaine', 'Jedco int. co. for pharmaceuticals', 'Gel', 'جل', '5%', '1', NULL, NULL, 'indication for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural tech', NULL, 762, '2022-07-17', NULL, 0, 'Lidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks [F4349, L5930].', 'Lidocaine is a local anesthetic of the amide type [F4349, L5930, L5948]. It is used to provide local anesthesia by nerve blockade at various sites in the body [F4349, L5930, L5948]. It does so by stabilizing the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action [F4349, L5930, L5948]. In particular, the lidocaine agent acts on sodium ion channels located on the internal surface of nerve cell membranes [F4349, L5930, L5948]. At these channels, neutral uncharged lidocaine molecules diffuse through neural sheaths into the axoplasm where they are subsequently ionized by joining with hydrogen ions [F4349, L5930, L5948]. The resultant lidocaine cations are then capable of reversibly binding the sodium channels from the inside, keeping them locked in an open state that prevents nerve depolarization [F4349, L5930, L5948]. As a result, with sufficient blockage, the membrane of the postsynaptic neuron will ultimately not depolarize and will thus fail to transmit an action potential [F4349, L5930, L5948]. This facilitates an anesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their generation in the first place [F4349, L5930, L5948].



In addition to blocking conduction in nerve axons in the peripheral nervous system, lidocaine has important effects on the central nervous system and cardiovascular system [F4349, L5930, L5948]. After absorption, lidocaine may cause stimulation of the CNS followed by depression and in the cardiovascular system, it acts primarily on the myocardium where it may produce decreases in electrical excitability, conduction rate, and force of contraction [F4349, L5930, L5948].', 'Excessive blood levels of lidocaine can cause changes in cardiac output, total peripheral resistance, and mean arterial pressure [F4349, L5930]. With central neural blockade these changes may be attributable to the block of autonomic fibers, a direct depressant effect of the local anesthetic agent on various components of the cardiovascular system, and/or the beta-adrenergic receptor stimulating action of epinephrine when present [F4349, L5930]. The net effect is normally a modest hypotension when the recommended dosages are not exceeded [F4349, L5930].



In particular, such cardiac effects are likely associated with the principal effect that lidocaine elicits when it binds and blocks sodium channels, inhibiting the ionic fluxes required for the initiation and conduction of electrical action potential impulses necessary to facilitate muscle contraction [F4349, L5930, L5948]. Subsequently, in cardiac myocytes, lidocaine can potentially block or otherwise slow the rise of cardiac action potentials and their associated cardiac myocyte contractions, resulting in possible effects like hypotension, bradycardia, myocardial depression, cardiac arrhythmias, and perhaps cardiac arrest or circulatory collapse [F4349, L5930, L5948].



Moreover, lidocaine possesses a dissociation constant (pKa) of 7.7 and is considered a weak base [L5948]. As a result, about 25% of lidocaine molecules will be un-ionized and available at the physiological pH of 7.4 to translocate inside nerve cells, which means lidocaine elicits an onset of action more rapidly than other local anesthetics that have higher pKa values [L5948]. This rapid onset of action is demonstrated in about one minute following intravenous injection and fifteen minutes following intramuscular injection [L5930]. The administered lidocaine subsequently spreads rapidly through the surrounding tissues and the anesthetic effect lasts approximately ten to twenty minutes when given intravenously and about sixty to ninety minutes after intramuscular injection [L5930].



Nevertheless, it appears that the efficacy of lidocaine may be minimized in the presence of inflammation [L5948]. This effect could be due to acidosis decreasing the amount of un-ionized lidocaine molecules, a more rapid reduction in lidocaine concentration as a result of increased blood flow, or potentially also because of increased production of inflammatory mediators like peroxynitrite that elicit direct actions on sodium channels [L5948].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Alfacalcidol 2mcg/ml oral dps. 10 ml', 315, 'الفاكالسيدول 2مكجم/مل نقط بالفم 10 مل', '86', '65', 'Vitamin d', 'Vitamin d', NULL, 'Alfacalcidol', 'Al esraa pharmaceutical optima', 'Unknown', 'غير محدد', '2mcg', '1', 'فيتامين د', NULL, 'description : alfacalcidol is an active metabolite of vitamin d indication : prescribed for hypocalcaemia hypoparathyroidism hypophosphataemia renal osteodystrophy and osteomalacia. dosage : adult- po- the recommended starting dose is 1mcg/day. maintenanc', '6223004160035', 3888, '2023-11-19', NULL, 0, 'Alfacalcidol is indicated in adult patients with chronic renal failure for the management of hypocalcemia, secondary hyperparathyroidism, or osteodystrophy.[L33284]



Alfacalcidol is indicated in the management of nutritional and malabsorptive rickets and osteomalacia, vitamin D-dependent rickets and osteomalacia, and hypophosphataemic vitamin D resistant rickets and osteomalacia.[L33364,L33369]', 'In conditions like chronic renal failure, renal bone disease, hypoparathyroidism, and vitamin D dependent rickets, the kidneys'' capacity for 1α-hydroxylation is impaired, leading to reduced production of endogenous 1,25-dihydroxyvitamin D and aberrated mineral metabolism. As an active and potent analog of vitamin D, alfacalcidol works to restore the functions and activities of endogenous 1,25-dihydroxyvitamin D.[L33369]', 'Alfacalcidol works to increase serum levels of calcium by stimulating intestinal calcium absorption, reabsorption of calcium from bone, and possibly the renal reabsorption of calcium. It also modestly promotes intestinal phosphorus absorption.[L33284] In patients with renal failure, alfacalcidol increased intestinal calcium and phosphorus absorption in a dose-related manner. This increase in calcium and phosphorus levels occurs within three days following drug administration: this effect was reversed within three days of drug discontinuation. In patients with chronic renal failure, serum calcium levels were elevated while parathyroid hormone and alkaline phosphatase levels returned to normal levels within five days following alfacalcidol administration.[L33369] Since alfacalcidol suppresses parathyroid hormone, a reduction in parathyroid hormone levels is achieved more rapidly in patients on intermittent intravenous therapy, with significant reductions occurring within three months of therapy. In patients receiving daily oral therapy of alfacalcidol, the time it takes alfacalcidol to normalize plasma calcium levels may be up to several months, possibly reflecting calcium being utilized for bone mineralization.[L33284] In patients with nutritional osteomalacia, alfacalcidol increased calcium absorption with six hours of oral administration and the effects peaked at 24 hours.[L33369]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Orlismart 120mg 30 caps.', 24278, 'اورليسمارت 120مجم 30 كبسولة', '249', '166.5', 'Weight loss', 'Weight loss', NULL, 'Orlistat', 'Pharopharma', 'Cap', 'كبسولة', '120mg', '3', NULL, NULL, NULL, '6221094000491', 1150, '2024-09-26', NULL, 0, 'Orlistat is indicated for obesity management including weight loss and weight maintenance when used in combination with calorie reduction in overweight and obese adults; this indication applies to both the prescription formulation of 120 mg[L11130] and the over-the-counter formulation of 60 mg.[L31963] Orlistat in the 120 mg prescription formulation is also indicated to reduce the risk of weight regain following weight loss.[L11130]', 'Orlistat is a potent and selective inhibitor of various lipase enzymes responsible for the metabolism of fat. It acts in the gastrointestinal (GI) tract via covalent binding to the serine residues located on the active site of both gastric and pancreatic lipase. When orlistat is taken with food containing fat, it partially inhibits the hydrolysis of triglycerides. This decreases absorption of monoaclglycerides and free fatty acids, contributing to weight maintenance and weight loss.[A37653,L11130]', 'Orlistat helps with weight reduction and maintenance by inhibiting the absorption of dietary fats via the inhibition of lipase enzymes.[A1734,A1735]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sylina 5 gm 10 sachets', 1063, 'سيلينا 5 جم 10 اكياس', '100', NULL, 'Food supplement source of fiber', 'Food supplement source of fiber', NULL, 'Psyllium husk+chromium picolinate+vitamin c+pineapple powder', 'Mb pharma', 'Sachet', 'أكياس', '5 gm', '1', NULL, NULL, NULL, NULL, 1223, '2022-12-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hero baby nutradefense plus 1 milk 400 gm', 20422, 'هيرو بيبي نيوتراديفينس بلس 1 لبن اطفال 400 جرام', '349', '339', 'Milk products.first stage (age 0-6 months)', 'Milk products.first stage (age 0-6 months)', NULL, 'Milk formula stage 1', 'Hero > hero mea trading', 'Unknown', 'غير محدد', '400 gm', '1', NULL, NULL, 'not to replace mother s milk. for infants from birth to 6 months age. to be used within one month from opening. hero baby nutradefense contains unique combination of three nutrients naturally present in motherï-s milk which have an important role in promo', '8410175080141', 1887, '2025-09-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Valsatens plus 160/25mg 30 f.c. tab.', 28945, 'فالساتينس بلس 160/25مجم 30 اقراص', '156', '118.5', 'Antihypertensive. combined angiotensin blocker with diuretic', 'Antihypertensive. combined angiotensin blocker with diuretic', NULL, 'Hydrochlorothiazide+valsartan', 'Amoun', 'Tab', 'أقراص', '25mg', '3', NULL, NULL, 'about hydrochlorothiazide thiazide derivatibve diuretic. mechanism of action of hydrochlorothiazide it is thiazide diuretic which exerts its action by acting at site-3(central dilating segment of early distal tubule). it binds to na+cl- symporter and inhi', '6221025032676', 1164, '2025-11-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Schizofy 30mg 10 f.c. tab.', 26610, 'شيزوفاي 30مجم 10 اقراص', '106', '81', 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Aripiprazole', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '30mg', '1', NULL, NULL, 'about aripiprazole second-generation atypical antipsychotic dopamine-serotonin stabilizer. mechanism of action of aripiprazole the mechanism of action of aripiprazole in the treatment of schizophrenia and bipolar disorder is unknown. the proposed mechanis', '6224007308424', 1120, '2025-02-03', NULL, 0, 'Aripiprazole is indicated for the treatment of acute manic and mixed episodes associated with bipolar I disorder, irritability associated with autism spectrum disorder, schizophrenia, and Tourette''s disorder.[L45859] It is also used as an adjunctive treatment of major depressive disorder.[L45859 An injectable formulation of aripiprazole is indicated for agitation associated with schizophrenia or bipolar mania.[L45859] Finally, an extended-release, bimonthly injection formulation of aripiprazole is indicated for the treatment of adult schizophrenia and maintenance therapy for adult bipolar I disorder.[L46203]', 'The antipsychotic action of aripiprazole is likely due to its partial agonist activity on D2 and 5-HT<sub>1A</sub> receptors as well as its antagonist activity at 5-HT<sub>2A</sub> receptors; however, the exact mechanism has not been fully elucidated.[A4393,L45859,L4620] One of the mechanisms that have been proposed is that aripiprazole both stimulates and inhibits dopamine as it engages the D2 receptor. It lowers dopamine neuronal firing at high dopamine concentrations and increases dopamine firing at low concentrations. Its partial agonist activity gives aripiprazole an intermediate level of dopaminergic neuronal tone between full agonist and antagonist of the D2 receptor.[A258699] In addition, some adverse effects may be due to action on other receptors.[L4620] For example, orthostatic hypotension may be explained by antagonism of the adrenergic alpha-1 receptors.[L4620,A4393]', 'Aripiprazole exhibits high affinity for dopamine D<sub>2</sub> and D<sub>3</sub>, serotonin 5-HT<sub>1a</sub> and 5-HT<sub>2a</sub> receptors (Ki values of 0.34 nM, 0.8 nM, 1.7 nM, and 3.4 nM, respectively), moderate affinity for dopamine D<sub>4</sub>, serotonin 5-HT<sub>2c</sub> and 5-HT<sub>7</sub>, alpha<sub>1</sub>-adrenergic and histamine H<sub>1</sub> receptors (Ki values of 44 nM, 15 nM, 39 nM, 57 nM, and 61 nM, respectively), and moderate affinity for the serotonin reuptake site (Ki=98 nM). Aripiprazole has no appreciable affinity for cholinergic muscarinic receptors (IC<sub>50</sub>>1000 nM).[L45859]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Andofuryl 100 mg 30 caps.', 14122, 'اندوفوريل 100 مجم 30 كبسولة', '35', NULL, 'Anti-ischemic', 'Anti-ischemic', NULL, 'Naftidrofuryl', 'Andalous pharma', 'Cap', 'كبسولة', '100 mg', '3', 'موسع للاوعية الدموية الطرفية لذلك يستخدم فى علاج العديد من الامراض الطرفية مثل تشنجات في الساقين ليلا و شحوب وازرقاق أصابع اليدين أو القدمين والتي تزداد سوء في البرد.و القروح المفتوحة على الساقين أو القدمين• ضعف الدورة الدموية في مرض السكري (اعتلال الشرايين السكري)', NULL, 'naftidrofuryl oxalate works in two main ways. firstly it causes the blood vessels to widen. secondly it increases the ability of cells to remove waste products. in peripheral vascular diseases the blood vessels in the extremities are narrowed and the bloo', NULL, 1889, '2022-07-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Thiotacid 600 original 30 tab.', 11375, 'ثيوتاسيد 600 اوريجينال 30 قرص', '245', '230', 'Antioxidant', 'Antioxidant', NULL, 'Thioctic acid(alpha lipoic acid)', 'Eva pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, '6223007357302', 4995, '2025-06-04', NULL, 0, 'Investigated for use/treatment in diabetes mellitus type 2, neuropathy (diabetic), and vascular diseases.', NULL, NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vitagreen-s 12 caps.', 12429, 'فيتاجرين-اس 12 كبسولة', '25', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Folic acid+vitamin e+ yeast+vitamin c+vitamin a+lemon bioflavonoids+wheat germ oil', 'Safe pharma > atos pharma', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, 'vitagreen-s is a specially prepared natural formula which ensures good absorption and tissue bioavailability of all vitamins. vitagreen-s contains high antioxidant elements (vitamin e a & c) which help prevent premature senility symptoms resulting from po', '6223000470862', 735, '2022-12-14', NULL, 0, 'Folic acid is indicated for the treatment of folic acid deficiency, megaloblastic anemia, and in anemias of nutritional origins, pregnancy, infancy, or childhood.', 'Folic acid, as it is biochemically inactive, is converted to tetrahydrofolic acid and methyltetrahydrofolate by dihydrofolate reductase (DHFR). These folic acid congeners are transported across cells by receptor-mediated endocytosis where they are needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate. Using vitamin B12 as a cofactor, folic acid can normalize high homocysteine levels by remethylation of homocysteine to methionine via methionine synthetase.', 'Folic acid is a water-soluble B-complex vitamin found in foods such as liver, kidney, yeast, and leafy, green vegetables. Also known as folate or Vitamin B9, folic acid is an essential cofactor for enzymes involved in DNA and RNA synthesis. More specifically, folic acid is required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. Folic acid is the precursor of tetrahydrofolic acid, which is involved as a cofactor for transformylation reactions in the biosynthesis of purines and thymidylates of nucleic acids. Impairment of thymidylate synthesis in patients with folic acid deficiency is thought to account for the defective deoxyribonucleic acid (DNA) synthesis that leads to megaloblast formation and megaloblastic and macrocytic anemias. Folic acid is particularly important during phases of rapid cell division, such as infancy, pregnancy, and erythropoiesis, and plays a protective factor in the development of cancer. As humans are unable to synthesize folic acid endogenously, diet and supplementation is necessary to prevent deficiencies. In order to function properly within the body, folic acid must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted by anti-metabolite therapies such as [DB00563] as they function as DHFR inhibitors to prevent DNA synthesis in rapidly dividing cells, and therefore prevent the formation of DHF and THF. 



In general, folate serum levels below 5 ng/mL indicate folate deficiency, and levels below 2 ng/mL usually result in megaloblastic anemia.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vitalita shampoo 125 ml', 29480, 'فيتاليتا شامبو 125 مل', '70', NULL, 'Hair care', 'Hair care', NULL, 'Caffeine+saw palmetto+rosemary', '> vitalita', 'Amp', 'أمبول', '125 ml', '1', NULL, NULL, NULL, NULL, 1001, '2022-07-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Spleet whitening cream 40 gm', 33674, 'سبليت كريم تفتيح 40 جم', '100', '80', 'Skin care', 'Skin care', NULL, 'Kojic acid + licorice + alpha arbutin + vit(c + a + e)', 'Interpharma egycare', 'Cream', 'كريم', '40 gm', '1', NULL, NULL, 'lighten hydrates skin rejuevnation', NULL, 512, '2024-04-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zolapar 0.25mg 10 tab.', 30001, 'زولابار 0.25مجم 10 اقراص', '5', NULL, 'Psychiatric.anxiolytics-hypnotics', 'Psychiatric.anxiolytics-hypnotics', NULL, 'Alprazolam', 'Delta pharma', 'Tab', 'أقراص', '0.25mg', '1', NULL, NULL, NULL, NULL, 741, '2022-07-15', NULL, 0, 'Alprazolam is indicated for the acute treatment of generalized anxiety disorder in adults.[L34783] Alprazolam is also indicated, either as a standard or extended-release formulation, for the treatment of panic disorder with or without agoraphobia in adults.[L34783, L34788]



Alprazolam may also be prescribed off-label for insomnia, premenstrual syndrome, and depression.[A177973]', 'Neurotransmission relies on excitatory and inhibitory signalling. γ-aminobutyric acid (GABA) type-A receptors (GABA<sub>A</sub>Rs) are members of the pentameric ligand-gated ion channel (PLGIC) superfamily located synaptically and perisynaptically to mediate phasic inhibition and extrasynaptically to mediate tonic inhibition. GABA<sub>A</sub>Rs comprise a variety of subunits from a homologous family whose members are named based on sequence identity as one of α1-6, β1-3, γ1-3, δ, ε, θ, π, and ρ1-3. Each subunit possesses an extracellular (ECD), transmembrane (TMD), and intracellular (ICD) domain; inter-subunit interfaces are the primary points of neurotransmitter and modulator binding, described by coordination of the principal (+) and complementary (-) sites in each subunit. Binding of GABA to GABA<sub>A</sub>Rs induces pore opening, rapid flow of chloride ions, and synaptic hyperpolarization, which in turn manifests as an inhibitory signal.[A236793, A236798]



The most prevalent GABA<sub>A</sub>Rs _in vivo_ are the α1β2γ2 receptors, which contain both GABA (β+/α-) and benzodiazepine (BZD, α+/γ-) binding sites in the intersubunit interfaces of the relevant subunits.[A236793, A236798, A236828] In general, any receptors containing an α<sub>x</sub>/γ<sub>z</sub> interface, where x = 1-3,5 and z = 1-3, have potential high-affinity BZD binding sites, although small sequence differences between subunits may alter binding affinity to individual molecules. The α4 and α6 subunits, in which an otherwise conserved histidine is replaced by arginine, do not bind traditional BZD ligands such as diazepam and hence are considered "diazepam-insensitive".[A236793, A236798, A236828] GABA binding results in a series of conformational changes in the ECDs of GABA<sub>A</sub>R β subunits, "locking" each to its neighbouring α- interface. The binding of alprazolam in the high-affinity BZD site stabilizes the α+/γ- interface and facilitates the conformational changes that lead to pore opening, hence functioning as a positive allosteric modulator.[A236833]



The exact manner in which GABA<sub>A</sub>R allosteric modulation mediates the therapeutic and unwanted effects of benzodiazepines remains unclear.[A177973, A18125] Earlier studies suggested that the primary factor was the α subunit composition, with α1-containing receptors mediating the sedative effects, α2/3-containing receptors the anxiolytic effects, and α5-containing receptors the memory effects of benzodiazepines.[A236838] More recent studies suggest a more complex set of factors including subunit composition, physiological location, neuronal circuit, and nerve cell type.[A236843] To further complicate matters, there may be up to five distinct BZD binding sites on GABA<sub>A</sub>Rs, with site 1 corresponding to the classical high-affinity α+/γ- interface. The effects of binding at sites 2-4 are not fully understood and likely impart greater complexity to benzodiazepine pharmacological action.[A236798, A236828]', 'Alprazolam is a benzodiazepine that binds γ-aminobutyric acid (GABA) type-A receptors (GABA<sub>A</sub>Rs) to enhance their inhibitory effect on neurotransmission, specifically in the brain.[L34783, L34788] Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death; patients taking benzodiazepines and opioids concurrently may require lower doses of one or both medications, depending on their clinical situation. Patients with pre-existing impaired respiratory function are at increased risk of adverse effects including death during treatment with benzodiazepines. In addition, due to its CNS depressant effects, patients taking alprazolam should avoid operating heavy machinery or driving and should avoid other CNS depressants such as alcohol. As with other benzodiazepines, alprazolam carries a risk of abuse, misuse, and addiction, which is higher in predisposed individuals and may require strict monitoring. Cessation of therapy may result in acute or protracted withdrawal symptoms, which may be life-threatening; the patient dose should be gradually tapered whenever discontinuation or reduced dosage are necessary. Newborns born to mothers using alprazolam later in pregnancy may suffer from sedation and withdrawal symptoms. As CYP3A is required for the initial step in alprazolam metabolism, alprazolam is contraindicated in patients taking strong CYP3A inhibitors, such as ketoconazole and itraconazole; milder CYP3A inhibitors still necessitate alprazolam dosage adjustments. Lastly, benzodiazepines may have negative effects, such as panic disorders, increased suicide incidence, and episodes of mania/hypomania, in patients suffering from depression.[A18125, A236788, L34783, L34788]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zetacort cream 15 gm', 29900, 'زيتاكورت كريم 15جم', '26', '16.5', 'Antibiotic with glucocorticoid', 'Antibiotic with glucocorticoid', NULL, 'Betamethasone+fucidic acid', 'Tabuk pharmaceutical manufacturing company > al ansar for marketing', 'Cream', 'كريم', '15 gm', '1', NULL, NULL, 'description betamethasone is a type of medicine called a topical corticosteroid. corticosteroids are medicines used for reducing inflammation. skin inflammation in eczema occurs due to the irritation of the skin and is caused by the release of various sub', '6223004710254', 1238, '2024-04-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Arromaprazan 20 mg tabs', 7353, 'ارومابرازان 20مجم اقراص', '138', NULL, 'Peptic ulcer.potassium-competitive acid blocker', 'Peptic ulcer.potassium-competitive acid blocker', NULL, 'Vonoprazan', 'Ep pharma', 'Tab', 'أقراص', '20 mg', '2', NULL, NULL, NULL, NULL, 1253, '2025-09-10', NULL, 0, 'Vonoprazan is indicated for the following conditions: 



- for healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults.[L51224]

- to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults.[L51224]

- for the relief of heartburn associated with non-erosive gastroesophageal reflux disease in adults.[L51224]

- in combination with [amoxicillin] and [clarithromycin] for the treatment of Helicobacter pylori (_H. pylori_) infection in adults.[L41695, L51224]

- in combination with amoxicillin for the treatment of H. pylori infection in adults.[L51224]', 'Vonoprazan is a potassium-competitive acid blocker (PCAB) that inhibits the H<sup>+</sup>, K<sup>+</sup>-ATPase enzyme system in a potassium-competitive manner. Through this mechanism, vonoprazan suppresses basal and stimulated gastric acid secretion at the secretory surface of gastric parietal cells.[L41695] 



Although both classes of drugs inhibit the H<sup>+</sup>, K<sup>+</sup>-ATPase, the mechanism of action of PCABs differs from that of proton-pump inhibitors (PPIs). PPIs form a covalent disulphide bond with a cysteine residue on the H<sup>+</sup>, K<sup>+</sup>-ATPase, which leads to the inactivation of the enzyme, while PCABs interfere with the binding of K<sup>+</sup> to the H<sup>+</sup>, K<sup>+</sup>-ATPase.[A253702]', 'The use of vonoprazan leads to an increase in intragastric pH. The inhibitory effect of vonoprazan on acid secretion increases with repeated daily dosing. Although the antisecretory effect of vonoprazan decreases after drug discontinuation, intragastric pH remains elevated for 24 to 48 hours. Vonoprazan does not have a clinically significant effect on QT prolongation.[L41695] 



Compared to other potassium-competitive acid blockers (PCABs), vonoprazan has a higher point-positive charge (pKa of 9.06). This allows vonoprazan to accumulate at higher concentrations in the canalicular space of the gastric parietal cells, where it binds H<sup>+</sup>, K<sup>+</sup>-ATPase in a  K<sup>+</sup>-competitive and reversible manner. Compared to other PCABs, such as SCH28080, or proton-pump inhibitors, such as lansoprazole, vonoprazan has a more potent H<sup>+</sup>, K<sup>+</sup>-ATPase inhibitory activity.[A253702]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Badotirizin 5mg/5ml syrup 125ml', 32489, 'بادوتيرزين 5 مجم /5 مل شراب 125 مل', '18', '11', 'Anti-histamine.anti-allergy', 'Anti-histamine.anti-allergy', NULL, 'Cetirizine', 'Badr pharma', 'Syrup', 'شراب', '5mg', '1', 'مضاد للحساسية والحكة وفعال فى التخلص من أعراض البرد والحساسية، مثل العطس، وسيلان الأنف، والحكة في العيون، أو الأنف، أو الحلق،', NULL, 'about cetirizine second generation h1 antagonist metabolite of hydroxyzine antihistamine. mechanism of action of cetirizine this drug is a selective peripheral h1 receptor antagonist. thus it inhibits the allergic symptoms produced by histamines like cold', NULL, 830, '2023-09-30', NULL, 0, '**Seasonal Allergic Rhinitis**: Indicated for the relief of symptoms associated with seasonal allergic rhinitis caused by allergens such as ragweed, grass and tree pollens in adults and children 2 years of age and above. Symptoms treated effectively include sneezing, rhinorrhea, nasal pruritus, ocular pruritus, tearing, and redness of the eyes [FDA label]. 



**Perennial allergic rhinitis**: This drug is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens including dust mites, animal dander, and molds in adults and children 6 months of age and older. Symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing [FDA label]. 



**Chronic urticaria**: Cetirizine is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older. It markedly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus [FDA label].', 'Cetirizine, a metabolite of _hydroxyzine_, is an antihistamine drug.  Its main effects are achieved through selective inhibition of peripheral H1 receptors. The antihistamine activity of cetirizine has been shown in a variety of animal and human models. _In vivo_ and _ex vivo_ animal models have shown insignificant anticholinergic and antiserotonergic effects. In clinical studies, however, dry mouth was found to be more frequent with cetirizine than with a placebo. In vitro receptor binding studies have demonstrated no detectable affinity of cetirizine for histamine receptors  other than the H1 receptors. Studies with radiolabeled cetirizine administration in the rat have demonstrated insignificant penetration into the brain. _Ex vivo_ studies in the mouse have shown that systemically administered cetirizine does not occupy cerebral H1 receptors significantly [FDA label].', '**General effects and respiratory effects**



Cetirizine, the active metabolite of the piperazine H<sub>1</sub>-receptor antagonist hydroxyzine, minimizes or eliminates the symptoms of chronic idiopathic urticaria, perennial allergic rhinitis, seasonal allergic rhinitis, allergic asthma, physical urticaria, and atopic dermatitis.

The clinical efficacy of cetirizine for allergic respiratory diseases has been well established in numerous trials [FDA label]. 



**Effects on urticaria/anti-inflammatory effects**



It has anti-inflammatory properties that may play a role in asthma management [A175051]. There is evidence that cetirizine improves symptoms of urticaria. Marked clinical inhibition of a wheal and flare response occurs in infants, children as well as adults within 20 minutes of one oral dose and lasts for 24 h [A175051].  Concomitant use of cetirizine reduces the duration and dose of topical anti-inflammatory formulas used for the treatment of atopic dermatitis [A175051]. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dekadel 200mg 20 f.c.tab.', 17189, 'ديكاديل 200 مجم 20 قرص', '13', NULL, 'Anti-epileptic.fatty acid', 'Anti-epileptic.fatty acid', NULL, 'Sodium valproate', 'Delta pharma', 'Tab', 'أقراص', '200mg', '1', NULL, NULL, 'about sodium valproate histone deacetylase inhibitor gaba agent anticonvulsant antimanic migraine prophylaxis. mechanism of action of sodium valproate sodium valproate is the sodium salt of valproic acid.after oral administration it is quiickly converted', '6221163015739', 928, '2022-07-22', NULL, 0, 'For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.', 'Sodium tetradecyl sulfate is a potent toxin for endothelial cells in that brief exposure to even low concentrations are effective in stripping endothelium over a considerable distance and exposing highly thrombogenic endothelium in the process. Diluted sodium tetradecyl sulfate is also able to induce a hypercoagulable state, possibly by selective inhibition of protein C, and can also promote platelet aggregation.', 'Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Move-free advanced 140 tab', 8365, 'موف-فري ادفانسد 140 قرص', '300', NULL, NULL, NULL, NULL, 'Glucosamine+chondrotoin', 'Reckitt benckiser group plc (slough, england) > schiff nutrition international (salt lake city, ut)', 'Tab', 'أقراص', NULL, '14', NULL, NULL, NULL, NULL, 1097, '2022-08-10', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Protam 10mg/ml (10ml) i.v.vial', 25404, 'بروتام 10مجم/مل 10 مل فيال', '38', '25.5', 'Heparin antidote', 'Heparin antidote', NULL, 'Protamine sulphate', 'Eipico', 'Vial', 'فيال', '10mg', '1', NULL, NULL, 'about protamine sulphate a highly cationic peptide heparin antagonist heparin antidote antihaemorrhagic. mechanism of action of protamine sulphate it is a basic protein obtained from sperm of a fish and acts as a heparin antagonist. it neutralizes heparin', NULL, 764, '2024-11-10', NULL, 0, 'Protamine sulfate is indicated for counteracting or reversing the anticoagulant effect of heparin as necessary [F3559, F3562, L5371, L5443]. Such reversal may, for example, be required often before surgery; after renal hemodialysis; post open heart surgery; whenever excessive bleeding results from heparin use; and/or for the treatment of heparin overdosage, among other similar or related circumstances [F3559, F3562, L5371, L5443].', 'It is generally understood that, when administered as an antidote to heparin, protamine sulfate is a fairly strong basic protein that subsequently binds with strongly acidic heparin to produce a stable and inactive complex (salt) [F3559, F3562, L5371, L5443]. This inactive complex between protamine sulfate and heparin neutralizes the anticoagulant effect of both solitary protamine and heparin [F3559, F3562, L5371, L5443]. In this way, protamine sulfate is used as an effective antidote to reverse the activity of heparin, and is useful for treating hemorrhage as a result of severe heparin or low-molecular weight heparin overdosage [F3559, F3562, L5371, L5443]. Moreover, protamine sulfate is also frequently used in the same manner to neutralize the effect of heparin given before surgery and during extracorporeal circulation procedures like those performed in hemodialysis or cardiac surgery [F3559, F3562, L5371, L5443]. ', 'When not complexed with heparin, protamine sulfate by itself demonstrates a weak anticoagulant effect and also evidently prolongs the euglycaemic phase of the human body when used as an excipient in certain injectable insulin formulations [F3562]. Furthermore, some animal studies have suggested that the long-term oral administration of protamine sulfate may favourably decrease serum lipid concentrations, presumably by enhancing the actions of the carnitine palmitoyltransferase-2 and acyl-CoA oxidase enzymes [F3562]. Related studies have also shown that protamine sulfate may be able to decrease intestinal fat absorption and might possess certain antibacterial effects [F3562].



Additionally, studies have also determined that protamine sulfate elicits effects on the clotting factors human factor Xa and human antithrombin (AT) [F3562]. In particular, it has been shown that protamine sulfate is capable of transforming and degrading factor Xa to inactive moieties, transforming Xa-AT complexes, promoting the digestive degradation of primary Xa-AT complexes to tertiary complexes, and ultimately promotes a reduction in total complex formulation via the hydrolysis of factor Xa moieties [F3562].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ciprofloxacin 200mg/100ml vial', 16383, 'سيبروفلوكساسين 200 مجم / 100 مل فيال', '31', '20.4', 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Ciprofloxacin', 'Amriya', 'Vial', 'فيال', '200mg', '1', NULL, NULL, 'about ciprofloxacin it is a broad spectrum fluoroquinolone with activity against pseudomonas aeruginosa. indications for ciprofloxacin 1.urinary tract infection 2.respiratory tract infection 3.bone and joint infections 4.infectious diarrhoea 5.gonorrhoea', '6221075070017', 2453, '2024-03-19', NULL, 0, 'Ciprofloxacin is only indicated in infections caused by susceptible bacteria.[L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493]



Ciprofloxacin immediate release tablets, oral suspensions, and intravenous injections are indicated for the treatment of skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections, nosocomial pneumonia, febrile neutropenia, adults who have inhaled anthrax, plague, chronic bacterial prostatitis, lower respiratory tract infections including acute exacerbations of chronic bronchitis, urinary tract infections, complicated urinary tract infections in pediatrics, complicated pyelonephritis in pediatrics, and acute sinusitis.[L6481,L6478]



A ciprofloxacin otic solution and otic suspension with hydrocortisone are indicated for acute otitis externa.[L6469,L6484] Ciprofloxacin suspension with dexamethasone is indicated for acute otitis media in pediatric patients with tympanostomy tubes or acute otitis externa.[L6490] A ciprofloxacin intratympanic injection is indicated for pediatric patients with bilateral otitis media with effusion who are having tympanostomy tubes placed or pediatric patients 6 months or older with acute otitis externa.[L6493]



A ciprofloxacin eye drop is indicated for bacterial corneal ulcers and conjunctivitis.[L6472] A ciprofloxacin eye ointment is indicated for bacterial conjunctivitis.[L6475]



A ciprofloxacin extended release tablet is indicated for uncomplicated urinary tract infections, complicated urinary tract infections, and acute uncomplicated pyelonephritis.[L6487]', 'Ciprofloxacin acts on bacterial topoisomerase II (DNA gyrase) and topoisomerase IV.[A178885] Ciprofloxacin''s targeting of the alpha subunits of DNA gyrase prevents it from supercoiling the bacterial DNA which prevents DNA replication.[A178876,A178882]', 'Ciprofloxacin is a second generation fluoroquinolone that is active against many Gram negative and Gram positive bacteria.[A178870,L6469,L6472,L6475,L6478,L6481,L6484,L6487,L6490,L6493] It produces its action through inhibition of bacterial DNA gyrase and topoisomerase IV.[A178885] Ciprofloxacin binds to bacterial DNA gyrase with 100 times the affinity of mammalian DNA gyrase.[A178894] There is no cross resistance between fluoroquinolones and other classes of antibiotics, so it may be of clinical value when other antibiotics are no longer effective.[A178894] Ciprofloxain and its derivatives are also being investigated for its action against malaria, cancers, and AIDS.[A178885]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cedem c 1000 mg 20 eff. tabs.', 7532, 'سيدم سي 1000مجم 20 قرص فوار', '98', NULL, 'Vitamin c', 'Vitamin c', NULL, 'Vitamin c', 'Rotabiogen', 'Tab', 'أقراص', '1000 mg', '2', 'علاج الحساسية -- علاج الحساسية الموسمية', NULL, NULL, NULL, 962, '2024-05-15', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mepadrin 250mg/5ml granules for 60ml susp.', 22568, 'ميبادرين 250مجم/5مل حبيبات لعمل معلق 60 مل', '10', NULL, 'Antibiotic.cephalosporin.first-generation', 'Antibiotic.cephalosporin.first-generation', NULL, 'Cephradine', 'Chemipharm', 'Susp', 'معلق', '250mg', '1', NULL, NULL, 'description a semi-synthetic cephalosporin antibiotic. mechanism of action cefradine is a first generation cephalosporin antibiotic with a spectrum of activity similar to cefalexin. cefradine like the penicillins is a beta-lactam antibiotic. by binding to', NULL, 669, '2022-07-23', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Neodine 10% antiseptic soln. 50 ml', 30972, 'نيودين 10%مطهر 50 مل', '38', '28', 'Antiseptic', 'Antiseptic', NULL, 'Povidone- iodine', 'Weiser', 'Sol', 'محلول', '10%', '1', NULL, NULL, 'about povidone iodine iodine preparation external broad microbicidal spectrum antiseptic. mechanism of action of povidone iodine povidone iodine is an iodophore antiseptic and is a microbicidal drug. it releases iodine from its complex and produces pharma', NULL, 1034, '2025-08-12', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dicynone 250mg 20 tab.', 3641, 'دايسينون 250مجم 20 قرص', '24', NULL, 'Systemic haemostatic', 'Systemic haemostatic', NULL, 'Ethamsylate', 'Memphis > om pharma', 'Tab', 'أقراص', '250mg', '2', NULL, NULL, NULL, '6221050030463', 1164, '2022-12-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sodium chloride 0.9% (mottahedoon) i.v. inf. 500 ml (rubber cap)', 8792, 'صوديوم كلوريد 0.9% محلول وريدي 500 مل (غطاء مطاطي)', '26', NULL, 'Sterile solution', 'Sterile solution', NULL, 'Sodium chloride', 'Al mottahedoon pharma', 'Cap', 'كبسولة', '0.9%', '1', NULL, NULL, NULL, NULL, 979, '2023-04-27', NULL, 0, 'This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives. ', 'Sodium and chloride — major electrolytes of the fluid compartment outside of cells (i.e., extracellular) — work together to control extracellular volume and blood pressure. Disturbances in sodium concentrations in the extracellular fluid are associated with disorders of water balance.', 'Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid.

Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Augmentin adults 1gm/125mg 12 pwd. oral susp. sachets', 14632, 'اوجمنتين 1125مجم 1جم/125مجم 12 كيس لعمل معلق شرب كبار', '169', '118', 'Penicillins.penicillin with b-lactamase inhibitor.antibiotic', 'Penicillins.penicillin with b-lactamase inhibitor.antibiotic', NULL, 'Amoxicillin+clavulanic acid', 'Mup > smithkline beecham', 'Susp', 'معلق', '1gm', '12', 'مضاد حيوي', NULL, 'amoxicillin is an analog of ampicillin derived from the basic penicillin nucleus 6-aminopenicillanic acid clavulanic acid is produced by the fermentation of streptomyces clavuligerus. it is a beta-lactam structurally related to the penicillins and possess', NULL, 1108, '2025-05-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Limitless c-zinc original 30 lozenges', 968, 'ليميتلس سي-زنك الاصلي 30 قطعة', '76', '63', 'Immune enhancer', 'Immune enhancer', NULL, 'Vitamin c+zinc gluconate', 'Eva pharma', 'Lozenges', 'استحلاب', NULL, '3', 'يحتوي على فيتامين سي وعنصر الزنك.', NULL, '100 mg vitamin c + 5 mg zinc ï- supports a healthy immune system for all family. dose: for adults & children from 6 years old : 2 lozenges daily.', '6223007352444', 5162, '2024-03-11', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zone cream 50 gm', 30022, 'زون كريم 50جم', '60', NULL, 'Whitening topical', 'Whitening topical', NULL, 'Stearic acid+ascorbic acid+chamomile extract+propylene glycol', 'Egyptian company for cosmetics', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, 'whitening cream', NULL, 820, '2022-07-13', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Epojet 4000 i.u./0.4ml prefilled syringe', 4313, 'ايبوجيت 4000وحدة دولية/0.4مل سرنجة معبأة للحقن', '115', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', NULL, 'Erythropoietin-alpha', 'Vacsera > multipharma', 'Syringe', 'حقنة', '0.4ml', '1', NULL, NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', NULL, 939, '2022-08-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sominal 60mg 10 tab.', 27286, 'سومينال 60مجم 10 قرص', '3', NULL, 'Anti-epileptic.barbiturates', 'Anti-epileptic.barbiturates', NULL, 'Phenobarbitone', 'Alexandria', 'Tab', 'أقراص', '60mg', '1', NULL, NULL, NULL, NULL, 1345, '2022-07-07', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ivywonder acne gel 30gm', 33021, 'ايفي وندر جل لحب الشباب 30 جم', '95', '85', 'Skin care.acne', 'Skin care.acne', NULL, 'Benzoyl broxide+salicylic acid+glycolic acid', 'Elnile > wonder pharma', 'Gel', 'جل', '30gm', '1', NULL, NULL, 'topical acne gel', NULL, 1524, '2025-10-23', NULL, 0, 'Benzoyl peroxide is formulated with antibiotics such as [erythromycin][L33264] and [clindamycin][L33269] for the treatment of acne vulgaris. Benzoyl peroxide is formulated as a number of topical products for the treatment of acne.[L33249, L33299] Benzoyl peroxide is also indicated in combination with [tretinoin] for the treatment of acne vulgaris in patients aged nine years and older.[L34869] A triple-combination therapy including both clindamycin and [adapalene] is also available and indicated for the treatment of acne vulgaris in patients ≥12 years of age.[L41613]



Topical benzoyl peroxide is also indicated for the treatment of inflammatory lesions of rosacea in adults.[L41613]', 'Acne vulgaris is caused by inflammation in the pilosebaceous gland.[A234064] Acne is generally caused by increased excretion of sebum from pilosebaceous glands, endocrine factors such as androgenic hormones, keratin developing around follicles, bacterial growth, and inflammation.[A234064] These factors contribute to the formation of comedones (whiteheads and blackheads).[A234064]



The peroxide bond of benzoyl peroxide is cleaved to form 2 benzoyloxy radicals.[A18903] These radicals interact nonspecifically with bacterial proteins, interfering with their function, and survival of the bacteria.[A233859] Over time, free radical interactions with bacterial proteins lead to decreased keratin and sebum around follicles.[A234059,A234064]



Benzoyl peroxide can also increase the turnover rate of epithelial cells, leading to skin peeling, and breaking down comedones.[A234069]', 'Benzoyl peroxide is a topical treatment for acne that generates free radicals to break down comedones and increase the rate of epithelial cell turnover.[A18903,A234059,A234064,A234069,L33264,L33269,L33299,L33314] It has a short duration of action as its active free radical metabolites quickly react to form inactive metabolites.[A18903] The therapeutic index is wide, as overdoses are rare, however patients may still experience skin peeling.[L33264,L33269,L33299,L33314] Patients should be counselled regarding increased risks of skin irritation, dryness, and sunburn.[L33264,L33269,L33299,L33314]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Thrombo 75mg 30 f.c.tab', 11390, 'ثرومبو 75مجم 30 قرص', '123', NULL, 'Antiplatelet.adp receptor blocker', 'Antiplatelet.adp receptor blocker', NULL, 'Clopidogrel', 'Eipico', 'Tab', 'أقراص', '75mg', '3', NULL, NULL, NULL, '6221032241191', 2002, '2022-12-13', NULL, 0, 'Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213]', 'Clopidogrel is activated via a 2 steps reaction to an active thiol-containing metabolite.[A180508] This active form is a platelet inhibitor that irreversibly binds to P2Y<sub>12</sub> ADP receptors on platelets.[L7213] This binding prevents ADP binding to P2Y<sub>12</sub> receptors, activation of the glycoprotein GPIIb/IIIa complex, and platelet aggregation.[L7213]', 'Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] It has a long duration of action as it is taken once daily and a large therapeutic window as it is given in doses of 75-300mg daily.[L7213]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Montekal 5mg 10 chew. tab.', 8315, 'مونتكال 5مجم 10 اقراص مضغ', '39', '30', 'Asthma.anti-inflammatory.leukotriene antagonist', 'Asthma.anti-inflammatory.leukotriene antagonist', NULL, 'Montelukast', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '5mg', '1', NULL, NULL, 'about montelukast leukotriene(cyslt1) receptor antagonist antiinflammatory antiasthma. mechanism of action of montelukast montelukast is competitively and selectively antagonizes cyslt1 receptor (leukotrienes receptor) mediated bronchoconstriction.montelu', '6221076010494', 1455, '2024-08-29', NULL, 0, 'Montelukast is indicated for:



(a) the prophylaxis and chronic treatment of asthma in adults and pediatric patients who are 12 months of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307] and also include indications for preventing day and night-time symptoms, and the treatment of acetylsalicylic acid-sensitive asthma[L6304];



(b) the prevention of exercise-induced bronchoconstriction (EIB) in patients who are 6 years of age and older[L6301], although other regional health authorities specifically note this indication for adults and adolescents who are 15 years and older[L6304,L6307]; and



(c) the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 6 months of age and older[L6301], although other regional health authorities specifically note the relief of seasonal allergic rhinitis symptoms for adults and adolescents who are 15 years and older[L6304,L6307].



Furthermore, some formulations like chewable montelukast tablets may also be specifically indicated by particular regulatory bodies for the prophylaxis and chronic treatment of asthma, including the prevention of day and night-time symptoms, the treatment of acetylsalicylic acid based asthma, and the prevention of exercise-induced bronchoconstriction in adult and pediatric patients aged 2 and older[L6328], between the ages 2 and 5[L6325], or between the ages of 6 and 14 years.[L6331]



Moreover, when employed for such indications montelukast is considered effective as monotherapy or when combined with other medications indicated for the maintenance treatment of chronic asthma.[L6304,L6328] For instance, montelukast and inhaled corticosteroids can be used concomitantly to demonstrate additive effects to control asthma or to decrease the necessary inhaled corticosteroid dose while still maintaining clinical stability.[L6304,L6328]



Additionally, in patients who continue to experience asthma symptoms, montelukast can also be combined with an ''as required'' short-acting beta-agonist, an inhaled corticosteroid, or inhaled corticosteroid paired with a long-acting beta-agonist.[L6304,L6328]', 'Cysteinyl leukotrienes (CysLT) like LTC4, LTD4, and LTE4, among others, are eicosanoids released by a variety of cells like mast cells and eosinophils.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] When such CysLT bind to corresponding CysLT receptors like CysLT type-1 receptors located on respiratory airway smooth muscle cells, airway macrophages, and on various pro-inflammatory cells like eosinophils and some specific myeloid stem cells activities that facilitate the pathophysiology of asthma and allergic rhinitis are stimulated.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, CysLT-mediated airway bronchoconstriction, occluding mucous secretion, vascular permeability, and eosinophil recruitment are all types of effects that facilitate asthma.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Alternatively, in allergic rhinitis, CysLTs are released by the nasal mucosa when exposed to allergens during both early and late phase reactions and participate in eliciting symptoms of allergic rhinitis like a congested nose and airway.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Subsequently, montelukast is a leukotriene receptor antagonist that binds with high affinity and selectivity to the CysLT type 1 receptor, which consequently assists in inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may facilitate asthma or allergic rhinitis.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'Montelukast is a leukotriene receptor antagonist that demonstrates a marked affinity and selectivity to the cysteinyl leukotriene receptor type-1 in preference to many other crucial airway receptors like the prostanoid, cholinergic, or beta-adrenergic receptors.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] As a consequence, the agent can elicit substantial blockage of LTD4 leukotriene-mediated bronchoconstriction with doses as low as 5 mg.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Moreover, a placebo-controlled, crossover study (n=12) demonstrated that montelukast is capable of inhibiting early and late phase bronchoconstriction caused by antigen challenge by 75% and 57% respectively.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



In particular, it has been documented that montelukast can cause bronchodilation as soon as within 2 hours of oral administration.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] This action can also be additive to the bronchodilation caused by the concomitant use of a beta agonist.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] Nevertheless, clinical investigations performed with adults 15 years of age and older revealed that no additional clinical benefit is obtained when doses of montelukast greater than 10 mg a day are used.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]



Additionally, in clinical trials with adults and pediatric asthmatic patients aged 6 to 14 years, it was also determined that montelukast can reduce mean peripheral blood eosinophils by about 13% to 15% from baseline in comparison to placebo during double-blind treatment periods.[L6301,L6304,L6307,L6310,L6325,L6328,L6331] At the same time, in patients aged 15 years and older who were experiencing seasonal allergic rhinitis, the use of montelukast caused a median reduction of 13% in peripheral blood eosinophil counts when compared to placebo as well.[L6301,L6304,L6307,L6310,L6325,L6328,L6331]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Kaminomoto nourishing rinse 200 ml', 21231, 'كامينوموتو غسول مغذي 200 مل', '319', NULL, 'Hair care', 'Hair care', NULL, NULL, 'Kabushiki kaisha kaminomoto hompo > multitrade', 'Unknown', 'غير محدد', '200 ml', '1', NULL, NULL, 'jojoba- oil and other selected ingredients keep hair and scalp healthy clean and beautiful. special keratin-active substances protect your hair and make it easy to manage. ideal before kaminomoto hair growth tonic or accelerator. ---directions for use: 1.', NULL, 542, '2022-08-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pea 400 mg 20 capsules', 3940, 'بي اي ايه 400 مجم 20 كبسولة', '150', NULL, NULL, NULL, NULL, 'Palmitoylethanolamide', 'P&C', 'Capsule', 'كبسولة', '400 mg', '2', NULL, NULL, NULL, '6224009650446', 1999, '2025-05-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Firmagon 120 mg 2 pd. in vial subcutaneous', 19054, 'فيرماجون 120مجم 2 فيال', '6,450', '1840', 'Antineoplastic', 'Antineoplastic', NULL, 'Degarelix', 'Ferring pharmaceuticals > multipharma', 'Vial', 'فيال', '120 mg', '2', NULL, NULL, NULL, NULL, 963, '2024-11-21', NULL, 0, 'In Canada and the US, degarelix is indicated for the treatment of advanced prostate cancer in patients requiring androgen deprivation therapy.[L49355,L49360] In the EU, it is more specifically indicated for the treatment of adult male patients with advanced hormone-dependent prostate cancer, and for treatment of high-risk localized and locally advanced hormone-dependent prostate cancer, in combination with radiotherapy or as a neo-adjuvant prior to radiotherapy.[L49374]', 'Degarelix competitively inhibits GnRH receptors in the pituitary gland, preventing the release of luteinizing hormone (LH) and follicle stimulating hormone. Reduced LH suppresses testosterone release, which slows the growth and reduces the size of prostate cancers.', 'Degarelix is a synthetic derivative of GnRH decapeptide, the ligand of the GnRH receptor. Gonadotropin and androgen production result from the binding of endogenous GnRH to the GnRH receptor. Degarelix antagonizes the GnRH receptor which in turn blocks the release of LH and FSH from the pituitary. LF and FSH decreases in a concentration-dependent manner. The reduction in LH leads to a decrease in testosterone release from the testes. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Crama cream 100 gm', 16887, 'كراما كريم100جم', '30', NULL, 'Diaper rash', 'Diaper rash', NULL, 'Grape seed extract+zinc oxide+chamomile+olive oil+vaseline+triclosan+vitamin e+calendula+lanolin', 'Hi-care > better health co.', 'Cream', 'كريم', '100 gm', '1', NULL, NULL, 'baby skin care for diaper rash', NULL, 700, '2022-07-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Betoxol 5mg/ml eye drops', 1485, 'بيتوكسول 5 مل نقط للعين', '9', NULL, 'Antiglaucoma', 'Antiglaucoma', NULL, 'Betaxolol', 'T3a pharma', 'Drops', 'نقط', '5mg', '1', NULL, NULL, 'about betaxolol cardioselective beta 1-adrenergic blocker anti glaucoma antihypertensive. mechanism of action of betaxolol betaxolol is a selective beta 1 (? 1) blocker. it inhibits the beta receptors present in the eye such as in the ciliary body epithel', NULL, 1114, '2022-09-19', NULL, 0, 'For the management of hypertension.', 'Betaxolol selectively blocks catecholamine stimulation of beta(1)-adrenergic receptors in the heart and vascular smooth muscle. This results in a reduction of heart rate, cardiac output, systolic and diastolic blood pressure, and possibly reflex orthostatic hypotension. Betaxolol can also competitively block beta(2)-adrenergic responses in the bronchial and vascular smooth muscles, causing bronchospasm.', 'Betaxolol is a competitive, beta(1)-selective (cardioselective) adrenergic antagonist. Betaxolol is used to treat hypertension, arrhythmias, coronary heart disease, glaucoma, and is also used to reduce non-fatal cardiac events in patients with heart failure. Activation of beta(1)-receptors (located mainly in the heart) by epinephrine increases the heart rate and the blood pressure, and the heart consumes more oxygen. Drugs such as betaxolol that block these receptors therefore have the reverse effect: they lower the heart rate and blood pressure and hence are used in conditions when the heart itself is deprived of oxygen. They are routinely prescribed in patients with ischemic heart disease. In addition, beta(1)-selective blockers prevent the release of renin, which is a hormone produced by the kidneys which leads to constriction of blood vessels. Betaxolol is lipophilic and exhibits no intrinsic sympathomimetic activity (ISA) or membrane stabilizing activity.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Max vit 20 caps.', 7785, 'ماكس فيت 20 كبسولة', '14', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Vitamins', 'Memphis', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, 'about vitamins vitamins are substances that are found in foods we eat. the term vitamin is derived from the words vital and amine because vitamins are required for life and were originally thought to be amines. all vitamins are not amines. vitamins are di', '6221050050331', 3663, '2023-03-30', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fexon 30mg/5 ml oral susp. 100 ml', 19029, 'فيكسون 30مجم/5مل معلق 100 مل', '10', NULL, 'Antihistamine.antiallergy', 'Antihistamine.antiallergy', NULL, 'Fexofenadine', 'Hikma pharma', 'Susp', 'معلق', '30mg', '1', NULL, NULL, 'about fexofenadinessecond generation h1 antagonist antihistamine.ssmechanism of action of fexofenadinesfexofenadine blocks one type of peripheral receptor for histamine (the h1 receptor) and thus prevents activation of h1 receptor-containing cells by hist', NULL, 825, '2022-07-24', NULL, 0, 'In the United States, fexofenadine is indicated for the symptomatic treatment of allergic rhinitis in patients ≥2 years old and chronic idiopathic urticaria in patients ≥6 months old.[L4269] In Canada, fexofenadine carries the same indications but is approved only for patients ≥12 years old.[L10779] Fexofenadine is also available in combination with [pseudoephedrine] for the symptomatic treatment of season allergic rhinitis in patients ≥12 years old.[L10800]', 'The H<sub>1</sub> histamine receptor is responsible for mediating hypersensitivity and allergic reactions. Exposure to an allergen results in degranulation of mast cells and basophils, which then release histamine and other inflammatory mediators. Histamine binds to, and activates, H<sub>1</sub> receptors, which results in the further release of pro-inflammatory cytokines, such as interleukins, from basophils and mast cells. These downstream effects of histamine binding are responsible for a wide variety of allergic symptoms, such as pruritus, rhinorrhea, and watery eyes.[A1495]



Fexofenadine is considered an “inverse agonist” of the H<sub>1</sub> receptor because it binds to and stabilizes the inactive form of the receptor, preventing its activation and subsequent downstream effects.[A1495] It has a potent and selective affinity for H<sub>1</sub> receptors, and there is no evidence that it carries antidopaminergic, antiserotonergic, anticholinergic, sedative, or adrenergic blocking activity.[L10779] Fexofenadine does not cross the blood-brain barrier and thus is unlikely to cause significant CNS effects.[L10779]', 'Fexofenadine relieves allergy symptoms by antagonizing the actions of histamine, an endogenous compound predominantly responsible for allergic symptomatology.[L4269] The relatively long duration of action of fexofenadine (approximately 24 hours)[A1495] allows for once or twice daily dosing, and its rapid absorption allows for an onset of action within 1-3 hours. Fexofenadine should not be taken with fruit juice, as this may impair its absorption.[L4269]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Claforan 500mg i.m/i.v.vial', 16436, 'كلافوران 500مجم فيال', '27', NULL, 'Antibiotic.cephalosporin.third-generation', 'Antibiotic.cephalosporin.third-generation', NULL, 'Cefotaxime', 'Sanofi', 'Vial', 'فيال', '500mg', '1', NULL, NULL, NULL, '6223003990398', 1014, '2022-12-03', NULL, 0, 'Used to treat gonorrhoea, meningitis, and severe infections including infections of the kidney (pyelonephritis) and urinary system. Also used before an operation to prevent infection after surgery.', 'The bactericidal activity of cefotaxime results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefotaxime shows high affinity for penicillin-binding proteins in the cell wall including PBP Ib and PBP III.', 'Cefotaxime is a third generation intravenous cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotaxime works by inhibiting bacterial cell wall biosynthesis. A positive feature of cefotaxime is that it display a resistance to penicillinases and is useful to treat infections that are resistant to penicillin derivatives.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hiderm whitening cream 50 gm', 20472, 'هاي ديرم كريم تفتيح 50 جم', '125', '110', 'Whitening topical', 'Whitening topical', NULL, 'Kojic acid+mulberry+avobenzone+vitamin c+liquorice+green tea+royal jelly', 'Hi-care > avano pharma', 'Cream', 'كريم', '50 gm', '1', 'كريم تفتيح للبشرة -- ترطيب الجلد وتنعيمه -- علاج اثار الشمس و الحروق', NULL, '-natural whitening formula. -lighten dark spots & age spots. -sun protection.', NULL, 1727, '2025-01-31', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Uni alpha oral pwd. 10 sachets', 28714, 'يوني الفا 10 كيس', '106', NULL, 'Antirheumatic.osteoarthritis.anabolic agents', 'Antirheumatic.osteoarthritis.anabolic agents', NULL, 'Gelatin (collagen) hydrolysate+vitamin c', 'Debeiky > maxare', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, 'for health joints use: 1 sachet in a glass add 100 ml of water stirr well till dissolve then drink daily for 3 months', NULL, 881, '2022-07-12', NULL, 0, 'Gelatin is used for weight loss and for treating osteoarthritis, rheumatoid arthritis, and brittle bones (osteoporosis). Some people also use it for strengthening bones, joints, and fingernails. Gelatin is also used for improving hair condition and to shorten the recovery after exercise and sports-related injury [L2113]. Gelatin is used in preparations of foods, cosmetics, and medicine [L2113].



Plasma volume expander in hypovolaemic shock [L2115]. Haemostatic [L2115].



Gelatin-based hydrogels are being used in drug delivery and tissue engineering because they are able to promote cell adhesion and proliferation. In addition, these hydrogels can be used as wound dressings because of their attractive fluid absorbance properties. Manufacturing technologies such as ultraviolet stereolithography and two-photon polymerization can be used to prepare structures containing photosensitive gelatin-based hydrogels [L2111].', 'It works as a hemostatic by providing a physical framework within which clotting may occur [L2115].



As a volume expander, gelatin remains in the vascular space. When used in the treatment of hypovolaemia gelatin can produce a significant increase in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery, increasing volume and pressure [L2117].



For intravascular volume expansion, the majority or gelatins produce an effect which is almost equivalent to of which are mild, although severe reactions albumin, with a duration of action of 3 to 4 hours to have been reported [L2118].



Gelatin or collagen chains suspended in solution can be covalently cross-linked to form matrices that are able to swell in the presence of aqueous solutions, forming what are called _gelatin hydrogels_. Hydrogels, characterized by their hydrophilicity and insolubility in water, have the capability of swelling into an equilibrium volume while maintaining their shape. The chemical cross-linkers used may be either small bifunctional molecules or polyfunctional macromolecules, for example, glutaraldehyde [L2122].', 'Gelatin contains collagen, which is one of the materials that make up cartilage and bone [L2113].



In addition to their well-established value as a nutritional protein source, collagen and collagen-derived products may exhibit various potential biological activities on cells and the extracellular matrix through the corresponding food-derived peptides post-ingestion.  This could justify their applications in dietary supplements and pharmaceutical agents [A32426].



Gelatin is a protein that is used as a hemostatic in surgical procedures.  It is also used as a plasma volume expander in hypovolemic shock. Gelatin rods structures may also be used to temporarily block tear outflow in cases of dry eye [L2115].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Domas 30 tabs', 32320, 'دوماس 30 قرص', '120', '89', 'Multivitamin', 'Multivitamin', NULL, 'Odorless omega 3+vitamin b complex+zinc+selelium+vitamin e+vitamin c', 'Med care > recovery', 'Tab', 'أقراص', NULL, '3', 'مكمل غذائى لتحسين الذاكرة وزيادة التركيز وتحسين الجهاز المناعى والعصبى', NULL, NULL, NULL, 3493, '2025-01-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Rimactazide 300mg 8 coated tab.', 9849, 'ريمكتازيد 300مجم 8 اقراص', '7', NULL, 'Antitubercular', 'Antitubercular', NULL, 'Isoniazid+rifampicin', 'Novartis', 'Tab', 'أقراص', '300mg', '1', NULL, NULL, 'about isoniazid hydrazine derivative antitubercular agent. mechanism of action of isoniazid isoniazid is a bactericidal drug. i t inhibits the mycolic acid synthesis which is essential for the cell wall formation. it also inhibits dna rna and protein synt', '6223002640621', 1315, '2022-12-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Olvita 30 tabs', 31022, 'اولفيتا 30 قرص', '65', '55', 'Multivitamin', 'Multivitamin', NULL, 'Vitamin b1+vitamin b6+vitamin b12+folic acid', 'Medcare > drug pharma egypt', 'Tab', 'أقراص', NULL, '1', NULL, NULL, 'vitamin b1 ... 6 mg vitamin b6 ... 7 mg vitamin b12 .... 500 mcg folic acid .... 500 mcg used for vitamin b deficiency diabetic complication preeclampsia spontaneous abortion preterm delivery neural tube defect', NULL, 804, '2024-02-05', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Roviaprega 150mg 20 cap.', 26350, 'روفيابريجا 150مجم 20 كبسول', '38', NULL, 'Anti-epileptic.gaba analogs', 'Anti-epileptic.gaba analogs', NULL, 'Pregabalin', 'Marcyrl co. > bahrain pharma', 'Cap', 'كبسولة', '150mg', '2', NULL, NULL, 'about pregabalin a gaba agonist anticonvulsant. mechanism of action of pregabalinspregabalin is a gaba neurotransmitter analog. it produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as glutamate norep', NULL, 783, '2022-07-14', NULL, 0, 'Pregabalin is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and as adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older.[L7066]', 'Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models.[L7066]  



By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide.[A31163] In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action.[A36628] 



Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors.[A31165]  ', 'Although the structure of pregabalin is similar to gamma-aminobutyric acid (GABA), it does not bind to GABA receptors.[A31163,A187190] Instead, it binds the alpha2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system.[A31163,A187190] Pregabalin does not modulate dopamine receptors, serotonin receptors, opiate receptors, sodium channels or cyclooxygenase activity.[A187190] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dg fresh tooth paste 75 gm', 6938, 'دي جي فريش معجون اسنان 75 جم', '40', NULL, 'Tooth paste', 'Tooth paste', NULL, 'Chlorhexidine+propolis+calcium carbonate+sodium bicarbonate', 'Al esraa pharmaceutical optima', 'Unknown', 'غير محدد', '75 gm', '1', NULL, NULL, NULL, NULL, 855, '2025-08-16', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Beriate p 500i.u. vial', 15090, 'بيريت بي 500 وحدة حقن', '2,200', NULL, 'Blood-coagulation factor', 'Blood-coagulation factor', NULL, 'Blood-coagulation factor viii', 'Aventis behring gmbh > 2s pharma group', 'Vial', 'فيال', NULL, '1', NULL, NULL, 'when blood vessels are cut or damaged the loss of blood from the system must be stopped before shock and possible death occur. this is accomplished by solidification of the blood a process called coagulation or clotting. a blood clot consists of a plug of', NULL, 1149, '2022-07-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Rimactane 300mg 8 capsules', 9848, 'ريمكتان 300مجم 8 كبسولات', '10', NULL, 'Antibiotic.antituberculosis', 'Antibiotic.antituberculosis', NULL, 'Rifampicin', 'Novartis', 'Capsule', 'كبسولة', '300mg', '1', 'مضاد حيوي . مضاد للدرن', NULL, NULL, '6223002640447', 6696, '2023-02-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Seroquel 200mg 30 tab', 10361, 'سيروكويل 200مجم 30 قرص', '429', '300', 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Quetiapine', 'Astra zeneca', 'Tab', 'أقراص', '200mg', '3', NULL, NULL, NULL, '6223003270179', 2366, '2024-04-09', NULL, 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dafrocin 30 hard gelatin capsules', 2708, 'دافروسين 30 كبسولة', '135', '105', 'Vascular-protecting agent', 'Vascular-protecting agent', NULL, 'Diosmin+hesperidin+rutin+vitamin c', 'Vortex pharma', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, '6224001079689', 4492, '2024-09-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hair mix hair cream 120 gm', 20188, 'هير ميكس هير كريم 120 جم', '250', '150', 'Hair care', 'Hair care', NULL, 'Caffeine+biotin+argan oil+vitamin e+oleic acid+shea butter+eruca oil+wheat germ oil+tea tree oil', 'Egyptian company for cosmetics > pharmix', 'Cream', 'كريم', '120 gm', '1', NULL, NULL, 'nourishing & hydrating cream. fortified with caffeine biotin & argan oil. for hair loss & anti-frizz. silicone-free. ** ingredients: caffeine + biotin + argan oil + vitamin e + oleic acid + shea butter + eruca oil + wheat germ oil + tea tree oil + amla oi', NULL, 1026, '2024-03-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ketoconazol 200 mg 10 tab', 6867, 'كيتوكونازول 200 جم 10 اقراص', '24', NULL, 'Antifungals.imidazoles', 'Antifungals.imidazoles', NULL, 'Ketoconazole', 'Company', 'Tab', 'أقراص', '200 mg', '1', 'مضاد للفطريات', NULL, NULL, NULL, 3367, '2022-06-01', NULL, 0, 'Ketoconazole is used in the treatment or prevention of fungal infections including blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis.[FDA Label] In Europe, it is also used in the treatment of endogenous Cushing''s syndrome.[L7736]', 'Ketoconazole interacts with 14-&alpha;-sterol demethylase, a cytochrome P-450 enzyme necessary for the conversion of lanosterol to ergosterol.[A181802,T116] This results in inhibition of ergosterol synthesis and increased fungal cellular permeability due to reduced amounts of ergosterol present in the fungal cell membrane. This metabolic inhibition also results in accumulation of 14α-methyl-3,6-diol, a toxic metabolite. The increase in membrane fluidity is also thought to produce impairment of membrane-bound enzyme systems as components become less closely packed.', 'Ketoconazole, similarly to other azole antifungals, is a fungistatic agent which causes growth arrest in fungal cells thereby preventing growth and spread of the fungus throughout the body.[T116]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tova guard sanitizer gel 50ml', 28377, 'توفا جارد جل 50مل', '10', NULL, 'Disinfectant', 'Disinfectant', NULL, 'Ethyl alcohol 70% + aloe vera + chlorhexidine', 'Marketova healthcare', 'Gel', 'جل', '50ml', '1', NULL, NULL, NULL, NULL, 621, '2022-08-03', NULL, 0, 'Investigated for use/treatment in burns and burn infections, cardiac surgery, inflammatory disorders (unspecified), ischemic reperfusion injury, and sepsis and septicemia.', 'CTI-01 inhibits the systemic release of cytokines, such as TNF-alpha and HMGB1, which promote the body''s inflammatory response. The over-expression of these cytokines has been linked to diseases that occur in critical care settings, such as severe organ damage following cardiopulmonary bypass (CPB) and post-operative ileus following abdominal surgery.', NULL, 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tabine 5 gm vial for i.v. s.c. inj. or intrathecal(n/a yet)', 27852, 'تابين 5جم فيال', '286', NULL, 'Antiviral.nucleoside', 'Antiviral.nucleoside', NULL, 'Cytarabine', 'Hikma specialized pharmaceuticals', 'Tab', 'أقراص', '5 gm', '1', NULL, NULL, 'description a pyrimidine nucleoside analog that is used mainly in the treatment of leukemia especially acute non-lymphoblastic leukemia. indication for the treatment of acute non-lymphocytic leukemia acute lymphocytic leukemia and blast phase of chronic m', NULL, 778, '2022-07-18', NULL, 0, 'For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.



Cytarabine is indicated in combination with [daunorubicin] for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.[L32843]', 'Cytarabine acts through direct DNA damage and incorporation into DNA. Cytarabine is cytotoxic to a wide variety of proliferating mammalian cells in culture. It exhibits cell phase specificity, primarily killing cells undergoing DNA synthesis (S-phase) and under certain conditions blocking the progression of cells from the G1 phase to the S-phase. Although the mechanism of action is not completely understood, it appears that cytarabine acts through the inhibition of DNA polymerase. A limited, but significant, incorporation of cytarabine into both DNA and RNA has also been reported.', 'Cytarabine is an antineoplastic anti-metabolite used in the treatment of several forms of leukemia including acute myelogenous leukemia and meningeal leukemia. Anti-metabolites masquerade as purine or pyrimidine - which become the building blocks of DNA. They prevent these substances becoming incorporated in to DNA during the "S" phase (of the cell cycle), stopping normal development and division. Cytarabine is metabolized intracellularly into its active triphosphate form (cytosine arabinoside triphosphate). This metabolite then damages DNA by multiple mechanisms, including the inhibition of alpha-DNA polymerase, inhibition of DNA repair through an effect on beta-DNA polymerase, and incorporation into DNA. The latter mechanism is probably the most important. Cytotoxicity is highly specific for the S phase of the cell cycle.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Rosita hair lotion 250 ml', 26310, 'روزيتا لوشن للشعر 250 مل', '160', '125', 'Hair care', 'Hair care', NULL, NULL, 'Leader cosmetics > kmit pharma', 'Lotion', 'لوشن', '250 ml', '1', 'لوشن للشعر لتقويته -- الحفاظ علي الشعر من الهيشان والتقصف', NULL, 'rosita hair lotion 250 ml. highly effective formula. for hair growth & care. ** ingredients: wheat germ oil + chamomile extract + aloe vera + bht + castor oil + panthenol + olive oil ** rosita hair lotion have been specially developed for hair care using', NULL, 2190, '2024-08-13', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Vanvilda plus 50/500 mg 30 tabs.', 33833, 'فانفيلدا بلس 50/500 مجم 30 قرص', '129', '102', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', 'Anti-diabetic.secretagogues.dpp-4 inhibitors', NULL, 'Metformin hydrochloride+vildagliptin', 'Gypto pharma', 'Tab', 'أقراص', '500 mg', '3', 'لعلاج مرضى السكر', NULL, NULL, NULL, 2617, '2025-07-29', NULL, 0, '**Metformin immediate-release formulations**

 

Metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients ≥10 years old with type 2 diabetes mellitus.[L40243]



**Metformin extended-release tablet (XR)**



The extended-release formulation of metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Safety in children has not been determined to this date.[L12207]



**Metformin combination products**



Metformin is a component of a variety of combination products with other anti-diabetic agents. It is indicated, along with diet and exercise, to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with DPP-4 inhibitors ([sitagliptin], [linagliptin], [alogliptin], or [saxagliptin]),[L11479,L40248,L40253,L40258,L40263] in combination with SGLT2 inhibitors ([canagliflozin], [empagliflozin], [ertugliflozin], or [dapagliflozin]),[L11479,L30503,L1134,L13679,L38729] or in combination with [pioglitazone].[L11419]', 'Metformin''s mechanisms of action are unique from other classes of oral antihyperglycemic drugs. Metformin decreases blood glucose levels by decreasing hepatic glucose production (also called gluconeogenesis), decreasing the intestinal absorption of glucose, and increasing insulin sensitivity by increasing peripheral glucose uptake and utilization.[L12207] It is well established that metformin inhibits mitochondrial complex I activity, and it has since been generally postulated that its potent antidiabetic effects occur through this mechanism.[A36534, A36557]   The above processes lead to a decrease in blood glucose, managing type II diabetes and exerting positive effects on glycemic control.



After ingestion, the organic cation transporter-1 (OCT1) is responsible for the uptake of metformin into hepatocytes (liver cells). As this drug is positively charged, it accumulates in cells and in the mitochondria because of the membrane potentials across the plasma membrane as well as the mitochondrial inner membrane. Metformin inhibits mitochondrial complex I, preventing the production of mitochondrial ATP leading to increased cytoplasmic ADP:ATP and AMP:ATP ratios.[A36534] These changes activate AMP-activated protein kinase (AMPK), an enzyme that plays an important role in the regulation of glucose metabolism.[A176348] Aside from this mechanism, AMPK can be activated by a lysosomal mechanism involving other activators.  Following this process, increases in AMP:ATP ratio also inhibit _fructose-1,6-bisphosphatase_ enzyme, resulting in the inhibition of gluconeogenesis, while also inhibiting _adenylate cyclase_ and decreasing the production of cyclic adenosine monophosphate (cAMP),[A36534] a derivative of ATP used for cell signaling [A176351]. Activated AMPK phosphorylates two isoforms of acetyl-CoA carboxylase enzyme, thereby inhibiting fat synthesis and leading to fat oxidation, reducing hepatic lipid stores and increasing liver sensitivity to insulin.[A36534] 



In the intestines, metformin increases anaerobic glucose metabolism in enterocytes (intestinal cells), leading to reduced net glucose uptake and increased delivery of lactate to the liver. Recent studies have also implicated the gut as a primary site of action of metformin and suggest that the liver may not be as important for metformin action in patients with type 2 diabetes. Some of the ways metformin may play a role on the intestines is by promoting the metabolism of glucose by increasing glucagon-like peptide I (GLP-1) as well as increasing gut utilization of glucose.[A36534] 



In addition to the above pathway, the mechanism of action of metformin may be explained by other ways, and its exact mechanism of action has been under extensive study in recent years.[A36535, A36554, A36555, A36557]', '**General effects**



Insulin is an important hormone that regulates blood glucose levels.[T514] Type II diabetes is characterized by a decrease in sensitivity to insulin, resulting in elevations in blood glucose when the pancreas can no longer compensate. In patients diagnosed with type 2 diabetes, insulin is unable to exert adequate effects on tissues and cells (i.e. insulin resistance)[T514] and insulin deficiency may also be present.[L5753]



Metformin reduces hepatic production of glucose, decreases the intestinal absorption of glucose, and enhances insulin sensitivity by increasing both peripheral glucose uptake and utilization. In contrast with drugs of the sulfonylurea class, which lead to hyperinsulinemia, the secretion of insulin is unchanged with metformin use.[L12207]



**Effect on fasting plasma glucose (FPG) and Glycosylated hemoglobin (HbA1c)**



HbA1c is an important periodic measure of glycemic control used to monitor diabetic patients. Fasting plasma glucose is also a useful and important measure of glycemic control. In a 29-week clinical trial of subjects diagnosed with type II diabetes, metformin decreased the fasting plasma glucose levels by an average of 59 mg/dL from baseline, compared to an average increase of 6.3 mg/dL from baseline in subjects taking a placebo.[L12207]  Glycosylated hemoglobin (HbA1c) was decreased by about 1.4% in subjects receiving metformin, and increased by 0.4% in subjects receiving placebo only.[L12207]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Maxa-flox 400mg 10 f.c.tab.', 7786, 'ماكسافلوكس 400مجم 10 اقراص', '24', NULL, 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Lomefloxacin', 'Pharopharma', 'Tab', 'أقراص', '400mg', '1', 'مضاد حيوي', NULL, NULL, NULL, 1651, '2022-05-12', NULL, 0, 'For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: <i>S.pneumoniae</i>, <i>H.influenzae</i>, <i>S.aureus</i>, <i>P.aeruginosa</i>, <i>E. cloacae</i>, <i>P. mirabilis</i>, <i>C. civersus</i>, <i>S. asprphyticus</i>, <i>E.coli</i>, and <i>K.pneumoniae</i>.', 'Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited.', 'Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as <i>E.coli</i> and <i>Neisseria gonorrhoea</i> as well as gram-positive bacteria including <i>S. pneumoniae</i> and <i>Staphylococcus aureus</i>. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Clindavert 2% vaginal cream 20 gm', 16527, 'كليندافيرت 2% كريم مهبلية 20 جم', '32', '15.6', 'Antibiotic.lincomycins', 'Antibiotic.lincomycins', NULL, 'Clindamycin', 'Al esraa pharmaceutical optima', 'Cream', 'كريم', '2%', '1', NULL, NULL, 'mechanism clindamycin works by preventing bacteria from producing proteins that are essential to them. without these proteins the bacteria cannot grow replicate and increase in numbers. the remaining bacteria eventually die or are destroyed by the immune', NULL, 1799, '2024-10-04', NULL, 0, 'In oral and parenteral formulations, clindamycin is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria, as well as susceptible staphylococci, streptococci, and pneumococci.[L11599,L11602] Used topically, it is indicated for the treatment of acne vulgaris[L11593,L11611,L11605] and is available in combination with [benzoyl peroxide][L11584] or [tretinoin][L11590] for this purpose, or as a triple combination therapy with benzoyl peroxide and [adapalene].[L48666] Clindamycin is also indicated as a vaginal cream[L11596], suppository[L11608], or gel[L39416] for the treatment of bacterial vaginosis in non-pregnant females.



Clindamycin is used for antimicrobial prophylaxis against _Viridans_ group streptococcal infections in susceptible patients undergoing oral, dental, or upper respiratory surgery, and may be used for prophylaxis against bacterial endocarditis in penicillin-allergic patients at high risk of these infections.[L11629]', 'Clindamycin inhibits bacterial protein synthesis by binding to 23S RNA of the 50S subunit of the bacterial ribosome.[L11599] It impedes both the assembly of the ribosome and the translation process.[L11629] The molecular mechanism through which this occurs is thought to be due to clindamycin''s three-dimensional structure, which closely resembles the 3''-ends of L-Pro-Met-tRNA and deacylated-tRNA during the peptide elongation cycle - in acting as a structural analog of these tRNA molecules, clindamycin impairs peptide chain initiation and may stimulate dissociation of peptidyl-tRNA from bacterial ribosomes.[A190621]



The mechanism through which topical clindamycin treats acne vulgaris is unclear, but may be related to its activity against _Propionibacterium acnes_, a bacteria that has been associated with acne.[L11593] ', 'Clindamycin exerts its bacteriostatic effect via inhibition of microbial protein synthesis.[A190621] Clindamycin has a relatively short T<sub>max</sub> and half-life necessitating administration every six hours to ensure adequate antibiotic concentrations.[L11629] 



_Clostridium difficile_ associated diarrhea (CDAD) has been observed in patients using clindamycin, ranging in severity from mild diarrhea to fatal colitis and occasionally occurring over two months following cessation of antibiotic therapy.[L11602] Overgrowth of _C. difficile_ resulting from antibiotic use, along with its production of A and B toxins, contributes to morbidity and mortality in these patients. Because of the associated risks, clindamycin should be reserved for serious infections for which the use of less toxic antimicrobial agents are inappropriate.[L11602]



Clindamycin is active against a number of gram-positive aerobic bacteria, as well as both gram-positive and gram-negative anaerobes.[L11599] Resistance to clindamycin may develop, and is generally the result of base modification within the 23S ribosomal RNA. Cross-resistance between clindamycin and lincomycin is complete, and may also occur between clindamycin and macrolide antibiotics (e.g. [erythromycin]) due to similarities in their binding sites.[L11599]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cofdietin 20 caps', 7550, 'كوفدايتين 20 كبسولة', '120', NULL, 'Weight loss', 'Weight loss', NULL, 'Decaffeinated green tea extract+coffee seed extract', 'Viomex pharma', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, NULL, '6225000360136', 1171, '2024-06-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Balkis syrup 125ml', 14893, 'بالكيز شراب 125 مل', '6', NULL, 'Cold drugs', 'Cold drugs', NULL, 'Chlorpheniramine+etilefrine', 'Eipico > dolorgit', 'Syrup', 'شراب', '125ml', '1', 'علاج نزلات البرد والكحة -- تقليل اعراض العطس و الرشح والزكام -- تقليل الحساسية -- مسكن -- خافض للحرارة', NULL, 'chlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. histamine can produce symptoms of sneezing itching watery eyes and runny nose. chlorpheniramine is used to treat sneezing itching watery eyes and runny nose caus', '6221032220059', 1026, '2022-12-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ela cool cream 60gram', 32784, 'ايلا كوول كريم 60 جرام', '60', '44.5', 'Massage cream', 'Massage cream', NULL, 'Menthol+peppermint+camphor+clove oil+msm+arnica+colchicine', 'United scientific office', 'Cream', 'كريم', NULL, '1', NULL, NULL, 'analgesic anti inflammatory muscle relaxant', NULL, 765, '2025-01-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Aerrane 100% liquid for inhalation (hospitals price)', 13562, 'ارين 100% سائل للاستنشاق', '182', NULL, 'Inhalation anaesthesia', 'Inhalation anaesthesia', NULL, 'Isoflurane', 'Baxter > multipharma', 'Unknown', 'غير محدد', '100%', '1', NULL, NULL, NULL, NULL, 777, '2022-08-27', NULL, 0, 'For induction and maintenance of general anesthesia.', 'Isoflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Isoflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. Also appears to bind the D subunit of ATP synthase and NADH dehydogenase. Isoflurane also binds to the GABA receptor, the large conductance Ca<sup>2+</sup> activated potassium channel, the glutamate receptor and the glycine receptor.', 'Isoflurane is a general inhalation anesthetic used for induction and maintenance of general anesthesia. It induces muscle relaxation and reduces pains sensitivity by altering tissue excitability. It does so by decreasing the extent of gap junction mediated cell-cell coupling and altering the activity of the channels that underlie the action potential.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pharmaceris a-opti-sensilium duo active anti-wrinkle eye cream 15 ml', 24788, 'فارماسيريز ايه اوبتي ديو كريم مضاد لتجاعيد العين 15مل', '230', NULL, 'Skin care', 'Skin care', NULL, NULL, 'Laboratorium kosmetyczne dr irena eris sp. z o.o. > multitrade', 'Cream', 'كريم', '15 ml', '1', NULL, NULL, 'smoothing & firming - allergic & sensitive - clinically tested - immuno-prebiotic / peptide / passiflora indication: this cream is recommended for the daily care of the mature skin which is hypersensitive and prone to allergic reactions in the eye area. d', NULL, 721, '2022-07-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pulmipure 300 mg 20 caps', 7807, 'بولميبيور 300مجم 20 كبسولة', '200', NULL, 'Mucolytic.anti-inflammatory.antihistamine', 'Mucolytic.anti-inflammatory.antihistamine', NULL, 'N-acetyl l-cysteine+quercetin+serrapeptase', 'Elsebaeypharma', 'Cap', 'كبسولة', '300 mg', '1', 'مذيب للبلغم ومضاد للحساسيه ومضاد للالتهابات', NULL, NULL, NULL, 872, '2025-11-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Peptec 40mg 10 tab.', 24715, 'بيبتك 40مجم 10 اقراص', '12', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Peptic ulcer.anti-histamine.h2 antagonist', NULL, 'Famotidine', 'Julphar', 'Tab', 'أقراص', '40mg', '1', NULL, NULL, 'about famotidine guanidine:thiazole derivative a histamine h2-receptor antagonist anti-secretory antiulcer. mechanism of action of famotidine famotidine is a h2 (histamine) receptor antagonist. histamine is the most potent stimulus of acid secretion and a', NULL, 1178, '2022-12-03', NULL, 0, 'Famotidine is indicated in pediatric and adult patients (with the bodyweight of 40 kg and above) for the management of active duodenal ulcer (DU), active gastric ulcer, symptomatic non-erosive gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD, diagnosed by biopsy.[L11139]



It is also indicated in adult patients for the treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome, multiple endocrine neoplasias) and reduction of the risk of DU recurrence.[L11139]



The intravenous formulation of famotidine is available for some hospitalized patients with pathological hypersecretory conditions or intractable ulcers or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.[L11142]



Over-the-counter famotidine is used for the management and prevention of heartburn caused by gastroesophageal reflux in children and adults. Off-label uses of famotidine include the reduction of NSAIDs-associated gastrointestinal effects, treatment of refractory urticarial, prevention of stress ulcer in critically-ill patients, and symptomatic relief of gastritis.[L11166,L11172]', 'Histamine acts as a local hormone that stimulates the acid output by parietal cells via a paracrine mechanism. Neuroendocrine cells called enterochromaffin-like (ECL) cells lie close to the parietal cells and regulate the basal secretion of histamine. Histamine release is also promoted from stimulation by acetylcholine and gastrin, a peptide hormone. Gastrin (G) cells release gastrin, which works on CCK<sub>2</sub> receptors on ECL cells. This action promotes the release of histamine from ECL cells. Upon release, histamine acts on H<sub>2</sub> receptors expressed on the basolateral membrane of parietal cells, leading to increased intracellular cAMP levels and activated proton pumps on parietal cells. Proton pump releases more protons into the stomach, thereby increasing the secretion of acid. [T28] In conditions that are associated with acid hypersecretion such as ulcers, there is a loss of regulation of acid secretion. Famotidine works on H<sub>2</sub> receptors and blocks the actions of histamine.[L11166]', 'Famotidine decreases the production of gastric acid, suppresses acid concentration and pepsin content, and decreases the volume of gastric secretion. Famotidine inhibits both basal and nocturnal gastric acid secretion, as well as acid secretion stimulated by food, caffeine, insulin, and pentagastrin.[L11139,L11142]



Famotidine has a dose-dependent therapeutic action, with the highest dose having the most extended duration of action and the highest inhibitory effect on gastric acid secretion. Following oral administration, the onset of action is within one hour, and the peak effect is reached within 1-3 hours. The duration of effect is about 10-12 hours.[A189459]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Brandaglob syrup 120 ml', 2690, 'برانداجلوب شراب 120 مل', '70', NULL, 'Multivitamin', 'Multivitamin', NULL, NULL, 'Generica pharm', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 4676, '2024-07-07', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ferromega chochlate jar 200 gm', 19001, 'فيروميجا شوكولاتة برطمان 200 جرام', '65', NULL, 'Iron supplement', 'Iron supplement', NULL, 'Iron+zinc+omega 3', 'Alphacure > healthy', 'Unknown', 'غير محدد', '200 gm', '1', NULL, NULL, NULL, NULL, 816, '2022-10-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Luveris 75 i.u. vial', 22136, 'ليوفيرس 75 وحدة فيال', '680', '200', 'Infertility drugs.luteinizing hormone', 'Infertility drugs.luteinizing hormone', NULL, 'Lutropin alfa', 'Merck serono > united company for trading & distribution', 'Vial', 'فيال', NULL, '1', NULL, NULL, 'used to facilitate female conception lutropin alfa performs the same actions as luteinizing hormone (lh) which is normally produced in the pituitary gland. lutropin is usually given in combination with follitropin alfa. together they stimulate the develop', NULL, 1792, '2024-11-29', NULL, 0, 'For treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency (LH <1.2 international units [IU]/L)', 'Luteinizing hormone binds to a receptor shared with the human chorionic gonadotropin hormone (hCG) on the ovarian theca (and granulosa) cells and testicular Leydig cells. This LH/CG transmembrane receptor is a member of the super-family of G protein-coupled receptors. Adenylate cyclase then activates many other pathways leading to steroid hormone production and other follicle maturation processes. ', 'Used to facilitate female conception, lutropin alfa performs the same actions as luteinizing hormone (LH), which is normally produced in the pituitary gland. Lutropin is usually given in combination with follitropin alfa. Together they stimulate the development of a follicle to prepare the reproductive tract for implementation and pregnancy. Lutropin alfa also stimulates the theca cells to produce androgens and the secretion of estradiol by the follicles. Lutropin alfa and follitropin alfa are discontinued once ultrasound assessment and serum estradiol concentrations show sufficient follicular maturation. hCG is then administered to complete follicular maturation and induce ovulation. In females, a LH surge about halfway through the menstrual cycle triggers the onset of ovulation. Lutropin alfa substitutes for endogenous LH and induces rupture of the preovulatory ovarian follicle and oocyte expulsion. Lutropin alfa induces and maintains the corpus luteum, which then secretes progesterone.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Novoeight 500 i.u. i.v. vial+prefilled syringe', 23802, 'نوفو ايت 500وحده فيال وريد سرنجة معبأة', '10,530', '5383', 'Blood coagulation factor', 'Blood coagulation factor', NULL, 'Blood-coagulation factor viii', 'Novo nordisk', 'Vial', 'فيال', NULL, '1', NULL, NULL, 'novoeightï- is an antihemophilic factor (recombinant) indicated for use in adults and children with hemophilia a for: ï- control and prevention of bleeding ï- perioperative management ï- routine prophylaxis to prevent or reduce the frequency of bleeding e', NULL, 2244, '2024-07-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Investa hair serum 120 ml', 32999, 'انفيستا هير سيروم 120 مل', '160', '120', 'Hair care', 'Hair care', NULL, 'Saw palmetto+caffeine+cyclopentasilxan+castor oil+lavender oil+coconut oil+olive oil+silicone oil+tea tree oil+almond oil+chamomile oil+jojoba oil', 'Safe life', 'Serum', 'سيروم', '120 ml', '1', NULL, NULL, NULL, NULL, 1826, '2024-12-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Levodel 500mg 5 f.c. tabs.', 7263, 'ليفوديل 500مجم 5 قرص', '67', '46.5', 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Levofloxacin', 'Delta pharma', 'Tab', 'أقراص', '500mg', '1', 'مضاد حيوي.', NULL, NULL, '6221163012462', 4420, '2024-08-29', NULL, 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Weeto 10 sachets', 29637, 'ويتو 10 كيس', '175', '145', 'Weight loss', 'Weight loss', NULL, 'Psyllium husk powder+chromium+pineapple ext.', 'Pharmazad > biohealth company for medicines', 'Sachet', 'أكياس', NULL, '1', 'يسرع عملية الحرق ويمد الجسم بالفيتامينات والمعادن', NULL, 'use: 1 sachet to be dissolved with a cup of water 30 minutes before main meal once daily.', NULL, 1514, '2023-11-07', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Molfen 6 sachets', 8277, 'مولفن فوار 6 اكياس', '4', NULL, 'Analgesic', 'Analgesic', NULL, 'Caffeine+paracetamol(acetaminophen)', 'Pharco', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, 'mechanism: it is thought paracetamol reduces fever by affecting an area of the brain that regulates our body temperature (the hypothalamic heat-regulating center). paracetamol is about as effective as aspirin or ibuprofen at relieving mild to moderate pai', '6221151002383', 941, '2022-12-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Datrini 4000 iu 30 tab', 22426, 'داتريني 4000 وحدة دولية 30 قرص', '110', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Vitamin d 4000 iu+calcium phosphate 150 mg+vitamin c 250 mg', 'Egy minds', 'Tab', 'أقراص', '4000 iu', '3', NULL, NULL, NULL, NULL, 3008, '2024-09-12', NULL, 0, 'For the treatment of vitamin A deficiency.', 'Vision:Vitamin A (all-<i>trans</i> retinol) is converted in the retina to the 11-<i>cis</i>-isomer of retinaldehyde or 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-<i>cis</i>-retinal, while attached to opsin in rhodopsin is isomerized to all-<i>trans</i>-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-<i>trans</i>-retinal is then released from opsin and reduced to all-<i>trans</i>-retinol. All-<i>trans</i>-retinol is isomerized to 11-<i>cis</i>-retinol in the dark, and then oxidized to 11-<i>cis</i>-retinal. 11-<i>cis</i>-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-<i>cis</i> retinal rapidly. Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.', 'Vitamin A is effective for the treatment of Vitamin A deficiency. Vitamin A refers to a group of fat-soluble substances that are structurally related to and possess the biological activity of the parent substance of the group called all-<i>trans</i> retinol or retinol. Vitamin A plays vital roles in vision, epithelial differentiation, growth, reproduction, pattern formation during embryogenesis, bone development, hematopoiesis and brain development. It is also important for the maintenance of the proper functioning of the immune system.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Declofenac 50mg 20 tab.', 17159, 'ديكلوفيناك 50 مجم 20 قرص', '12', NULL, 'Nsaid.acetic acid derivatives', 'Nsaid.acetic acid derivatives', NULL, 'Diclofenac sodium', 'El nasr', 'Tab', 'أقراص', '50mg', '2', NULL, NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221067001043', 2575, '2024-12-04', NULL, 0, 'Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with [misoprostol] as a gastro-protective agent in patients with high risk of developing NSAID-induced ulcers.', 'Diclofenac inhibits cyclooxygenase-1 and -2, the enzymes responsible for production of prostaglandin (PG) G<sub>2</sub> which is the precursor to other PGs.[label,T116] These molecules have broad activity in pain and inflammation and the inhibition of their production is the common mechanism linking each effect of diclofenac.



PGE<sub>2</sub> is the primary PG involved in modulation of nociception.[A179023] It mediates peripheral sensitization through a variety of effects.[T116,A179023] PGE<sub>2</sub> activates the G<sub>q</sub>-coupled EP<sub>1</sub> receptor leading to increased activity of the inositol trisphosphate/phospholipase C pathway. Activation of this pathway releases intracellular stores of calcium which directly reduces action potential threshold and activates protein kinase C (PKC) which contributes to several indirect mechanisms. PGE<sub>2</sub> also activates the EP<sub>4</sub> receptor, coupled to G<sub>s</sub>, which activates the adenylyl cyclase/protein kinase A (AC/PKA) signaling pathway. PKA and PKC both contribute to the potentiation of transient receptor potential cation channel subfamily V member 1 (TRPV1) potentiation, which increases sensitivity to heat stimuli. They also activate tetrodotoxin-resistant sodium channels and inhibit inward potassium currents. PKA further contributes to the activation of the P2X3 purine receptor and sensitization of T-type calcium channels. The activation and sensitization of depolarizing ion channels and inhibition of inward potassium currents serve to reduce the intensity of stimulus necessary to generate action potentials in nociceptive sensory afferents. PGE<sub>2</sub> act via EP<sub>3</sub> to increase sensitivity to bradykinin and via EP<sub>2</sub> to further increase heat sensitivity. Central sensitization occurs in the dorsal horn of the spinal cord and is mediated by the EP<sub>2</sub> receptor which couples to G<sub>s</sub>. Pre-synaptically, this receptor increases the release of pro-nociceptive neurotransmitters glutamate, CGRP, and substance P. Post-synaptically it increases the activity of AMPA and NMDA receptors and produces inhibition of inhibitory glycinergic neurons. Together these lead to a reduced threshold of activating, allowing low intensity stimuli to generate pain signals. PGI<sub>2</sub> is known to play a role via its G<sub>s</sub>-coupled IP receptor although the magnitude of its contribution varies. It has been proposed to be of greater importance in painful inflammatory conditions such as arthritis. By limiting sensitization, both peripheral and central, via these pathways NSAIDs can effectively reduce inflammatory pain.



PGI<sub>2</sub> and PGE<sub>2</sub> contribute to acute inflammation via their IP and EP<sub>2</sub> receptors.[T116,A179044] Similarly to β adrenergic receptors these are G<sub>s</sub>-coupled and mediate vasodilation through the AC/PKA pathway. PGE<sub>2</sub> also contributes by increasing leukocyte adhesion to the endothelium and attracts the cells to the site of injury.[T116] PGD<sub>2</sub> plays a role in the activation of endothelial cell release of cytokines through its DP<sub>1</sub> receptor.[A179044] PGI<sub>2</sub> and PGE<sub>2</sub> modulate T-helper cell activation and differentiation through IP, EP<sub>2</sub>, and EP<sub>4</sub> receptors which is believed to be an important activity in the pathology of arthritic conditions. By limiting the production of these PGs at the site of injury, NSAIDs can reduce inflammation.



PGE<sub>2</sub> can cross the blood-brain barrier and act on excitatory G<sub>q</sub> EP<sub>3</sub> receptors on thermoregulatory neurons in the hypothalamus.[T116] This activation triggers an increase in heat-generation and a reduction in heat-loss to produce a fever. NSAIDs prevent the generation of PGE<sub>2</sub> thereby reducing the activity of these neurons.

', 'Diclofenac reduces inflammation and by extension reduces nociceptive pain and combats fever.[label,T116] It also increases the risk of developing a gastrointestinal ulcer by inhibiting the production of protective mucus in the stomach.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Galacto pure 30 capsules', 6123, 'جالاكتو بيور 30 كبسولة', '150', NULL, 'Breastfeeding', 'Breastfeeding', NULL, 'Fenugreek seed extract (trigonella foenum-graecum)+moringa oleifera powder extract (moringa oleifera)+anise powder extract (pimpinella anisum)', 'Hetero cure pharma', 'Capsule', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 713, '2025-07-21', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ultravist-370 vial 100 ml', 3319, 'الترافيست-370 فيال 100 مل', '1,088', NULL, 'Radiographic procedures.contrast agent المنورة', 'Radiographic procedures.contrast agent المنورة', NULL, 'Iopromide', 'Bayer healthcare', 'Vial', 'فيال', '100 ml', '1', 'مضاد للقيء والترجيع', NULL, NULL, NULL, 838, '2025-03-15', NULL, 0, 'Iopromide, as the product IOVIST, is approved by the FDA for use as an intra-arterial or intravenous X-ray contrast agent.[L46906] For intra-arterial administration, iopromide is indicated for cerebral arteriography, peripheral arteriography, coronary arteriography, left ventriculography, visceral angiography, and aortography in adults and radiographic evaluation of cardiac chambers and related arteries in pediatric patients aged 2 years and older.[L46906] For intravenous administration, iopromide is indicated for excretory urography in adults and pediatric patients aged 2 years and older, contrast Computed Tomography (CT) of the head and body (intrathoracic, intra-abdominal, and retroperitoneal regions) for the evaluation of neoplastic and non-neoplastic lesions in adults and pediatric patients aged 2 years and older, and contrast mammography to visualize known or suspected lesions of the breast in adults, as an adjunct following mammography and/or ultrasound.[L46906]



Iopromide is also approved by Health Canada as an intravascular contrasting agent, although the indications differ depending on the dosage. At 300 mg I/mL, iopromide is indicated for computed tomography (CT), excretory urography, pediatric excretory urography, renal arteriography, peripheral arteriography (bifemoral pelvis/leg), cerebral arteriography, phlebography of the extremities, and arthrography.[L46911]

', 'Iopromide is a nonionic iodinated, water-soluble, radiographic contrast medium that is available in two stable, ready-to-use solutions of different concentrations (i.e., 300 mg I/mL and 370 mg I/mL). Following intravascular injection, iopromide provides radiographic opacification of the vasculature and extracellular space in the path of flow of the agent, allowing diagnostic assessment of the limbs and internal organs until significant dilution occurs.[L46911] ', 'After intravenous injection, opacification of the renal parenchyma begins within 1 minute. Excretion of the contrast agent becomes apparent in 1 to 3 minutes with optimal contrast in the calyces and collecting system occurring between 5 and 15 minutes. In nephropathic conditions, particularly when excretory capacity has been altered, the excretion rate varies unpredictably and opacification may be delayed for several hours after injection.[L46911] the degree of contrast enhancement is related to the iodine concentration in the tissue of interest.[L46906] 

', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Silimar 140mg 30 tabs', 26967, 'سيليمار 140مجم 30 قرص', '18', NULL, 'Hepatoprotective', 'Hepatoprotective', NULL, 'Silymarin', 'El-obour', 'Tab', 'أقراص', '140mg', '3', 'نوع من أنواع الفيتامينات التي تساعد علي حماية الكبد من الفيروسات والميكروبات __ يعمل علي تحسين وظائف الكبد', NULL, NULL, NULL, 3332, '2022-04-11', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Glucose 5% (gypto) i.v. inf. 500 ml (silicon cap)', 6601, 'جلوكوز 5% جيبتو محلول وريدي زجاجة 500 مل بغطاء سيليكون', '30', NULL, 'Sterile solution', 'Sterile solution', NULL, 'Glucose (dextrose)', 'Gypto pharma', 'Cap', 'كبسولة', '5%', '1', NULL, NULL, NULL, NULL, 949, '2025-08-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Orovex clove mouth wash 250 ml', 24294, 'اوروفيكس بالقرنفل غسول للفم 250مل', '85', '75', 'Oral care', 'Oral care', NULL, 'Thymol+menthol+glycerin+sodium saccharine+sodium monofluorophosphate+chlorhexidine', 'Macro group pharmaceuticals', 'Mouth wash', 'غسول للفم', '250 ml', '1', NULL, NULL, 'fights germs that cause bad breath - fights tartar and plaque build up - protects against tooth decay', '6224000437800', 1811, '2025-03-17', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dextrose 5% & sodium chloride 0.9% (el nile) i.v. inf. 250 ml', 17498, 'دكستروز 5% و صوديوم كلورايد 0.9% النيل محلول وريدي 250 مل', '10', NULL, 'Sterile solution', 'Sterile solution', NULL, 'Glucose (dextrose)+sodium chloride', 'El nile.', 'Unknown', 'غير محدد', '5%', '1', NULL, NULL, NULL, NULL, 666, '2022-07-14', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mycospor 1% topical solution 15 ml', 23158, 'ميكوسبور 1% محلول 15مل', '16', NULL, 'Antifungals.imidazoles', 'Antifungals.imidazoles', NULL, 'Bifonazole', 'Hikma pharma > bayer healthcare', 'Solution', 'محلول', '1%', '1', NULL, NULL, 'about bifonazole bifonazole is a substituted imidazole antifungal agent. mechanism of action of bifonazole bifonazole is an imidazole antifungal.it inhibits the conversion of lanosterol to 14 demethyl lanosterol by inhibiting the cytochromep450 enzyme 14', NULL, 727, '2022-07-24', NULL, 0, 'Used for the treatment of various topical fungal infections, including athlete''s foot (tinea pedis).', 'Bifonazole works by inhibiting the production of a substance called ergosterol, which is an essential component of fungal cell membranes.It acts to destabilize the fungal cyctochrome p450 51 enzyme (also known as Lanosterol 14-alpha demethylase). This is vital in the cell membrance structure of the fungus. Its inhibition leads to cell lysis. The disruption in production of ergosterol disrupts the cell membrane and causes holes to appear. The cell membranes of fungi are vital for their survival. They keep unwanted substances from entering the cells and stop the contents of the cells from leaking out. As bifonazole causes holes to appear in the cell membranes, essential constituents of the fungal cells can leak out. This kills the fungi.', 'Bifonazole is a type of antifungal medicine known as an imidazole. It kills fungi and yeasts by interfering with their cell membranes.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Onetoly intimate wash 250 ml', 4382, 'اونيتولي غسول للسيدات 250 مل', '85', NULL, 'Vaginal care', 'Vaginal care', NULL, 'Tea tree oil+chlorhexidine+chamomile+aloe barbadensis leaf juice+rosa damascena flower oil+calendula+thymus vulgaris flower', 'On pharmaceuticals', 'Unknown', 'غير محدد', '250 ml', '1', NULL, NULL, NULL, NULL, 719, '2025-06-17', NULL, 0, 'Indicated for topical use to help protect against infection in minor cuts, scrapes, and burns. No FDA-approved therapeutic indications.', 'The components of tea tree oil, particularly terpinen-4-ol and α-terpineol, mediate antimicrobial actions by disrupting the structural and functional integrity of bacterial membrane. Hydrocarbons are capable of partitioning into the cell and cytoplasmic membrane of microorganisms and disrupt their vital functions, which may result in leakage of ions such as potassium, and the inhibition of respiration [A32439]. Eventually, cell lysis may occur due to weakening of the cell wall, and loss of turgor pressure and subsequent rupture of the cytoplasmic membrane [A32441]. The loss of 260-nm-absorbing material may be indicative of a damaged cytoplasmic membrane and loss of nucleic acids [A32441]. In _E. coli_, perturbed potassium homeostasis, glucose-dependent respiration, cell morphology, and ability to exclude propidium iodide was observed. 



Tea tree oil also mediates its antifungal actions in a similar way, where it alters the permeability of Candida albicans and inhibits its respiration in a dose-dependent manner [A32439]. Plasma and mitochondrial membranes of fungal species are also thought to be negatively affected by inhibition of glucose-induced medium acidification by tea tree oil, which involves inhibition of membrane ATPase responsible for the expulsion of protons [A32439]. Tea tree oil also inhibits the formation of germ tubes, or mycelial conversion, in _C. albicans_, thereby disrupting cell morphogenesis [A32439]. Water-soluble fraction of TTO, terpinen-4-ol, and α-terpineol, can inhibit the lipopolysaccharide-induced production of the inflammatory mediators such as TNF-α, IL-1β and IL-10 by human peripheral monocytes by approximately 50% and that of prostaglandin E2 by about 30% after 40 h [A32439]. These components of tea tree oil may also suppress superoxide production by agonist-stimulated monocytes and decrease the production of reactive oxygen species by both stimulated neutrophils and monocytes [A32439].', 'Tea tree oil exhibits antibacterial, antifungal, antiviral, and antiprotozoal activities [A32439]. It mostly mediates bactericidal actions at concentrations of 1.0% or less in most bacteria such as _Staphylococcus aureus_ and _Escherichia coli_, and causes bacteriostatic effects at lower concentrations [A32439]. Organisms such as commensal skin staphylococci and micrococci, _Enterococcus faecalis_, and Pseudomonas aeruginosa_emphasized text_ were susceptible to tea tree oil concentrations of 2% [A32439]. It is proposed that water-soluble components of tea tree oil are capable in inducing anti-inflammatory actions; terpinen-4-ol attenuates the vasodilation and plasma extravasation associated with histamine-induced inflammation in humans [A32438].', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cortopect syrup 60 ml', 5480, 'كورتوبيكت شراب 60 مل', '50', NULL, 'Mucolytic', 'Mucolytic', NULL, 'Acetylcysteine', 'Biomed', 'Syrup', 'شراب', '60 ml', '1', NULL, NULL, NULL, NULL, 836, '2025-06-27', NULL, 0, 'Acetylcysteine is indicated for mucolytic therapy and in the management of [acetaminophen] overdose.[L31378,L31383,L31388,L31478]', 'A number of possible mechanisms for the mucolytic activity of acetylcysteine have been proposed. Acetylcysteine''s sulfhydryl groups may hydrolize disulfide bonds within mucin, breaking down the oligomers, and making the mucin less viscous.[A228173,L31388] Acetylcysteine has also been shown to reduce mucin secretion in rat models.[A228173] It is an antioxidant in its own right but is also deacetylated to cysteine, which participates in the synthesis of the antioxidant glutathione.[A228173] The antioxidant activity may also alter intracellular redox reactions, decreasing phosphorylation of EGFR and MAPK, which decrease transcription of the gene MUC5AC which produces mucin.[A228173]



In the case of acetaminophen overdoses, a portion of the drug is metabolized by CYP2E1 to form the potentially toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI).[L31388] The amount of NAPQI produced in an overdose saturates and depletes glutathione stores.[L31388] The free NAPQI promiscuously binds to proteins in hepatocytes, leading to cellular necrosis.[L31388] Acetylcysteine can directly conjugate NAPQI or provide cysteine for glutathione production and NAPQI conjugation.[L31388]', 'Acetylcysteine is indicated for mucolytic therapy and in the management of acetaminophen overdose.[L31378,L31383,L31388,L31478] It has a short duration of action as it is given every 1-8 hours depending on route of administration, and has a wide therapeutic window.[L31378,L31383,L31388,L31478] Patients should be counselled regarding diluting oral solutions in cola for taste masking,[A228153] the risk of hypersensitivity, and the risk of upper gastrointestinal hemorrhage.[L31378,L31383,L31388,L31478]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Parkvill whitening soap 125 gm', 24586, 'باركفيل صابون تفتيح 125جم', '12', NULL, 'Whitening topical', 'Whitening topical', NULL, NULL, 'Egyptian company for cosmetics > parkville pharmaceuticals', 'Soap', 'صابون', '125 gm', '1', NULL, NULL, 'reduces melanin hyper-pigment synthesis by inhibition tyrosinase enzyme in dark skin in sensitive area knee elbow.', NULL, 883, '2022-07-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dosin 2mg 20 tab.', 17848, 'دوزين 2مجم 20 قرص', '32', '22', 'Antihypertensive.selective alpha 1 receptor blockers', 'Antihypertensive.selective alpha 1 receptor blockers', NULL, 'Doxazosin', 'Eipico', 'Tab', 'أقراص', '2mg', '2', NULL, NULL, NULL, '6221032115294', 1424, '2024-12-07', NULL, 0, 'Doxazosin is indicated to treat the symptoms of benign prostatic hypertrophy, which may include urinary frequency, urgency, and nocturia, among other symptoms. In addition, doxazosin is indicated alone or in combination with various antihypertensive agents for the management of hypertension.[L7282] Off-label uses of doxazosin include the treatment of pediatric hypertension[A180634] and the treatment of ureteric calculi.[A180637]', 'Doxazosin selectively inhibits the postsynaptic alpha-1 receptors on vascular smooth muscle by nonselectively blocking the alpha-1a, alpha-1b, and alpha-1d subtypes[A180688,A4649]. This action on blood vessels decreases systemic peripheral vascular resistance, reducing blood pressure, exerting minimal effects on the heart rate due to its receptor selectivity.[A180649,A180676] Norepinephrine-activated alpha-1 receptors located on the prostate gland and bladder neck normally cause contraction of regional muscular tissue, obstructing urinary flow and contributing to the symptoms of benign prostatic hypertrophy.  Alpha-1 antagonism causes smooth muscle relaxation in the prostate and bladder, effectively relieving urinary frequency, urgency, weak urinary stream, and other unpleasant effects of BPH.[A180655] Recently, doxazosin was found to cause apoptosis of hERG potassium channels in an in vitro setting, possibly contributing to a risk of heart failure with doxazosin use.[A15296,A180697,A180700] ', 'Doxazosin decreases standing and supine blood pressure[A180649] and relieves the symptoms of benign prostatic hypertrophy through the inhibition of alpha-1 receptors.

Doxazosin may cause hypotension due to its pharmacological actions. This frequently occurs in the upright position, leading to a feeling of dizziness or lightheadedness. The first dose of doxazosin may lead to such effects, however, subsequent doses may also cause them. The risk of these effects is particularly high when dose adjustments occur or there are long intervals between doxazosin doses. Treatment should be started with the 1 mg dose of doxazosin, followed by slow titration to the appropriate dose.[L7282] Patients must be advised of this risk and to avoid situations in which syncope and dizziness could be hazardous following the ingestion of doxazosin.[L7282] Interestingly doxazosin exerts beneficial effects on plasma lipids. It reduces LDL (low-density lipoprotein) cholesterol and triglyceride levels and increases HDL (high-density lipoprotein) cholesterol levels.[A180649]



A note on priapism risk



In rare cases, doxazosin and other alpha-1 blockers may cause priapism, a painful occurrence of persistent and unrelievable penile erection that can lead to impotence if medical attention is not sought as soon as possible. Patients must be advised of the priapism risk associated with doxazosin and to seek medical attention immediately if it is suspected.[A180670,L7282]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Anafronil 25mg 30 tab.', 14090, 'انافرونيل 25مجم 30 قرص', '66', '45', 'Psychiatric.antidepressants', 'Psychiatric.antidepressants', NULL, 'Clomipramine', 'Novartis > sandoz', 'Tab', 'أقراص', '25mg', '3', 'مضاد للاكتئاب مفيد في علاج اضطراب الوسواس القهري ، الرهاب الاجتماعي ، اضطراب الهلع ، اضطراب القلق العام', NULL, 'about clomipramine tricyclic antidepressant (tertiary amine) antiobsessional. mechanism of action clomipramine acts by inhibiting the re-uptake of noradrenaline and serotonin (5 ht) in the cns nerve terminals.this will result in an increased concentration', '6223002642045', 4171, '2024-11-09', NULL, 0, 'May be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette’s disorder).

Unlabeled indications include: depression, panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy (limited evidence), autistic disorder (limited evidence), trichotillomania (limited evidence), onchophagia (limited evidence), stuttering (limited evidence), premature ejaculation, and premenstrual syndrome. ', 'Clomipramine is a strong, but not completely selective serotonin reuptake inhibitor (SRI), as the active main metabolite desmethyclomipramine acts preferably as an inhibitor of noradrenaline reuptake. &alpha;<sub>1</sub>-receptor blockage and &beta;-down-regulation have been noted and most likely play a role in the short term effects of clomipramine. A blockade of sodium-channels and NDMA-receptors might, as with other tricyclics, account for its effect in chronic pain, in particular the neuropathic type.', 'Clomipramine, a tricyclic antidepressant, is the 3-chloro derivative of Imipramine. It was thought that tricyclic antidepressants work exclusively by inhibiting the re-uptake of the neurotransmitters norepinephrine and serotonin by nerve cells. However, this response occurs immediately, yet mood does not lift for around two weeks. It is now thought that changes occur in receptor sensitivity in the cerebral cortex and hippocampus. The hippocampus is part of the limbic system, a part of the brain involved in emotions. Presynaptic receptors are affected: &alpha;<sub>1</sub> and &beta;<sub>1</sub> receptors are sensitized, &alpha;<sub>2</sub> receptors are desensitized (leading to increased noradrenaline production). Tricyclics are also known as effective analgesics for different types of pain, especially neuropathic or neuralgic pain.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pranoso brandy spray 30 ml', 10365, 'برانوسو براندي سبراي 30 مل', '75', '70', 'Soothing.moisturizing', 'Soothing.moisturizing', NULL, NULL, 'Company', 'Spray', 'بخاخ', '30 ml', '1', 'مضاد اكتئاب', NULL, NULL, NULL, 1166, '2025-07-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Care mix plus hair cream 50 gm', 15875, 'كير ميكس بلس كريم شعر 50جم', '30', NULL, 'Hair care', 'Hair care', NULL, 'Panthenol+wheat protein+white soft paraffin+liquid paraffin+lanolin+cetostearyl alcohol', 'Vita pharm > care mix', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 909, '2022-07-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Inlife intimate feminine washable gel 220 ml', 20842, 'انلايف جل للسيدات 220 مل', '74', '59', 'Vaginal wash', 'Vaginal wash', NULL, 'Aloe vera+tea tree oil+calendula+liquorice+chamomile+thyme+bearberry', 'Egpi > a.s.cosmo', 'Gel', 'جل', '220 ml', '1', 'غسول وتشطيف مهبلي للسيدات', NULL, 'daily cleanser of intimate area for protection against common inections inflamation itching irritation unpleasnet odours as well as helping whiten hyperpigmented intimate area safe during pregenecy suitable for all females girls after puberty ** available', NULL, 1516, '2023-09-29', NULL, 0, 'Indicated for use as a topical agent to soothe sensitive skin and to relieve symptoms of various skin conditions, including contact or atopic dermatitis, eczema, dermatitis and acne urticata, first- and second-degree burns, radiation dermatitis, and sunburn. ', 'It is suggested that aloe polysaccharides mediate skin-protectant effects in damaged skin, induced by internal or other external factors such as radiation, via inhibiting apoptosis of normal cell lines _in vitro_ and thrombocytes _in vivo_ [A32473]. Following irradiation, aloe polysaccharides block the upregulation of pro-apoptotic p53, Bax, and Bad while blocking downregulating anti-apoptotic Bcl-2 [A32473]. _In vivo_, aloe polysaccharides may act as a scavenger for oxygen free radicals including DPPH, alkyl radicals, superoxides, and singlet oxygen and hydroxyl radicals that may also be generated by superoxides [A32470, A32476]. Hydrogen peroxide, which is a weak initiate lipid peroxidation, may also be effectively scavenged by aloe polysaccharides [A32476]. In a Fenton reaction system, aloe polysaccharides demonstrated a concentration-dependent scavenging activity against hydroxyl radical that were generated during the reaction [A32476]. Aloe polysaccharides may also compete with oxygen to react with nitric oxide (NO), thereby inhibiting the generation of nitrite and peroxynitrite anions that act as free radicals [A32476]. 



Findings from a study investigating the effects of aloe polysaccharides on doxorubicin-induced oxidative stress suggest that aloe polysaccharides mediate potent antioxidant actions _in vivo_ [A32476]. Doxorubicin, known to generate reactive oxygen species such as superoxide and hydroxy radicals, was administered to albino rats. This led to myocardial oxidative stress and cardiac injury accompanied by leakage of LDH and CPK from cardiac myocytes and to serum due to lipid peroxidation of cardiac membranes, reduced levels of antioxidant coenzyme GSH, and increased levels of SOD from a compensatory and combative mechanism of oxidative stress [A32476]. Treatment with aloe polysaccharides resulted in a significant decrease in serum LDH and CPK levels, indicating that aloe polysaccharides are capable in stabilizing cardiac membranes from peroxidative damage. Restored levels of endogenous GSH and SOD in a dose-dependent manner were also observed with the treatment of aloe polysaccharides, suggesting that aloe polysaccharides exhibit potent antioxidant properties [A32476].



In a study of rats with open cutaneous back wounds, treatment with aloe polysaccharides decreased the levels of matrix metalloproteinase-3 (MMP-3) and induced tissue inhibitors of matrix metalloproteinase-2 (TIMP-2) during the early stage of wound repair, resulting in decreased collagen breakdown and increased preservation of collagen content in the injured area [A32471]. A study proposes that acemannan, a common aloe polysaccharide, stimulates BMSC proliferation, ALPase activity, expression of VEGF, BMP-2, OPN, BSP, and mineralization leading to osteoblast differentiation and bone formation during socket healing [A32475]. ', 'Aloe polysaccharides mediate antioxidant and anti-inflammatory actions, as well as immunoregulatory activities. Various studies indicate that aloe polysaccharides possess effective free radical scavenging activity _in vitro_, and produce potent antioxidant potential during oxidative stress _in vivo_ [A32476]. According to the findings of studies _in vitro_ and _in vivo_, aloe polysaccharides exhibit radioprotective activity. Treatment with acemmanan, which is a common aloe polysaccharide, on CH3 mice with radiation-induced skin reactions resulted in reduced signs of those reactions [A32473]. Studies suggest that aloe polysaccharides may evidently attenuate tumor growth in mice [A32473]. Treatment of aloe polysaccharides in Vero cells as well as in the in vivo zebrafish model led to protective effects against AAPH-indued oxidative stress resulting from accumulation of free radical species and improved cell viability [A32470]. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Flegaron agar oral drop15 ml', 7846, 'فليجارون اجار نقط فم 15 مل', '80', NULL, 'Agar drop', 'Agar drop', NULL, 'Agar agar extract+high purity+high quality+palatable taste', 'I pharma', 'Drop', 'نقط', '15 ml', '1', NULL, NULL, NULL, NULL, 657, '2022-12-06', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Cisplatin 0.5mg/ml (10mg) vial.', 16407, 'سيسبلاتين 0.5 مجم / مل (10مجم) فيال', '17', NULL, 'Antineoplastic', 'Antineoplastic', NULL, 'Cisplatin', 'Sandoz > b.p pharma', 'Vial', 'فيال', '0.5mg', '1', NULL, NULL, 'description cisplatin cisplatinum or cis-diamminedichloroplatinum(ii) (cddp) is a platinum-based chemotherapy drug used to treat various types of cancers including sarcomas some carcinomas (e.g. small cell lung cancer and ovarian cancer) lymphomas and ger', NULL, 800, '2022-07-13', NULL, 0, 'For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.', 'Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations.', 'Cisplatin is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Novoeight 250 i.u. i.v. vial+prefilled syringe', 23801, 'نوفو ايت 250وحدة فيال للحقن الوريدي', '3,035', NULL, 'Blood coagulation factor', 'Blood coagulation factor', NULL, 'Blood-coagulation factor viii', 'Novo nordisk', 'Vial', 'فيال', NULL, '1', NULL, NULL, 'novoeightï- is an antihemophilic factor (recombinant) indicated for use in adults and children with hemophilia a for: ï- control and prevention of bleeding ï- perioperative management ï- routine prophylaxis to prevent or reduce the frequency of bleeding e', NULL, 774, '2022-08-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Fungifree 100000 i.u./ml oral drops 30 ml', 19468, 'فانجيفري 100000 وحدة دولية/مل نقط 30 مل', '6', NULL, 'Antifungal.polyene', 'Antifungal.polyene', NULL, 'Nystatin', 'European egyptian pharm. ind.', 'Drops', 'نقط', '30 ml', '1', NULL, NULL, 'about nystatin polyene antifungal. mechanism of action of nystatin nystatin is a fungicidal as well as a fungistatic drug. it has high affinity for ergosterol present in the fungal cell membrane and bind with it and they orients in such a way that micropo', NULL, 833, '2022-07-27', NULL, 0, 'Nystatin is available in oral formulations for the treatment and/or prevention of oral candidiasis (a.k.a. thrush), intestinal candidiasis, and anal candidiasis.[L10686,L10728] It is indicated topically for the treatment of vulvovaginal candidiasis and other cutaneous candida infections.[L10728] A combination product containing nystatin alongside [neomycin], [gramicidin D], and [triamcinolone] (Viaderm K.C.®) is indicated in the treatment of corticosteroid-responsive dermatoses caused by bacterial or candidal infections and for pruritus ani/vulvae.[L10731] It is also available in combination with [metronidazole] for the treatment of mixed infections due to _Trichomonas vaginalis_ and _Candida albicans_.[L10776]



Nystatin is also sometimes used off-label for the prevention of invasive candidiasis in low birth weight neonates,[A188565] though it is generally reserved as a second-line option after [fluconazole].', 'Nystatin is a channel-forming ionophore, meaning it exerts its therapeutic effect via formation of a membrane-spanning pore in the fungal plasma membrane.[A188592] The formation of this pore results in a change in membrane permeability that allows for leakage of intracellular contents and the subsequent disruption of electrochemical gradients necessary for proper cell function.[L10686,A188562] Selectivity for fungal cells over mammalian cells is due to nystatin’s greater binding affinity for ergosterol, a key sterol found in fungal cell walls, as opposed to its mammalian counterpart, cholesterol.[A16808]', 'Nystatin is an antifungal that is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It exerts its antifungal effects via disruption of the fungal cell membrane. Resistance to nystatin is minimal in _Candida albicans_, but tends to develop in other species of _Candida_.[L10686] Nystatin carries no significant activity against bacteria, protozoa, or viruses. It carries significant systemic toxicity and is currently unavailable in a formula appropriate for systemic use - its efficacy is currently restricted, therefore, to topical, oral, and gastrointestinal infections.[A188562]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Calcichew 500 mg 20 chew. tabs.', 1861, 'كالسيتشو د3 20قرص', '22', NULL, 'Calcium supplement', 'Calcium supplement', NULL, 'Calcium+magnesium+povidone', 'Marcyrl co. > takeda', 'Tab', 'أقراص', '500 mg', '2', NULL, NULL, NULL, '6224000335007', 1072, '2022-12-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Isoptin retard 240mg 30 f.c.tab.', 6627, 'ايسوبتن ريتارد 240مجم 30 قرص', '170', '97.5', 'Antihypertensive.cardioselective calcium chennel blocker', 'Antihypertensive.cardioselective calcium chennel blocker', NULL, 'Verapamil', 'Kahira > abbott laboratories', 'Tab', 'أقراص', '240mg', '3', 'علاج ارتفاع ضغط الدم', NULL, NULL, '8002660037664', 4692, '2025-01-02', NULL, 0, 'Verapamil is indicated in the treatment of vasopastic (i.e. Prinzmetal''s) angina, unstable angina, and chronic stable angina. It is also indicated to treat hypertension, for the prophylaxis of repetitive paroxysmal supraventricular tachycardia, and in combination with digoxin to control ventricular rate in patients with atrial fibrillation or atrial flutter.[L8791] Given intravenously, it is indicated for the treatment of various supraventricular tachyarrhythmias, including rapid conversion to sinus rhythm in patients with supraventricular tachycardia and for temporary control of ventricular rate in patients with atrial fibrillation or atrial flutter.[L10481]



Verapamil is commonly used off-label for prophylaxis of cluster headaches.[A13983]', 'Verapamil inhibits L-type calcium channels by binding to a specific area of their alpha-1 subunit,[L10478]Cav1.2, which is highly expressed on L-type calcium channels in vascular smooth muscle and myocardial tissue where these channels are responsible for the control of peripheral vascular resistance and heart contractility.[A175396] Calcium influx through these channels allows for the propagation of action potentials necessary for the contraction of muscle tissue and the heart''s electrical pacemaker activity. Verapamil binds to these channels in a voltage- and frequency-dependent manner, meaning affinity is increased 1) as vascular smooth muscle membrane potential is reduced, and 2) with excessive depolarizing stimulus.[L10478] 



Verapamil''s mechanism of action in the treatment of angina and hypertension is likely due to the mechanism described above. Inhibition of calcium influx prevents the contraction of vascular smooth muscle, causing relaxation/dilation of blood vessels throughout the peripheral circulation - this lowers systemic vascular resistance (i.e. afterload) and thus blood pressure. This reduction in vascular resistance also reduces the force against which the heart must push, decreasing myocardial energy consumption and oxygen requirements and thus alleviating angina.[L8791]



Electrical activity through the AV node is responsible for determining heart rate, and this activity is dependent upon calcium influx through L-type calcium channels. By inhibiting these channels and decreasing the influx of calcium, verapamil prolongs the refractory period of the AV node and slows conduction, thereby slowing and controlling the heart rate in patients with arrhythmia.[L8791]



Verapamil''s mechanism of action in the treatment of cluster headaches is unclear, but is thought to result from an effect on other calcium channels (e.g. N-, P-, Q-, or T-type).[A13983]



Verapamil is known to interact with other targets, including other calcium channels,[A188490,A13984,A188502,A15331] potassium channels,[A188496,A13985,A13983] and adrenergic receptors.[A20291,A31755]', 'Verapamil is an L-type calcium channel blocker with antiarrhythmic, antianginal, and antihypertensive activity.[L8791] Immediate-release verapamil has a relatively short duration of action, requiring dosing 3 to 4 times daily,[L8791] but extended-release formulations are available that allow for once-daily dosing.[L10478,L10637] As verapamil is a negative inotropic medication (i.e. it decreases the strength of myocardial contraction), it should not be used in patients with severe left ventricular dysfunction or hypertrophic cardiomyopathy as the decrease in contractility caused by verapamil may increase the risk of exacerbating these pre-existing conditions.[L10478]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dibiotimycin extra aerosol powder 85 ml', 17603, 'ديبيوتيميسين بودرة 85 مل', '28', NULL, 'Antibiotic topical', 'Antibiotic topical', NULL, 'Bacitracin+neomycin+polymyxin', 'Egyptian co. for adv. pharma. (ecap)', 'Sol', 'محلول', '85 ml', '1', NULL, NULL, NULL, NULL, 791, '2022-07-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Rhinex 0.1% adult 10ml nasal drops', 12998, 'رينكس نقط انف 0.1% كبار 10 مل', '18', '12', 'Decongestant', 'Decongestant', NULL, 'Xylometazoline', 'Cid', 'Drops', 'نقط', '0.1%', '1', 'مضاد احتقان نقط انف للكبار', NULL, NULL, '6221043011943', 1922, '2024-08-24', NULL, 0, 'Xylometazoline is indicated for the temporary relief of nasal congestion due to cold, hay fever or other respiratory allergies.[L31598]', 'Nasal congestion is caused by various etiologies, such as rhinosinusitis and allergic or non-allergic rhinitis, leading to congestion of the venous sinusoids lining the nasal mucosa. Activation of α-adrenergic receptors leads to vasoconstriction of the blood vessels of the nasal mucosa and resumption of nasal airflow.[A228533] As the most abundantly expressed in the human nasal mucosa, α<sub>1A</sub>- and α<sub>2B</sub>-adrenoceptors may play the most important role in vasoconstriction of the human nasal mucosa. Xylometazoline is a more selective agonist at α<sub>2B</sub>-adrenoceptors,[A6969, A228533] with affinity at α<sub>1A</sub>-, α<sub>2A</sub>-, α<sub>2C</sub>-, α<sub>1B</sub>-, and α<sub>1D</sub>-adrenoceptors.[A6969] Xylometazoline decreases nasal resistance during inspiration and expiration and increases the volume of nasal airflow. Compared to [oxymetazoline], another imidazoline nasal decongestant, xylometazoline had a slightly faster onset of action although they had a similar duration of action.[A228533] In one study, subjects with nasal congestion reported relief of earache and sore throat in addition to nasal decongestion: it is speculated that oxymetazoline mediates this effect by causing vasoconstriction of the nasal mucosa that contains the venous sinuses and nasal decongestion allows breathing through the nose, providing relief from sore throat caused by mouth breathing that dries and irritates the throat.[A228508]', 'Xylometazoline is a sympathomimetic agent that causes vasoconstriction of the nasal mucosa. In one study comprising subjects with nasal congestion associated with the common cold, the median time of onset of subjective relief of nasal congestion was about 1.7 minutes and the time of subjective peak relief of nasal congestion was 30 minutes.[A228508] Previous studies reported rebound swelling, rebound nasal congestion, rhinitis medicamentosa, and shorter duration of decongestant effect from the long-term use of xylometazoline in healthy volunteers, suggesting that the drug is most effective if used temporarily.[A228508, A228518]



An early _in vitro_ study demonstrated xylometazoline to exert anti-oxidant actions, where it inhibited microsomal lipid peroxidation and mediated hydroxyl radical scavenging activity. This suggests that xylometazoline has a beneficial effect against oxidants, which play a role in tissue damage in inflammation.[A228538]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tramal 100mg/2ml 3 amps', 481, 'امادول 100 مجم/2مل 3 امبولات', '14', NULL, 'Analgesics.narcotic opioid', 'Analgesics.narcotic opioid', NULL, 'Tramadol', 'Adwia', 'Amp', 'أمبول', '100mg', '3', NULL, NULL, NULL, NULL, 1884, '2022-08-31', NULL, 0, 'Tramadol is approved for the management of moderate to severe pain in adults.[L9257,F4679]



Tramadol is also used off-label in the treatment of premature ejaculation.[A173986]', 'Tramadol is a centrally acting μ-opioid receptor agonist and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to [codeine] and [morphine]. Tramadol binds weakly to κ- and δ-opioid receptors and to the μ-opioid receptor with 6000-fold less affinity than morphine.[A182300]



Tramadol exists as a racemic mixture consisting of two pharmacologically active enantiomers that both contribute to its analgesic property through different mechanisms: (+)-tramadol and its primary metabolite (+)-O-desmethyl-tramadol (M1) are agonists of the μ opioid receptor while (+)-tramadol inhibits serotonin reuptake and (-)-tramadol inhibits norepinephrine reuptake. These pathways are complementary and synergistic, improving tramadol''s ability to modulate the perception of and response to pain.[A4269] 



In animal models, M1 is up to 6 times more potent than tramadol in producing analgesia and 200 times more potent in μ-opioid binding.[L9257] 



Tramadol has also been shown to affect a number of pain modulators including alpha2-adrenoreceptors, neurokinin 1 receptors, the voltage-gated sodium channel type II alpha subunit[A183728], transient receptor potential cation channel subfamily V member 1 (TRPV1 - also known as the capsaicin receptor)[A183734], muscarinic receptors (M1 and M3), N-methyl-D-aspartate receptor (also known as the NMDA receptor or glutamate receptor)[A17158], Adenosine A1 receptors[A183761], and nicotinic acetylcholine receptor.[A17159] 



In addition to the above neuronal targets, tramadol has a number of effects on inflammatory and immune mediators involved in the pain response. This includes inhibitory effects on cytokines, prostaglandin E2 (PGE2), nuclear factor-κB, and glial cells as well as a change in the polarization state of M1 macrophages.[A182300]', 'Tramadol modulates the descending pain pathways within the central nervous system through the binding of parent and M1 metabolite to μ-opioid receptors and the weak inhibition of the reuptake of norepinephrine and serotonin.[A173983,A173980] 



Apart from analgesia, tramadol may produce a constellation of symptoms (including dizziness, somnolence, nausea, constipation, sweating and pruritus) similar to that of other opioids. 



**Central Nervous System**



In contrast to [morphine], tramadol has not been shown to cause histamine release. At therapeutic doses, tramadol has no effect on heart rate, left-ventricular function or cardiac index. Orthostatic hypotension has been observed.[L9257]



Tramadol produces respiratory depression by direct action on brain stem respiratory centres. The respiratory depression involves both a reduction in the responsiveness of the brain stem centres to increases in CO2 tension and to electrical stimulation. 



Tramadol depresses the cough reflex by a direct effect on the cough centre in the medulla. Antitussive effects may occur with doses lower than those usually required for analgesia.



Tramadol causes miosis, even in total darkness. Pinpoint pupils are a sign of opioid overdose but

are not pathognomonic (e.g., pontine lesions of hemorrhagic or ischemic origin may produce

similar findings). Marked mydriasis rather than miosis may be seen with hypoxia in the setting of

oxycodone overdose.[F4679]



Seizures have been reported in patients receiving tramadol within the recommended dosage range. Spontaneous post-marketing reports indicate that seizure risk is increased with doses of tramadol above the recommended range. Risk of convulsions may also increase in patients with epilepsy, those with a history of seizures

or in patients with a recognized risk for seizure (such as head trauma, metabolic disorders,

alcohol and drug withdrawal, CNS infections), or with concomitant use of other drugs known to reduce the seizure threshold.[F4679]



Tramadol can cause a rare but potentially life-threatening condition resulting from concomitant administration of serotonergic drugs (e.g., anti-depressants, migraine medications). Treatment with the serotoninergic drug should be discontinued if such events (characterized by clusters of symptoms such as hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, mental status changes including confusion, irritability, extreme agitation progressing to delirium and coma) occur and supportive symptomatic treatment should be initiated. Tramadol should not be used in combination with MAO inhibitors or serotonin-precursors (such as L-tryptophan, oxitriptan) and should be used with caution in combination with other serotonergic drugs (triptans, certain tricyclic antidepressants, lithium, St. John’s Wort) due to the risk of serotonin syndrome.[F4679]



**Gastrointestinal Tract and Other Smooth Muscle**



Tramadol causes a reduction in motility associated with an increase in smooth muscle tone in the antrum of the stomach and duodenum. Digestion of food in the small intestine is delayed and propulsive contractions are decreased. Propulsive peristaltic waves in the colon are decreased, while tone may be increased to the point of spasm resulting in constipation. Other opioid-induced effects may include a reduction in gastric, biliary and pancreatic secretions, spasm of the sphincter of Oddi, and transient elevations in serum amylase.[F4679]



**Endocrine System**



Opioids may influence the hypothalamic-pituitary-adrenal or -gonadal axes. Some changes that can be seen include an increase in serum prolactin and decreases in plasma cortisol and testosterone. Clinical signs and symptoms may be manifest from these hormonal changes.[F4679]



Hyponatremia has been reported very rarely with the use of tramadol, usually in patients with predisposing risk factors, such as elderly patients and/or patients using concomitant medications that may cause hyponatremia (e.g., antidepressants, benzodiazepines, diuretics). In some reports, hyponatremia appeared to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and resolved with discontinuation of tramadol and appropriate treatment (e.g., fluid restriction). During tramadol treatment, monitoring for signs and symptoms of hyponatremia is recommended for patients with predisposing risk factors.[F4679]



**Cardiovascular**



Tramadol administration may result in severe hypotension in patients whose ability to maintain adequate blood pressure is compromised by reduced blood volume, or concurrent administration of drugs such as phenothiazines and other tranquillizers, sedative/hypnotics, tricyclic antidepressants or general anesthetics. These patients should be monitored for signs of hypotension after initiating or titrating the dose of tramadol.[F4679]



**QTc-Interval Prolongation**



The maximum placebo-adjusted mean change from baseline in the QTcF interval was 5.5 ms in the 400 mg/day treatment arm and 6.5 ms in the 600 mg/day mg treatment arm, both occurring at the 8h time point. Both treatment groups were within the 10 ms threshold for QT prolongation. Post-marketing experience with the use of tramadol containing products included rare reports of QT prolongation reported with an overdose. Particular care should be exercised when administering tramadol to patients who are suspected to be at an increased risk of experiencing torsade de pointes during treatment with a QTc-prolonging drug.[F4679]



**Abuse and Misuse**



Like all opioids, tramadol has the potential for abuse and misuse, which can lead to overdose and death. Therefore, tramadol should be prescribed and handled with caution.[F4679]



**Dependence/Tolerance**



Physical dependence and tolerance reflect the neuroadaptation of the opioid receptors to chronic exposure to an opioid and are separate and distinct from abuse and addiction. Tolerance, as well as physical dependence, may develop upon repeated administration of opioids, and are not by themselves evidence of an addictive disorder or abuse. Patients on prolonged therapy should be tapered gradually from the drug if it is no longer required for pain control. Withdrawal symptoms may occur following abrupt discontinuation of therapy or upon administration of an opioid antagonist. Some of the symptoms that may be associated with abrupt withdrawal of an opioid analgesic include body aches, diarrhea, gooseflesh, loss of appetite, nausea, nervousness or restlessness, anxiety, runny nose, sneezing, tremors or shivering, stomach cramps, tachycardia, trouble with sleeping, unusual increase in sweating, palpitations, unexplained fever, weakness and yawning.[F4679]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Viracure 7.5% cream 15g', 12330, 'فيراكيور 7.5% كريم 15 جرام', '18', NULL, 'Antiviral.nucleoside', 'Antiviral.nucleoside', NULL, 'Ribavirin', 'October pharma', 'Cream', 'كريم', '7.5%', '1', NULL, NULL, NULL, '6221088050044', 723, '2022-12-14', NULL, 0, 'Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates [A19644].



The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis. 



Resistance: viral genetic determinants resulting in variable response to ribavirin therapy has not been yet determined. ', 'Ribavirin is reported to have several mechanism of actions that lead to inhibition of viral RNA and protein synthesis. 

After activation by adenosine kinase to ribavirin mono-, di-, and triphosphate metabolites. Ribavirin triphosphate (RTP) is the predominant metabolite which directly inhibits viral mRNA polymerase by binding to the nucleotide binding site of the enzyme. This prevents the binding of the correct nucleotides, leading to a reduction in viral replication or to the production of defective virions [A19645]. RTP also demonstrates an inhibitory action on viral mRNA guanylyltransferase and mRNA 2′-O-methyltransferase of dengue virus. Inhibition of these enzymes disrupts the posttranslational capping of the 5′ end of viral mRNA through ribavirin being incorporated at the 5′ end in place of guanosine and preventing the cap methylation step. 



Inhibition of host inosine monophosphate dehydrogenase (IMPDH) and subsequent depletion of GTP pool is proposed to be another mechanism of action of ribavirin. IMPDH catalyzes the rate-limiting step where inosine 5′-monophosphate is converted to xanthine monophosphate during guanosine monophosphate (GMP) synthesis. GMP is later converted to guanosine triphoshpate (GTP). Ribavirin monophosphate mimics inosine 5′-monophosphate and acts as a competitive inhibitor of IMPDH. Inhibited de novo synthesis of guanine nucleotides and decreased intracellular GTP pools leads to a decline in viral protein synthesis and limit replication of viral genomes [A19645].



Ribavirin acts as a mutagen in the target virus to cause an ''error catastrophe'' due to increased viral mutations. RTP pairs with cytidine triphosphate or uridine triphosphate with equal efficiency and to block HCV RNA elongation. It causes premature termination of nascent HCV RNA and increases mutagenesis by producing defective virions [A19645].



Ribavirin also exerts an immunomodulatory action of the host to the virus by shifting a Th2 response in favor of a Th1 phenotype. Th2 response and production of type 2 cytokines such as IL-4, IL-5, and IL-10 stimulates the humoral response which enhances immunity toward the virus [A19645]. Ribavirin enhanced induction of interferon-related genes, including the interferon-α receptor, and down-regulation of genes involved in interferon inhibition, apoptosis, and hepatic stellate cell activation in vitro [A19644]. ', 'Ribavirin mediates direct antiviral activity against a number of DNA and RNA viruses by increasing the mutation frequency in the genomes of several RNA viruses. It is a member of the nucleoside antimetabolite drugs that interfere with duplication of the viral genetic material. The drug inhibits the activity of the enzyme RNA dependent RNA polymerase, due to its resemblence to building blocks of the RNA molecules. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Norigyncin 50/5mg i.m. amp.', 26128, 'نوريجينسين 50/5مجم امبول عضل', '31', '23.5', 'Contraceptive', 'Contraceptive', NULL, 'Estradiol+norethisterone', 'Ait', 'Amp', 'أمبول', '5mg', '1', 'مانع للحمل', NULL, NULL, '6224000588526', 2857, '2025-09-30', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Visceralgine 5mg/2ml im iv 6 ampoules', 12999, 'فيسرالجين حقن 5 مجم/2 مل عضل/وريد 6 أمبولات', '90', '63', 'Spasmolytic', 'Spasmolytic', NULL, 'Tiemonium methylsulphate', 'Sedico', 'Ampoule', 'أمبول', '5mg', '6', 'مضاد للتقلصات / للمغص', NULL, NULL, '6221042406061', 13252, '2024-06-27', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dexamethasone-inad 8mg/2ml 3amp', 18450, 'ديكساميثازون ايناد 8مجم/2مل 3 امبولات', '36', '22.5', NULL, NULL, NULL, 'Dexamethasone phosphate', 'Inad pharma', 'Amp', 'أمبول', '8mg', '3', NULL, NULL, NULL, NULL, 1940, '2024-08-01', NULL, 0, 'Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.[L10698] Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Oral tablets are indicated for the treatment of multiple myeloma.[L10710] An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.[L10719] Various ophthalmic formulations are indicated for inflammatory conditions of the eye.[L10704,L10707,L10713,L10716,L10722,L10725]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.[A187463] Dexamethasone''s duration of action varies depending on the route.[L10698,L10701,L10704,L10707,L10710,L10713,L10716,L10719,L10722,L10725] Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces.[A187463] Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Diet-sweet 350 tabs', 17631, 'دايت-سويت 350 قرص', '74', '60', 'Sweetener', 'Sweetener', NULL, 'Aspartame', 'Amriya', 'Tab', 'أقراص', NULL, '1', 'سكر دايت -- محلي للطعام -- يستخدم في عدم زيادة الوزن', NULL, NULL, '6221075010112', 3080, '2024-03-20', NULL, 0, 'Used as a diet supplement and sugar substitute.', '180 to 200 times sweeter than sucrose, it is metabolized as a protein and its subsequent amino-acids used up in there respective mechanisms.', 'Aspartame (L-alpha-aspartyl-L-phenylalanine methyl ester) is a low-calorie sweetener used to sweeten a wide variety of low- and reduced-calorie foods and beverages, including low-calorie tabletop sweeteners. Aspartame is composed of two amino acids, aspartic acid and phenylalanine, as the methyl ester. Aspartic acid and phenylalanine are also found naturally in protein containing foods, including meats, grains and dairy products. Methyl esters are also found naturally in many foods such as fruits and vegetable and their juices. Upon digestion, aspartame breaks down into three components (aspartic acid, phenylalanine and methanol), which are then absorbed into the blood and used in normal body processes. Neither aspartame nor its components accumulates in the body. These components are used in the body in the same ways as when they are derived from common foods.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Spironolactone (delta) 25mg 10 tab', 10817, 'سبيرونولاكتون 25مجم 10 اقراص', '3', NULL, 'Diuretic.potassium-sparing diuretics', 'Diuretic.potassium-sparing diuretics', NULL, 'Spironolactone', 'Global napi pharmaceuticals > al delta pharmaceuticals trading co.', 'Tab', 'أقراص', '25mg', '1', 'مدر للبول', NULL, NULL, NULL, 3809, '2022-11-07', NULL, 0, 'Spironolactone is indicated for the treatment of the following conditions:



- NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and reduce the need for hospitalization for heart failure. Spironolactone is usually administered in conjunction with other heart failure therapies.[L44602]

- Hypertension, as add-on therapy, in patients not adequately controlled by other agents.[L44602, L47810]

- Edema associated with hepatic cirrhosis when edema is not responsive to fluid and sodium restriction.[L44602, L47810]

- Edema associated with nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.[L44602]

- Refractory edema associated with congestive cardiac failure, malignant ascites, hepatic cirrhosis with ascites, and essential hypertension.[L47810]

- Short-term preoperative treatment of patients with primary hyperaldosteronism.[L44602, L47810]

- Diagnosis of primary aldosteronism.[L47810]

- Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are not candidates for surgery.[L44602]

- Long-term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism).[L44602]



As spironolactone has antiandrogenic activity, its off-label uses include the treatment of hirsutism, female pattern hair loss, and adult acne vulgaris.[A178135, A261025]', 'Aldosterone is a key hormone in the renin-angiotensin-aldosterone system. By binding to the mineralocorticoid receptor at the distal tubules and collecting duct, it causes sodium reabsorption and potassium secretion, increases vascular stiffness and remodelling, and activates pro-inflammatory pathways.[A178192, A261025]



Spironolactone and its active metabolites are aldosterone antagonists that produce a potassium-sparing diuretic effect. They competitively bind to receptors at the aldosterone-dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone causes increased amounts of sodium and water to be excreted while potassium is retained. Spironolactone acts both as a diuretic and as an antihypertensive drug by this mechanism. It may be given alone or with other diuretic agents that act more proximally in the renal tubule.[A178192, L44602]', 'Spironolactone has a potassium-sparing diuretic effect. It promotes sodium and water excretion and potassium retention. It increases renin and aldosterone levels.[A11837] Spironolactone is a mineralocorticoid receptor antagonist and has a low affinity for the glucocorticoid receptor.[A11834] It also exhibits progestogenic and anti-androgenic actions as it binds to the androgen receptor and, to a lesser extent, estrogen and progesterone receptors.[A11837, A178192, A261025] Spironolactone exhibits anti-inflammatory effects.[A178192]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Safe white cream 50 gm', 26446, 'سيف كريم 50جم', '45', NULL, 'Whitening topical', 'Whitening topical', NULL, 'Kojic acid+wheat germ oil+ascorbyl palmitate(vitamin c)+liquorice ext', 'Beauty pharm international > pioneer leaders', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, 'natural whitening cream ** use: to be applied once or twice a day at night.', NULL, 702, '2022-07-26', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Zahaslim 30 caps.', 31641, 'زاهاسليم 30 كبسولة', '295', '245', 'Weight loss and fat burning', 'Weight loss and fat burning', NULL, 'L-carnitine l-tartrate+chromium+vitamin d3+biotin+riboflavin (vitamin b2)+niacin (vitamin b3)+vitamin b6', 'Copad pharma > rovex pharma', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, 'mechanism of action : l-carnitine pley important role in energy production and fat burning by: transports fat to cell (mitochondria) then mitochondria burn those fat to produce energy 2-chromium increases glucose metabolism and decrease insulin resistance', NULL, 1185, '2025-08-08', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Trusty soap 100 gm', 28596, 'تراستي صابون 100 جرام لحب الشباب', '50', '35.95', 'Anti-acne', 'Anti-acne', NULL, 'Salicylic acid+lemon oil+zinc acetate+tea tree oil+panthenol+lavender oil+liquorice+triclosan+titani', 'Egyptian company for cosmetics > pearla pharm co.', 'Soap', 'صابون', '100 gm', '1', 'لعلاج حالات حب الشباب بالوجه', NULL, 'for all forms of acne.', NULL, 1249, '2023-12-23', NULL, 0, 'Key additive in many skin-care products for the treatment of acne, psoriasis, callouses, corns, keratosis pilaris and warts.', 'Salicylic acid directly irreversibly inhibits COX-1 and COX-2 to decrease conversion of arachidonic acid to precursors of prostaglandins and thromboxanes. Salicylate''s use in rheumatic diseases is due to it''s analgesic and anti-inflammatory activity. Salicylic acid is a key ingredient in many skin-care products for the treatment of acne, psoriasis, calluses, corns, keratosis pilaris, and warts. Salicylic acid allows cells of the epidermis to more readily slough off. Because of its effect on skin cells, salicylic acid is used in several shampoos used to treat dandruff. Salicylic acid is also used as an active ingredient in gels which remove verrucas (plantar warts). Salicylic acid competitively inhibits oxidation of uridine-5-diphosphoglucose (UDPG) with nicotinamide adenosine dinucleotide (NAD) and noncompetitively with UDPG. It also competitively inhibits the transferring of the glucuronyl group of uridine-5-phosphoglucuronic acid (UDPGA) to a phenolic acceptor. Inhibition of mucopoly saccharide synthesis is likely responsible for the slowing of wound healing with salicylates.', 'Salicylic acid treats acne by causing skin cells to slough off more readily, preventing pores from clogging up. This effect on skin cells also makes salicylic acid an active ingredient in several shampoos meant to treat dandruff. Use of straight salicylic solution may cause hyperpigmentation on unpretreated skin for those with darker skin types (Fitzpatrick phototypes IV, V, VI), as well as with the lack of use of a broad spectrum sunblock. Subsalicylate in combination with bismuth form the popular stomach relief aid known commonly as Pepto-Bismol. When combined the two key ingredients help control diarrhea, nausea, heartburn, and even gas. It is also very mildly anti-biotic.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ampicillin-el nasr 500 mg vial', 14030, 'امبيسللين 500مجم فيال', '3', NULL, 'Penicillins.monocomponent', 'Penicillins.monocomponent', NULL, 'Ampicillin', 'El nasr', 'Amp', 'أمبول', '500 mg', '1', NULL, NULL, 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', NULL, 940, '2022-10-29', NULL, 0, 'For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc', 'By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Ampicillin interferes with an autolysin inhibitor.', 'Ampicillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Ampicillin has <i>in vitro</i> activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Ampicillin results from the inhibition of cell wall synthesis and is mediated through Ampicillin binding to penicillin binding proteins (PBPs). Ampicillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dg-wash clove mouth wash 220ml', 17514, 'دي جي-ووش غسول للفم 220 مل', '65', '29.95', 'Oral care', 'Oral care', NULL, 'Chlorhexidine+clove oil+propolis', 'Al esraa pharmaceutical optima', 'Mouth wash', 'غسول للفم', '220ml', '1', NULL, NULL, 'new squeazy bottle', NULL, 1163, '2022-07-11', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Avantgarde baby diaper 75 gm cream', 1391, 'افانتجاردي بيبي ديابر كريم للحفاضة 75 جرام', '89', NULL, 'Zinc oxide bees wax olive oil avocado extract panthenol', 'Zinc oxide bees wax olive oil avocado extract panthenol', NULL, 'Zinc oxide+bees wax+olive oil+avocado extract+panthenol', 'Avantgarde pharma', 'Cream', 'كريم', '75 gm', '1', NULL, NULL, NULL, NULL, 1150, '2024-05-20', NULL, 0, 'Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].  



', '**Zinc has three primary biological roles**: _catalytic_, _structural_, and _regulatory_. The catalytic and structural role of zinc is well established, and there are various noteworthy reviews on these functions. For example, zinc is a structural constituent in numerous proteins, inclusive of growth factors, cytokines, receptors, enzymes, and transcription factors for different cellular signaling pathways. It is implicated in numerous cellular processes as a cofactor for approximately 3000 human proteins including enzymes, nuclear factors, and hormones [L2096].



Zinc promotes resistance to epithelial apoptosis through cell protection (cytoprotection) against reactive oxygen species and bacterial toxins, likely through the antioxidant activity of the cysteine-rich metallothioneins [A32419].



In HL-60 cells (promyelocytic leukemia cell line), zinc enhances the up-regulation of A20 mRNA, which, via TRAF pathway, decreases NF-kappaB activation, leading to decreased gene expression and generation of tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8 [A32418].



There are several mechanisms of action of zinc on acute diarrhea. Various mechanisms are specific to the gastrointestinal system: zinc restores mucosal barrier integrity and enterocyte brush-border enzyme activity, it promotes the production of antibodies and circulating lymphocytes against intestinal pathogens, and has a direct effect on ion channels, acting as a potassium channel blocker of adenosine 3-5-cyclic monophosphate-mediated chlorine secretion. Cochrane researchers examined the evidence available up to 30 September 2016 [L2106].



Zinc deficiency in humans decreases the activity of serum _thymulin_ (a hormone of the thymus), which is necessary for the maturation of T-helper cells. T-helper 1 (Th(1)) cytokines are decreased but T-helper 2 (Th(2)) cytokines are not affected by zinc deficiency in humans [A32417].



The change of _Th(1)_ to _Th(2)_ function leads to cell-mediated immune dysfunction. Because IL-2 production (Th(1) cytokine) is decreased, this causes decreased activity of natural-killer-cell (NK cell) and T cytolytic cells, normally involved in killing viruses, bacteria, and malignant cells [A32424]. 



In humans, zinc deficiency may lead to the generation of new CD4+ T cells, produced in the thymus. In cell culture studies (HUT-78, a Th(0) human malignant lymphoblastoid cell line), as a result of zinc deficiency, nuclear factor-kappaB (NF-kappaB) activation, phosphorylation of IkappaB, and binding of NF-kappaB to DNA are decreased and this results in decreased Th(1) cytokine production [A32417].



In another study, zinc supplementation in human subjects suppressed the gene expression and production of pro-inflammatory cytokines and decreased oxidative stress markers [A32424]. In HL-60 cells (a human pro-myelocytic leukemia cell line), zinc deficiency increased the levels of TNF-alpha, IL-1beta, and IL-8 cytokines and mRNA. In such cells, zinc was found to induce A20, a zinc finger protein that inhibited NF-kappaB activation by the tumor necrosis factor receptor-associated factor pathway. This process decreased gene expression of pro-inflammatory cytokines and oxidative stress markers [A32417].



The exact mechanism of zinc in acne treatment is poorly understood. However, zinc is considered to act directly on microbial inflammatory equilibrium and facilitate antibiotic absorption when used in combination with other agents. Topical zinc alone as well as in combination with other agents may be efficacious because of its anti-inflammatory activity and ability to reduce P. acnes bacteria by the inhibition of P. acnes lipases and free fatty acid levels [L2102].', 'Zinc is involved in various aspects of cellular metabolism. It has been estimated that approximately 10% of human proteins may bind zinc, in addition to hundreds of proteins that transport and traffic zinc. It is required for the catalytic activity of more than 200 enzymes, and it plays a role in immune function wound healing, protein synthesis, DNA synthesis, and cell division. Zinc is an essential element for a proper sense of taste and smell and supports normal growth and development during pregnancy, childhood, and adolescence. It is thought to have antioxidant properties, which may be protective against accelerated aging and helps to speed up the healing process after an injury; however, studies differ as to its effectiveness. Zinc ions are effective antimicrobial agents even if administered in low concentrations [L2211].



Studies on oral zinc for specific conditions shows the following evidence in various conditions [L2095]:



**Colds:** Evidence suggests that if zinc lozenges or syrup are taken within 24 hours after cold symptoms start, the supplement may shorten the length of colds. The use intranasal zinc has been associated with the loss of the sense of smell, in some cases long-term or permanently [L2095].



**Wound healing:** Patients with skin ulcers and decreased levels of zinc may benefit from oral zinc supplements [L2095]. 



**Diahrrea**: Oral zinc supplements can reduce the symptoms of diarrhea in children with low levels of zinc, especially in cases of malnutrition [L2095].

', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Revivogen pro hair mask 207 ml', 25966, 'ريفيفوجين برو ماسك للشعر 207مل', '824', NULL, 'Hair care', 'Hair care', NULL, NULL, 'Advanced skin and hair inc. > vamer pharma', 'Unknown', 'غير محدد', '207 ml', '1', NULL, NULL, NULL, NULL, 614, '2022-08-03', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Ferrorave one 30 cap', 32851, 'فيروريف وان 30 كبسولة', '88', '58', 'Multivitamin', 'Multivitamin', NULL, 'Iron( liposomal)+vit c+vit b 12+vit b 6+vit d+folic acid', 'Pharma-one', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 1279, '2024-10-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Winzoxib 60 mg 30 f.c.tabs.', 6168, 'وينزوكسيب 60مجم 30 قرص', '189', NULL, 'Nsaid.selective cox-2 inhibitors', 'Nsaid.selective cox-2 inhibitors', NULL, 'Etoricoxib', 'Al esraa pharmaceutical optima', 'Tab', 'أقراص', '60 mg', '3', NULL, NULL, NULL, NULL, 961, '2023-04-28', NULL, 0, 'For the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.', 'Like any other COX-2 selective inhibitor Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2), preventing production of prostaglandins (PGs) from arachidonic acid.', 'Etoricoxib is a COX-2 selective inhibitor (approximately 106 times more selective for COX-2 inhibition over COX-1).', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Methotrexate 2.5mg 100 tablets (orion)', 22648, 'ميثوتريكسات 2.5مجم 100 قرص (اوريون)', '130', NULL, 'Antineoplastic', 'Antineoplastic', NULL, 'Methotrexate', 'Orion pharma-finland > s.m. pharma', 'Tablet', 'أقراص', '2.5mg', '10', 'مضاد للاورام - مضاد التهابات', NULL, NULL, '6222003456354', 15483, '2023-05-29', NULL, 0, 'Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis.[L7144] Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis.[L7147,L7150,L10457] It has also been approved by the EMA for the treatment of adult patients requiring systemic therapy for moderate-to-severe plaque psoriasis.[L48796]



Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin''s lymphoma.[L7180] It is also used in the maintenance of acute lymphocytic leukemia.[L7180] Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.[L7180]', 'Methotrexate enters tissues and is converted to a methotrexate polyglutamate by folylpolyglutamate.[A180322]



Methotrexate''s mechanism of action is due to its inhibition of enzymes responsible for nucleotide synthesis including  dihydrofolate reductase, thymidylate synthase, aminoimidazole caboxamide ribonucleotide transformylase (AICART), and amido phosphoribosyltransferase.[A180322] Inhibtion of nucleotide synthesis prevents cell division.



In rheumatoid arthritis, methotrexate polyglutamates inhibit AICART more than methotrexate.[A180322] This inhibition leads to accumulation of AICART ribonucleotide, which inhibits adenosine deaminase, leading to an accumulation of adenosine triphosphate and adenosine in the extracellular space, stimulating adenosine receptors, leading to anti-inflammatory action.[A180322]', 'Methotrexate inhibits enzymes responsible for nucleotide synthesis which prevents cell division and leads to anti-inflammatory actions.[A180322] It has a long duration of action and is generally given to patients once weekly.[A180322,L7144,L7147,L7150] Methotrexate has a narrow therapeutic index.[A180325]



Do not take methotrexate daily.[L7147,L7150]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Theragran hematenic 30 tab.', 11358, 'ثيراجران هيماتينيك 30 قرص', '29', NULL, 'Multivitamins', 'Multivitamins', NULL, 'Multivitamins+iron', 'Smithkline beecham', 'Tab', 'أقراص', NULL, '3', '1- مقويات مع فيتامينات للضعف العام.', NULL, NULL, '6224001007408', 8459, '2023-03-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Utoprost 10 caps.', 28885, 'يوتوبروست 10 كبسولات', '15', NULL, 'Prostate support', 'Prostate support', NULL, 'Saw palmetto+pumpkin seed oil+echinaceae purpurea+zinc sulphate', 'Future pharmaceutical industries (fpi) > utopia pharmaceuticals company', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, 'saw palmetto .. 160 mg pumpkin seed oil .. 300 mg echinaceae purpurea .. 100 mg zinc sulphate .. 30.4 mg', NULL, 1550, '2022-06-28', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Accofil 30 miu/0.5ml 5 prefilled syringes', 13308, 'اكوفيل 30مليون وحدة/0.5مل 5 سرنجات معبأة', '1,625', NULL, 'Granulocyte colony-stimulating factor (g-csf)', 'Granulocyte colony-stimulating factor (g-csf)', NULL, 'Filgrastim', 'Accord healthcare limited > united group pharmaceutical(u.g.p.)', 'Syringe', 'حقنة', '0.5ml', '5', 'عامل نمو مكون للدم -- يستخدم بعد عملية زرع نخاع العظام -- يستخدم بعد العلاج الكميائي', NULL, 'about filgrastim a cytokine glycoprotein a human granulocyte colony-stimulating factor (g-csf) analog immunostimulant. mechanism of action of filgrastim filgrastim is a cytokine glycoprotein that stimulates proliferation differentiation and functional act', NULL, 1070, '2022-10-04', NULL, 0, 'Filgrastim is indicated to decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever.[L40714]



Filgrastim is indicated for reducing the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia.[L40714]



Filgrastim is indicated to reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation.[L40714]



Filgrastim is indicated for the mobilization of autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis.[L40714]



Filgrastim is indicated for chronic administration to reduce the incidence and duration of sequelae of neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia.[L40714]



Filgrastim is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation.[L40714]', 'Neutrophils are critical granulocytes involved in the acute inflammatory response and host defences against bacterial infections.[A245873] They also contribute to long-term adaptive immunity by promoting immediate host immune response and attracting other cells, such as macrophages and dendritic cells. As neutrophils promote both the initiation and the maintenance of inflammation at sites of infection, suppressed neutrophil responses lead to extreme susceptibility to infection.[A35605] Low neutrophil levels, or neutropenia, caused by chronic neutropenia, myelosuppressive chemotherapy, and radiation therapy increases the risk of infection and related events.[A245868] Neutropenia caused by chemotherapy or radiation therapy can further progress into febrile neutropenia, which is associated with an elevated risk for life-threatening systemic infections and chemotherapy-associated morbidity and mortality.[A35591]



The production and release of functional neutrophils from the bone marrow are normally regulated by granulocyte colony-stimulating factors (G-CSF), which are major cytokine regulators of neutrophilic granulocytes.[A35605] G-CSFs act on hematopoietic cells by binding to specific cell surface receptors to stimulate the proliferation‚ differentiation‚ and maturation of neutrophil progenitors. G-CSF also induces some end-cell functional activation of neutrophils, including enhanced phagocytic ability‚ priming of the cellular metabolism associated with respiratory burst‚ antibody-dependent killing, and the increased expression of some cell surface antigens.[L40714]  Filgrastim is a short-acting recombinant G-CSF that mimics the biological actions of endogenous G-CSF. It also facilitates the release of neutrophils from the bone marrow into the blood to reduce the incidence of infection and manage neutropenia.[A245858, A245868]', 'Filgrastim is used to reduce the incidence, severity and duration of neutropenia and febrile neutropenia in patients undergoing cytotoxic chemotherapy. In clinical trials in patients, filgrastim reduced the duration of febrile neutropenia, antibiotic use, and hospitalization after induction chemotherapy for acute myelogenous leukemia or myeloablative therapy followed by bone marrow transplantation; however, the incidence of fever and documented infections were not reduced in either setting.[L40719] 



Filgrastim is also used to mobilize hematopoietic progenitor cells into the peripheral blood in order to reduce the risk for bleeding complications and the need for platelet transfusions. Recipients of allogeneic PBPCs mobilized with filgrastim experienced significantly more rapid hematological recovery, leading to a significant decrease in time to unsupported platelet recovery when compared with allogeneic bone marrow transplantation.[L40719] 



Filgrastim causes a dose-dependent increase in circulating neutrophil counts within 24 hours of administration. Filgrastim can also cause a minor increase in monocyte and lymphocyte counts, but the clinical significance of these effects is unknown.[L40714] In some patients, filgrastim also caused a minor increase in the number of circulating eosinophils and basophils relative to baseline; however, these patients may already have had elevated eosinophils and basophils prior to filgrastim treatment. Following termination of filgrastim therapy, circulating neutrophil counts decrease by 50% within one to two days, and to normal levels within one to seven days. As with other hematopoietic growth factors, G-CSF has shown _in vitro_ stimulating properties on human endothelial cells.[L40719] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Osteopause 2gm 7 gr. in sachets', 24338, 'اوستيوبوز 2جم 7 اكياس', '43', NULL, 'Osteoporosis.antiresorptives', 'Osteoporosis.antiresorptives', NULL, 'Strontium ranelate', 'Marcyrl co.', 'Sachet', 'أكياس', '2gm', '1', NULL, NULL, 'about strontium ranel bone metabolism modulator antiosteoporotic agent mechanism of action of strontium ranel strontium ranelate is an antiosteoporotic agent which both increases bone formation and reduces bone resorption. strontium ranelate stimulates th', '6223003579814', 962, '2022-12-07', NULL, 0, 'Strontium ranelate is therapeutically indicated for the treatment of severe osteoperosis in: a) postmenopasual women, and b) adult men, who are at high risk of fractures, for whom treatment with other medical products approved for the treatment of osteoperosis is not possible due to, for example, contraindications or intolerance. [L1127]



In postmenopausal women, strontium ranelate can also reduce the risk of vertebral and hip fractures [L1127].', 'The underlying pathogenesis of osteperosis involves an imbalance between bone resorption and bone formation. Osteoclasts are a kind of differentiated or specialized bone cell that breaks down bone tissue while osteoblasts are another set of differentiated bone cells that synthesize and rebuild bone tissue. When osteoclasts degrade bone tissue faster than the osteoblasts are capable of rebuilding the bone tissue, low or inadequate bone mass density and osteoperosis can resula One of the mechanisms with which strontium ranelate is thought to act is its functionality as an agonist of the extracellular calcium sensing receptors (CaSRs) [A31553] of osteoblasts and osteoclasts [A31542]. Ordinary interaction between calcium 2+ divalent cations with mature osteoclast CaSRs is known to induce osteoclast apoptosis. Subsequently, strontium 2+ divalent cations from strontium ranelate use can also bind CaSRs on osteoclasts to induce their apoptosis because of the strontium 2+ cation''s close resemeblance to calcium 2+. Contact between extracelluar calcium 2+ and osteoclast CaSRs stimulates the phospholipase C (PLC) dependant breakdown of phosphatidylinositol 4,5-biphosphate (PIP2) into the two secondary messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). Whereas the calcium-CaSRs interaction then performs IP3 Adependent translocation of nuclear factor NF-kB from the cytoplasm to the nucleus in mature osteoclasts, strontium-CaSRs interactions involves a DAG-PKC beta II (protein kinase C beta II) signalling pathway for translocating NF-kB from the cytoplasm to the nucleus in an IP3-independent manner. Although the calcium 2+ and strontium 2+ mediated signalling pathways are different, both CaSR interactions induce osteoclast apoptosis and are in fact capable of potentiating each other, leading to enhanced osteoclast apoptosis and decreased bone tissue degradation [A31565].



At the same time, given the similarity between the calcium 2+ and strontium 2+ cations, strontium 2+ cations from strontium ranelate are seemingly also able to act as an agonist and stimulate the CaSRs on osteoblasts, possibly in tandem with various local osteoblast stimulatory growth factors like transforming growth factor β (TGF β) and/or bone morphogenetic proteins (BMPs), to stimulate cyclic D genes and early oncogenes like c-fos and egr-1 that can mediate the mitogenesis and proliferation of new or more osteoblasts [A31580]. Moreover, although the involvement of the PLC mediated pathway may be a part of the signalling mechanism in osteoblasts following the stimulation of their CaSRs, this has not yet been fully elucidated [A31580].



Furthermore, strontium ranelate is also thought to be capable of stimulating osteoblasts to enhance the expression of osteoprotegerin while also concurrently reducing the expression of receptor activator of nuclear factor kappa-Β ligand (RANKL) in primary human osteoblastic cells. As osteoprotegerin can competitively bind to RANKL as a decoy receptor, which can prevent RANKL from binding to RANK, which is an activity that facilitates the signaling pathway for the differentiation and activaiton of osteoclasts. The subsequent net effect of these actions ultiamtely results in decreased osteoclastogenesis. [A31553]



Moreover, bone biopsies obtained from patients treated with stronatium ranelate in clinical study reveal improvements in intrinsic bone tissue quality and microarchitecutre in ostepoerosis as evidenced by increased trabecular number, decreased trabecular separation, lower structure model index, and increased cortical thickness associated with a shift in trabecular structure from rod to plate like configurations compared with control patients [A31553].



Additionally, strontium from administered strontium ranelate is absorbed onto the crystal surface of treated bones and only slightly substitiutes for calcium in the apatite crystal of newly formed bone. As a result, there is an increased X-ray absorption of strontium as compared to calcium, which can lead to an amplification of bone mineral density (BMD) measurement by dual-proton X-ray absorptiometry. In essence, although strontium ranelate use can increase BMD some of the observations may be overestimations due to skeletal accretion of strontium in strontium ranelate treated patients [A31553].



Having the ability to both generate more osetoblasts and decrease the number of osteoclasts gives strontium ranelate an apparent dual mechanism of action when used to treat osteoperosis.', 'In general, it is believed that strontium ranelate is capable of affecting a rebalance in bone turnover in favour of bone formation by: (1) increasing osteoblast differentiation from progenitors, osteoblast activity and survival, as well as regulating osteoblast-induced osteoclastogenesis, and (2) decreasing osteoclast differentiation and activity, as well as increasing osteoclast apoptosis [A31541]. 



It has also been shown that strontium ranelate is capable of improving and strengthening various components of overall bone tissue quality like bone mineral density and bone microarchitecture [A31541, A31542, A31553].   ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Trix hair lotion 120 ml', 28559, 'تريكس لوسيون للشعر 120 مل', '413', '359', 'Hair care', 'Hair care', NULL, NULL, 'Egyptian company for cosmetics > hayah lab.', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, 'help to reduce hair loss nourishing and strengthening', NULL, 772, '2024-12-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lamisil 1% topical cream 15 gm', 7081, 'لاميزيل 1% كريم 15 جرام', '16', NULL, 'Antifungals.allylamines', 'Antifungals.allylamines', NULL, 'Terbinafine', 'Novartis > glaxo smithkline', 'Cream', 'كريم', '1%', '1', NULL, NULL, 'about terbinafine a synthetic allylamine derivative antifungal. mechanism of action of terbinafine terbinafine is a fungicidal drug. it interfere the conversion of squalene to ergosterol by inhibiting the enzyme squalene epoxidase.this results in accumula', '6223002641062', 3695, '2022-12-06', NULL, 0, 'Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by _Trichophyton_ species, _Microsporum canis_, _Epidermophyton floccosum_,[L9068] and _Tinea_ species.[L9065] Terbinafine hydrochloride also treats yeast infections of the skin caused by _Candida_ species and _Malassezia furfur_.[L9068]', 'Terbinafine inhibits the enzyme squalene monooxygenase (also called squalene epoxidase), preventing the conversion of squalene to 2,3-oxydosqualene, a step in the synthesis of ergosterol.[A1279,A1281,L9068] This inhibition leads to decreased ergosterol, which would normally be incorporated into the cell wall, and accumulation of squalene.[A1281,L9068]



Generation of a large number of squalene containing vesicles in the cytoplasm may leach other lipids away from, and further weaken, the cell wall.[A1281]', 'Terbinafine is an allylamine antifungal that inhibits squalene epoxidase (also known as squalene monooxygenase) to prevent the formation of ergosterol and cause an accumulation of squalene, weakening the cell wall of fungal cells.[A1279,A1281,L9068] Terbinafine distributes into tissues and has a long terminal elimination half life, so the duration of action is long.[A1279] Overdose with terbinafine is rare, even above the therapeutic dose, so the therapeutic index is wide.[L9065,L9068] Patients taking oral terbinafine should have liver function tests performed prior to treatment to reduce the risk of liver injury.[L9065]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Bekcium 500mg 10 caps', 1373, 'بيكسيوم 500 مجم 10 كبسولات', '9', NULL, 'Vasoprotective', 'Vasoprotective', NULL, 'Calcium dobesilate', 'Alexandria', 'Cap', 'كبسولة', '500mg', '1', NULL, NULL, NULL, NULL, 1264, '2022-09-19', NULL, 0, 'Calcium acetate is one of a number of calcium salts used to treat hyperphosphatemia (too much phosphate in the blood) in patients with kidney disease.', 'Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed.', 'Patients with advanced renal insufficiency (creatinine clearance less than 30 ml/min) exhibit phosphate retention and some degree of hyperphosphatemia. The retention of phosphate plays a pivotal role in causing secondary hyperparathyroidism associated with osteodystrophy, and soft-tissue calcification. The mechanism by which phosphate retention leads to hyperparathyroidism is not clearly delineated. Therapeutic efforts directed toward the control of hyperphosphatemia include reduction in the dietary intake of phosphate, inhibition of absorption of phosphate in the intestine with phosphate binders, and removal of phosphate from the body by more efficient methods of dialysis. The rate of removal of phosphate by dietary manipulation or by dialysis is insufficient. Dialysis patients absorb 40% to 80% of dietary phosphorus. Therefore, the fraction of dietary phosphate absorbed from the diet needs to be reduced by using phosphate binders in most renal failure patients on maintenance dialysis. Calcium acetate when taken with meals combines with dietary phosphate to form insoluble calcium phosphate which is excreted in the feces. Maintenance of serum phosphorus below 6.0 mg/dl is generally considered as a clinically acceptable outcome of treatment with phosphate binders. Calcium acetate is highly soluble at neutral pH, making the calcium readily available for binding to phosphate in the proximal small intestine.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sperience 10 sachets 10 gm', 27385, 'سبيريانس 10 اكياس 10 جرام', '130', '79', 'Iron supplement', 'Iron supplement', NULL, 'Lactoferrin+iron+vitamin b-complex+vitamin c+calcium+folic acid', 'Med care > rony trade', 'Sachet', 'أكياس', '10 gm', '1', NULL, NULL, '** usage: add 1 sachet to a cup of water & stir well ** serving unit: 1 sachet once daily', NULL, 1988, '2025-11-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dixvit 10.000 i.u. 20 tabs.', 12037, 'ديكسفيت 10.000 وحدة دولية 20 قرص', '120', '110', 'Vitamin d', 'Vitamin d', NULL, 'Cholecalciferol(vitamin d3)', 'Safe life', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 12862, '2025-07-21', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Relat hair lotion 120 ml', 33495, 'ريلات هير لوشن 120 مل', '250', '195', 'Hair care', 'Hair care', NULL, 'Caffeine 2% + vital hair & scalp complex + ginseng extract + garlic oil + panthenol + rosemary oil + marula oil + birch ext + peppermint oil + nigella sativa seed ext + hydrolyzed soy protein + green tea ext + yarrow ext + aloe vera ext + argan oil', 'Prime pharma', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, 'innovative formula helps in hair falling control preferred with oily scalp 3x triple action formula: -extreme nourishment -enhance circulation -follicles reproduction', NULL, 621, '2025-07-31', NULL, 0, 'Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth.[T716,L9851] In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs.[L9899] Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.[T716,L9854,L9872]', 'The mechanism of action of caffeine is complex, as it impacts several body systems, which are listed below. The effects as they relate to various body systems are described as follows:



**General and cellular actions**



Caffeine exerts several actions on cells, but the clinical relevance is poorly understood. One probable mechanism is the inhibition of nucleotide phosphodiesterase enzymes, adenosine receptors, regulation of calcium handling in cells, and participates in adenosine receptor antagonism.[A187721,L9857] Phosphodiesterase enzymes regulate cell function via actions on second messengers cAMP and cGMP.[A187724] This causes lipolysis through activation of hormone-sensitive lipases, releasing fatty acids and glycerol.[T722]



**Respiratory**



The exact mechanism of action of caffeine in treating apnea related to prematurity is unknown, however, there are several proposed mechanisms, including respiratory center stimulation in the central nervous system, a reduced threshold to hypercapnia with increased response, and increased consumption of oxygen, among others.[L9851] The blocking of the adenosine receptors enhances respiratory drive via an increase in brain medullary response to carbon dioxide, stimulating ventilation and respiratory drive, while increasing contractility of the diaphragm.[T716]



**Central nervous system**



Caffeine demonstrates antagonism of all 4 adenosine receptor subtypes (A1, A2a, A2b, A3) in the central nervous system.[T716,L9851] Caffeine''s effects on alertness and combatting drowsiness are specifically related to the antagonism of the A2a receptor.[T716]



**Renal system**



Caffeine has diuretic effects due to is stimulatory effects on renal blood flow, increase in glomerular filtration, and increase in sodium excretion.[T716]



**Cardiovascular system**



Adenosine receptor antagonism at the A1 receptor by caffeine stimulates inotropic effects in the heart. Blocking of adenosine receptors promotes catecholamine release, leading to stimulatory effects occurring in the heart and the rest of the body.  In the blood vessels, caffeine exerts direct antagonism of adenosine receptors, causing vasodilation. It stimulates the endothelial cells in the blood vessel wall to release nitric oxide, potentiating blood vessel relaxation. Catecholamine release, however, antagonizes this and exerts inotropic and chronotropic effects on the heart, ultimately leading to vasoconstriction. Finally, caffeine is shown to raise systolic blood pressure measurements by 5 to 10 mmHg when it is not taken regularly, versus no effect in those who consume it regularly.[T716] The vasoconstricting effects of caffeine are beneficial in migraines and other types of headache, which are normally caused by vasodilation in the brain.[A187709,L9872]', 'Caffeine stimulates the central nervous system (CNS), heightening alertness, and sometimes causing restlessness and agitation. It relaxes smooth muscle, stimulates the contraction of cardiac muscle, and enhances athletic performance.[A298,T716,L9857] Caffeine promotes gastric acid secretion and increases gastrointestinal motility. It is often combined in products with analgesics and ergot alkaloids, relieving the symptoms of migraine and other types of headaches. Finally, caffeine acts as a mild diuretic.[T716]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Carecan cream 50 gm', 15878, 'كيركان كريم 50 جرام', '140', '116', 'Moisturizing cream', 'Moisturizing cream', NULL, NULL, 'Dbk pharma > we can co.', 'Cream', 'كريم', '50 gm', '1', 'حالات الحروق في الجلد -- مرطب للبشرة -- ملطف للجلد', NULL, 'skin soothing cream', NULL, 2089, '2025-08-09', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Extra-1000 sedico 30 cap', 4561, 'اكسترا 1000 سيديكو 30 كبسولة', '45', NULL, 'Vitamin e', 'Vitamin e', NULL, 'Wheat germ oil', 'Sedico', 'Cap', 'كبسولة', NULL, '3', 'مصدر لفيتامين اي الذي يساعد علي تحسين الذاكرة __ مصدر لزيت جنين القمح __ مصدر للطاقة __ علاج الاثار السلبية علي الشعر والبشرة والشعر', NULL, NULL, '6221042171082', 5724, '2023-06-14', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Hpg vitamin b12 30 caps', 7026, 'اتش بي جي فيتامين ب12 30 كبسولة', '120', '90', NULL, NULL, NULL, NULL, 'Egyptian for healthcare', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 1334, '2024-07-29', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Liposedra 20 mg 30 f.c.tabs.', 30834, 'ليبوسيدرا 20مجم 30 قرص', '111', '80.5', 'Antihyperlipidemic.statins', 'Antihyperlipidemic.statins', NULL, 'Atorvastatin', 'Delta pharma > suecal pharma', 'Tab', 'أقراص', '20 mg', '3', 'خافض للكوليسترول بالدم', NULL, 'description : is a member of the drug class known as statins. dose: adult po- initial- the recommended dose is 10 mg daily. maximum: 80 mg/day. indication : may be used as primary prevention in individuals with multiple risk factors for coronary heart dis', NULL, 1002, '2025-03-06', NULL, 0, 'Atorvastatin is indicated for the treatment of several types of dyslipidemias, including primary hyperlipidemia and mixed dyslipidemia in adults, hypertriglyceridemia, primary dysbetalipoproteinemia, homozygous familial hypercholesterolemia, and heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications.[A177397]



Dyslipidemia describes an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis.[L6025] 



Atorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles.[A177397]



Atorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors and in patients with type 2 diabetes without coronary heart disease but multiple risk factors.[A177397]



Atorvastatin may be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease.[A177397]



Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.[A181087, A181406]', 'Atorvastatin is a statin medication and a competitive inhibitor of the enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase, which catalyzes the conversion of HMG-CoA to mevalonate, an early rate-limiting step in cholesterol biosynthesis.[A177388,A181421] Atorvastatin acts primarily in the liver, where decreased hepatic cholesterol concentrations stimulate the upregulation of hepatic low-density lipoprotein (LDL) receptors, which increases hepatic uptake of LDL. Atorvastatin also reduces Very-Low-Density Lipoprotein-Cholesterol (VLDL-C), serum triglycerides (TG) and Intermediate Density Lipoproteins (IDL), as well as the number of apolipoprotein B (apo B) containing particles, but increases High-Density Lipoprotein Cholesterol (HDL-C). 



_In vitro_ and _in vivo_ animal studies also demonstrate that atorvastatin exerts vasculoprotective effects independent of its lipid-lowering properties, also known as the pleiotropic effects of statins.[A181424] These effects include improvement in endothelial function, enhanced stability of atherosclerotic plaques, reduced oxidative stress and inflammation, and inhibition of the thrombogenic response. Statins were also found to bind allosterically to β2 integrin function-associated antigen-1 (LFA-1), which plays an essential role in leukocyte trafficking and T cell activation.[A181559]', 'Atorvastatin is an oral antilipemic agent that reversibly inhibits HMG-CoA reductase. It lowers total cholesterol, low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B (apo B), non-high density lipoprotein-cholesterol (non-HDL-C), and triglyceride (TG) plasma concentrations while increasing HDL-C concentrations. High LDL-C, low HDL-C and high TG concentrations in the plasma are associated with increased risk of atherosclerosis and cardiovascular disease. The total cholesterol to HDL-C ratio is a strong predictor of coronary artery disease, and high ratios are associated with a higher risk of disease. Increased levels of HDL-C are associated with lower cardiovascular risk. By decreasing LDL-C and TG and increasing HDL-C, atorvastatin reduces the risk of cardiovascular morbidity and mortality.[A174580,A181087,A181406,A181925] 



Elevated cholesterol levels (and high low-density lipoprotein (LDL) levels in particular) are an important risk factor for the development of CVD.[A181087] Clinical studies have shown that atorvastatin reduces LDL-C and total cholesterol by 36-53%.[A177415] In patients with dysbetalipoproteinemia, atorvastatin reduced the levels of intermediate-density lipoprotein cholesterol.[A177397] It has also been suggested that atorvastatin can limit the extent of angiogenesis, which can be useful in the treatment of chronic subdural hematoma.[A177388]



**Myopathy/Rhabdomyolysis**



Atorvastatin, like other HMG-CoA reductase inhibitors, is associated with a risk of drug-induced myopathy characterized by muscle pain, tenderness, or weakness in conjunction with elevated levels of creatine kinase (CK). Myopathy often manifests as rhabdomyolysis with or without acute renal failure secondary to myoglobinuria. The risk of statin-induced myopathy is dose-related, and the symptoms of myopathy are typically resolved upon drug discontinuation. Results from observational studies suggest that 10-15% of people taking statins may experience muscle aches at some point during treatment.[A182258]



**Liver Dysfunction**



Statins, like some other lipid-lowering therapies, have been associated with biochemical abnormalities of liver function. Persistent elevations (> 3 times the upper limit of normal [ULN] occurring on two or more occasions) in serum transaminases occurred in 0.7% of patients who received atorvastatin in clinical trials. This effect appears to be dose-related.[F4670,F4673]



**Endocrine Effects**



Statins are associated with a risk of increased serum HbA1c and glucose levels. An _in vitro_ study demonstrated a dose-dependent cytotoxic effect on human pancreatic islet β cells following treatment with atorvastatin. Moreover, insulin secretion rates decreased relative to control.[A182012]



HMG-CoA reductase inhibitors interfere with cholesterol synthesis and may theoretically interfere with the production of adrenal and/or gonadal steroids. Clinical studies with atorvastatin and other HMG-CoA reductase inhibitors have suggested that these agents do not affect plasma cortisol concentrations, basal plasma testosterone concentration, or adrenal reserve. However, the effect of statins on male fertility has not been fully investigated. The effects of statins on the pituitary-gonadal axis in premenopausal women are unknown.[F4673]



**Cardiovascular**



Significant decreases in circulating ubiquinone levels in patients treated with atorvastatin and other statins have been observed. The clinical significance of a potential long-term statin-induced deficiency of ubiquinone has not been established. It has been reported that a decrease in myocardial ubiquinone levels could lead to impaired cardiac function in patients with borderline congestive heart failure.[F4673]



**Lipoprotein A**



In some patients, the beneficial effect of lowered total cholesterol and LDL-C levels may be partly blunted by the concomitant increase in Lp(a) lipoprotein concentrations. Present knowledge suggests the importance of high Lp(a) levels as an emerging risk factor for coronary heart disease.[F4673] Further studies have demonstrated statins affect Lp(a) levels differently in patients with dyslipidemia depending on their apo(a) phenotype; statins increase Lp(a) levels exclusively in patients with the low molecular weight apo(a) phenotype.[A181418]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Isopto maxidex 0.1% eye drops 5 ml', 21025, 'ايزوبتو ماكسيديكس 0.1% قطرة 5 مل', '10', NULL, 'Glucocorticoid', 'Glucocorticoid', NULL, 'Dexamethasone', 'Novartis > novartis scientific office', 'Drops', 'نقط', '0.1%', '1', NULL, NULL, 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. mechanism of action of dexamethasone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and ca', '5413895006159', 894, '2022-12-06', NULL, 0, 'Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.[L10698] Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Oral tablets are indicated for the treatment of multiple myeloma.[L10710] An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.[L10719] Various ophthalmic formulations are indicated for inflammatory conditions of the eye.[L10704,L10707,L10713,L10716,L10722,L10725]', 'The short term effects of corticosteroids are decreased vasodilation and permeability of capillaries, as well as decreased leukocyte migration to sites of inflammation.[A187463] Corticosteroids binding to the glucocorticoid receptor mediates changes in gene expression that lead to multiple downstream effects over hours to days.[A187463]



Glucocorticoids inhibit neutrophil apoptosis and demargination; they inhibit phospholipase A2, which decreases the formation of arachidonic acid derivatives; they inhibit NF-Kappa B and other inflammatory transcription factors; they promote anti-inflammatory genes like interleukin-10.[A187463]



Lower doses of corticosteroids provide an anti-inflammatory effect, while higher doses are immunosuppressive.[A187463] High doses of glucocorticoids for an extended period bind to the mineralocorticoid receptor, raising sodium levels and decreasing potassium levels.[A187463]', 'Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals.[A187463] Dexamethasone''s duration of action varies depending on the route.[L10698,L10701,L10704,L10707,L10710,L10713,L10716,L10719,L10722,L10725] Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces.[A187463] Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.[A187463]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('No gravida 12 vaginal supp.', 8930, 'نو جرافيدا لبوس مهبلي', '42', '29', 'Surfactant spermicide', 'Surfactant spermicide', NULL, 'Nonoxynol 9', 'Sedico > dkt', 'Supp', 'لبوس', NULL, '1', 'يستخدم كمانع للحمل', NULL, NULL, '6225000023512', 12224, '2023-11-22', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lomexcure 3mg/ml eye drops 5 ml', 22004, 'لوميكسكور 3 مجم / مل قطرة 5 مل', '9', NULL, 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Lomefloxacin', 'Pharco', 'Drops', 'نقط', '3mg', '1', NULL, NULL, 'about lomefloxacin a second generation fluoroquinolone antibiotic antibiotic. mechanism of action of lomefloxacin lomefloxacin is a bactericidal drug. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.dna gyrase helps in the', '6221151002895', 697, '2022-07-25', NULL, 0, 'For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: <i>S.pneumoniae</i>, <i>H.influenzae</i>, <i>S.aureus</i>, <i>P.aeruginosa</i>, <i>E. cloacae</i>, <i>P. mirabilis</i>, <i>C. civersus</i>, <i>S. asprphyticus</i>, <i>E.coli</i>, and <i>K.pneumoniae</i>.', 'Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited.', 'Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as <i>E.coli</i> and <i>Neisseria gonorrhoea</i> as well as gram-positive bacteria including <i>S. pneumoniae</i> and <i>Staphylococcus aureus</i>. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Gastamoxacine 400mg 7 f.c. tab.', 5346, 'جاستاموكساسين 400مجم 7 قرص', '45', NULL, 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Moxifloxacin', 'Medizen pharmaceutical industries > gast pharma group-egypt', 'Tab', 'أقراص', '400mg', '1', NULL, NULL, 'about moxifloxacin a third generation synthetic fluoroquinolone antibiotic a broad spectrum antibiotic. mechanism of action of moxifloxacin moxifloxacin acts by inhibiting the enzyme dna gyrase (topoisomerase 2) and topoisomerase 4.dna gyrase helps in the', NULL, 1169, '2022-07-12', NULL, 0, 'For the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Also for the treatment of bacterial conjunctivitis (pinkeye).', 'The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.', 'Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin can be used to treat infections caused by the following bacteria: Aerobic Gram-positive microorganisms: _Corynebacterium_ species, _Micrococcus luteus_, _Staphylococcus aureus_, _Staphylococcus epidermidis_, _Staphylococcus haemolyticus_, _Staphylococcus hominis_, _Staphylococcus warneri_, _Streptococcus pneumoniae_, and _Streptococcus viridans_ group. Aerobic Gram-negative microorganisms: _Acinetobacter lwoffii_, _Haemophilus influenzae_, and _Haemophilus parainfluenzae_. Other microorganisms: _Chlamydia trachomatis_. Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Candesartan 8mg 14 tabs.', 15756, 'كانديسارتان 8 مجم 14 قرص', '10', NULL, 'Antihypertensive.arbs', 'Antihypertensive.arbs', NULL, 'Candesartan cilexetil', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '8mg', '2', NULL, NULL, 'about candesartan cilexetil angiotensin || antagonist antihypertensive agent mechanism of action of candesartan cilexetil it is a antagonist of angiotensin 2 at at-1 receptor.it decreases peripheral resistance and lowers bp in hypertensive individuals. it', NULL, 818, '2022-07-28', NULL, 0, 'May be used as a first line agent to treat uncomplicated hypertension, isolated systolic hypertension and left ventricular hypertrophy. May be used as a first line agent to delay progression of diabetic nephropathy. Candesartan may be also used as a second line agent in the treatment of congestive heart failure, systolic dysfunction, myocardial infarction and coronary artery disease in those intolerant of ACE inhibitors.', 'Candesartan selectively blocks the binding of angiotensin II to AT1 in many tissues including vascular smooth muscle and the adrenal glands. This inhibits the AT1-mediated vasoconstrictive and aldosterone-secreting effects of angiotensin II and results in an overall decrease in blood pressure. Candesartan is greater than 10,000 times more selective for AT1 than AT2. Inhibition of aldosterone secretion may increase sodium and water excretion while decreasing potassium excretion.', 'Candesartan cilexetil is an ARB prodrug that is rapidly converted to candesartan, its active metabolite, during absorption from the gastrointestinal tract. Candesartan confers blood pressure lowering effects by antagonizing the hypertensive effects of angiotensin II via the RAAS. RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from granular cells of the juxtaglomerular apparatus in the kidneys. Renin cleaves circulating angiotensinogen to angiotensin I, which is cleaved by angiotensin converting enzyme (ACE) to angiotensin II. Angiotensin II increases blood pressure by increasing total peripheral resistance, increasing sodium and water reabsorption in the kidneys via aldosterone secretion, and altering cardiovascular structure. Angiotensin II binds to two receptors: type-1 angiotensin II receptor (AT1) and type-2 angiotensin II receptor (AT2). AT1 is a G-protein coupled receptor (GPCR) that mediates the vasoconstrictive and aldosterone-secreting effects of angiotensin II. Studies performed in recent years suggest that AT2 antagonizes AT1-mediated effects and directly affects long-term blood pressure control by inducing vasorelaxation and increasing urinary sodium excretion. Angiotensin receptor blockers (ARBs) are non-peptide competitive inhibitors of AT1. ARBs block the ability of angiotensin II to stimulate pressor and cell proliferative effects. Unlike ACE inhibitors, ARBs do not affect bradykinin-induced vasodilation. The overall effect of ARBs is a decrease in blood pressure.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Emijectacin 100mg/2ml i.m./i.v. vial', 18248, 'ايميجيكتاسين 100مجم/2مل فيال عضل/وريد', '13', '5', 'Aminoglycoside antibiotic', 'Aminoglycoside antibiotic', NULL, 'Amikacin', 'Hikma specialized pharmaceuticals', 'Vial', 'فيال', '100mg', '1', 'مضاد حيوي', NULL, 'description amikacin is a semi-synthetic aminoglycoside antibiotic derived from kanamycin a. similar to other aminoglycosides amikacin disrupts bacterial protein synthesis by binding to the 30s ribosome of susceptible organisms. binding interferes with mr', NULL, 977, '2025-01-03', NULL, 0, 'The amikacin sulfate injection is indicated in the short-term treatment of serious bacterial infections due to susceptible strains of gram-negative bacteria, including Pseudomonas species, Escherichia coli, species of indole-positive and indole-negative Proteus, Providencia species, Klebsiella-Enterobacter-Serratia species, as well as Acinetobacter (Mima-Herellea) species.[F1954]



Clinical studies have shown amikacin sulfate injection to be effective in bacterial septicemia (including neonatal sepsis); in serious infections of the respiratory tract, bones and joints, central nervous system (including meningitis) and skin and soft tissue; intra-abdominal infections (including peritonitis); and in burns and postoperative infections (including post-vascular surgery).[F1954]



Clinical studies have shown amikacin also to be effective in serious, complicated, and recurrent urinary tract infections due to the above organisms. Aminoglycosides, including amikacin, are not indicated in uncomplicated first-time episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics which are less toxic.[F1954]



In September 2018, a new indication with a new dosage route was approved for this drug. Amikacin liposome inhalation suspension was approved for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease).[L4673] This indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by Month 6 of treatment. Clinical benefit has not yet been established.[Label]



**Important notes regarding Staphylococcus and Sensitivity testing:**



Staphylococcus aureus, including methicillin-resistant strains, is the principal Gram-positive organism sensitive to amikacin.

The use of amikacin in the treatment of staphylococcal infections should be restricted only to second-line therapy, and should be limited to only those patients suffering from severe infections caused by susceptible strains of staphylococcus species who have failed to show sensitivity to other available antibiotics.[F1949]



Bacteriologic studies should be performed to identify causative organisms and their susceptibilities to amikacin. Amikacin may be used as initial therapy in suspected gram-negative infections and therapy may be initiated before obtaining the results of susceptibility testing.[Label,F1949,F1954]', 'The primary mechanism of action of amikacin is the same as that for all aminoglycosides. It binds to bacterial 30S ribosomal subunits and interferes with mRNA binding and tRNA acceptor sites, interfering with bacterial growth. This leads to disruption of normal protein synthesis and production of non-functional or toxic peptides. Other actions have been postulated for drugs of this class.[Label,F1949,F1950] Amikacin, as well as the rest of the aminoglycosides, are generally bacteriocidal against gram-positive and gram-negative bacteria.[L4680,F1954]', 'Amikacin is an aminoglycoside antibiotic. Aminoglycosides bind to the bacteria, causing misreading of t-RNA, leaving bacteria unable to synthesize proteins vital to their growth. Aminoglycosides are useful mainly in the treatment infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, however, other antibiotics may be more potent and less toxic to humans.[Label,F1949]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Charcomeg 30 capsules', 2529, 'تشاكوميج 30 كبسولة', '160', NULL, 'Anti-spamodic carminative and relieves dyspeptic and irritable bowel syndrome symptoms', 'Anti-spamodic carminative and relieves dyspeptic and irritable bowel syndrome symptoms', NULL, 'Activated charcoal 125 mg+fennel ext. 125 mg+caraway ext. 75 mg+anise ext. 25 mg+chamomile ext. 25 mg+ginger ext. 25 mg', 'Valuemed pharma egypt', 'Capsule', 'كبسولة', NULL, '1', NULL, NULL, NULL, NULL, 1092, '2025-01-21', NULL, 0, 'Used as a antidote to treat poisonings following excessive oral ingestion of certain medications or poisons. ', 'Active charcoal acts by binding to the pharmaceutical drugs or poisons such as organophosphates and decreasing the systemic absorption of toxic agents. Molecules with large volume of distribution, thus likely having higher lipid solubility, tends to bind have better absorptive binding to activated charcoal. Following the administration of activated charcoal, cathartics are indicated to evacuate the charcoal-poison bonded complex from the gastrointestinal tract. 

Activated charcoal may also have an effect on systemic drug levels by lowering the serum levels of already absorbed drugs or toxins. Many absorbed drugs that undergo significant hepatic metabolism and conjugation are eliminated via bile into the small intestines. When they reach the small intestines, drug conjugates can undergo hydrolysis and return to the enterohepatic circulation. Activated charcoal interferes with this process and binds to the conjugated drug before hydrolysis or the free deconjugated drug before reabsorption. ', 'Activated charcoal is used as a gastric decontamination agent in emergency clinical settings in case of poison or medication overdose. Studies show that early administration of one dose of activated charcoal can adsorb poison in the stomach and reduce absorption while it also works long after ingestion, by interruption of enterohepatic and enterovascular cycling of poison. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Trevicta 525mg prefilled syringe', 28446, 'تريفيكتا 525مجم سرنجة معبأة', '18,878', NULL, 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Paliperidone', 'Janssen cilag > soficopharm', 'Syringe', 'حقنة', '525mg', '1', NULL, NULL, 'about paliperidone antipsychotic mechanism of action of paliperidone paliperidone is a benzisoxazole atypical antipsychotic which is a main active metabolite of risperidone. it is reported to be an antagonist at dopamine d2 serotonin (5-ht2) adrenergic a1', NULL, 1582, '2022-06-22', NULL, 0, 'As an oral extended-release tablet and a once-monthly extended-release suspension for intramuscular injection, paliperidone is indicated for the treatment of adults and adolescents with schizophrenia and in the treatment of schizoaffective disorder in combination with antidepressants or mood stabilizers.[L16168,L37744] Paliperidone is also available in both an every-three-month and twice-yearly extended-release suspension for intramuscular injection for the treatment of schizophrenia.[L4137,L37749]', 'Paliperidone is the major active metabolite of risperidone. The mechanism of action of paliperidone, as with other drugs having efficacy in schizophrenia, is unknown, but it has been proposed that the drug''s therapeutic activity in schizophrenia is mediated through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism.', 'Paliperidone is an atypical antipsychotic developed by Janssen Pharmaceutica. Chemically, paliperidone is primary active metabolite of the older antipsychotic risperidone (paliperidone is 9-hydroxyrisperidone). The mechanism of action is unknown but it is likely to act via a similar pathway to risperidone.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Skrofad cream 100 gm', 27080, 'سكرو فاد كريم 100 جم', '80', NULL, 'Firming topical', 'Firming topical', NULL, 'Collagen+elastin+cocoa butter+allantoin+dimethicon+grape fruit seed extract+vit.e&c+retinol+glycerin', 'Hi-care > scin.off scientific office', 'Cream', 'كريم', '100 gm', '1', 'علاج لعلامات تمدد الجلد.', NULL, 'stretch marks reducing cream', NULL, 893, '2022-05-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Pravotin 100mg 14 sachets', 25132, 'برافوتين 100مجم 14 كيس', '180', '150', 'Iron supplement', 'Iron supplement', NULL, 'Lactoferrin', 'Medizen pharmaceutical industries > hygint pharmaceuticals-egypt', 'Sachet', 'أكياس', '100mg', '1', 'مكمل غذائي بالحديد -مقوي للمناعة', NULL, NULL, '6225000177833', 8163, '2025-02-02', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Licht whitening cream 50 gm', 30823, 'ليشت كريم تفتيح 50 جم', '96', '72', 'Skin care.whitening', 'Skin care.whitening', NULL, NULL, '> bio pharma group', 'Cream', 'كريم', '50 gm', '1', 'كريم لترطيب وتفتيح البشرة وازالة التصبغات والكلف', NULL, NULL, NULL, 752, '2024-08-24', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sigmazidim 500 mg vial for i.v./i.m. inj.', 10439, 'سيجمازيديم 500 مجم فيال', '10', NULL, 'Antibiotic.cephalosporin.third-generation', 'Antibiotic.cephalosporin.third-generation', NULL, 'Ceftazidime', 'Pharco b > sigma tec', 'Inj', 'حقن', '500 mg', '1', NULL, NULL, NULL, '6221172002430', 965, '2022-12-08', NULL, 0, 'Ceftazidime is indicated for the treatment of lower respiratory tract infections, skin and skin structure infections, urinary tract infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections (including peritonitis), and central nervous system infections (including meningitis) caused by susceptible bacteria.[L32935]



Ceftazidime is indicated in combination with [avibactam] to treat infections caused by susceptible Gram-negative organisms, including complicated intra-abdominal infections (cIAI), in conjunction with [metronidazole], and complicated urinary tract infections (cUTI), including pyelonephritis, in patients aged three months and older. This combination is also indicated to treat hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older.[L45128]



In all cases, to mitigate the risk of bacterial resistance and preserve clinical efficacy, ceftazidime should only be used for infections that are confirmed or strongly suspected to be caused by susceptible bacterial strains.[L32935, L45128]', 'The bacterial cell wall, which is located at the periphery of Gram-positive bacteria and within the periplasm of Gram-negative bacteria, comprises a glycopeptide polymer synthesized through cross-linking of glycans to peptide stems on alternating saccharides, which is known commonly as peptidoglycan.[A232920] Cell wall formation, recycling, and remodelling require numerous enzymes, including a family of enzymes with similar active site character despite distinct and sometimes overlapping roles as carboxypeptidases, endopeptidases, transpeptidases, and transglycosylases, known as "penicillin-binding proteins" (PBPs). The number of PBPs differs between bacteria, in which some are considered essential and others redundant. In general, inhibition of one or more essential PBPs results in impaired cell wall homeostasis, loss of cell integrity, and is ultimately bactericidal.[A232920, A232925, A232930]



Ceftazidime is a semisynthetic third-generation cephalosporin with broad activity against numerous Gram-negative and some Gram-positive bacteria.[L32935] Like other β-lactam antibiotics, ceftazidime exhibits its bactericidal effect primarily through direct inhibition of specific PBPs in susceptible bacteria.[A232935] _In vitro_ experiments in Gram-negative bacteria such as _Escherichia coli_, _Pseudomonas aeruginosa_, _Acinetobacter baumannii_, and _Klebsiella pneumoniae_ suggest that ceftazidime primarily binds to PBP3, with weaker binding to PBP1a/1b and PBP2 as well; although binding to other PBPs, such as PBP4, is detectable, the concentrations required are much greater than those achieved clinically.[A232935, A16721, A232940, A232945, A232950] Similarly, ceftazidime showed binding to _Staphylococcus aureus_ PBP 1, 2, and 3 with a much lower affinity for PBP4.[A16721] Recent data for _Mycobacterium abcessus_ suggest that ceftazidime can inhibit PonA1, PonA2, and PbpA at intermediate concentrations.[A232930]', 'Ceftazidime is a semisynthetic, broad-spectrum, third-generation cephalosporin antibiotic that is bactericidal through inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin-binding protein 3 (PBP3).[L32935] Among cephalosporins, ceftazidime is notable for its resistance to numerous β-lactamases and its broad spectrum of activity against Gram-negative bacteria, including _Pseudomonas aeruginosa_.[A232935] However, it is less active than first- and second-generation cephalosporins against _Staphylococcus aureus_ and other Gram-positive bacteria and also has low activity against anaerobes.[A232935, A233160] Ceftazidime has confirmed activity against clinically relevant Gram-negative bacteria including _Citrobacter_ spp., _Enterobacter_ spp., _Klebsiella_ spp., _Proteus_ spp., _Serratia spp., _Escherichia coli_, _Haemophilus influenzae_, _Neisseria meningitidis_, _Pseudomonas aeruginosa_, and some Gram-positive bacteria including _Staphylococcus_ spp. and _Streptococcus_ spp. There are also _in vitro_ data for ceftazidime efficacy against a wide variety of other bacteria, such as _Acinetobacter baumannii_ and _Neisseria gonorrhoeae_, but no clear clinical studies to support the use of ceftazidime for infections caused by these bacteria.[L32935]



Although β-lactam antibiotics like ceftazidime are generally well tolerated, there remains a risk of serious acute hypersensitivity reactions, which is higher in patients with a known allergy to ceftazidime or any other β-lactam antibiotic. As with all antibiotics, ceftazidime may result in the overgrowth of non-susceptible organisms and potentially serious effects including _Clostridium difficile_-associated diarrhea (CDAD); CDAD should be considered in patients who develop diarrhea and, in confirmed cases, supportive care initiated immediately. Ceftazidime is primarily renally excreted such that high and prolonged serum concentrations can occur in patients with renal insufficiency, leading to seizures, nonconvulsive status epilepticus (NCSE), encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia. Treatment may lead to the development or induction of resistance with a risk of treatment failure. Periodic susceptibility testing should be considered, and monotherapy failure may necessitate the addition of another antibiotic such as an aminoglycoside. Cephalosporin use may decrease prothrombin activity, which may be improved by exogenous vitamin K. Inadvertent intra-arterial administration of ceftazidime may result in distal necrosis.[L32935]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Treato hair serum ampoules 10 * 5 ml', 28418, 'تريتو سيروم للشعر 10*5 مل امبولات', '260', NULL, 'Hair care', 'Hair care', NULL, 'Procapil+stem cells+hydrolyzed glycosaminglycans+silanediol salicylate+niacinamide+octapeptide-2+vitamin h+provitamin b5', 'Egyptian company for cosmetics > infinity pharm', 'Ampoule', 'أمبول', '5 ml', '10', NULL, NULL, 'protects against free radicals and environmental pollutants. corrects cracks of hair follicle and smoothes away frizz. moisturizes hair leaving smooth and silky. nourishes hair shaft via supplying the scalp with essential oils. treats chemically damaged a', NULL, 832, '2022-07-25', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Beclosone forte inhaler 0.1 mg/dose 200 doses', 14965, 'بكلوزون فورت 0.1 مجم / جرعة 200 جرعة', '75', '45', 'Bronchodilator.anti-inflammatory.glucocorticoid steroid', 'Bronchodilator.anti-inflammatory.glucocorticoid steroid', NULL, 'Beclomethasone dipropionate', 'Arab drug company.', 'Inhaler', 'جهاز استنشاق', '0.1 mg', '1', NULL, NULL, 'about beclomethasone dipropionate potent glucocorticoid potent anti-inflammatory agent in respiratory tract and nasal passages. indications : 1.eczema 2.psoriasis 3.contact dermatitis 4.anal and vulval pruritis 5.inflammation of the skin contra-indication', '6221060005703', 1419, '2024-11-28', NULL, 0, 'Indicated for oral inhalation use in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. The aerosol form of beclomethasone diproprionate is not indicated for the relief of acute bronchospasm.[L6871]



Indicated for intranasal use to relieve the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis and prevent the recurrence of nasal polyps following surgical removal.[L6880]



Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age and older.[L10782] Corticosteroid-responsive dermatoses include psoriasis, contact dermatitis (dermatitis venenata), atopic dermatitis (infantile eczema, allergic dermatitis), neurodermatitis (lichen simplex chronicus, lichen planus, eczema, eczematous dermatitis), intertrigo, dyshidroses (pompholyx), seborrheic dermatitis, exfoliative dermatitis, solar dermatitis, stasis dermatitis, and anogenital and senile pruritus.[L6886]', 'Beclomethasone dipropionate is a corticosteroid and prodrug that is rapidly activated by hydrolysis to the active monoester, 17 monopropionate (17-BMP), which mediates anti-inflammatory actions. 17-BMP has been shown _in vitro_ to exhibit a binding affinity for the human glucocorticoid receptor which is approximately 13 times that of dexamethasone and 25 times that of beclomethasone dipropionate.[L6871] Upon binding of the ligand, the glucocorticoid receptors dimerize and translocate into the nucleus, where they subsequently bind to glucocorticoid response elements (GRE) on glucocorticoid-responsive genes, leading to changes in transcription. There are several proposed mechanisms for the anti-inflammatory action of corticosteroids. Corticosteroids may work by increasing the transcription of genes coding for anti-inflammatory proteins, including lipocortin-1 and interleukin-10.[A179875] Corticosteroids were also shown to inhibit the expression of multiple genes that encode pro-inflammatory factors, such as cytokines, chemokines, and adhesion molecules, that are activated during the chronic inflammatory process.[A31449] This is thought to be due to the direct inhibitory interaction between activated glucocorticoid receptors and activated pro-inflammatory transcription factors, such as nuclear factor-kappa B and activator protein-1.[A179875] Chronic inflammation is often characterized by enhanced expression of these transcription factors that bind to and activate coactivator molecules, which then acetylate core histones to switch on gene transcription to further amplify the inflammatory process.[A31449] Corticosteroids suppress the multiple inflammatory gene expression by promoting histone deacetylation, resulting in tighter coiling of DNA and reduced access of transcription factors to their binding sites.[A179875] ', 'Inflammatory conditions, including asthma, dermatoses, and allergic rhinitis, involve the activation of cascades by inflammatory mediators. Inflammation is a primary defense mechanism and the homeostatic response of the immune system; however, a prolonged inflammatory response in certain disorders may lead to tissue damage, pain, and swelling. Beclomethasone dipropionate works by attenuating the inflammatory responses associated with asthma, allergic rhinitis, nasal polyps, and corticosteroid-responsive dermatoses. It suppresses the actions of inflammatory cells, such as mast cells, eosinophils, basophils, lymphocytes, macrophages, and neutrophils. It also inhibits the release of inflammatory mediators, such as histamine, eicosanoids, leukotrienes, and cytokines.[L6871] Beclomethasone dipropionate is reported to exhibit potent topical activity while possessing low systemic effects.[A179845] 



Beclomethasone dipropionate is a corticosteroid drug with anti-inflammatory and vasoconstrictive effects used to treat chronic inflammatory processes such as asthma, allergic rhinitis, corticosteroid-responsive dermatoses. When inhaled, it improves lung function, decreases airway hyper-reactivity, and reduces the severity of asthmatic symptoms.[A180160] Although inhaled corticosteroids, including beclomethasone dipropionate, are reported to mainly act locally in the lungs, systemic effects such as disruption of hypothalamic-pituitary-adrenal (HPA) axis function, bone turnover, osteoporosis, and growth suppression may still be observed with chronic use or high dose administration. There were varying findings from clinical studies examining the effect of beclomethasone dipropionate on growth suppression in pediatric patients.[A180160] It was shown to suppress the hypothalamo-pituitary-adrenal (HPA) axis in a dose-dependent manner.[A179917] HPA axis is a central hormonal response system to stress and activation of HPA axis leads to the production of endogenous steroid hormone production.[A179920] Long-term use of high-dose systemic corticosteroids, including those inhaled, was often associated with signs and symptoms of adrenal insufficiency when exposed to stress conditions, such as trauma, surgery, or infections. As corticosteroids work by suppressing the immune system, there may be an increased risk for developing infections.[L6871] Cases of _Candida albicans_ infection of the mouth and throat have been reported with inhaled beclomethasone dipropionate therapy.[A180010]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Seleno care hair shampoo 150 ml', 26730, 'سيلينو كير شامبو للشعر للقشرة 150 مل', '98', '69', 'Anti-dandruff', 'Anti-dandruff', NULL, 'Selenium sulphide', 'Sigma > interpharma', 'Amp', 'أمبول', '150 ml', '1', 'شامبو للشعر للقشرة', NULL, 'about selenium sulphide selenium compound antifungal anti-dandruff in seborrheic dermatitis. mechanism of action of selenium sulphide topical selenium sulfide produces antimitotic (cytostatic) action on cells of the epidermis and follicular epithelium and', '6225000123540', 3977, '2023-09-14', NULL, 0, 'For treatment of tinea versicolor, tinea capitis, dandruff and seborrheic dermatitis of the scalp.', 'Topical selenium sulfide may act by an antimitotic action, resulting in a reduction in the turnover of epidermal cells. It also has local irritant, antibacterial, and mild antifungal activity, which may contribute to its effectiveness. An antimitotic mechanism of action is suggested by data showing that selenium sulfide decreases the rate of incorporation of radioactively labeled thymidine into the DNA of dermal epithelial cells. The following organisms are generally considered susceptible to selenium sulfide in vitro: <i>Malassezia furfur</i>, <i>Microsporum sp.</i> including <i>Microsporum audouinii</i> and <i>Microsporum canis</i>, <i>Pityrosporon sp.</i>, <i>Trichophyton sp.</i> including <i>Trichophyton schoenleinii</i> and <i>Trichophyton tonsurans</i>. Selenium sulfide has been shown to be sporicidal to <i>T. tonsurans</i>, the most common etiologic agent of tinea capitis. One in-vitro study demonstrated that 2.5% selenium sulfide was equivalent in sporicidal activity to both 1% and 2% zinc pyrithione.', 'Selenium sulfide is an antifungal agent often used in shampoos for the treatment of dandruff and seborrheic dermatitis. Selenium sulfide is highly active in inhibiting the growth of <i>P. ovale</i>. It is also a proven cytostatic agent, slowing the growth of both hyperproliferative and normal cells in dandruff and seborrheic dermatitis. A 0.6% micronized form of selenium sulfide is also safe and effective for dandruff.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Azalide 500mg 3 caps.', 1185, 'ازالايد 500 مجم 3 كبسولات', '52', '38', 'Antibiotic.macrolide', 'Antibiotic.macrolide', NULL, 'Azithromycin', 'T3a pharma', 'Cap', 'كبسولة', '500mg', '1', NULL, NULL, 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6223005980199', 3343, '2025-07-10', NULL, 0, 'Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin [FDA label].



Azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the microorganisms listed in the specific conditions below. Recommended dosages, duration of therapy and considerations for various patient populations may vary among these infections. Refer to the FDA label and "Indications" section of this drug entry for detailed information [FDA label]. 



**Adults**:



Acute bacterial exacerbations of chronic obstructive pulmonary disease due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Acute bacterial sinusitis due to _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.

Uncomplicated skin and skin structure infections due to _Staphylococcus aureus_, _Streptococcus pyogenes_, or _Streptococcus agalactiae_. Abscesses usually require surgical drainage.



Urethritis and cervicitis due to _Chlamydia trachomatis_ or _Neisseria gonorrhoeae_.



Genital ulcer disease in men due to _Haemophilus ducreyi_ (chancroid). Due to the small number of women included in clinical trials, the efficacy of azithromycin in the treatment of chancroid in women has not been established.



**Pediatric Patients**



Acute otitis media caused by _Haemophilus influenzae_, _Moraxella catarrhalis_ or _Streptococcus pneumoniae_



Community-acquired pneumonia due to _Chlamydophila pneumoniae_, _Haemophilus influenzae_, _Mycoplasma pneumoniae_ or _Streptococcus pneumoniae_ in patients appropriate for oral therapy.



Pharyngitis/tonsillitis caused by _Streptococcus pyogenes_ as an alternative to first-line therapy in individuals who cannot use first-line therapy.', 'In order to replicate, bacteria require a specific process of protein synthesis, enabled by ribosomal proteins [A6505]. Azithromycin binds to the 23S rRNA of the bacterial 50S ribosomal subunit. It stops bacterial protein synthesis by inhibiting the transpeptidation/translocation step of protein synthesis and by inhibiting the assembly of the 50S ribosomal subunit [FDA label], [A14179]. This results in the control of various bacterial infections [A174193], [FDA label].   The strong affinity of macrolides, including azithromycin, for bacterial ribosomes, is consistent with their broad‐spectrum antibacterial activities [A174193].





Azithromycin is highly stable at a low pH, giving it a longer serum half-life and increasing its concentrations in tissues compared to erythromycin [A174175]. 



', 'Macrolides stop bacterial growth by inhibiting protein synthesis and translation, treating bacterial infections [A174175].

Azithromycin has additional immunomodulatory effects and has been used in chronic respiratory inflammatory diseases for this purpose [A174172].



', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Monosho 500 mg 5 f.c.tabs.', 8302, 'مونوشو 500مجم 5 قرص', '52', '35', 'Antibiotic.quinolone', 'Antibiotic.quinolone', NULL, 'Levofloxacin', 'Egpi > arabian international group (aig)', 'Tab', 'أقراص', '500 mg', '1', 'مضاد حيوي', NULL, 'about levofloxacin third generation fluoroquinolone (or quinolone) a broad spectrum antiinfective. mechanism of action of levofloxacin levofloxacin is a broad spectrum antibacterial agent. it act by inhibiting the enzyme dna gyrase (topoisomerase 2) and t', '6224009726011', 3494, '2024-10-29', NULL, 0, 'In oral and intravenous formulations, levofloxacin is indicated in adults for the treatment of various infections caused by susceptible bacteria, including infections of the upper respiratory tract, lower respiratory tract, skin, skin structures, urinary tract, and prostate.[L11638,L11692] The oral formulation is also indicated in both adults and children 6 months of age and older for the post-exposure management of inhalational anthrax caused by _Bacillus anthracis_ and for the treatment and/or prophylaxis of plague caused by _Yersinia pestis_.[L11638]



In its ophthalmic formulation, levofloxacin is indicated for the treatment of bacterial conjunctivitis caused by susceptible organisms.[L11641] An inhalational solution available in Canada is indicated for the management of cystic fibrosis patients aged 18 years or older with chronic pulmonary _Pseudomonas aeruginosa_ infections.[L11689]', 'Levofloxacin, like other fluoroquinolone antibiotics, exerts its antimicrobial activity via the inhibition of two key bacterial enzymes: DNA gyrase and topoisomerase IV.[L11638] Both targets are type II topoisomerases, but have unique functions within the bacterial cell. DNA gyrase is an enzyme found only in bacteria that introduces negative supercoils into DNA during replication - this helps to relieve torsional strain caused by the introduction of positive supercoils during replication, and these negative supercoils are essential for chromosome condensation and the promotion of transcription initiation.[A31453] It is comprised of four subunits (two A subunits and two B subunits) of which the A subunits appear to be the target of fluoroquinolone antibiotics.[A190663] Bacterial topoisomerase IV, in addition to contributing to the relaxation of positive supercoils, is essential at the terminal stages of DNA replication and functions to “unlink” newly replicated chromosomes to allow for the completion of cell division.[A31453]



Inhibition of these enzymes by levofloxacin likely occurs via complexation with the topoisomerase enzymes.[A31453] The end result is a blockade of DNA replication, thus inhibiting cell division and resulting in cell death.', 'Levofloxacin is bactericidal and exerts its antimicrobial effects via inhibition of bacterial DNA replication.[L11638] It has a relatively long duration of action in comparison with other antibiotics that allows for once or twice daily dosing. Levofloxacin is associated with QTc-interval prolongation and should be used with caution in patients with other risk factors for prolongation (e.g. hypokalemia, concomitant medications).[L11638]



Levofloxacin has demonstrated _in vitro_ activity against a number of aerobic gram-positive and gram-negative bacteria and may carry some activity against certain species of anaerobic bacteria[L11638] and other pathogens such as _Chlamydia_ and _Legionella_.[A190663] Resistance to levofloxacin may develop, and is generally due to mutations in DNA gyrase or topoisomerase IV, or via alterations to drug efflux.[L11638,A31453] Cross-resistance may occur between levofloxacin and other fluoroquinolones, but is unlikely to develop between levofloxacin and other antibiotic classes (e.g. macrolides) due to significant differences in chemical structure and mechanism of action.[L11638]



As antimicrobial susceptibility patterns are geographically distinct, local antibiograms should be consulted to ensure adequate coverage of relevant pathogens prior to use.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Docetaxel filaxis 80mg/2ml vial', 17752, 'دوسيتاكسيل 80 مجم / 2 مل فيال', '2,400', NULL, 'Antineoplastic', 'Antineoplastic', NULL, 'Docetaxel', 'Filaxis laboratories-argentine > multipharma', 'Vial', 'فيال', '80mg', '1', NULL, NULL, 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', NULL, 1716, '2022-07-11', NULL, 0, 'Docetaxel is indicated as a single agent for the treatment of locally advanced or metastatic breast cancer after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC. It is also indicated as a single agent for locally advanced or metastatic non-small cell lung cancer (NSCLC) after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC. For the treatment of metastatic castration-resistant prostate cancer, docetaxel is indicated with prednisone. Docetaxel is also indicated with cisplatin and fluorouracil for untreated, advanced gastric adenocarcinoma, including the gastroesophageal junction, and with cisplatin and fluorouracil for induction treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN).[L46466]', 'Docetaxel interferes with the normal function of microtubule growth. Whereas drugs like [colchicine] cause the depolymerization of microtubules in vivo, docetaxel arrests their function by having the opposite effect; it hyper-stabilizes their structure. This destroys the cell''s ability to use its cytoskeleton in a flexible manner. Specifically, docetaxel binds to the &beta;-subunit of tubulin. Tubulin is the "building block" of microtubules, and the binding of docetaxel locks these building blocks in place. The resulting microtubule/docetaxel complex does not have the ability to disassemble. This adversely affects cell function because the shortening and lengthening of microtubules (termed dynamic instability) is necessary for their function as a transportation highway for the cell. Chromosomes, for example, rely upon this property of microtubules during mitosis. Further research has indicated that docetaxel induces programmed cell death (apoptosis) in cancer cells by binding to an apoptosis-stopping protein called Bcl-2 (B-cell leukemia 2), thus arresting its function.[A259666,A259671,L46466]', 'Docetaxel is a taxoid antineoplastic agent. It promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network which is essential for vital interphase and mitotic cellular functions. In addition, docetaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.[A259666,A259671]



The use of docetaxel may lead to treatment-related deaths in breast cancer and non-small cell lung cancer patients, hepatic impairment, hematologic effects, enterocolitis and neutropenic colitis, hypersensitivity reactions, fluid retention, second primary malignancies, cutaneous reactions, neurologic reactions, eye disorders, asthenia, embryo-fetal toxicity, and tumor lysis syndrome.[L46466]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Dandel hair cream 100 gm', 3298, 'داندل كريم شعر 60 جم', '130', '110', 'Hair care', 'Hair care', NULL, NULL, 'Egyptian company for cosmetics > infinity pharm', 'Cream', 'كريم', '100 gm', '1', NULL, NULL, 'a restorative formula for both hair and scalp that are suffering from dandruff dandel cream maintains a healthy scalp and strengthens the fine hair. re-constructs damaged hair by bonding to the weak sites of every strand thus strengthens & nourishes exhau', '6224000547646', 953, '2024-06-10', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Combitrust 2.5/2.5/12.5mg 30 caps.', 31840, 'كومبيتراست 2.5/2.5/12.5مجم 30 كبسولة', '50', NULL, 'Anti-hypertensive.combined beta blocker ace with diuretic', 'Anti-hypertensive.combined beta blocker ace with diuretic', NULL, 'Bisoprolol+ramipril+hydrochlorothiazide', 'Jedco int. co. for pharmaceuticals > pharmadar', 'Cap', 'كبسولة', '12.5mg', '3', NULL, NULL, 'this combination product contains three active ingredients: bisoprolol ramipril and hydrochlorothiazide. ramipril belongs to the class of medications called ace inhibitors. it works by relaxing blood vessels and by making the heart pump more efficiently.', NULL, 706, '2023-05-04', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Aloekita ds hair shampoo 250 ml', 13809, 'الوكيتا دي اس شامبو للشعر 250 مل', '229', '199', 'Hair care', 'Hair care', NULL, 'Caffeine+saw palmetto+amla+aloe vera+tea tree oil+menthol', 'Leader cosmetics > beauty & beyond international', 'Amp', 'أمبول', '250 ml', '1', NULL, NULL, NULL, '6224007424469', 1539, '2024-10-20', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Quadrostar 10 tabs.', 25527, 'كوادروستار 10 اقراص', '16', NULL, 'Antitubercular', 'Antitubercular', NULL, 'Ethambutol+isoniazid+pyrazinamide+rifampicin', 'International drug agency (idi)', 'Tab', 'أقراص', NULL, '1', 'لعلاج حالات مرضى الجزام ومرضى الدرن', NULL, NULL, NULL, 760, '2022-07-15', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Triaxone 1g i.v vial', 11643, 'ترياكسون 1 جرام للحقن الوريدي', '53', NULL, 'Antibiotic.cephalosporin.third-generation', 'Antibiotic.cephalosporin.third-generation', NULL, 'Ceftriaxone', 'Tabuk pharmaceutical manufacturing company', 'Vial', 'فيال', NULL, '1', NULL, NULL, 'about ceftriaxone third generation cephalosporin antibiotic(parenteral). mechanism of action of ceftriaxone ceftriaxone is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiti', '6281102233303', 2509, '2022-12-13', NULL, 0, 'Ceftriaxone is used for the treatment of the infections (respiratory, skin, soft tissue, UTI, ENT) caused by susceptible organisms.[L15082] Organisms that are generally susceptible to ceftriaxone include S. pneumoniae, S. pyogenes (group A beta-hemolytic streptococci), coagulase-negative staphylococci, Some Enterobacter spp, H. influenzae, N. gonorrhoeae, P. mirabilis, E. coli, Klebsiella spp, M. catarrhalis, B. burgdorferi, and some oral anaerobes.[A215582] ', 'Ceftriaxone works by inhibiting the mucopeptide synthesis in the bacterial cell wall.[T324,L15082] The beta-lactam moiety of ceftriaxone binds to carboxypeptidases, endopeptidases, and transpeptidases in the bacterial cytoplasmic membrane. These enzymes are involved in cell-wall synthesis and cell division. Binding of ceftriaxone to these enzymes causes the enzyme to lose activity; therefore, the bacteria produce defective cell walls, causing cell death.', 'Ceftriaxone is a cephalosporin/cephamycin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms.[L15082] Ceftriaxone has <i>in vitro</i> activity against gram-positive aerobic, gram-negative aerobic, and anaerobic bacteria.[L15087] The bactericidal activity of ceftriaxone results from the inhibition of cell wall synthesis and is mediated through ceftriaxone binding to penicillin-binding proteins (PBPs).[T324] Ceftriaxone is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended-spectrum beta-lactamases.[L15082] However, resistance to ceftriaxone usually occurs through beta-lactamase hydrolysis, altered PBPs, or reduced bacterial cell permeability.[T324] Ceftriaxone should not be mixed with or giving in the same IV line as diluents/products containing calcium as they may cause ceftriaxone to precipitate.[L15082] Ceftriaxone use may also cause biliary sludge or gallbladder pseudolithiasis.[L15082,A215602] ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Arimidex 1 mg 28 tab.', 14391, 'اريميدكس 1مجم 28 قرص', '706', '542', 'Non-steroidal aromatase-inhibitor', 'Non-steroidal aromatase-inhibitor', NULL, 'Anastrozole', 'Astra zeneca', 'Tab', 'أقراص', '1 mg', '2', NULL, NULL, 'it is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery as well as for metastasis in both pre and post-menopausal women. the severity of breast cancer can be increased by estrogen as sex hormones cause hyperpl', '6223003270377', 11373, '2024-11-12', NULL, 0, 'Anastrozole is indicated as adjunct therapy in the treatment of hormone receptor-positive early breast cancer in postmenopausal women, and as a first-line treatment for hormone receptor-positive (or hormone receptor-unknown) locally advanced or metastatic breast cancer in postmenopausal women.[L8863] It may also be used in the treatment of advanced breast cancer in postmenopausal women who experience disease progression despite treatment with [tamoxifen].[L8866,L8863] ', 'Anastrazole exerts its anti-estrogenic effects via selective and competitive inhibition of the aromatase enzyme found predominantly in the adrenal glands, liver, and fatty tissues.[A186877] Many breast cancers are hormone receptor-positive, meaning their growth is stimulated and/or maintained by the presence of hormones such as estrogen or progesterone.[L8863] In postmenopausal women, estrogen is primarily derived from the conversion of adrenally-produced androgens into estrogens by the aromatase enzyme - by competitively inhibiting the biosynthesis of estrogen at these enzymes, anastrozole effectively suppresses circulating estrogen levels and, subsequently, the growth of hormone receptor-positive tumours.[A186877,A186958]', 'Anastrozole prevents the conversion of adrenal androgens (e.g. [testosterone]) to estrogen in peripheral and tumour tissues. As the growth of many breast cancers is stimulated and/or maintained by the presence of estrogen, anastrozole helps to treat these cancers by decreasing the levels of circulating estrogens.[L8869,A186958] Anastrozole has a relatively long duration of action allowing for once daily dosing - serum estradiol is reduced by approximately 70% within 24 hours of beginning therapy with 1mg once daily, and levels remain suppressed for up to 6 days following cessation of therapy.[L8863] 



The incidence of ischemic cardiovascular events was increased during anastrozole therapy and patients with pre-existing ischemic heart disease should consider the risks and benefits of anastrozole before beginning therapy. Anastrozole has also been reported to decrease spine and hip bone mineral density (BMD), so consideration should be given to monitoring of BMD in patients receiving long-term therapy.[L8863,A186955]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Herbamix hair oil 60 ml', 6051, 'هيربامكس زيت للشعر 60 مل', '90', '75', 'Hair care. hair fall', 'Hair care. hair fall', NULL, NULL, 'Hi-care > roventis pharma', 'Hair oil', 'زيت شعر', '60 ml', '1', 'لتساقط الشعر', NULL, '** indications ï- brittle damaged and dry hair. ï- weak hair growth rates. ï- hair falling thinning and split ends. ï- exhausted and over stressed hair from harsh chemicals or other environmental factors. **direction of use before shampooing the hair appl', '6224000201531', 1890, '2024-05-11', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Lamidine 100mg 30 f.c. tab.', 7077, 'لاميدين 100مجم 30 قرص', '123', '90', 'Antiviral.nucleoside', 'Antiviral.nucleoside', NULL, 'Lamivudine', 'Eva pharma', 'Tab', 'أقراص', '100mg', '3', NULL, NULL, NULL, '6223002453672', 1929, '2023-09-19', NULL, 0, 'Lamivudine is indicated in combination with other antiretrovirals the treatment of HIV infection and chronic hepatitis B (HBV).[L51474]



In combination with [dolutegravir], lamivudine is indicated for the treatment of HIV-1 in patients ≥12 years of age and weighing ≥25 kg.[L51469]', 'Lamivudine is a synthetic nucleoside analogue and is phosphorylated intracellularly to its active 5''-triphosphate metabolite, lamivudine triphosphate (L-TP). This nucleoside analogue is incorporated into viral DNA by HIV reverse transcriptase and HBV polymerase, resulting in DNA chain termination.', 'Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV) to disrupt viral DNA synthesis. When phosphorylated, lamivudine can form active metabolites that compete for incorporation into viral DNA. Via DNA incorporation, lamivudine metabolites competitively inhibit the activity of the HIV reverse transcriptase enzyme and act as a chain terminator of DNA synthesis. Due to the lack of a 3''-OH group, incorporated nucleoside analogues prevent the formation of a 5'' to 3'' phosphodiester linkage that is essential for DNA chain elongation. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Tykerb 250 mg 70 f.c.tabs.', 11771, 'تايكرب 250مجم 70 قرص', '11,848', '8565', 'Antineoplastic', 'Antineoplastic', NULL, 'Lapatinib', 'Glaxo smithkline > novartis', 'Tab', 'أقراص', '250 mg', '1', 'مضاد للاورام -- لعلاج حالات الاورام السرطانية', NULL, NULL, NULL, 3660, '2024-10-27', NULL, 0, 'Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzumab.', 'Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both epidermal growth factor receptor (HER1/EGFR/ERBB1) and human epidermal growth factor receptor type 2 (HER2/ERBB2)with a dissociation half-life of &ge;300 minutes. Lapatinib inhibits ERBB-driven tumor cell growth in vitro and in various animal models. An additive effect was demonstrated in an in vitro study when lapatinib and 5-florouracil (the active metabolite of capecitabine) were used in combination in the 4 tumor cell lines tested. The growth inhibitory effects of lapatinib were evaluated in trastuzumab-conditioned cell lines. Lapatinib retained significant activity against breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro. These in vitro findings suggest non-cross-resistance between these two agents.', 'Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. An anti-cancer drug, lapatinib was developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine. ', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Quitcool xr 150mg 30 ext. rel. f.c. tabs.', 33456, 'كويتكول اكس ار 150مجم 30 قرص', '243', '186', 'Psychiatric.antipsychotics', 'Psychiatric.antipsychotics', NULL, 'Quetiapine', 'Hikma pharma', 'Tab', 'أقراص', '150mg', '3', NULL, NULL, 'indication for the treatment of schizophrenia and related psychotic disorders. pharmacodynamics quetiapine is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. quetiapine', NULL, 712, '2025-02-09', NULL, 0, 'Quetiapine is used in the symptomatic treatment of schizophrenia.  In addition, it may be used for the management of acute manic or mixed episodes in patients with bipolar I disorder, as a monotherapy or combined with other drugs. It may be used to manage depressive episodes in bipolar disorder. In addition to the above indications, quetiapine is used in combination with antidepressant drugs for the treatment of major depression.[L8546]



Some off-label uses for this drug include the management of post-traumatic stress disorder (PTSD), generalized anxiety disorder, and psychosis associated with Parkinson''s disease.[A185438,A185447,T685]

', 'Although the mechanism of action of quetiapine is not fully understood, several proposed mechanisms exist. In schizophrenia, its actions could occur from the antagonism of dopamine type 2 (D2) and serotonin 2A (5HT2A) receptors. In bipolar depression and major depression, quetiapine''s actions may be attributed to the binding of this drug or its metabolite to the norepinephrine transporter. Additional effects of quetiapine, including somnolence, orthostatic hypotension, and anticholinergic effects, may result from the antagonism of H1 receptors, adrenergic α1 receptors, and muscarinic M1 receptors, respectively.[A2189,A185438,L8546]', 'Quetiapine improves the positive and negative symptoms of schizophrenia and major depression by acting on various neurotransmitter receptors, such as the serotonin and dopamine receptors. In bipolar disorder, it improves both depressive and manic symptoms.[A2189,A185441,A185444]



**A note on suicidality in young patients and administration in the elderly**



Quetiapine can cause suicidal thinking or behavior in children and adolescents and should not be given to children under 10 years of age. It is important to monitor for suicidality if this drug is given to younger patients. In addition, this drug is not indicated for the treatment of psychosis related to dementia due to an increased death rate in elderly patients taking this drug.[L8546]', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Sedalostate 2% vaginal cream 6.6 gm', 26677, 'سيدالوستات 2% كريم مهبلي 6.6 جم', '79', '45', 'Antifungal', 'Antifungal', NULL, 'Butoconazole', 'Egpi', 'Cream', 'كريم', '2%', '2', 'مضاد للفطريات', NULL, 'indication: vulvo-vaginal candidiasis use: only one dose of one tube intravaginally.', '6223003930882', 2875, '2025-11-02', NULL, 0, 'For the local treatment of vulvovaginal candidiasis (infections caused by Candida)', 'The exact mechanism of the antifungal action of butoconazole is unknown, however, it is presumed to function as other imidazole derivatives via inhibition of steroid synthesis. Imidazoles generally inhibit the conversion of lanosterol to ergosterol via the inhibition of the enzyme cytochrome P450 14&alpha;-demethylase, resulting in a change in fungal cell membrane lipid composition. This structural change alters cell permeability and, ultimately, results in the osmotic disruption or growth inhibition of the fungal cell.', 'Butoconazole is an imidazole derivative that has fungicidal activity <i>in vitro</i> against <i>Candida</i> spp. and has been demonstrated to be clinically effective against vaginal infections due to <i>Candida albicans</i>. <i>Candida albicans</i> has been identified as the predominant species responsible for vulvovaginal candidasis.', 'DrugBank');
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Luteye care 100 gm 30 tabs', 1317, 'لوتي كير 100 جم 30 قرص', '120', NULL, 'Multivitamin', 'Multivitamin', NULL, 'Lutein+zeaxanthin+vit.c+vit e+zinc+copper+selenium+omega 3+ginkgo biloba', 'Bioven', 'Tab', 'أقراص', '100 gm', '3', NULL, NULL, NULL, NULL, 1510, '2022-09-18', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Mega calm lotion 120 ml', 22460, 'ميجا كالم لوشن 120مل', '13', NULL, 'Soothing topical', 'Soothing topical', NULL, NULL, 'Debeiky', 'Lotion', 'لوشن', '120 ml', '1', NULL, NULL, 'soothing lotion', NULL, 690, '2022-08-01', NULL, 0, NULL, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (tradeName, id, arabicName, price, oldPrice, mainCategory, category, category_ar, active, company, dosageForm, dosageForm_ar, concentration, unit, usage, usage_ar, description, barcode, visits, lastPriceUpdate, imageUrl, updatedAt, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology) VALUES ('Flabu 40mg/ml oral drops. 15 ml', 4887, 'فلابو 40مجم/مل نقط بالفم 15 مل', '6', NULL, 'Nsaid.propionic acid derivatives', 'Nsaid.propionic acid derivatives', NULL, 'Ibuprofen', 'Delta pharma', 'Drops', 'نقط', '40mg', '1', 'مسكن وخافض للحرارة ومضاد للالتهابات', NULL, NULL, '6221163003767', 1650, '2022-12-05', NULL, 0, 'Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.[A39096]



The use of ibuprofen and its enantiomer [DB09213] in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.[A39097]



Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.[A39092]



As ibuprofen is a widely used medication, the main therapeutic indications are:



* Patent Ductus Arteriosus - it is a neonatal condition wherein the ductus arteriosus (blood vessel that connects the main pulmonary artery to the proximal descending aorta) fails to close after birth causing severe risk of heart failure. The prostaglandin inhibition of ibuprofen has been studied for the treatment of this condition as it is known that prostaglandin E2 is responsible for keeping the ductus arteriosus open.[A39100]



* Rheumatoid- and osteo-arthritis - ibuprofen is very commonly used in the symptomatic treatment of inflammatory, musculoskeletal and rheumatic disorders.[A39176]



* Cystic fibrosis - the use of high dosages of ibuprofen has been proven to decrease inflammation and decreasing polymorphonuclear cell influx in the lungs.[A39177]



* Orthostatic hypotension - ibuprofen can induce sodium retention and antagonize the effect of diuretics which has been reported to be beneficial for patients with severe orthostatic hypotension.[A1651]



* Dental pain - ibuprofen is used to manage acute and chronic orofacial pain.[A10901]



* Pain - ibuprofen is widely used to reduce minor aches and pains as well as to reduce fever and manage dysmenorrhea. It is very commonly used for the relief of acute indications such as fever and tension headaches.[A39092] It is also used to manage mild to moderate pain and moderate to severe pain as an adjunct to opioid analgesics.[L40208]



* Investigational uses - efforts have been put into developing ibuprofen for the prophylaxis of Alzheimer''s disease, Parkinson disease, and breast cancer.[A39092]', 'The exact mechanism of action of ibuprofen is unknown. However, ibuprofen is considered an NSAID and thus it is a non-selective inhibitor of cyclooxygenase, which is an enzyme involved in prostaglandin (mediators of pain and fever) and thromboxane (stimulators of blood clotting) synthesis via the arachidonic acid pathway.[L4614]



Ibuprofen is a non-selective COX inhibitor and hence, it inhibits the activity of both COX-1 and COX-2. The inhibition of COX-2 activity decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling while the inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration.[A39195]', 'Ibuprofen has multiple actions in different inflammatory pathways involved in acute and chronic inflammation. The main effects reported in ibuprofen are related to the control of pain, fever and acute inflammation by the inhibition of the synthesis of prostanoids by COX-1 and COX-2. Pain relief is attributed to peripheral affected regions and central nervous system effects in the pain transmission mediated by the dorsal horn and higher spinothalamic tract. Some reports have tried to link the pain regulation with a possible enhancement on the synthesis of endogenous cannabinoids and action on the NMDA receptors. The effect on pain has been shown to be related to the cortically evoked potentials.[A39190]



The antipyretic effect is reported to be linked to the effect on the prostanoid synthesis due to the fact that the prostanoids are the main signaling mediator of pyresis in the hypothalamic-preoptic region.[A39190]



The use of ibuprofen in dental procedures is attributed to the local inhibition of prostanoid production as well as to anti-oedemic activity and an increase of plasma beta-endorphins. Some reports have suggested a rapid local reduction of the expression of COX-2 in dental pulp derived by the administration of ibuprofen.[A39190]



The administration of ibuprofen in patients with rheumatic diseases has shown to control joint symptoms.[A39092] 



Ibuprofen is largely used in OTC products such as an agent for the management of dysmenorrhea which has been proven to reduce the amount of menstrual prostanoids and to produce a reduction in the uterine hypercontractility.[A39181] As well, it has been reported to reduce significantly the fever and the pain caused by migraines.[A39182, A39183] This effect is thought to be related to the effect on platelet activation and thromboxane A2 production which produces local vascular effects in the affected regions. This effect is viable as ibuprofen can enter in the central nervous system.[A39190]



In the investigational uses of ibuprofen, it has been reported to reduce neurodegeneration when given in low doses over a long time.[A39184] On the other hand, its use in Parkinson disease is related to the importance of inflammation and oxidative stress in the pathology of this condition.[A39185] The use of ibuprofen for breast cancer is related to a study that shows a decrease of 50% in the rate of breast cancer.[A39186]', 'DrugBank');
